ID	Disease_ID	Disorder_name	gene	Gene_symbols	OMIM_ID	Chromosome	Class	OMIM_Disease_ID
1	1	17,20-lyase deficiency, isolated, 202110 (3)	CYP17A1	CYP17A1, CYP17, P450C17	609300	10q24.3	Endocrine	202110
2	1	17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3)	CYP17A1	CYP17A1, CYP17, P450C17	609300	10q24.3	Endocrine	202110
3	3	2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, 300438 (3)	HADH2	HADH2, ERAB	300256	Xp11.2	Metabolic	300438
4	4	2-methylbutyrylglycinuria (3)	ACADSB	ACADSB	600301	10q25-q26	Metabolic	
5	5	3-beta-hydroxysteroid dehydrogenase, type II, deficiency (3)	HSD3B2	HSD3B2	201810	1p13.1	Metabolic	
6	6	3-hydroxyacyl-CoA dehydrogenase deficiency, 609609 (3)	HADHSC	HADHSC, SCHAD	601609	4q22-q26	Metabolic	609609
7	7	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)	MCCC1	MCCC1, MCCA	609010	3q25-q27	Metabolic	210200
8	7	3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)	MCCC2	MCCC2, MCCB	609014	5q12-q13	Metabolic	210210
9	8	3-methylglutaconic aciduria, type I, 250950 (3)	AUH	AUH	600529	Chr.9	Metabolic	250950
10	9	3-methylglutaconicaciduria, type III, 258501 (3)	OPA3	OPA3, MGA3	606580	19q13.2-q13.3	Metabolic	258501
11	10	3-M syndrome, 273750 (3)	CUL7	CUL7	609577	6p21.1	multiple	273750
12	12	6-mercaptopurine sensitivity (3)	TPMT	TPMT	187680	6p22.3	Metabolic	
13	13	Aarskog-Scott syndrome (3)	FGD1	FGD1, FGDY, AAS	305400	Xp11.21	multiple	
14	14	Abacavir hypersensitivity, susceptibility to (3)	HLA-B	HLA-B	142830	6p21.3	Immunological	
15	15	ABCD syndrome, 600501 (3)	EDNRB	EDNRB, HSCR2, ABCDS	131244	13q22	multiple	600501
16	17	Abetalipoproteinemia, 200100 (3)	MTP	MTP	157147	4q22-q24	Metabolic	200100
17	17	Abetalipoproteinemia (3)	APOB	APOB, FLDB	107730	2p24	Metabolic	
18	18	Acampomelic campolelic dysplasia, 114290 (3)	SOX9	SOX9, CMD1, SRA1	608160	17q24.3-q25.1	Skeletal	114290
19	21	Acatalasemia (3)	CAT	CAT	115500	11p13	Hematological	
20	22	Accelerated tumor formation, susceptibility to (3)	MDM2	MDM2	164785	12q14.3-q15	Cancer	
21	24	Achalasia-addisonianism-alacrimia syndrome, 231550 (3)	AAAS	AAAS, AAA	605378	12q13	multiple	231550
22	25	Acheiropody, 200500 (3)	C7orf2	C7orf2, ACHP, LMBR1	605522	7q36	Skeletal	200500
23	26	Achondrogenesis-hypochondrogenesis, type II, 200610 (3)	COL2A1	COL2A1	120140	12q13.11-q13.2	Bone	200610
24	27	Achondrogenesis Ib, 600972 (3)	SLC26A2	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32-q33.1	Bone	600972
25	28	Achondroplasia, 100800 (3)	FGFR3	FGFR3, ACH	134934	4p16.3	Skeletal	100800
26	29	Achromatopsia-2, 216900 (3)	CNGA3	CNGA3, CNG3, ACHM2	600053	2q11	Ophthamological	216900
27	29	Achromatopsia-3, 262300 (3)	CNGB3	CNGB3, ACHM3	605080	8q21-q22	Ophthamological	262300
28	29	Achromatopsia-4 (3)	GNAT2	GNAT2, ACHM4	139340	1p13	Ophthamological	
29	30	Acid-labile subunit, deficiency of (3)	IGFALS	IGFALS, ALS	601489	16p13.3	Endocrine	
30	31	Acquired long QT syndrome, susceptibility to (3)	KCNH2	KCNH2, LQT2, HERG	152427	7q35-q36	Cardiovascular	
31	32	Acrocallosal syndrome, 200990 (3)	GLI3	GLI3, PAPA, PAPB, ACLS	165240	7p13	multiple	200990
32	33	Acrocapitofemoral dysplasia, 607778 (3)	IHH	IHH, BDA1	600726	2q33-q35	Skeletal	607778
33	34	Acrodermatitis enteropathica, 201100 (3)	SLC39A4	SLC39A4, ZIP4	607059	8q24.3	Dermatological	201100
34	36	Acrokeratosis verruciformis, 101900 (3)	ATP2A2	ATP2A2, ATP2B, DAR	108740	12q23-q24.1	Dermatological	101900
35	38	Acromegaly, 102200 (3)	GNAS	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO	139320	20q13.2	Endocrine	102200
36	38	Acromegaly, 102200 (3)	SSTR5	SSTR5	182455	16p13.3	Endocrine	102200
37	39	Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3)	GDF5	GDF5, CDMP1	601146	20q11.2	Skeletal	201250
38	39	Acromesomelic dysplasia, Maroteaux type, 602875 (3)	NPR2	NPR2, ANPRB, AMDM	108961	9p21-p12	Skeletal	602875
39	44	Acyl-CoA dehydrogenase, long chain, deficiency of (3)	ACADL	ACADL, LCAD	201460	2q34-q35	Metabolic	
40	44	Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)	ACADM	ACADM, MCAD	607008	1p31	Metabolic	201450
41	44	Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)	ACADS	ACADS, SCAD	606885	12q22-qter	Metabolic	201470
42	45	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)	EGFR	EGFR	131550	7p12.3-p12.1	Cancer	211980
43	45	Adenocarcinoma of lung, somatic, 211980 (3)	BRAF	BRAF	164757	7q34	Cancer	211980
44	45	Adenocarcinoma of lung, somatic, 211980 (3)	ERBB2	ERBB2, NGL, NEU, HER2	164870	17q21.1	Cancer	211980
45	45	Adenocarcinoma of lung, somatic, 211980 (3)	PRKN	PRKN, PARK2, PDJ	602544	6q25.2-q27	Cancer	211980
46	45	Adenocarcinoma, ovarian, somatic (3)	PRKN	PRKN, PARK2, PDJ	602544	6q25.2-q27	Cancer	
47	46	Adenoma, periampullary (3)	APC	APC, GS, FPC	175100	5q21-q22	Cancer	
48	47	Adenomas, multiple colorectal, 608456 (3)	MUTYH	MUTYH	604933	1p34.3-p32.1	Cancer	608456
49	47	Adenomas, salivary gland pleomorphic, 181030 (3)	PLAG1	PLAG1, SGPA, PSA	603026	8q12	Cancer	181030
50	47	Adenomatous polyposis coli (3)	APC	APC, GS, FPC	175100	5q21-q22	Cancer	
51	47	Adenomatous polyposis coli, attenuated (3)	APC	APC, GS, FPC	175100	5q21-q22	Cancer	
52	49	Adenosine deaminase deficiency, partial, 102700 (3)	ADA	ADA	608958	20q13.11	Immunological	102700
53	50	Adenylosuccinase deficiency, 103050 (3)	ADSL	ADSL	608222	22q13.1	Metabolic	103050
54	52	Adiponectin deficiency (3)	APM1	APM1, GBP28	605441	3q27	Endocrine	
55	2053	Adrenal adenoma, sporadic (3)	MEN1	MEN1	131100	11q13	Cancer	
56	2054	Adrenal cortical carcinoma, 202300 (3)	TP53	TP53, P53, LFS1	191170	17p13.1	Cancer	202300
57	53	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency (3)	CYP11B1	CYP11B1, P450C11, FHI	202010	8q21	Endocrine	
58	53	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency (3)	CYP21A2	CYP21A2, CYP21, CA21H	201910	6p21.3	Endocrine	
59	53	Adrenal hyperplasia, congenital, due to combined P450C17 and P450C21 deficiency, 201750 (3)	POR	POR	124015	7q11.2	Endocrine	201750
60	53	Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism, 300200 (3)	DAX1	DAX1, AHC, AHX, NROB1	300473	Xp21.3-p21.2	Endocrine	300200
61	2055	Adrenocortical insufficiency without ovarian defect (3)	FTZF1	FTZF1, FTZ1, SF1	184757	9q33	Endocrine	
62	54	Adrenocortical tumor, somatic (3)	PRKAR1A	PRKAR1A, TSE1, CNC1, CAR	188830	17q23-q24	Cancer	
63	55	Adrenocorticotropic hormone deficiency, 201400 (3)	TBS19	TBS19	604614	1q23-q24	Endocrine	201400
64	56	Adrenoleukodystrophy, 300100 (3)	ABCD1	ABCD1, ALD, AMN	300371	Xq28	Neurological	300100
65	56	Adrenoleukodystrophy, neonatal, 202370 (3)	PEX10	PEX10, NALD	602859	Chr.1	Neurological	202370
66	56	Adrenoleukodystrophy, neonatal, 202370 (3)	PEX13	PEX13, ZWS, NALD	601789	2p15	Neurological	202370
67	56	Adrenoleukodystrophy, neonatal, 202370 (3)	PEX1	PEX1, ZWS1	602136	7q21-q22	Neurological	202370
68	56	Adrenoleukodystrophy, neonatal, 202370 (3)	PEX26	PEX26	608666	22q11.21	Neurological	202370
69	56	Adrenoleukodystrophy, neonatal, 202370 (3)	PXR1	PXR1, PEX5, PTS1R	600414	12p13.3	Neurological	202370
70	57	Adrenomyeloneuropathy, 300100 (3)	ABCD1	ABCD1, ALD, AMN	300371	Xq28	Metabolic	300100
71	58	Adult i phenotype with congenital cataract, 110800 (3)	GCNT2	GCNT2	600429	6p24-p23	Hematological	110800
72	58	Adult i phenotype without cataract, 110800 (3)	GCNT2	GCNT2	600429	6p24-p23	Hematological	110800
73	59	ADULT syndrome, 103285 (3)	TP73L	TP73L, TP63, KET, EEC3, SHFM4, LMS, RHS	603273	3q27	multiple	103285
74	60	Advanced sleep phase syndrome, familial, 604348 (3)	PER2	PER2, FASPS, KIAA0347	603426	2q37.3	Neurological	604348
75	61	Afibrinogenemia, 202400 (3)	FGA	FGA	134820	4q28	Hematological	202400
76	61	Afibrinogenemia, congenital, 202400 (3)	FGB	FGB	134830	4q28	Hematological	202400
77	63	Agammaglobulinemia, 601495 (3)	IGHM	IGHM, MU	147020	14q32.33	Hematological	601495
78	63	Agammaglobulinemia, autosomal recessive (3)	IGLL1	IGLL1, IGO, IGL5, VPREB2	146770	22q11.21	Hematological	
79	63	Agammaglobulinemia, non-Bruton type, 601495 (3)	LRRC8	LRRC8, KIAA1437	608360	9q34.13	Hematological	601495
80	63	Agammaglobulinemia, type 1, X-linked (3)	BTK	BTK, AGMX1, IMD1, XLA, AT	300300	Xq21.3-q22	Hematological	
81	64	AGAT deficiency (3)	GATM	GATM, AGAT	602360	15q15.3	Metabolic	
82	65	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	SLC12A6	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN	604878	15q13-q14	Neurological	218000
83	69	AICA-ribosiduria due to ATIC deficiency, 608688 (3)	ATIC	ATIC, PURH, AICAR	601731	2q35	Metabolic	608688
84	70	AIDS, delayed/rapid progression to (3)	KIR3DL1	KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1	604946	19q13.4	Immunological	
85	70	AIDS, rapid progression to, 609423 (3)	IFNG	IFNG	147570	12q14	Immunological	609423
86	70	AIDS, resistance to (3)	CXCL12	CXCL12, SDF1	600835	10q11.1	Immunological	
87	71	Alagille syndrome, 118450 (3)	JAG1	JAG1, AGS, AHD	601920	20p12	multiple	118450
88	72	Albinism, brown oculocutaneous, (3)	OCA2	OCA2, P, PED, D15S12, BOCA	203200	15q11.2-q12	Dermatological	
89	72	Albinism, ocular, autosomal recessive (3)	OCA2	OCA2, P, PED, D15S12, BOCA	203200	15q11.2-q12	Dermatological	
90	72	Albinism, oculocutaneous, type IA, 203100 (3)	TYR	TYR	606933	11q14-q21	Dermatological	203100
91	72	Albinism, oculocutaneous, type IB, 606952 (3)	TYR	TYR	606933	11q14-q21	Dermatological	606952
92	72	Albinism, oculocutaneous, type II (3)	OCA2	OCA2, P, PED, D15S12, BOCA	203200	15q11.2-q12	Dermatological	
93	72	Albinism, rufous, 278400 (3)	TYRP1	TYRP1, CAS2, GP75	115501	9p23	Dermatological	278400
94	74	Alcohol dependence, susceptibility to, 103780 (3)	HTR2A	HTR2A	182135	13q14-q21	Unclassified	103780
95	2074	Alcohol intolerance, acute (3)	ALDH2	ALDH2	100650	12q24.2	Metabolic	
96	75	Alcoholism, susceptibility to, 103780 (3)	GABRA2	GABRA2	137140	4p13-p12	Unclassified	103780
97	76	Aldolase A deficiency (3)	ALDOA	ALDOA	103850	16q22-q24	Metabolic	
98	77	Aldosterone to renin ratio raised (3)	CYP11B2	CYP11B2	124080	8q21	Endocrine	
99	78	Aldosteronism, glucocorticoid-remediable, 103900 (3)	CYP11B1	CYP11B1, P450C11, FHI	202010	8q21	Endocrine	103900
100	79	Alexander disease, 203450 (3)	GFAP	GFAP	137780	17q21	multiple	203450
101	79	Alexander disease, 203450 (3)	NDUFV1	NDUFV1, UQOR1	161015	11q13	multiple	203450
102	80	Alkaptonuria, 203500 (3)	HGD	HGD, AKU	607474	3q21-q23	Metabolic	203500
103	82	Allan-Herndon-Dudley syndrome, 300523 (3)	SLC16A2	SLC16A2, DXS128, XPCT	300095	Xq13.2	Neurological	300523
104	83	Allergic rhinitis, susceptibility to, 607154 (3)	IL13	IL13, ALRH	147683	5q31	Immunological	607154
105	85	Alopecia universalis, 203655 (3)	HR	HR, AU	602302	8p21.2	Dermatological	203655
106	86	Alpers syndrome, 203700 (3)	POLG	POLG, POLG1, POLGA, PEO	174763	15q25	Neurological	203700
107	87	Alpha-1-antichymotrypsin deficiency (3)	SERPINA3	SERPINA3, AACT, ACT	107280	14q32.1	Respiratory	
108	88	Alpha-actinin-3 deficiency (3)	ACTN3	ACTN3	102574	11q13-q14	Muscular	
109	90	Alpha-methylacetoacetic aciduria, 203750 (3)	ACAT1	ACAT1	607809	11q22.3-q23.1	Metabolic	203750
110	91	Alpha-methylacyl-CoA racemase deficiency (3)	AMACR	AMACR	604489	5p13.2-q11.1	Metabolic	
111	92	Alpha-thalassemia/mental retardation syndrome, 301040 (3)	ATRX	ATRX, XH2, XNP, MRXS3, SHS	300032	Xq13	Hematological	301040
112	92	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3)	ATRX	ATRX, XH2, XNP, MRXS3, SHS	300032	Xq13	Hematological	300448
113	94	Alport syndrome, 301050 (3)	COL4A5	COL4A5, ATS, ASLN	303630	Xq22.3	Renal	301050
114	94	Alport syndrome, autosomal recessive, 203780 (3)	COL4A3	COL4A3	120070	2q36-q37	Renal	203780
115	94	Alport syndrome, autosomal recessive, 203780 (3)	COL4A4	COL4A4	120131	2q36-q37	Renal	203780
116	95	Alstrom syndrome, 203800 (3)	ALMS1	ALMS1, ALSS, KIAA0328	606844	2p13	Neurological	203800
117	96	Alternating hemiplegia of childhood, 104290 (3)	ATP1A2	ATP1A2, FHM2, MHP2	182340	1q21-q23	Neurological	104290
118	97	Alveolar soft-part sarcoma, 606243 (3)	ASPCR1	ASPCR1, RCC17, ASPL, ASPS	606236	17q25	Cancer	606243
119	98	Alzheimer disease-1, APP-related (3)	APP	APP, AAA, CVAP, AD1	104760	21q21	Neurological	
120	98	Alzheimer disease-2, 104310 (3)	APOE	APOE, AD2	107741	19q13.2	Neurological	104310
121	98	Alzheimer disease-4, 606889 (3)	PSEN2	PSEN2, AD4, STM2	600759	1q31-q42	Neurological	606889
122	98	Alzheimer disease, late-onset, 104300 (3)	APBB2	APBB2, FE65L1	602710	4p14	Neurological	104300
123	98	Alzheimer disease, late-onset, susceptibility to, 104300 (3)	NOS3	NOS3	163729	7q36	Neurological	104300
124	98	Alzheimer disease, late-onset, susceptibility to, 104300 (3)	PLAU	PLAU, URK	191840	10q24	Neurological	104300
125	98	Alzheimer disease, susceptibility to, 104300 (3)	ACE	ACE, DCP1, ACE1	106180	17q23	Neurological	104300
126	98	Alzheimer disease, susceptibility to, 104300 (3)	MPO	MPO	606989	17q23.1	Neurological	104300
127	98	Alzheimer disease, susceptibility to, 104300 (3)	PACIP1	PACIP1, PAXIP1L, PTIP	608254	7q36	Neurological	104300
128	98	Alzheimer disease, susceptibility to (3)	A2M	A2M	103950	12p13.3-p12.3	Neurological	
129	98	Alzheimer disease, susceptibility to (3)	BLMH	BLMH, BMH	602403	17q11.2	Neurological	
130	98	Alzheimer disease, type 3, 607822 (3)	PSEN1	PSEN1, AD3	104311	14q24.3	Neurological	607822
131	98	Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3)	PSEN1	PSEN1, AD3	104311	14q24.3	Neurological	607822
132	98	Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3)	PSEN1	PSEN1, AD3	104311	14q24.3	Neurological	607822
133	99	Amelogenesis imperfecta 2, hypoplastic local, 104500 (3)	ENAM	ENAM	606585	4q21	Bone	104500
134	99	Amelogenesis imperfecta, 301200 (3)	AMELX	AMELX, AMG, AIH1, AMGX	300391	Xp22.3-p22.1	Bone	301200
135	99	Amelogenesis imperfecta, hypomaturation-hypoplastic type, with taurodontism, 104510 (3)	DLX3	DLX3, TDO	600525	17q21.3-q22	Bone	104510
136	99	Amelogenesis imperfecta, hypoplastic, and openbite malocclusion, 608563 (3)	ENAM	ENAM	606585	4q21	Bone	608563
137	99	Amelogenesis imperfecta, pigmented hypomaturation type, 204700 (3)	KLK4	KLK4, EMSP1, PRSS17	603767	19q13.3-q13.4	Bone	204700
138	100	Amish infantile epilepsy syndrome, 609056 (3)	SIAT9	SIAT9, ST3GALV	604402	2p11.2	Neurological	609056
139	101	AMP deaminase deficiency, erythrocytic (3)	AMPD3	AMPD3	102772	11pter-p13	Hematological	
140	102	Amyloid neuropathy, familial, several allelic types (3)	TTR	TTR, PALB	176300	18q11.2-q12.1	Neurological	
141	103	Amyloidosis, 3 or more types (3)	APOA1	APOA1	107680	11q23	Neurological	
142	103	Amyloidosis, cerebroarterial, Dutch type (3)	APP	APP, AAA, CVAP, AD1	104760	21q21	Neurological	
143	103	Amyloidosis, Finnish type, 105120 (3)	GSN	GSN	137350	9q34	Neurological	105120
144	103	Amyloidosis, hereditary renal, 105200 (3)	FGA	FGA	134820	4q28	Neurological	105200
145	103	Amyloidosis, renal, 105200 (3)	LYZ	LYZ	153450	Chr.12	Neurological	105200
146	103	Amyloidosis, senile systemic (3)	TTR	TTR, PALB	176300	18q11.2-q12.1	Neurological	
147	104	Amyotrophic lateral sclerosis 8, 608627 (3)	VAPB	VAPB, VAPC, ALS8	605704	20q13.3	Neurological	608627
148	104	Amyotrophic lateral sclerosis, due to SOD1 deficiency, 105400 (3)	SOD1	SOD1, ALS1	147450	21q22.1	Neurological	105400
149	104	Amyotrophic lateral sclerosis, juvenile, 205100 (3)	ALS2	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33	Neurological	205100
150	104	Amyotrophic lateral sclerosis, susceptibility to, 105400 (3)	DCTN1	DCTN1	601143	2p13	Neurological	105400
151	104	Amyotrophic lateral sclerosis, susceptibility to, 105400 (3)	NEFH	NEFH	162230	22q12.2	Neurological	105400
152	104	Amyotrophic lateral sclerosis, susceptibility to, 105400 (3)	PRPH	PRPH	170710	12q12-q13	Neurological	105400
153	105	Analbuminemia (3)	ALB	ALB	103600	4q11-q13	Hematological	
154	107	Analgesia from kappa-opioid receptor agonist, female-specific (3)	MC1R	MC1R	155555	16q24.3	Unclassified	
155	108	Anderson disease, 607689 (3)	SARA2	SARA2, SAR1B, CMRD	607690	5q31.1	Gastrointestinal	607689
156	109	Androgen insensitivity, 300068 (3)	AR	AR, DHTR, TFM, SBMA, KD, SMAX1	313700	Xq11-q12	Endocrine	300068
157	110	Anemia, congenital dyserythropoietic, type I, 224120 (3)	CDAN1	CDAN1, CDA1	607465	15q15	Hematological	224120
158	110	Anemia, Diamond-Blackfan, 105650 (3)	RPS19	RPS19, DBA	603474	19q13.2	Hematological	105650
159	110	Anemia, hemolytic, due to PK deficiency (3)	PKLR	PKLR, PK1	266200	1q21	Hematological	
160	110	Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)	NT5C3	NT5C3, UMPH1, PSN1	606224	7p15-p14	Hematological	266120
161	110	Anemia, hemolytic, Rh-null, regulator type, 268150 (3)	RHAG	RHAG, RH50A	180297	6p21.1-p11	Hematological	268150
162	110	Anemia, hypochromic microcytic, 206100 (3)	NRAMP2	NRAMP2	600523	12q13	Hematological	206100
163	110	Anemia, neonatal hemolytic, fatal and near-fatal (3)	SPTB	SPTB	182870	14q22-q23.2	Hematological	
164	110	Anemia, sideroblastic/hypochromic (3)	ALAS2	ALAS2, ANH1, ASB	301300	Xp11.21	Hematological	
165	110	Anemia, sideroblastic, with ataxia, 301310 (3)	ABCB7	ABCB7, ABC7, ASAT	300135	Xq13.1-q13.3	Hematological	301310
166	2112	Aneurysm, familial arterial (3)	COL3A1	COL3A1	120180	2q31	Unclassified	
167	113	Angelman syndrome, 105830 (3)	MECP2	MECP2, RTT, PPMX, MRX16, MRX79	300005	Xq28	Developmental	105830
168	113	Angelman syndrome, 105830 (3)	UBE3A	UBE3A, ANCR	601623	15q11-q13	Developmental	105830
169	114	Angioedema, hereditary, 106100 (3)	C1NH	C1NH, HAE1, HAE2, SERPING1	606860	11q11-q13.1	Immunological	106100
170	114	Angioedema induced by ACE inhibitors, susceptibility to (3)	XPNPEP2	XPNPEP2	300145	Xq25	Immunological	
171	115	Angiofibroma, sporadic (3)	MEN1	MEN1	131100	11q13	Endocrine	
172	117	Angiotensin I-converting enzyme, benign serum increase (3)	ACE	ACE, DCP1, ACE1	106180	17q23	Endocrine	
173	118	Anhaptoglobinemia (3)	HP	HP	140100	16q22.1	Hematological	
174	119	Aniridia, type II, 106210 (3)	PAX6	PAX6, AN2, MGDA	607108	11p13	Ophthamological	106210
175	121	Ankylosing spoldylitis, susceptibility to, 106300 (3)	HLA-B	HLA-B	142830	6p21.3	Connective tissue	106300
176	122	Anophthalmia 3, 206900 (3)	SOX2	SOX2, ANOP3	184429	3q26.3-q27	Ophthamological	206900
177	124	Anorexia nervosa, susceptibility to, 606788 (3)	HTR2A	HTR2A	182135	13q14-q21	Nutritional	606788
178	126	Anterior segment anomalies and cataract (3)	EYA1	EYA1, BOR	601653	8q13.3	Ophthamological	
179	126	Anterior segment mesenchymal dysgenesis, 107250 (3)	FOXE3	FOXE3, FKHL12, ASMD	601094	1p32	Ophthamological	107250
180	126	Anterior segment mesenchymal dysgenesis (3)	FOXC1	FOXC1, FKHL7, FREAC3	601090	6p25	Ophthamological	
181	126	Anterior segment mesenchymal dysgenesis and cataract, 107250 (3)	PITX3	PITX3	602669	10q25	Ophthamological	107250
182	127	Antithrombin III deficiency (3)	AT3	AT3	107300	1q23-q25	Hematological	
183	128	Antley-Bixler syndrome, 207410 (3)	POR	POR	124015	7q11.2	Unclassified	207410
184	129	Anxiety-related personality traits (3)	SLC6A4	SLC6A4, HTT, OCD1	182138	17q11.1-q12	Psychiatric	
185	130	Aortic aneurysm, ascending, and dissection (3)	FBN1	FBN1, MFS1, WMS	134797	15q21.1	Cardiovascular	
186	131	Apert syndrome, 101200 (3)	FGFR2	FGFR2, BEK, CFD1, JWS	176943	10q26	Connective tissue	101200
187	132	Aplasia of lacrimal and salivary glands, 180920 (3)	FGF10	FGF10	602115	5p13-p12	Gastrointestinal	180920
188	133	Aplastic anemia, 609135 (3)	IFNG	IFNG	147570	12q14	Hematological	609135
189	133	Aplastic anemia, 609135 (3)	TERC	TERC, TRC3, TR	602322	3q21-q28	Hematological	609135
190	133	Aplastic anemia, susceptibility to, 609135 (3)	TERT	TERT, TCS1, EST2	187270	5p15.33	Hematological	609135
191	134	Apnea, postanesthetic (3)	BCHE	BCHE, CHE1	177400	3q26.1-q26.2	Unclassified	
192	136	ApoA-I and apoC-III deficiency, combined (3)	APOA1	APOA1	107680	11q23	Metabolic	
193	136	Apolipoprotein A-II deficiency (3)	APOA2	APOA2	107670	1q21-q23	Metabolic	
194	136	Apolipoprotein C3 deficiency (3)	APOC3	APOC3	107720	11q23	Metabolic	
195	136	Apolipoprotein H deficiency (3)	APOH	APOH	138700	17q23-qter	Metabolic	
196	137	Apparent mineralocorticoid excess, hypertension due to (3)	HSD11B2	HSD11B2, HSD11K	218030	16q22	Bone	
197	138	Aquaporin-1 deficiency (3)	AQP1	AQP1, CHIP28, CO	107776	7p14	Unclassified	
198	139	ARC syndrome, 208085 (3)	VPS33B	VPS33B	608552	15q26.1	Gastrointestinal	208085
199	140	Argininemia, 207800 (3)	ARG1	ARG1	608313	6q23	Metabolic	207800
200	140	Argininosuccinic aciduria, 207900 (3)	ASL	ASL	608310	7cen-q11.2	Metabolic	207900
201	142	Aromatase deficiency (3)	CYP19A1	CYP19A1, CYP19, ARO	107910	15q21.1	Metabolic	
202	143	Aromatic L-amino acid decarboxylase deficiency, 608643 (3)	DDC	DDC	107930	7p11	Metabolic	608643
203	144	Arrhythmogenic right ventricular dysplasia 2, 600996 (3)	RYR2	RYR2, VTSIP	180902	1q42.1-q43	Cardiovascular	600996
204	144	Arrhythmogenic right ventricular dysplasia 8, 607450 (3)	DSP	DSP, KPPS2, PPKS2	125647	6p24	Cardiovascular	607450
205	144	Arrhythmogenic right ventricular dysplasia, familial, 9, 609040 (3)	PKP2	PKP2, ARVD9	602861	12p11	Cardiovascular	609040
206	146	Arthrogryposis multiplex congenita, distal, type 1, 108120 (3)	TPM2	TPM2, TMSB, AMCD1, DA1	190990	9p13.2-p13.1	Developmental	108120
207	146	Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)	TNNI2	TNNI2, AMCD2B, DA2B, FSSV	191043	11p15.5	Developmental	601680
208	147	Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3)	WISP3	WISP3, PPAC, PPD	603400	6q22-q23	Bone	208230
209	146	Arthyrgryposis multiplex congenita, distal, type 2B, 601680 (3)	TNNT3	TNNT3, AMCD2B, DA2B, FSSV	600692	11p15.5	Developmental	601680
210	150	Aspartylglucosaminuria (3)	AGA	AGA	208400	4q32-q33	Metabolic	
211	151	Asperger syndrome, 300494 (3)	NLGN3	NLGN3	300336	Xq13	Psychiatric	300494
212	151	Asperger syndrome, 300497 (3)	NLGN4	NLGN4, KIAA1260, AUTSX2	300427	Xp22.33	Psychiatric	300497
213	153	Asthma, 600807 (3)	PHF11	PHF11, NYREN34	607796	13q14.1	Respiratory	600807
214	153	Asthma, atopic, susceptibility to (3)	MS4A2	MS4A2, FCER1B	147138	11q13	Respiratory	
215	153	Asthma, dimished response to antileukotriene treatment in, 600807 (3)	ALOX5	ALOX5	152390	10q11.2	Respiratory	600807
216	153	Asthma, nocturnal, susceptibility to (3)	ADRB2	ADRB2	109690	5q32-q34	Respiratory	
217	153	Asthma, susceptibility to, 1, 607277 (3)	PTGDR	PTGDR, AS1	604687	14q22.1	Respiratory	607277
218	153	Asthma, susceptibility to, 2, 608584 (3)	GPR154	GPR154, GPRA, VRR1, PGR14	608595	7p15-p14	Respiratory	608584
219	153	Asthma, susceptibility to (3)	HNMT	HNMT	605238	1p32	Respiratory	
220	153	Asthma, susceptibility to, 600807 (3)	IL12B	IL12B, NKSF2	161561	5q31.1-q33.1	Respiratory	600807
221	153	Asthma, susceptibility to, 600807 (3)	IL13	IL13, ALRH	147683	5q31	Respiratory	600807
222	153	Asthma, susceptibility to, 600807 (3)	PLA2G7	PLA2G7, PAFAH	601690	6p21.2-p12	Respiratory	600807
223	153	Asthma, susceptibility to, 600807 (3)	SCGB3A2	SCGB3A2, UGRP1	606531	5q31-q34	Respiratory	600807
224	153	Asthma, susceptibility to, 600807 (3)	TNF	TNF, TNFA	191160	6p21.3	Respiratory	600807
225	153	Asthma, susceptibility to, 600807 (3)	UGB	UGB, CC10, CCSP, SCGB1A1	192020	11q12.3-q13.1	Respiratory	600807
226	154	Ataxia, cerebellar, Cayman type, 601238 (3)	ATCAY	ATCAY, CLAC, KIAA1872	608179	19p13.3	Neurological	601238
227	154	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)	APTX	APTX, AOA, AOA1	606350	9p13.3	Neurological	208920
228	154	Ataxia, episodic (3)	CACNB4	CACNB4, EJM	601949	2q22-q23	Neurological	
229	154	Ataxia-ocular apraxia-2, 606002 (3)	SETX	SETX, SCAR1, AOA2	608465	9q34	Neurological	606002
230	157	Ataxia-telangiectasia, 208900 (3)	ATM	ATM, ATA, AT1	607585	11q22.3	Immunological	208900
231	157	Ataxia-telangiectasia-like disorder, 604391 (3)	MRE11A	MRE11A, MRE11, ATLD	600814	11q21	Immunological	604391
232	154	Ataxia with isolated vitamin E deficiency, 277460 (3)	TTPA	TTPA, TTP1, AVED	600415	8q13.1-q13.3	Neurological	277460
233	160	Atelosteogenesis II, 256050 (3)	SLC26A2	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32-q33.1	Connective tissue	256050
234	160	Atelostogenesis, type I, 108720 (3)	FLNB	FLNB, SCT, AOI	603381	3p14.3	Connective tissue	108720
235	162	Athabaskan brainstem dysgenesis syndrome, 601536 (3)	HOXA1	HOXA1, HOX1F, BSAS	142955	7p15.3	Neurological	601536
236	163	Atherosclerosis, susceptibility to (3)	ALOX5	ALOX5	152390	10q11.2	Cardiovascular	
237	164	Atopy, 147050 (3)	SPINK5	SPINK5, LEKTI	605010	5q32	Immunological	147050
238	164	Atopy, resistance to, 147050 (3)	HAVCR1	HAVCR1, HAVCR	606518	5q33.2	Immunological	147050
239	164	Atopy, susceptibility to, 147050 (3)	PLA2G7	PLA2G7, PAFAH	601690	6p21.2-p12	Immunological	147050
240	164	Atopy, susceptibility to, 147050 (3)	SELP	SELP, GRMP	173610	1q23-q25	Immunological	147050
241	164	Atopy, susceptibility to (3)	IL4R	IL4R, IL4RA	147781	16p12.1-p11.2	Immunological	
242	165	Atransferrinemia, 209300 (3)	TF	TF	190000	3q21	Hematological	209300
243	166	Atrial fibrillation, familial, 607554 (3)	KCNE2	KCNE2, MIRP1, LQT6	603796	21q22.1	Cardiovascular	607554
244	166	Atrial fibrillation, familial, 607554 (3)	KCNQ1	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB1	607542	11p15.5	Cardiovascular	607554
245	166	Atrial septal defect-2, 607941 (3)	GATA4	GATA4	600576	8p23.1-p22	Cardiovascular	607941
246	166	Atrial septal defect 3 (3)	MYH6	MYH6, ASD3, MYHCA	160710	14q12	Cardiovascular	3
247	166	Atrial septal defect with atrioventricular conduction defects, 108900 (3)	NKX2E	NKX2E, CSX	600584	5q34	Cardiovascular	108900
248	167	Atrichia with papular lesions, 209500 (3)	HR	HR, AU	602302	8p21.2	Dermatological	209500
249	168	Atrioventricular block, idiopathic second-degree (3)	NKX2E	NKX2E, CSX	600584	5q34	Cardiovascular	
250	168	Atrioventricular septal defect, 600309 (3)	GJA1	GJA1, CX43, ODDD, SDTY3, ODOD	121014	6q21-q23.2	Cardiovascular	600309
251	168	Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)	CRELD1	CRELD1, AVSD2	607170	3p25.3	Cardiovascular	606217
252	168	Atrioventricular septal defect, susceptibility to, 2, 606217 (3)	CRELD1	CRELD1, AVSD2	607170	3p25.3	Cardiovascular	606217
253	171	Attention deficit-hyperactivity disorder, susceptibility to, 143465 (3)	DRD5	DRD5, DRD1B, DRD1L2	126453	4p16.1-p15.3	Psychiatric	143465
254	173	Autism, susceptibility to, 209850 (3)	GLO1	GLO1	138750	6p21.3-p21.2	Psychiatric	209850
255	173	Autism, X-linked, 300425 (3)	MECP2	MECP2, RTT, PPMX, MRX16, MRX79	300005	Xq28	Psychiatric	300425
256	173	Autism, X-linked, 300425 (3)	NLGN3	NLGN3	300336	Xq13	Psychiatric	300425
257	173	Autism, X-linked, 300495 (3)	NLGN4	NLGN4, KIAA1260, AUTSX2	300427	Xp22.33	Psychiatric	300495
258	174	Autoimmune lymphoproliferative syndrome, 601859 (3)	TNFRSF6	TNFRSF6, APT1, FAS, CD95, ALPS1A	134637	10q24.1	Immunological	601859
259	174	Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	TNFRSF6	TNFRSF6, APT1, FAS, CD95, ALPS1A	134637	10q24.1	Immunological	601859
260	174	Autoimmune lymphoproliferative syndrome, type II, 603909 (3)	CASP10	CASP10, MCH4, ALPS2	601762	2q33-q34	Immunological	603909
261	174	Autoimmune lymphoproliferative syndrome, type IIB, 607271 (3)	CASP8	CASP8, MCH5	601763	2q33-q34	Immunological	607271
262	174	Autoimmune polyglandular disease, type I, 240300 (3)	AIRE	AIRE, APECED	607358	21q22.3	Immunological	240300
263	2174	Autoimmune thyroid disease, susceptibility to 3, 608175 (3)	TG	TG, AITD3	188450	8q24.2-q24.3	Endocrine	608175
264	175	Autonomic nervous system dysfunction (3)	DRD4	DRD4	126452	11p15.5	Psychiatric	
265	177	Axenfeld anomaly (3)	FOXC1	FOXC1, FKHL7, FREAC3	601090	6p25	Ophthamological	
266	178	Azoospermia (3)	USP9Y	USP9Y, DFFRY	400005	Yq11.2	Endocrine	
267	178	Azoospermia due to perturbations of meiosis, 270960 (3)	SYCP3	SYCP3, SCP3, COR1	604759	12q23	Endocrine	270960
268	180	Bamforth-Lazarus syndrome, 241850 (3)	FOXE1	FOXE1, FKHL15, TITF2, TTF2	602617	9q22	Endocrine	241850
269	182	Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)	PTEN	PTEN, MMAC1	601728	10q23.31	Unclassified	153480
270	182	Bannayan-Zonana syndrome, 153480 (3)	PTEN	PTEN, MMAC1	601728	10q23.31	Unclassified	153480
271	183	Bardet-Biedl syndrome 1, 209900 (3)	BBS1	BBS1	209901	11q13	multiple	209900
272	183	Bardet-Biedl syndrome 1, modifier of, 209900 (3)	ARL6	ARL6, BBS3	608845	3p12-q13	multiple	209900
273	183	Bardet-Biedl syndrome, 209900 (3)	BBS7	BBS7	607590	4q27	multiple	209900
274	183	Bardet-Biedl syndrome 2, 209900 (3)	BBS2	BBS2	606151	16q21	multiple	209900
275	183	Bardet-Biedl syndrome 3, 600151 (3)	ARL6	ARL6, BBS3	608845	3p12-q13	multiple	600151
276	183	Bardet-Biedl syndrome 4, 209900 (3)	BBS4	BBS4	600374	15q22.3-q23	multiple	209900
277	183	Bardet-Biedl syndrome 5, 209900 (3)	BBS5	BBS5	603650	2q31	multiple	209900
278	183	Bardet-Biedl syndrome 6, 209900 (3)	MKKS	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12	multiple	209900
279	183	Bardet-Biedl syndrome 8, 209900 (3)	TTC8	TTC8, BBS8	608132	14q32.1	multiple	209900
280	184	Bare lymphocyte syndrome, type I, 604571 (3)	TAPBP	TAPBP, TPSN	601962	6p21.3	Immunological	604571
281	184	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)	TAP2	TAP2, ABCB3, PSF2, RING11	170261	6p21.3	Immunological	604571
282	184	Bare lymphocyte syndrome, type II, complementation group A, 209920 (3)	MHC2TA	MHC2TA, C2TA	600005	16p13	Immunological	209920
283	184	Bare lymphocyte syndrome, type II, complementation group C, 209920 (3)	RFX5	RFX5	601863	1q21.1-q21.3	Immunological	209920
284	184	Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)	RFXAP	RFXAP	601861	13q14	Immunological	209920
285	184	Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)	RFX5	RFX5	601863	1q21.1-q21.3	Immunological	209920
286	185	Barth syndrome, 302060 (3)	TAZ	TAZ, EFE2, BTHS, CMD3A, LVNCX	300394	Xq28	multiple	302060
287	186	Bart-Pumphrey syndrome, 149200 (3)	GJB2	GJB2, CX26, DFNB1, PPK, DFNA3, KID, HID	121011	13q11-q12	multiple	149200
288	187	Bartter syndrome, type 1, 601678 (3)	SLC12A1	SLC12A1, NKCC2	600839	15q15-q21.1	multiple	601678
289	187	Bartter syndrome, type 2, 241200 (3)	KCNJ1	KCNJ1, ROMK1	600359	11q24	multiple	241200
290	187	Bartter syndrome, type 3, 607364 (3)	CLCNKB	CLCNKB	602023	1p36	multiple	607364
291	187	Bartter syndrome, type 4, 602522 (3)	BSND	BSND	606412	1p31	multiple	602522
292	187	Bartter syndrome, type 4, digenic, 602522 (3)	CLCNKA	CLCNKA	602024	1p36	multiple	602522
293	187	Bartter syndrome, type 4, digenic, 602522 (3)	CLCNKB	CLCNKB	602023	1p36	multiple	602522
294	188	Basal cell carcinoma (3)	RASA1	RASA1, GAP, CMAVM, PKWS	139150	5q13.3	Cancer	
295	188	Basal cell carcinoma, somatic, 605462 (3)	PTCH2	PTCH2	603673	1p32	Cancer	605462
296	188	Basal cell carcinoma, somatic, 605462 (3)	PTCH	PTCH, NBCCS, BCNS, HPE7	601309	9q22.3	Cancer	605462
297	188	Basal cell carcinoma, sporadic (3)	SMOH	SMOH, SMO	601500	7q31-q32	Cancer	
298	2188	Basal cell nevus syndrome, 109400 (3)	PTCH	PTCH, NBCCS, BCNS, HPE7	601309	9q22.3	multiple	109400
299	4188	Basal ganglia disease, adult-onset, 606159 (3)	FTL	FTL	134790	19q13.3-q13.4	Neurological	606159
300	4188	Basal ganglia disease, biotin-responsive, 607483 (3)	SLC19A3	SLC19A3	606152	2q36.3	Neurological	607483
301	190	B-cell non-Hodgkin lymphoma, high-grade (3)	BCL7A	BCL7A, BCL7	601406	12q24.1	Cancer	
302	191	BCG infection, generalized familial (3)	IFNGR1	IFNGR1	107470	6q23-q24	Immunological	
303	192	Beare-Stevenson cutis gyrata syndrome, 123790 (3)	FGFR2	FGFR2, BEK, CFD1, JWS	176943	10q26	multiple	123790
304	193	Becker muscular dystrophy, 300376 (3)	DMD	DMD, BMD	300377	Xp21.2	Muscular	300376
305	193	Becker muscular dystrophy modifier, 310200 (3)	MYF6	MYF6	159991	12q21	Muscular	310200
306	194	Beckwith-Wiedemann syndrome, 130650 (3)	CDKN1C	CDKN1C, KIP2, BWS	600856	11p15.5	multiple	130650
307	194	Beckwith-Wiedemann syndrome, 130650 (3)	H19	H19, D11S813E, ASM1, BWS	103280	11p15.5	multiple	130650
308	194	Beckwith-Wiedemann syndrome, 130650 (3)	KCNQ10T1	KCNQ10T1, LIT1	604115	11p15.5	multiple	130650
309	194	Beckwith-Wiedemann syndrome, 130650 (3)	NSD1	NSD1, ARA267, STO	606681	5q35	multiple	130650
310	195	Benzene toxicity, susceptibility to (3)	NQO1	NQO1, DIA4, NMOR1	125860	16q22.1	Unclassified	
311	196	Bernard-Soulier syndrome, 231200 (3)	GP1BA	GP1BA	606672	17pter-p12	Hematological	231200
312	196	Bernard-Soulier syndrome, type B, 231200 (3)	GP1BB	GP1BB	138720	22q11.2	Hematological	231200
313	196	Bernard-Soulier syndrome, type C (3)	GP9	GP9	173515	Chr.3	Hematological	
314	197	Beryllium disease, chronic, susceptibility to (3)	HLA-DPB1	HLA-DPB1	142858	6p21.3	Unclassified	
315	198	Beta-2-adrenoreceptor agonist, reduced response to (3)	ADRB2	ADRB2	109690	5q32-q34	Unclassified	
316	199	Beta-ureidopropionase deficiency (3)	UPB1	UPB1, BUP1	606673	22q11.2	Metabolic	
317	200	Bethlem myopathy, 158810 (3)	COL6A1	COL6A1, OPLL	120220	21q22.3	Muscular	158810
318	200	Bethlem myopathy, 158810 (3)	COL6A2	COL6A2	120240	21q22.3	Muscular	158810
319	200	Bethlem myopathy, 158810 (3)	COL6A3	COL6A3	120250	2q37	Muscular	158810
320	201	Bietti crystalline corneoretinal dystrophy, 210370 (3)	CYP4V2	CYP4V2, BCD	608614	4q35.1	Ophthamological	210370
321	202	Bile acid malabsorption, primary (3)	SLC10A2	SLC10A2, NTCP2	601295	13q33	Gastrointestinal	
322	203	Biotinidase deficiency, 253260 (3)	BTD	BTD	609019	3p25	Metabolic	253260
323	204	Bipolar disorder, susceptibility to, 125480 (3)	XBP1	XBP1, XBP2	194355	22q12	Psychiatric	125480
324	205	Birt-Hogg-Dube syndrome, 135150 (3)	FLCN	FLCN, BHD	607273	17p11.2	Dermatological	135150
325	207	Bladder cancer, 109800 (3)	FGFR3	FGFR3, ACH	134934	4p16.3	Cancer	109800
326	207	Bladder cancer, 109800 (3)	KRAS2	KRAS2, RASK2	190070	12p12.1	Cancer	109800
327	207	Bladder cancer, 109800 (3)	RB1	RB1	180200	13q14.1-q14.2	Cancer	109800
328	207	Bladder cancer, somatic, 109800 (3)	HRAS	HRAS	190020	11p15.5	Cancer	109800
329	208	Blau syndrome, 186580 (3)	CARD15	CARD15, NOD2, IBD1, CD, ACUG, PSORAS1	605956	16q12	multiple	186580
330	209	Bleeding disorder due to defective thromboxane A2 receptor (3)	TBXA2R	TBXA2R	188070	19p13.3	Hematological	
331	209	Bleeding due to platelet ADP receptor defect, 600515 (3)	P2RX1	P2RX1, P2X1	600845	17p13.3	Hematological	600515
332	210	Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3)	FOXL2	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q23	multiple	110100
333	210	Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3)	FOXL2	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q23	multiple	110100
334	211	Blepharospasm, primary benign, 606798 (3)	DRD5	DRD5, DRD1B, DRD1L2	126453	4p16.1-p15.3	Ophthamological	606798
335	212	Blood group, ABO system (3)	ABO	ABO	110300	9q34	Hematological	
336	212	Blood group, Auberger system (3)	LU	LU, AU, BCAM	111200	19q13.2	Hematological	
337	212	Blood group, Colton, 110450 (3)	AQP1	AQP1, CHIP28, CO	107776	7p14	Hematological	110450
338	212	Blood group Cromer (3)	DAF	DAF	125240	1q32	Hematological	
339	212	Blood group, Diego, 110500 (3)	SLC4A1	SLC4A1, AE1, EPB3	109270	17q21-q22	Hematological	110500
340	212	Blood group, Dombrock (3)	ART4	ART4, DO	110600	12p13-p12	Hematological	
341	212	Blood group, Gerbich (3)	GYPC	GYPC, GE, GPC	110750	2q14-q21	Hematological	
342	212	Blood group GIL, 607457 (3)	AQP3	AQP3	600170	9p13	Hematological	607457
343	212	Blood group, Ii, 110800 (3)	GCNT2	GCNT2	600429	6p24-p23	Hematological	110800
344	212	Blood group, Indian system (3)	CD44	CD44, MDU2, MDU3, MIC4	107269	11pter-p13	Hematological	
345	212	Blood group, Kell (3)	KEL	KEL	110900	7q33	Hematological	
346	212	Blood group, Kidd (3)	SLC14A1	SLC14A1, JK, UTE, UT1	111000	18q11-q12	Hematological	
347	212	Blood group, Knops system, 607486 (3)	CR1	CR1, C3BR	120620	1q32	Hematological	607486
348	212	Blood group, Landsteiner-Wiener (3)	LW	LW	111250	19p13.3	Hematological	
349	212	Blood group, Lewis (3)	FUT3	FUT3, LE	111100	19p13.3	Hematological	
350	212	Blood group, Lutheran system (3)	LU	LU, AU, BCAM	111200	19q13.2	Hematological	
351	212	Blood group, MN (3)	GYPA	GYPA, MN, GPA	111300	4q28.2-q31.1	Hematological	
352	212	Blood group, OK, 111380 (3)	BSG	BSG	109480	19p13.3	Hematological	111380
353	212	Blood group, P system, 111400 (3)	A4GALT	A4GALT, PK	607922	22q13.2	Hematological	111400
354	212	Blood group, P system, 111400 (3)	B3GALT3	B3GALT3, GLCT3, P	603094	3q25	Hematological	111400
355	212	Blood group, Rhesus (3)	RHCE	RHCE	111700	1p36.2-p34	Hematological	
356	212	Blood group, Ss (3)	GYPB	GYPB, SS, MNS	111740	4q28-q31	Hematological	
357	212	Blood group, Waldner, 112010 (3)	SLC4A1	SLC4A1, AE1, EPB3	109270	17q21-q22	Hematological	112010
358	212	Blood group, Wright, 112050 (3)	SLC4A1	SLC4A1, AE1, EPB3	109270	17q21-q22	Hematological	112050
359	212	Blood group, XG system (3)	XG	XG	314700	Xpter-p22.32	Hematological	
360	212	Blood group, Yt system, 112100 (3)	ACHE	ACHE, YT	100740	7q22	Hematological	112100
361	213	Bloom syndrome, 210900 (3)	RECQL3	RECQL3, RECQ2, BLM, BS	604610	15q26.1	Cancer	210900
362	214	Blue-cone monochromacy, 303700 (3)	OPN1LW	OPN1LW, RCP, CBP, CBBM	303900	Xq28	Ophthamological	303700
363	214	Blue-cone monochromacy, 303700 (3)	OPN1MW	OPN1MW, GCP, CBD, CBBM	303800	Xq28	Ophthamological	303700
364	216	Bombay phenotype (3)	FUT1	FUT1, H, HH	211100	19q13.3	Hematological	
365	216	Bombay phenotype (3)	FUT2	FUT2, SE	182100	19q13.3	Hematological	
366	217	Bone mineral density variability 1, 601884 (3)	LRP5	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2	603506	11q13.4	Bone	601884
367	218	Borjeson-Forssman-Lehmann syndrome, 301900 (3)	PHF6	PHF6, BFLS	300414	Xq26.3	multiple	301900
368	220	Bosley-Salih-Alorainy syndrome, 601536 (3)	HOXA1	HOXA1, HOX1F, BSAS	142955	7p15.3	Neurological	601536
369	221	Bothnia retinal dystrophy, 607475 (3)	RLBP1	RLBP1	180090	15q26	Ophthamological	607475
370	224	Brachydactyly, type A1, 112500 (3)	IHH	IHH, BDA1	600726	2q33-q35	Skeletal	112500
371	224	Brachydactyly, type A2, 112600 (3)	BMPR1B	BMPR1B, ALK6	603248	4q23-q24	Skeletal	112600
372	224	Brachydactyly, type B1, 113000 (3)	ROR2	ROR2, BDB1, BDB, NTRKR2	602337	9q22	Skeletal	113000
373	224	Brachydactyly, type C, 113100 (3)	GDF5	GDF5, CDMP1	601146	20q11.2	Skeletal	113100
374	224	Brachydactyly, type D, 113200 (3)	HOXD13	HOXD13, HOX4I, SPD	142989	2q31-q32	Skeletal	113200
375	224	Brachydactyly, type E, 113300 (3)	HOXD13	HOXD13, HOX4I, SPD	142989	2q31-q32	Skeletal	113300
376	225	Bradyopsia, 608415 (3)	R9AP	R9AP, RGS9, PERRS	607814	19q13.11	Ophthamological	608415
377	225	Bradyopsia, 608415 (3)	RGS9	RGS9, PERRS	604067	17q23-q24	Ophthamological	608415
378	226	Branchiootic syndrome (3)	EYA1	EYA1, BOR	601653	8q13.3	Neurological	
379	226	Branchiootorenal syndrome, 113650 (3)	EYA1	EYA1, BOR	601653	8q13.3	Neurological	113650
380	226	Branchiootorenal syndrome with cataract, 113650 (3)	EYA1	EYA1, BOR	601653	8q13.3	Neurological	113650
381	228	Breast and colorectal cancer, susceptibility to (3)	CHEK2	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	Cancer	
382	228	Breast cancer, 114480 (3)	PIK3CA	PIK3CA	171834	3q26.3	Cancer	114480
383	228	Breast cancer, 114480 (3)	PPM1D	PPM1D, WIP1	605100	17q22-q23	Cancer	114480
384	228	Breast cancer, 114480 (3)	SLC22A1L	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.5	Cancer	114480
385	228	Breast cancer, 114480 (3)	TP53	TP53, P53, LFS1	191170	17p13.1	Cancer	114480
386	228	Breast cancer-1 (3)	BRCA1	BRCA1, PSCP	113705	17q21	Cancer	
387	228	Breast cancer 2, early onset (3)	BRCA2	BRCA2, FANCD1	600185	13q12.3	Cancer	
388	228	Breast cancer (3)	TSG101	TSG101	601387	11p15.2-p15.1	Cancer	
389	228	Breast cancer, early-onset, 114480 (3)	BRIP1	BRIP1, BACH1, FANCJ	605882	17q22	Cancer	114480
390	228	Breast cancer, invasive intraductal (3)	RAD54L	RAD54L, HR54, HRAD54	603615	1p32	Cancer	
391	228	Breast cancer, lobular (3)	CDH1	CDH1, UVO	192090	16q22.1	Cancer	
392	228	Breast cancer, male, susceptibility to, 114480 (3)	BRCA2	BRCA2, FANCD1	600185	13q12.3	Cancer	114480
393	228	Breast cancer, male, with Reifenstein syndrome (3)	AR	AR, DHTR, TFM, SBMA, KD, SMAX1	313700	Xq11-q12	Cancer	
394	228	Breast cancer, somatic, 114480 (3)	KRAS2	KRAS2, RASK2	190070	12p12.1	Cancer	114480
395	228	Breast cancer, somatic, 114480 (3)	RB1CC1	RB1CC1, CC1, KIAA0203	606837	8q11	Cancer	114480
396	228	Breast cancer, sporadic (3)	PHB	PHB	176705	17q21	Cancer	
397	228	Breast cancer, susceptibility to, 114480 (3)	ATM	ATM, ATA, AT1	607585	11q22.3	Cancer	114480
398	228	Breast cancer, susceptibility to, 114480 (3)	BARD1	BARD1	601593	2q34-q35	Cancer	114480
399	228	Breast cancer, susceptibility to, 114480 (3)	CHEK2	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	Cancer	114480
400	228	Breast cancer, susceptibility to, 114480 (3)	RAD51A	RAD51A, RECA	179617	15q15.1	Cancer	114480
401	228	Breast cancer, susceptibility to (3)	XRCC3	XRCC3	600675	14q32.3	Cancer	
402	228	Breast-ovarian cancer (3)	BRCA1	BRCA1, PSCP	113705	17q21	Cancer	
403	231	Brody myopathy, 601003 (3)	ATP2A1	ATP2A1, SERCA1	108730	16p12	Muscular	601003
404	233	Bruck syndrome 2, 609220 (3)	PLOD2	PLOD2	601865	3q23-q24	Unclassified	609220
405	234	Brugada syndrome, 601144 (3)	SCN5A	SCN5A, LQT3, IVF, HB1, SSS1	600163	3p21	Cardiovascular	601144
406	235	Brunner syndrome (3)	MAOA	MAOA	309850	Xp11.23	Unclassified	
407	237	Burkitt lymphoma, 113970 (3)	MYC	MYC	190080	8q24.12-q24.13	Cancer	113970
408	238	Buschke-Ollendorff syndrome, 166700 (3)	LEMD3	LEMD3, MAN1	607844	12q14	multiple	166700
409	239	Butterfly dystrophy, retinal, 169150 (3)	RDS	RDS, RP7, PRPH2, PRPH, AVMD, AOFMD	179605	6p21.1-cen	Ophthamological	169150
410	240	C1q deficiency, type A (3)	C1QA	C1QA	120550	1p36.3-p34.1	Immunological	
411	240	C1q deficiency, type B (3)	C1QB	C1QB	120570	1p36.3-p34.1	Immunological	
412	240	C1q deficiency, type C (3)	C1QG	C1QG	120575	1p36.3-p34.1	Immunological	
413	240	C1s deficiency, isolated (3)	C1S	C1S	120580	12p13	Immunological	
414	240	C2 deficiency (3)	C2	C2	217000	6p21.3	Immunological	
415	240	C3b inactivator deficiency (3)	IF	IF	217030	4q25	Immunological	
416	240	C3 deficiency (3)	C3	C3	120700	19p13.3-p13.2	Immunological	
417	240	C4 deficiency (3)	C4A	C4A, C4S	120810	6p21.3	Immunological	
418	240	C4 deficiency (3)	C4B	C4B, C4F	120820	6p21.3	Immunological	
419	240	C6 deficiency (3)	C6	C6	217050	5p13	Immunological	
420	240	C7 deficiency (3)	C7	C7	217070	5p13	Immunological	
421	240	C8 deficiency, type II (3)	C8B	C8B	120960	1p32	Immunological	
422	240	C9 deficiency (3)	C9	C9	120940	5p13	Immunological	
423	240	C9 deficiency with dermatomyositis (3)	C9	C9	120940	5p13	Immunological	
424	252	Cafe-au-lait spots, multiple, with leukemia, 114030 (3)	MSH2	MSH2, COCA1, FCC1, HNPCC1	609309	2p22-p21	Cancer	114030
425	252	Cafe-au-lait spots with glioma or leukemia, 114030 (3)	MLH1	MLH1, COCA2, HNPCC2	120436	3p21.3	Cancer	114030
426	253	Caffey disease, 114000 (3)	COL1A1	COL1A1	120150	17q21.31-q22	Connective tissue	114000
427	254	Calcinosis, tumoral, 211900 (3)	FGF23	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.3	Bone	211900
428	254	Calcinosis, tumoral, 211900 (3)	GALNT3	GALNT3	601756	2q24-q31	Bone	211900
429	255	Campomelic dysplasia, 114290 (3)	SOX9	SOX9, CMD1, SRA1	608160	17q24.3-q25.1	Skeletal	114290
430	255	Campomelic dysplasia with autosomal sex reversal, 114290 (3)	SOX9	SOX9, CMD1, SRA1	608160	17q24.3-q25.1	Skeletal	114290
431	256	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	PRG4	PRG4, CACP, MSF, SZP, HAPO	604283	1q24-q25	Skeletal	208250
432	257	Camurati-Engelmann disease, 131300 (3)	TGFB1	TGFB1, DPD1, CED	190180	19q13.1	Skeletal	131300
433	258	Canavan disease, 271900 (3)	ASPA	ASPA	608034	17pter-p13	Metabolic	271900
434	259	Cancer progression/metastasis (3)	FGFR4	FGFR4	134935	5q35.1-qter	Cancer	
435	259	Cancer susceptibility (3)	MSH6	MSH6, GTBP, HNPCC5	600678	2p16	Cancer	
436	261	Capillary malformation-arteriovenous malformation, 608354 (3)	RASA1	RASA1, GAP, CMAVM, PKWS	139150	5q13.3	Cardiovascular	608354
437	262	Carbamoylphosphate synthetase I deficiency, 237300 (3)	CPS1	CPS1	608307	2q35	Metabolic	237300
438	263	Carbohydrate-deficient glycoprotein syndrome, type I, 212065 (3)	PMM2	PMM2, CDG1	601785	16p13.3-p13.2	Metabolic	212065
439	263	Carbohydrate-deficient glycoprotein syndrome, type Ib, 602579 (3)	MPI	MPI, PMI1	154550	15q22-qter	Metabolic	602579
440	263	Carbohydrate-deficient glycoprotein syndrome, type II, 212066 (3)	MGAT2	MGAT2, CDGS2	602616	14q21	Metabolic	212066
441	264	Carboxypeptidase N deficiency, 212070 (3)	CPN1	CPN1, SCPN, CPN	603103	10q24.2	Hematological	212070
442	2265	Carcinoid tumor of lung (3)	MEN1	MEN1	131100	11q13	Cancer	
443	265	Carcinoid tumors, intestinal, 114900 (3)	SDHD	SDHD, PGL1	602690	11q23	Cancer	114900
444	267	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency, 604377 (3)	SCO2	SCO2	604272	22q13	Cardiovascular	604377
445	268	Cardiomyopathy, Familial hypertrophic, 8, 608751 (3)	MYL3	MYL3, CMH8	160790	3p	Cardiovascular	608751
446	268	Cardiomyopathy, dilated, 115200 (3)	ACTC	ACTC	102540	15q14	Cardiovascular	115200
447	268	Cardiomyopathy, dilated, 115200 (3)	MYH7	MYH7, CMH1, MPD1	160760	14q12	Cardiovascular	115200
448	268	Cardiomyopathy, dilated, 1A, 115200 (3)	LMNA	LMNA, LMN1, EMD2, FPLD, CMD1A, HGPS, LGMD1B	150330	1q21.2	Cardiovascular	115200
449	268	Cardiomyopathy, dilated, 1D, 601494 (3)	TNNT2	TNNT2, CMH2, CMD1D	191045	1q32	Cardiovascular	601494
450	268	Cardiomyopathy, dilated, 1G, 604145 (3), Tibial muscular dystrophy, tardive, 600334 (3)	TTN	TTN, CMD1G, TMD, LGMD2J	188840	2q24.3	Cardiovascular	600334
451	268	Cardiomyopathy, dilated, 1I, 604765 (3)	DES	DES, CMD1I	125660	2q35	Cardiovascular	604765
452	268	Cardiomyopathy, dilated, 1J, 605362 (3)	EYA4	EYA4, DFNA10, CMD1J	603550	6q23	Cardiovascular	605362
453	268	Cardiomyopathy, dilated, 1L, 606685 (3)	SGCD	SGCD, SGD, LGMD2F, CMD1L	601411	5q33	Cardiovascular	606685
454	268	Cardiomyopathy, dilated, 1M, 607482 (3)	CSRP3	CSRP3, CRP3, CLP, CMD1M	600824	11p15.1	Cardiovascular	607482
455	268	Cardiomyopathy, dilated, 1N, 607487 (3)	TCAP	TCAP, LGMD2G, CMD1N	604488	17q12	Cardiovascular	607487
456	268	Cardiomyopathy, dilated, with ventricular tachycardia, 608569 (3)	ABCC9	ABCC9, SUR2	601439	12p12.1	Cardiovascular	608569
457	268	Cardiomyopathy, dilated, X-linked, 302045 (3)	DMD	DMD, BMD	300377	Xp21.2	Cardiovascular	302045
458	268	Cardiomyopathy, familial hypertrophic, 10, 608758 (3)	MYL2	MYL2, CMH10	160781	12q23-q24.3	Cardiovascular	608758
459	268	Cardiomyopathy, familial hypertrophic, 1, 192600 (3)	MYH7	MYH7, CMH1, MPD1	160760	14q12	Cardiovascular	192600
460	268	Cardiomyopathy, familial hypertrophic, 192600 (3)	ACTC	ACTC	102540	15q14	Cardiovascular	192600
461	268	Cardiomyopathy, familial hypertrophic, 192600 (3)	CAV3	CAV3, LGMD1C	601253	3p25	Cardiovascular	192600
462	268	Cardiomyopathy, familial hypertrophic, 192600 (3)	MYH6	MYH6, ASD3, MYHCA	160710	14q12	Cardiovascular	192600
463	268	Cardiomyopathy, familial hypertrophic, 192600 (3) ()	TNNC1	TNNC1	191040	3p21.3-p14.3	Cardiovascular	-3
464	268	Cardiomyopathy, familial hypertrophic, 2, 115195 (3)	TNNT2	TNNT2, CMH2, CMD1D	191045	1q32	Cardiovascular	115195
465	268	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)	TPM1	TPM1, CMH3	191010	15q22.1	Cardiovascular	115196
466	268	Cardiomyopathy, familial hypertrophic (3)	TNNI3	TNNI3	191044	19q13.4	Cardiovascular	
467	268	Cardiomyopathy, familial hypertrophic, 4, 115197 (3)	MYBPC3	MYBPC3, CMH4	600958	11p11.2	Cardiovascular	115197
468	268	Cardiomyopathy, familial hypertrophic, 9 (3)	TTN	TTN, CMD1G, TMD, LGMD2J	188840	2q24.3	Cardiovascular	9
469	268	Cardiomyopathy, familial restrictive, 115210 (3)	TNNI3	TNNI3	191044	19q13.4	Cardiovascular	115210
470	268	Cardiomyopathy, hypertrophic, early-onset fatal (3)	COX15	COX15	603646	10q24	Cardiovascular	
471	268	Cardiomyopathy, hypertrophic, mid-left ventricular chamber type, 608758 (3)	MYL2	MYL2, CMH10	160781	12q23-q24.3	Cardiovascular	608758
472	268	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)	MYLK2	MYLK2, MLCK	606566	20q13.3	Cardiovascular	192600
473	268	Cardiomyopathy, hypertrophic, with WPW, 600858 (3)	PRKAG2	PRKAG2, WPWS	602743	7q36	Cardiovascular	600858
474	268	Cardiomyopathy, idiopathic dilated, 115200 (3)	PLN	PLN, PLB	172405	6q22.1	Cardiovascular	115200
475	268	Cardiomyopathy, X-linked dilated, 300069 (3)	TAZ	TAZ, EFE2, BTHS, CMD3A, LVNCX	300394	Xq28	Cardiovascular	300069
476	269	Carney complex, type 1, 160980 (3)	PRKAR1A	PRKAR1A, TSE1, CNC1, CAR	188830	17q23-q24	multiple	160980
477	269	Carney complex variant, 608837 (3)	MYH8	MYH8	160741	17p13.1	multiple	608837
478	271	Carnitine-acylcarnitine translocase deficiency (3)	SLC25A20	SLC25A20, CACT, CAC	212138	3p21.31	Metabolic	
479	272	Carnitine deficiency, systemic primary, 212140 (3)	SLC22A5	SLC22A5, OCTN2, CDSP, SCD	603377	5q31.1	Metabolic	212140
480	275	Carpal tunnel syndrome, familial (3)	TTR	TTR, PALB	176300	18q11.2-q12.1	Unclassified	
481	276	Cartilage-hair hypoplasia, 250250 (3)	RMRP	RMRP, RMRPR, CHH	157660	9p21-p12	Skeletal	250250
482	277	Cataract, autosomal dominant nuclear (3)	CRYAA	CRYAA, CRYA1	123580	21q22.3	Ophthamological	
483	277	Cataract, cerulean, type 2, 601547 (3)	CRYBB2	CRYBB2, CRYB2	123620	22q11.2-q12.2	Ophthamological	601547
484	277	Cataract, congenital (3)	PITX3	PITX3	602669	10q25	Ophthamological	
485	277	Cataract, congenital, 604219 (3)	BFSP2	BFSP2, CP49, CP47	603212	3q21-q25	Ophthamological	604219
486	277	Cataract, congenital progressive, autosomal recessive (3)	CRYAA	CRYAA, CRYA1	123580	21q22.3	Ophthamological	
487	277	Cataract, congenital, with late-onset corneal dystrophy (3)	PAX6	PAX6, AN2, MGDA	607108	11p13	Ophthamological	
488	277	Cataract, congenital zonular, with sutural opacities, 600881 (3)	CRYBA1	CRYBA1, CRYB1	123610	17q11.1-q12	Ophthamological	600881
489	277	Cataract, Coppock-like, 604307 (3)	CRYGC	CRYGC, CRYG3, CCL	123680	2q33-q35	Ophthamological	604307
490	277	Cataract, cortical pulverulent, late-onset (3)	LIM2	LIM2, MP19	154045	19q13.4	Ophthamological	
491	277	Cataract, crystalline aculeiform, 115700 (3)	CRYGD	CRYGD, CRYG4	123690	2q33-q35	Ophthamological	115700
492	277	Cataract, juvenile-onset, 604219 (3)	BFSP2	BFSP2, CP49, CP47	603212	3q21-q25	Ophthamological	604219
493	277	Cataract, lamellar, 116800 (3)	HSF4	HSF4, CTM	602438	16q21-q22.1	Ophthamological	116800
494	277	Cataract, Marner type, 116800 (3)	HSF4	HSF4, CTM	602438	16q21-q22.1	Ophthamological	116800
495	277	Cataract, polymorphic and lamellar, 604219 (3)	MIP	MIP, AQP0	154050	12q13	Ophthamological	604219
496	277	Cataract, posterior polar 2 (3)	CRYAB	CRYAB, CRYA2, CTPP2	123590	11q22.3-q23.1	Ophthamological	2
497	277	Cataract, pulverulent (3)	CRYBB1	CRYBB1	600929	22q11.2-q12.1	Ophthamological	
498	277	Cataracts, punctate, progressive juvenile-onset (3)	CRYGD	CRYGD, CRYG4	123690	2q33-q35	Ophthamological	
499	277	Cataract, sutural, with punctate and cerulean opacities, 607133 (3)	CRYBB2	CRYBB2, CRYB2	123620	22q11.2-q12.2	Ophthamological	607133
500	277	Cataract, variable zonular pulverulent (3)	CRYGC	CRYGC, CRYG3, CCL	123680	2q33-q35	Ophthamological	
501	277	Cataract, zonular central nuclear, autosomal dominant (3)	CRYAA	CRYAA, CRYA1	123580	21q22.3	Ophthamological	
502	277	Cataract, zonular pulverulent-1, 116200 (3)	GJA8	GJA8, CX50, CAE1	600897	1q21.1	Ophthamological	116200
503	277	Cataract, zonular pulverulent-3, 601885 (3)	GJA3	GJA3, CX46, CZP3, CAE3	121015	13q11	Ophthamological	601885
504	279	Cavernous malformations of CNS and retina, 116860 (3)	CCM1	CCM1, CAM, KRIT1	604214	7q11.2-q21	Cardiovascular	116860
505	283	CD59 deficiency (3)	CD59	CD59, MIC11	107271	11p13	Immunological	
506	284	CD8 deficiency, familial, 608957 (3)	CD8A	CD8A	186910	2p12	Immunological	608957
507	2287	Central core disease, 117000 (3)	RYR1	RYR1, MHS, CCO	180901	19q13.1	Muscular	117000
508	2287	Central core disease, one form (3) ()	MYH7	MYH7, CMH1, MPD1	160760	14q12	Muscular	-3
509	287	Central hypoventilation syndrome, 209880 (3)	GDNF	GDNF	600837	5p13.1-p12	Respiratory	209880
510	287	Central hypoventilation syndrome, congenital, 209880 (3)	BDNF	BDNF	113505	11p13	Respiratory	209880
511	287	Central hypoventilation syndrome, congenital, 209880 (3)	EDN3	EDN3	131242	20q13.2-q13.3	Respiratory	209880
512	287	Central hypoventilation syndrome, congenital, 209880 (3)	PMX2B	PMX2B, NBPHOX, PHOX2B	603851	4p12	Respiratory	209880
513	287	Central hypoventilation syndrome, congenital, 209880 (3)	RET	RET, MEN2A	164761	10q11.2	Respiratory	209880
514	289	Cerebellar ataxia, 604290 (3)	CP	CP	117700	3q23-q24	Neurological	604290
515	289	Cerebellar ataxia, pure (3)	CACNA1A	CACNA1A, CACNL1A4, SCA6	601011	19p13	Neurological	
516	4289	Cerebellar hypoplasia, VLDLR-associated, 224050 (3)	VLDLR	VLDLR, VLDLRCH	192977	9p24	Neurological	224050
517	291	Cerebral amyloid angiopathy, 105150 (3)	ABCA1	ABCA1, ABC1, HDLDT1, TGD	600046	9q22-q31	Neurological	105150
518	291	Cerebral amyloid angiopathy, 105150 (3)	CST3	CST3	604312	20p11.2	Neurological	105150
519	2291	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)	NOTCH3	NOTCH3, CADASIL, CASIL	600276	19p13.2-p13.1	Cardiovascular	125310
520	4291	Cerebral cavernous malformations-1, 116860 (3)	CCM1	CCM1, CAM, KRIT1	604214	7q11.2-q21	Neurological	116860
521	4291	Cerebral cavernous malformations-2, 603284 (3)	C7orf22	C7orf22, CCM2, MGC4067	607929	7p13	Neurological	603284
522	4291	Cerebral cavernous malformations 3, 603285 (3)	PDCD10	PDCD10, TFAR15, CCM3	609118	3q26.1	Neurological	603285
523	6291	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3)	SNAP29	SNAP29, CEDNIK	604202	22q11.2	Neurological	609528
524	292	Cerebrooculofacioskeletal syndrome, 214150 (3)	ERCC2	ERCC2, EM9	126340	19q13.2-q13.3	multiple	214150
525	292	Cerebrooculofacioskeletal syndrome, 214150 (3)	ERCC5	ERCC5, XPG	133530	13q33	multiple	214150
526	292	Cerebrooculofacioskeletal syndrome 214150 (3)	ERCC6	ERCC6, CKN2, COFS, CSB	609413	10q11	multiple	214150
527	293	Cerebrotendinous xanthomatosis, 213700 (3)	CYP27A1	CYP27A1, CYP27, CTX	606530	2q33-qter	Metabolic	213700
528	294	Cerebrovascular disease, occlusive (3)	SERPINA3	SERPINA3, AACT, ACT	107280	14q32.1	Unclassified	
529	295	Ceroid lipofuscinosis, neuronal-1, infantile, 256730 (3)	PPT1	PPT1, CLN1	600722	1p32	Neurological	256730
530	296	Ceroid-lipofuscinosis, neuronal 2, classic late infantile, 204500 (3)	CLN2	CLN2	607998	11p15.5	Neurological	204500
531	296	Ceroid-lipofuscinosis, neuronal-3, juvenile, 204200 (3)	CLN3	CLN3, BTS	607042	16p12.1	Neurological	204200
532	296	Ceroid-lipofuscinosis, neuronal-5, variant late infantile, 256731 (3)	CLN5	CLN5	608102	13q21.1-q32	Neurological	256731
533	296	Ceroid-lipofuscinosis, neuronal-6, variant late infantile, 601780 (3)	CLN6	CLN6	606725	15q21-q23	Neurological	601780
534	296	Ceroid lipofuscinosis, neuronal 8, 600143 (3)	CLN8	CLN8, EPMR	607837	8pter-p22	Neurological	600143
535	296	Ceroid lipofuscinosis, neuronal, variant juvenile type, with granular osmiophilic deposits (3)	PPT1	PPT1, CLN1	600722	1p32	Neurological	
536	298	Cervical cancer, somatic, 603956 (3)	FGFR3	FGFR3, ACH	134934	4p16.3	Cancer	603956
537	299	CETP deficiency, 607322 (3)	CETP	CETP	118470	16q21	Metabolic	607322
538	300	Chanarin-Dorfman syndrome, 275630 (3)	ABHD5	ABHD5, CGI58, IECN2, NCIE2	604780	3p21	Metabolic	275630
539	301	Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)	HSPB1	HSPB1, HSP27, CMT2F	602195	7q11.23	Neurological	606595
540	301	Charcot-Marie-Tooth disease, dominant intermediate 3, 607791 (3)	MPZ	MPZ, CMT1B, CMTDI3, CHM, DSS	159440	1q22	Neurological	607791
541	301	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3)	DNM2	DNM2	602378	19p13.2	Neurological	606482
542	301	Charcot-Marie-Tooth disease, foot deformity of (3)	HOXD10	HOXD10, HOX4D	142984	2q31-q32	Neurological	
543	301	Charcot-Marie-Tooth disease, mixed axonal and demyelinating type, 214400 (3)	GDAP1	GDAP1, CMT4A, CMT2K, CMT2G	606598	8q13-q21.1	Neurological	214400
544	301	Charcot-Marie-Tooth disease, type 1A, 118220 (3)	PMP22	PMP22, CMT1A, CMT1E, DSS	601097	17p11.2	Neurological	118220
545	301	Charcot-Marie-Tooth disease, type 1B, 118200 (3)	MPZ	MPZ, CMT1B, CMTDI3, CHM, DSS	159440	1q22	Neurological	118200
546	301	Charcot-Marie-Tooth disease, type 1C, 601098 (3)	LITAF	LITAF, CMT1C	603795	16p13.3-p12	Neurological	601098
547	301	Charcot-Marie-Tooth disease, type 1D, 607678 (3)	EGR2	EGR2, KROX20	129010	10q21.1-q22.1	Neurological	607678
548	301	Charcot-Marie-Tooth disease, type 1E, 118300 (3)	PMP22	PMP22, CMT1A, CMT1E, DSS	601097	17p11.2	Neurological	118300
549	301	Charcot-Marie-Tooth disease, type 1F, 607734 (3)	NEFL	NEFL, CMT2E, CMT1F	162280	8p21	Neurological	607734
550	301	Charcot-Marie-Tooth disease, type 2A1, 118210 (3)	KIF1B	KIF1B, CMT2A, CMT2A1	605995	1p36.2	Neurological	118210
551	301	Charcot-Marie-Tooth disease, type 2A2, 609260 (3)	MFN2	MFN2, KIAA0214, CMT2A2	608507	1p36.2	Neurological	609260
552	301	Charcot-Marie-Tooth disease, type 2B, 600882 (3)	RAB7	RAB7, CMT2B, PSN	602298	3q21	Neurological	600882
553	301	Charcot-Marie-Tooth disease, type 2D, 601472 (3)	GARS	GARS, SMAD1, CMT2D	600287	7p15	Neurological	601472
554	301	Charcot-Marie-Tooth disease, type 2E, 607684 (3)	NEFL	NEFL, CMT2E, CMT1F	162280	8p21	Neurological	607684
555	301	Charcot-Marie-Tooth disease, type 2G, 607706 (3)	GDAP1	GDAP1, CMT4A, CMT2K, CMT2G	606598	8q13-q21.1	Neurological	607706
556	301	Charcot-Marie-Tooth disease, type 2I, 607677 (3)	MPZ	MPZ, CMT1B, CMTDI3, CHM, DSS	159440	1q22	Neurological	607677
557	301	Charcot-Marie-Tooth disease, type 2J, 607736 (3)	MPZ	MPZ, CMT1B, CMTDI3, CHM, DSS	159440	1q22	Neurological	607736
558	301	Charcot-Marie-Tooth disease, type 2K, 607831 (3)	GDAP1	GDAP1, CMT4A, CMT2K, CMT2G	606598	8q13-q21.1	Neurological	607831
559	301	Charcot-Marie-Tooth disease, type 4A, 214400 (3)	GDAP1	GDAP1, CMT4A, CMT2K, CMT2G	606598	8q13-q21.1	Neurological	214400
560	301	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)	MTMR2	MTMR2, CMT4B1	603557	11q22	Neurological	601382
561	301	Charcot-Marie-Tooth disease, type 4B2, 604563 (3)	SBF2	SBF2, MTMR13, CMT4B2	607697	11p15	Neurological	604563
562	301	Charcot-Marie-Tooth disease, type 4B2, with early-onset glaucoma, 607739 (3)	SBF2	SBF2, MTMR13, CMT4B2	607697	11p15	Neurological	607739
563	301	Charcot-Marie-Tooth disease, type 4C, 601596 (3)	KIAA1985	KIAA1985	608206	5q32	Neurological	601596
564	301	Charcot-Marie-Tooth disease, type 4D, 601455 (3)	NDRG1	NDRG1, HMSNL, CMT4D	605262	8q24.3	Neurological	601455
565	301	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)	GJB1	GJB1, CX32, CMTX1	304040	Xq13.1	Neurological	302800
566	302	CHARGE syndrome, 214800 (3)	CHD7	CHD7	608892	8q12.1	multiple	214800
567	303	Char syndrome, 169100 (3)	TFAP2B	TFAP2B, CHAR	601601	6p12	multiple	169100
568	304	Chediak-Higashi syndrome, 214500 (3)	CHS1	CHS1, LYST	606897	1q42.1-q42.2	multiple	214500
569	305	Cherubism, 118400 (3)	SH3BP2	SH3BP2, CRPM	602104	4p16.3	Unclassified	118400
570	306	CHILD syndrome, 308050 (3)	NSDHL	NSDHL	300275	Xq28	Developmental	308050
571	307	Chitotriosidase deficiency (3)	CHIT	CHIT	600031	1q31-q32	Metabolic	
572	308	Chloride diarrhea, congenital, Finnish type, 214700 (3)	SLC26A3	SLC26A3, DRA, CLD	126650	7q22-q31.1	Gastrointestinal	214700
573	309	Cholelithiasis, 600803 (3)	ABCB4	ABCB4, PGY3, MDR3	171060	7q21.1	Gastrointestinal	600803
574	310	Cholestasis, benign recurrent intrahepatic, 243300 (3)	ATP8B1	ATP8B1, FIC1, BRIC, PFIC1	602397	18q21	Gastrointestinal	243300
575	310	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3)	ABCB4	ABCB4, PGY3, MDR3	171060	7q21.1	Gastrointestinal	147480
576	310	Cholestasis, progressive familial intrahepatic 1, 211600 (3)	ATP8B1	ATP8B1, FIC1, BRIC, PFIC1	602397	18q21	Gastrointestinal	211600
577	310	Cholestasis, progressive familial intrahepatic 2, 601847 (3)	ABCB11	ABCB11, BSEP, SPGP, PFIC2	603201	2q24	Gastrointestinal	601847
578	310	Cholestasis, progressive familial intrahepatic 3, 602347 (3)	ABCB4	ABCB4, PGY3, MDR3	171060	7q21.1	Gastrointestinal	602347
579	310	Cholestasis, progressive familial intrahepatic 4, 607765 (3)	HSD3B7	HSD3B7, PFIC4	607764	16p12-p11.2	Gastrointestinal	607765
580	313	Cholesteryl ester storage disease (3)	LIPA	LIPA	278000	10q24-q25	Metabolic	
581	314	Chondrocalcinosis 2, 118600 (3)	ANKH	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2-p14.1	Connective tissue disorder	118600
582	2315	Chondrodysplasia, Grebe type, 200700 (3)	GDF5	GDF5, CDMP1	601146	20q11.2	Skeletal	200700
583	315	Chondrodysplasia punctata, rhizomelic, type 2, 222765 (3)	GNPAT	GNPAT, DHAPAT	602744	1q42	Connective tissue	222765
584	315	Chondrodysplasia punctata, X-linked dominant, 302960 (3)	EBP	EBP, CDPX2, CPXD, CPX	300205	Xp11.23-p11.22	Connective tissue	302960
585	315	Chondrodysplasia punctata, X-linked recessive, 302950 (3)	ARSE	ARSE, CDPX1, CDPXR	300180	Xp22.3	Connective tissue	302950
586	316	Chondrosarcoma, 215300 (3)	EXT1	EXT1	608177	8q24.11-q24.13	Cancer	215300
587	316	Chondrosarcoma, extraskeletal myxoid (3)	CSMF	CSMF	600542	9q22	Cancer	
588	316	Chondrosarcoma, extraskeletal myxoid (3)	EWSR1	EWSR1, EWS	133450	22q12	Cancer	
589	318	Chorea, hereditary benign, 118700 (3)	TITF1	TITF1, NKX2A, TTF1	600635	14q13	Neurological	118700
590	319	Choreoacanthocytosis, 200150 (3)	VPS13A	VPS13A, CHAC	605978	9q21	Neurological	200150
591	320	Choreoathetosis, hypothyroidism, and respiratory distress (3)	TITF1	TITF1, NKX2A, TTF1	600635	14q13	multiple	
592	323	Choroideremia, 303100 (3)	CHM	CHM, TCD	300390	Xq21.2	Ophthamological	303100
593	326	Chromosome 22q13.3 deletion syndrome, 606232 (3)	PSAP2	PSAP2, PROSAP2, KIAA1650	606230	22q13.3	multiple	606232
594	327	Chronic granulomatous disease, autosomal, due to deficiency of CYBA, 233690 (3)	CYBA	CYBA	608508	16q24	Immunological	233690
595	327	Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3)	NCF1	NCF1	608512	7q11.23	Immunological	233700
596	327	Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3)	NCF2	NCF2	608515	1q25	Immunological	233710
597	327	Chronic granulomatous disease, X-linked, 306400 (3)	CYBB	CYBB, CGD	300481	Xp21.1	Immunological	306400
598	2327	Chronic infections, due to opsonin defect (3)	MBL2	MBL2, MBL, MBP1	154545	10q11.2-q21	Immunological	
599	328	Chudley-Lowry syndrome, 309490 (3)	ATRX	ATRX, XH2, XNP, MRXS3, SHS	300032	Xq13	multiple	309490
600	329	Chylomicronemia syndrome, familial (3)	LPL	LPL, LIPD	238600	8p22	Metabolic	
601	330	Chylomicron retention disease, 246700 (3)	SARA2	SARA2, SAR1B, CMRD	607690	5q31.1	Gastrointestinal	246700
602	330	Chylomicron retention disease with Marinesco-Sjogren syndrome, 607692 (3)	SARA2	SARA2, SAR1B, CMRD	607690	5q31.1	Gastrointestinal	607692
603	331	Ciliary dyskinesia, primary, 1, 242650 (3)	DNAI1	DNAI1, CILD1, ICS, PCD	604366	9p21-p13	Respiratory	242650
604	331	Ciliary dyskinesia, primary, 3 608644 (3)	DNAH5	DNAH5, HL1, PCD, CILD3	603335	5p15-p14	Respiratory	608644
605	332	CINCA syndrome, 607115 (3)	CIAS1	CIAS1, C1orf7, FCU, FCAS	606416	1q44	multiple	607115
606	334	Cirrhosis, cryptogenic (3)	KRT18	KRT18	148070	12q13	Gastrointestinal	
607	334	Cirrhosis, cryptogenic (3)	KRT8	KRT8	148060	12q13	Gastrointestinal	
608	334	Cirrhosis, noncryptogenic, susceptibility to, 215600 (3)	KRT18	KRT18	148070	12q13	Gastrointestinal	215600
609	334	Cirrhosis, noncryptogenic, susceptibility to, 215600 (3)	KRT8	KRT8	148060	12q13	Gastrointestinal	215600
610	334	Cirrhosis, North American Indian childhood type, 604901 (3)	CIRH1A	CIRH1A, NAIC, TEX292, KIAA1988	607456	16q22	Gastrointestinal	604901
611	335	Citrullinemia, 215700 (3)	ASS	ASS	603470	9q34	Metabolic	215700
612	335	Citrullinemia, adult-onset type II, 603471 (3)	SLC25A13	SLC25A13, CTLN2	603859	7q21.3	Metabolic	603471
613	335	Citrullinemia, type II, neonatal-onset, 605814 (3)	SLC25A13	SLC25A13, CTLN2	603859	7q21.3	Metabolic	605814
614	336	Cleft lip/palate ectodermal dysplasia syndrome, 225000 (3)	HVEC	HVEC, PVRL1, PVRR1, PRR1	600644	11q23-q24	Developmental	225000
615	336	Cleft lip/palate, nonsyndromic, 608874 (3)	MSX1	MSX1, HOX7, HYD1, OFC5	142983	4p16.1	Developmental	608874
616	336	Cleft palate with ankyloglossia, 303400 (3)	TBX22	TBX22, CPX	300307	Xq12-q21	Developmental	303400
617	337	Cleidocranial dysplasia, 119600 (3)	RUNX2	RUNX2, CBFA1, PEBP2A1, AML3	600211	6p21	Skeletal	119600
618	338	Coats disease, 300216 (3)	NDP	NDP, ND	310600	Xp11.4	Ophthamological	300216
619	339	Cockayne syndrome, type A, 216400 (3)	ERCC8	ERCC8, CKN1, CSA	609412	5q12	multiple	216400
620	339	Cockayne syndrome, type B, 133540 (3)	ERCC6	ERCC6, CKN2, COFS, CSB	609413	10q11	multiple	133540
621	340	Codeine sensitivity (3)	CYP2D@	CYP2D@, CYP2D, P450C2D	124030	22q13.1	Metabolic	
622	341	Coffin-Lowry syndrome, 303600 (3)	RPS6KA3	RPS6KA3, RSK2, MRX19	300075	Xp22.2-p22.1	multiple	303600
623	342	Cohen syndrome, 216550 (3)	COH1	COH1	607817	8q22-q23	multiple	216550
624	343	Colchicine resistance (3)	ABCB1	ABCB1, PGY1, MDR1	171050	7q21.1	Unclassified	
625	344	Cold-induced autoinflammatory syndrome, familial, 120100 (3)	CIAS1	CIAS1, C1orf7, FCU, FCAS	606416	1q44	Immunological	120100
626	2344	Cold-induced sweating syndrome, 272430 (3)	CRLF1	CRLF1, CISS	604237	19p12	multiple	272430
627	345	Coloboma, ocular, 120200 (3)	PAX6	PAX6, AN2, MGDA	607108	11p13	Ophthamological	120200
628	345	Coloboma, ocular, 120200 (3)	SHH	SHH, HPE3, HLP3, SMMCI	600725	7q36	Ophthamological	120200
629	346	Colon adenocarcinoma (3)	RAD54B	RAD54B	604289	8q21.3-q22	Cancer	
630	346	Colon adenocarcinoma (3)	RAD54L	RAD54L, HR54, HRAD54	603615	1p32	Cancer	
631	346	Colon cancer (3)	BCL10	BCL10	603517	1p22	Cancer	
632	346	Colon cancer (3)	PTPN12	PTPN12, PTPG1	600079	7q11.23	Cancer	
633	346	Colon cancer (3)	TGFBR2	TGFBR2, HNPCC6	190182	3p22	Cancer	
634	346	Colon cancer, advanced (3)	SRC	SRC, ASV, SRC1	190090	20q12-q13	Cancer	
635	346	Colon cancer, hereditary nonpolypopsis, type 7 (3)	MLH3	MLH3, HNPCC7	604395	14q24.3	Cancer	7
636	346	Colon cancer, somatic, 114500 (3)	PTPRJ	PTPRJ, DEP1	600925	11p11.2	Cancer	114500
637	346	Colonic adenoma recurrence, reduced risk of, 114500 (3)	ODC1	ODC1	165640	2p25	Cancer	114500
638	347	Colonic aganglionosis, total, with small bowel involvement (3)	RET	RET, MEN2A	164761	10q11.2	Gastrointestinal	
639	348	Colorblindness, deutan (3)	OPN1MW	OPN1MW, GCP, CBD, CBBM	303800	Xq28	Ophthamological	
640	348	Colorblindness, protan (3)	OPN1LW	OPN1LW, RCP, CBP, CBBM	303900	Xq28	Ophthamological	
641	348	Colorblindness, tritan (3)	OPN1SW	OPN1SW, BCP, CBT	190900	7q31.3-q32	Ophthamological	
642	346	Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3)	MUTYH	MUTYH	604933	1p34.3-p32.1	Cancer	132600
643	346	Colorectal cancer, 114500 (3)	AXIN2	AXIN2	604025	17q24	Cancer	114500
644	346	Colorectal cancer, 114500 (3)	BUB1B	BUB1B, BUBR1	602860	15q15	Cancer	114500
645	346	Colorectal cancer, 114500 (3)	EP300	EP300	602700	22q13	Cancer	114500
646	346	Colorectal cancer, 114500 (3)	PDGFRL	PDGFRL, PDGRL, PRLTS	604584	8p22-p21.3	Cancer	114500
647	346	Colorectal cancer, 114500 (3)	PIK3CA	PIK3CA	171834	3q26.3	Cancer	114500
648	346	Colorectal cancer, 114500 (3)	TP53	TP53, P53, LFS1	191170	17p13.1	Cancer	114500
649	346	Colorectal cancer (3)	APC	APC, GS, FPC	175100	5q21-q22	Cancer	
650	346	Colorectal cancer (3)	BAX	BAX	600040	19q13.3-q13.4	Cancer	
651	346	Colorectal cancer (3)	CTNNB1	CTNNB1	116806	3p22-p21.3	Cancer	
652	346	Colorectal cancer (3)	DCC	DCC	120470	18q21.3	Cancer	
653	346	Colorectal cancer (3)	MCC	MCC	159350	5q21	Cancer	
654	346	Colorectal cancer (3)	NRAS	NRAS	164790	1p13.2	Cancer	
655	346	Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3)	MSH2	MSH2, COCA1, FCC1, HNPCC1	609309	2p22-p21	Cancer	120435
656	346	Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3)	MLH1	MLH1, COCA2, HNPCC2	120436	3p21.3	Cancer	609310
657	346	Colorectal cancer, hereditary nonpolyposis, type 3 (3)	PMS1	PMS1, PMSL1, HNPCC3	600258	2q31-q33	Cancer	3
658	346	Colorectal cancer, hereditary nonpolyposis, type 4 (3)	PMS2	PMS2, PMSL2, HNPCC4	600259	7p22	Cancer	4
659	346	Colorectal cancer, hereditary nonpolyposis, type 5 (3)	MSH6	MSH6, GTBP, HNPCC5	600678	2p16	Cancer	5
660	346	Colorectal cancer, hereditary nonpolyposis, type 6 (3)	TGFBR2	TGFBR2, HNPCC6	190182	3p22	Cancer	6
661	346	Colorectal cancer, somatic, 109800 (3)	FGFR3	FGFR3, ACH	134934	4p16.3	Cancer	109800
662	346	Colorectal cancer, somatic, 114500 (3)	FLCN	FLCN, BHD	607273	17p11.2	Cancer	114500
663	346	Colorectal cancer, somatic, 114500 (3)	MLH3	MLH3, HNPCC7	604395	14q24.3	Cancer	114500
664	346	Colorectal cancer, somatic (3)	BRAF	BRAF	164757	7q34	Cancer	
665	346	Colorectal cancer, somatic (3)	DLC1	DLC1	604258	8p22-p21.3	Cancer	
666	346	Colorectal cancer, sporadic, 114500 (3)	PLA2G2A	PLA2G2A, PLA2B, PLA2L, MOM1	172411	1p35	Cancer	114500
667	346	Colorectal cancer, susceptibility to (3)	CCND1	CCND1, PRAD1, BCL1	168461	11q13	Cancer	
668	346	Colorectal cancer with chromosomal instability (3)	BUB1	BUB1	602452	2q14	Cancer	
669	4350	Combined C6/C7 deficiency (3)	C6	C6	217050	5p13	Immunological	
670	350	Combined factor V and VIII deficiency, 227300 (3)	LMAN1	LMAN1, ERGIC53, F5F8D, MCFD1	601567	18q21.3-q22	Hematological	227300
671	2350	Combined hyperlipemia, familial (3)	LPL	LPL, LIPD	238600	8p22	Metabolic	
672	4350	Combined immunodeficiency, X-linked, moderate, 312863 (3)	IL2RG	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13	Immunological	312863
673	6350	Combined oxidative phosphorylation deficiency, 609060 (3)	GFM1	GFM1, EFG1, GFM	606639	3q25.1-q26.2	multiple	609060
674	8350	Combined SAP deficiency (3)	PSAP	PSAP, SAP1	176801	10q22.1	Metabolic	
675	351	Complex I, mitochondrial respiratory chain, deficiency of, 252010 (3)	NDUFS6	NDUFS6	603848	5pter-p15.33	multiple	252010
676	351	Complex V, mitochondrial respiratory chain, deficiency of, 604273 (3)	ATPAF2	ATPAF2, ATP12	608918	17p11.2	multiple	604273
677	352	Cone dystrophy-1, 304020 (3)	RPGR	RPGR, RP3, CRD, RP15, COD1	312610	Xp21.1	Ophthamological	304020
678	352	Cone dystrophy-3, 602093 (3)	GUCA1A	GUCA1A, GCAP	600364	6p21.1	Ophthamological	602093
679	352	Cone-rod dystrophy, 300029 (3)	RPGR	RPGR, RP3, CRD, RP15, COD1	312610	Xp21.1	Ophthamological	300029
680	352	Cone-rod dystrophy 3 (3)	ABCA4	ABCA4, ABCR, STGD1, FFM, RP19	601691	1p21-p13	Ophthamological	3
681	352	Cone-rod dystrophy (3)	AIPL1	AIPL1, LCA4	604392	17p13.1	Ophthamological	
682	352	Cone-rod dystrophy 6, 601777(3)	GUCY2D	GUCY2D, GUC2D, LCA1, CORD6	600179	17p13.1	Ophthamological	6
683	352	Cone-rod dystrophy 9, 608194 (3)	RPGRIP1	RPGRIP1, LCA6, CORD9	605446	14q11	Ophthamological	608194
684	352	Cone-rod retinal dystrophy-2, 120970 (3)	CRX	CRX, CORD2, CRD	602225	19q13.3	Ophthamological	120970
685	2354	Congenital bilateral absence of vas deferens, 277180 (3)	CFTR	CFTR, ABCC7, CF, MRP7	602421	7q31.2	Unclassified	277180
686	4354	Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)	CTDP1	CTDP1, FCP1, CCFDN	604927	18q23	Ophthamological	604168
687	354	Congenital disorder of glycosylation, type Ic, 603147 (3)	ALG6	ALG6	604566	1p22.3	Metabolic	603147
688	354	Congenital disorder of glycosylation, type Id, 601110 (3)	ALG3	ALG3, NOT56L, CDGS4	608750	3q27	Metabolic	601110
689	354	Congenital disorder of glycosylation, type Ie, 608799 (3)	DPM1	DPM1, MPDS, CDGIE	603503	20q13.13	Metabolic	608799
690	354	Congenital disorder of glycosylation, type If, 609180 (3)	MPDU1	MPDU1, SL15, CDGIF	604041	17p13.1-p12	Metabolic	609180
691	354	Congenital disorder of glycosylation, type Ig, 607143 (3)	ALG12	ALG12	607144	Chr.22	Metabolic	607143
692	354	Congenital disorder of glycosylation, type Ih, 608104 (3)	ALG8	ALG8	608103	11pter-p15.5	Metabolic	608104
693	354	Congenital disorder of glycosylation, type Ii, 607906 (3)	ALG2	ALG2, CDGII	607905	9q22	Metabolic	607906
694	354	Congenital disorder of glycosylation, type II, 608776 (3)	DIBD1	DIBD1, ALG9	606941	11q23	Metabolic	608776
695	354	Congenital disorder of glycosylation, type IIc, 266265 (3)	SLC35C1	SLC35C1, FUCT1	605881	11p11.2	Metabolic	266265
696	354	Congenital disorder of glycosylation, type IId, 607091 (3)	B4GALT1	B4GALT1, GGTB2, GT1, GTB	137060	9p13	Metabolic	607091
697	354	Congenital disorder of glycosylation, type IIe, 608779 (3)	COG7	COG7, CDG2E	606978	16p	Metabolic	608779
698	354	Congenital disorder of glycosylation, type Ij, 608093 (3)	DPAGT2	DPAGT2, DGPT	191350	11q23.3	Metabolic	608093
699	354	Congenital disorder of glycosylation, type Ik, 608540 (3)	ALG1	ALG1, HMAT1, HMT1	605907	16p13.3	Metabolic	608540
700	355	Congestive heart failure, susceptibility to (3)	ADRA2C	ADRA2C, ADRA2L2	104250	4p16.1	Cardiovascular	
701	355	Congestive heart failure, susceptibility to (3)	ADRB1	ADRB1, ADRB1R, RHR	109630	10q24-q26	Cardiovascular	
702	356	Conjunctivitis, ligneous, 217090 (3)	PLG	PLG	173350	6q26	Ophthamological	217090
703	357	Conotruncal anomaly face syndrome, 217095 (3)	TBX1	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.2	Cardiovascular	217095
704	358	Contractural arachnodactyly, congenital (3)	FBN2	FBN2, CCA	121050	5q23-q31	Connective tissue	
705	359	Convulsions, familial febrile, 4, 604352 (3)	MASS1	MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14	Neurological	604352
706	360	COPD, rate of decline of lung function in, 606963 (3)	MMP1	MMP1, CLG	120353	11q22-q23	Respiratory	606963
707	361	Coproporphyria (3)	CPO	CPO	121300	3q12	Metabolic	
708	362	Corneal clouding, autosomal recessive (3)	APOA1	APOA1	107680	11q23	Ophthamological	
709	362	Corneal dystrophy, Avellino type, 607541 (3)	TGFBI	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2	601692	5q31	Ophthamological	607541
710	362	Corneal dystrophy, gelatinous drop-like, 204870 (3)	TACSTD2	TACSTD2, TROP2, M1S1	137290	1p32	Ophthamological	204870
711	362	Corneal dystrophy, Groenouw type I, 121900 (3)	TGFBI	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2	601692	5q31	Ophthamological	121900
712	362	Corneal dystrophy, hereditary polymorphous posterior, 122000 (3)	VSX1	VSX1, RINX, PPCD, PPD, KTCN	605020	20p11.2	Ophthamological	122000
713	362	Corneal dystrophy, hereditary polymorphous posterior, 2, 122000 (3)	COL8A2	COL8A2, FECD, PPCD2	120252	1p34.3-p32.3	Ophthamological	122000
714	362	Corneal dystrophy, lattice type I, 122200 (3)	TGFBI	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2	601692	5q31	Ophthamological	122200
715	362	Corneal dystrophy, lattice type IIIA, 608471 (3)	TGFBI	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2	601692	5q31	Ophthamological	608471
716	362	Corneal dystrophy, Reis-Bucklers type, 608470 (3)	TGFBI	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2	601692	5q31	Ophthamological	608470
717	362	Corneal dystrophy, Thiel-Behnke type, 602082 (3)	TGFBI	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2	601692	5q31	Ophthamological	602082
718	362	Corneal fleck dystrophy, 121850 (3)	PIP5K3	PIP5K3, CFD	609414	2q35	Ophthamological	121850
719	362	Cornea plana congenita, recessive, 217300 (3)	KERA	KERA, CNA2	603288	12q22	Ophthamological	217300
720	364	Cornelia de Lange syndrome, 122470 (3)	NIPBL	NIPBL, CDLS	608667	5p13.1	Developmental	122470
721	365	Coronary artery disease, autosomal dominant, 1, 608320 (3)	MEF2A	MEF2A, ADCAD1	600660	15q26	Cardiovascular	608320
722	365	Coronary artery disease in familial hypercholesterolemia, protection against, 143890 (3)	ABCA1	ABCA1, ABC1, HDLDT1, TGD	600046	9q22-q31	Cardiovascular	143890
723	365	Coronary artery disease, susceptibility to (3)	KL	KL	604824	13q12	Cardiovascular	
724	365	Coronary artery disease, susceptibility to (3)	PON1	PON1, PON, ESA	168820	7q21.3	Cardiovascular	
725	365	Coronary artery disease, susceptibility to (3)	PON2	PON2	602447	7q21.3	Cardiovascular	
726	365	Coronary artery spasm, susceptibility to (3)	PON1	PON1, PON, ESA	168820	7q21.3	Cardiovascular	
727	365	Coronary heart disease, susceptibility to (3)	MMP3	MMP3, STMY1	185250	11q23	Cardiovascular	
728	2365	Coronary spasms, susceptibility to (3)	NOS3	NOS3	163729	7q36	Cardiovascular	
729	366	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, 300472 (3)	IGBP1	IGBP1	300139	Xq13.1-q13.3	Neurological	300472
730	367	Cortisol resistance (3)	NR3C1	NR3C1, GCR, GRL	138040	5q31	Endocrine	
731	368	Cortisone reductase deficiency, 604931 (3)	GDH	GDH	138090	1pter-p36.13	Metabolic	604931
732	368	Cortisone reductase deficiency, 604931 (3)	HSD11B1	HSD11B1, HSD11, HSD11L	600713	1q32-q41	Metabolic	604931
733	369	Costello syndrome, 218040 (3)	HRAS	HRAS	190020	11p15.5	multiple	218040
734	370	Coumarin resistance, 122700 (3)	CYP2A6	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	Hematological	122700
735	372	Cowden disease, 158350 (3)	PTEN	PTEN, MMAC1	601728	10q23.31	Cancer	158350
736	372	Cowden-like syndrome, 158350 (3)	BMPR1A	BMPR1A, ACVRLK3, ALK3	601299	10q22.3	Cancer	158350
737	374	CPT deficiency, hepatic, type IA, 255120 (3)	CPT1A	CPT1A	600528	11q13	Metabolic	255120
738	374	CPT deficiency, hepatic, type II, 600649 (3)	CPT2	CPT2	600650	1p32	Metabolic	600649
739	374	CPT II deficiency, lethal neonatal, 608836 (3)	CPT2	CPT2	600650	1p32	Metabolic	608836
740	376	Cramps, familial, potassium-aggravated (3)	SCN4A	SCN4A, HYPP, NAC1A	603967	17q23.1-q25.3	Muscular	
741	377	Craniofacial anomalies, empty sella turcica, corneal endothelial changes, and abnormal retinal and auditory bipolar cells (3)	VSX1	VSX1, RINX, PPCD, PPD, KTCN	605020	20p11.2	multiple	
742	378	Craniofacial-deafness-hand syndrome, 122880 (3)	PAX3	PAX3, WS1, HUP2, CDHS	606597	2q35	multiple	122880
743	379	Craniofacial-skeletal-dermatologic dysplasia (3)	FGFR2	FGFR2, BEK, CFD1, JWS	176943	10q26	multiple	
744	380	Craniofrontonasal dysplasia, 304110 (3)	EFNB1	EFNB1, EPLG2, CFNS, CFND	300035	Xq12	Skeletal	304110
745	382	Craniometaphyseal dysplasia, 123000 (3)	ANKH	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2-p14.1	Bone	123000
746	383	Craniosynostosis, nonspecific (3)	FGFR2	FGFR2, BEK, CFD1, JWS	176943	10q26	Skeletal	
747	383	Craniosynostosis, type 2, 604757 (3)	MSX2	MSX2, CRS2, HOX8	123101	5q34-q35	Skeletal	604757
748	384	CRASH syndrome, 303350 (3)	L1CAM	L1CAM, CAML1, HSAS1	308840	Xq28	multiple	303350
749	2385	Creatine deficiency syndrome, X-linked, 300352 (3)	SLC6A8	SLC6A8, CRTR	300036	Xq28	Neurological	300352
750	385	Creatine phosphokinase, elevated serum, 123320 (3)	CAV3	CAV3, LGMD1C	601253	3p25	Metabolic	123320
751	385	Creatine phosphokinase, elevated serum, 123320 (3)	CAV3	CAV3, LGMD1C	601253	3p25	Metabolic	123320
752	388	Creutzfeldt-Jakob disease, 123400 (3)	PRNP	PRNP, PRIP	176640	20pter-p12	Neurological	123400
753	388	Creutzfeldt-Jakob disease, variant, resistance to, 123400 (3)	HLA-DQB1	HLA-DQB1	604305	6p21.3	Neurological	123400
754	389	Crigler-Najjar syndrome, type I, 218800 (3)	UGT1A1	UGT1A1, UGT1, GNT1	191740	2q37	multiple	218800
755	389	Crigler-Najjar syndrome, type II, 606785 (3)	UGT1A1	UGT1A1, UGT1, GNT1	191740	2q37	multiple	606785
756	390	Crohn disease, susceptibility to, 266600 (3)	CARD15	CARD15, NOD2, IBD1, CD, ACUG, PSORAS1	605956	16q12	Gastrointestinal	266600
757	390	Crohn disease, susceptibility to, 266600 (3)	DLG5	DLG5, PDLG, KIAA0583	604090	10q23	Gastrointestinal	266600
758	391	Crouzon syndrome, 123500 (3)	FGFR2	FGFR2, BEK, CFD1, JWS	176943	10q26	Skeletal	123500
759	391	Crouzon syndrome with acanthosis nigricans (3)	FGFR3	FGFR3, ACH	134934	4p16.3	Skeletal	
760	392	Cryptorchidism, bilateral, 219050 (3)	LGR8	LGR8, GREAT	606655	13q13.1	Renal	219050
761	392	Cryptorchidism, idiopathic, 219050 (3)	INSL3	INSL3	146738	19p13.2	Renal	219050
762	394	Currarino syndrome, 176450 (3)	HLXB9	HLXB9, HOXHB9, SCRA1	142994	7q36	Skeletal	176450
763	395	Cutis laxa, AD, 123700 (3)	ELN	ELN	130160	7q11.2	Connective tissue	123700
764	395	Cutis laxa, autosomal dominant, 123700 (3)	FBLN5	FBLN5, ARMD3	604580	14q32.1	Connective tissue	123700
765	395	Cutis laxa, autosomal recessive, 219100 (3)	FBLN5	FBLN5, ARMD3	604580	14q32.1	Connective tissue	219100
766	395	Cutis laxa, neonatal (3)	ATP7A	ATP7A, MNK, MK, OHS	300011	Xq12-q13	Connective tissue	
767	396	Cyclic ichthyosis with epidermolytic hyperkeratosis, 607602 (3)	KRT1	KRT1	139350	12q13	Dermatological	607602
768	397	Cylindromatosis, familial, 132700 (3)	CYLD1	CYLD1, CDMT, EAC	605018	16q12-q13	Dermatological	132700
769	398	Cystathioninuria, 219500 (3)	CTH	CTH	607657	1p31.1	Metabolic	219500
770	399	Cystic fibrosis, 219700 (3)	CFTR	CFTR, ABCC7, CF, MRP7	602421	7q31.2	Respiratory	219700
771	400	Cystinosis, atypical nephropathic (3)	CTNS	CTNS	606272	17p13	Renal	
772	400	Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3)	CTNS	CTNS	606272	17p13	Renal	219900
773	400	Cystinosis, nephropathic, 219800 (3)	CTNS	CTNS	606272	17p13	Renal	219800
774	400	Cystinosis, ocular nonnephropathic, 219750 (3)	CTNS	CTNS	606272	17p13	Renal	219750
775	401	Cystinuria, 220100 (3)	SLC3A1	SLC3A1, ATR1, D2H, NBAT	104614	2p16.3	Renal	220100
776	401	Cystinuria, type II (3)	SLC7A9	SLC7A9, CSNU3	604144	19q13.1	Renal	
777	401	Cystinuria, type III (3)	SLC7A9	SLC7A9, CSNU3	604144	19q13.1	Renal	
778	402	D-2-hydroxyglutaric aciduria, 600721 (3)	D2HGD	D2HGD	609186	2p25.3	Metabolic	600721
779	404	Darier disease, 124200 (3)	ATP2A2	ATP2A2, ATP2B, DAR	108740	12q23-q24.1	Dermatological	124200
780	405	D-bifunctional protein deficiency, 261515 (3)	HSD17B4	HSD17B4	601860	5q2	Metabolic	261515
781	406	Deafness, autosomal dominant 10, 601316 (3)	EYA4	EYA4, DFNA10, CMD1J	603550	6q23	Ear,Nose,Throat	601316
782	406	Deafness, autosomal dominant 1, 124900 (3)	DIAPH1	DIAPH1, DFNA1, LFHL1	602121	5q31	Ear,Nose,Throat	124900
783	406	Deafness, autosomal dominant 11, neurosensory, 601317 (3)	MYO7A	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	Ear,Nose,Throat	601317
784	406	Deafness, autosomal dominant 12, 601842 (3)	TECTA	TECTA, DFNA8, DFNA12, DFNB21	602574	11q22-q24	Ear,Nose,Throat	601842
785	406	Deafness, autosomal dominant 13, 601868 (3)	COL11A2	COL11A2, STL3, DFNA13	120290	6p21.3	Ear,Nose,Throat	601868
786	406	Deafness, autosomal dominant 15, 602459 (3)	POU4F3	POU4F3, BRN3C	602460	5q31	Ear,Nose,Throat	602459
787	406	Deafness, autosomal dominant 17, 603622 (3)	MYH9	MYH9, MHA, FTNS, DFNA17	160775	22q11.2	Ear,Nose,Throat	603622
788	406	Deafness, autosomal dominant 20/26, 604717 (3)	ACTG1	ACTG1, DFNA20, DFNA26	102560	17q25.3	Ear,Nose,Throat	604717
789	406	Deafness, autosomal dominant 22, 606346 (3)	MYO6	MYO6, DFNA22, DFNB37	600970	6q13	Ear,Nose,Throat	606346
790	406	Deafness, autosomal dominant 2, 600101 (3)	GJB3	GJB3, CX31, DFNA2	603324	1p35.1	Ear,Nose,Throat	600101
791	406	Deafness, autosomal dominant 2, 600101 (3)	KCNQ4	KCNQ4, DFNA2	603537	1p34	Ear,Nose,Throat	600101
792	406	Deafness, autosomal dominant 28, 608641 (3)	TFCP2L3	TFCP2L3, DFNA28	608576	8q22	Ear,Nose,Throat	608641
793	406	Deafness, autosomal dominant 3, 601544 (3)	GJB2	GJB2, CX26, DFNB1, PPK, DFNA3, KID, HID	121011	13q11-q12	Ear,Nose,Throat	601544
794	406	Deafness, autosomal dominant 3, 601544 (3)	GJB6	GJB6, CX30, DFNA3, HED, ED2	604418	13q12	Ear,Nose,Throat	601544
795	406	Deafness, autosomal dominant 36, 606705 (3)	TMC1	TMC1, DFNB7, DFNB11, DFNA36	606706	9q13-q21	Ear,Nose,Throat	606705
796	406	Deafness, autosomal dominant 36, with dentinogenesis, 605594 (3)	DSPP	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q21.3	Ear,Nose,Throat	605594
797	406	Deafness, autosomal dominant 40 (3)	CRYM	CRYM, DFNA40	123740	16p13.11-p12.3	Ear,Nose,Throat	40
798	406	Deafness, autosomal dominant 4, 600652 (3)	MYH14	MYH14, KIAA2034, DFNA4	608568	19q13.33	Ear,Nose,Throat	600652
799	406	Deafness, autosomal dominant 5 (3)	DFNA5	DFNA5	600994	7p15	Ear,Nose,Throat	5
800	406	Deafness, autosomal dominant 8, 601543 (3)	TECTA	TECTA, DFNA8, DFNA12, DFNB21	602574	11q22-q24	Ear,Nose,Throat	601543
801	406	Deafness, autosomal dominant 9, 601369 (3)	COCH	COCH, DFNA9	603196	14q12-q13	Ear,Nose,Throat	601369
802	406	Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)	MYO1A	MYO1A	601478	12q13-q15	Ear,Nose,Throat	607841
803	406	Deafness, autosomal dominant, with peripheral neuropathy (3)	GJB3	GJB3, CX31, DFNA2	603324	1p35.1	Ear,Nose,Throat	
804	406	Deafness, autosomal recessive 10, congenital, 605316 (3)	TMPRSS3	TMPRSS3, ECHOS1, DFNB8, DFNB10	605511	21q22.3	Ear,Nose,Throat	605316
805	406	Deafness, autosomal recessive 1, 220290 (3)	GJB2	GJB2, CX26, DFNB1, PPK, DFNA3, KID, HID	121011	13q11-q12	Ear,Nose,Throat	220290
806	406	Deafness, autosomal recessive 12, 601386 (3)	CDH23	CDH23, USH1D	605516	10q21-q22	Ear,Nose,Throat	601386
807	406	Deafness, autosomal recessive 12, modifier of, 601386 (3)	ATP2B2	ATP2B2, PMCA2	108733	3p26-p25	Ear,Nose,Throat	601386
808	406	Deafness, autosomal recessive 16, 603720 (3)	STRC	STRC, DFNB16	606440	15q15	Ear,Nose,Throat	603720
809	406	Deafness, autosomal recessive 18, 602092 (3)	USH1C	USH1C, DFNB18	605242	11p15.1	Ear,Nose,Throat	602092
810	406	Deafness, autosomal recessive 21, 603629 (3)	TECTA	TECTA, DFNA8, DFNA12, DFNB21	602574	11q22-q24	Ear,Nose,Throat	603629
811	406	Deafness, autosomal recessive 22, 607039 (3)	OTOA	OTOA, DFNB22	607038	16p12.2	Ear,Nose,Throat	607039
812	406	Deafness, autosomal recessive 23, 609533 (3)	PCDH15	PCDH15, DFNB23	605514	10q21-q22	Ear,Nose,Throat	609533
813	406	Deafness, autosomal recessive 29 (3)	CLDN14	CLDN14, DFNB29	605608	21q22.3	Ear,Nose,Throat	29
919	457	Dysfibrinogenemia, alpha type, causing bleeding diathesis (3)	FGA	FGA	134820	4q28	Hematological	
814	406	Deafness, autosomal recessive 2, neurosensory, 600060 (3)	MYO7A	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	Ear,Nose,Throat	600060
815	406	Deafness, autosomal recessive 30, 607101 (3)	MYO3A	MYO3A, DFNB30	606808	10p11.1	Ear,Nose,Throat	607101
816	406	Deafness, autosomal recessive 31, 607084 (3)	WHRN	WHRN, CIP98, KIAA1526, DFNB31	607928	9q32-q34	Ear,Nose,Throat	607084
817	406	Deafness, autosomal recessive 3, 600316 (3)	MYO15A	MYO15A, DFNB3	602666	17p11.2	Ear,Nose,Throat	600316
818	406	Deafness, autosomal recessive 36, 609006 (3)	ESPN	ESPN	606351	1p36.3-p36.1	Ear,Nose,Throat	609006
819	406	Deafness, autosomal recessive 37, 607821 (3)	MYO6	MYO6, DFNA22, DFNB37	600970	6q13	Ear,Nose,Throat	607821
820	406	Deafness, autosomal recessive (3)	GJB3	GJB3, CX31, DFNA2	603324	1p35.1	Ear,Nose,Throat	
821	406	Deafness, autosomal recessive 4, 600791 (3)	SLC26A4	SLC26A4, PDS, DFNB4	605646	7q31	Ear,Nose,Throat	600791
822	406	Deafness, autosomal recessive 61 (3)	PRES	PRES, DFNB61, SLC26A5	604943	7q22.1	Ear,Nose,Throat	61
823	406	Deafness, autosomal recessive 6, 600971 (3)	TMIE	TMIE, DFNB6	607237	3p21	Ear,Nose,Throat	600971
824	406	Deafness, autosomal recessive 7, 600974 (3)	TMC1	TMC1, DFNB7, DFNB11, DFNA36	606706	9q13-q21	Ear,Nose,Throat	600974
825	406	Deafness, autosomal recessive 8, childhood onset, 601072 (3)	TMPRSS3	TMPRSS3, ECHOS1, DFNB8, DFNB10	605511	21q22.3	Ear,Nose,Throat	601072
826	406	Deafness, autosomal recessive 9, 601071 (3)	OTOF	OTOF, DFNB9, NSRD9	603681	2p23-p22	Ear,Nose,Throat	601071
827	406	Deafness, congenital heart defects, and posterior embryotoxon (3)	JAG1	JAG1, AGS, AHD	601920	20p12	Ear,Nose,Throat	
828	406	Deafness, nonsyndromic (3) ()	KIAA1199	KIAA1199	608366	15q24	Ear,Nose,Throat	-3
829	406	Deafness, nonsyndromic neurosensory, digenic (3)	GJB6	GJB6, CX30, DFNA3, HED, ED2	604418	13q12	Ear,Nose,Throat	
830	406	Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)	MYO6	MYO6, DFNA22, DFNB37	600970	6q13	Ear,Nose,Throat	606346
831	406	Deafness, X-linked 1, progressive (3)	TIMM8A	TIMM8A, DFN1, DDP, MTS, DDP1	300356	Xq22	Ear,Nose,Throat	
832	406	Deafness, X-linked 3, conductive, with stapes fixation, 304400 (3)	POU3F4	POU3F4, DFN3	300039	Xq21.1	Ear,Nose,Throat	304400
833	407	Debrisoquine sensitivity (3)	CYP2D@	CYP2D@, CYP2D, P450C2D	124030	22q13.1	Metabolic	
834	410	Dejerine-Sottas disease, 145900 (3)	PMP22	PMP22, CMT1A, CMT1E, DSS	601097	17p11.2	multiple	145900
835	410	Dejerine-Sottas neuropathy, 145900 (3)	EGR2	EGR2, KROX20	129010	10q21.1-q22.1	multiple	145900
836	410	Dejerine-Sottas neuropathy, autosomal recessive, 145900 (3)	PRX	PRX, CMT4F	605725	19q13.1-q13.2	multiple	145900
837	410	Dejerine-Sottas syndrome, 145900 (3)	MPZ	MPZ, CMT1B, CMTDI3, CHM, DSS	159440	1q22	multiple	145900
838	411	Delayed sleep phase syndrome, susceptibility to (3)	AANAT	AANAT, SNAT	600950	17q25	Psychiatric	
839	412	Dementia, familial British, 176500 (3)	ITM2B	ITM2B, BRI, ABRI, FBD	603904	13q14	Neurological	176500
840	412	Dementia, familial Danish, 117300 (3)	ITM2B	ITM2B, BRI, ABRI, FBD	603904	13q14	Neurological	117300
841	412	Dementia, frontotemporal, 600274 (3)	PSEN1	PSEN1, AD3	104311	14q24.3	Neurological	600274
842	412	Dementia, frontotemporal, with parkinsonism, 600274 (3)	MAPT	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.1	Neurological	600274
843	412	Dementia, Lewy body, 127750 (3)	SNCA	SNCA, NACP, PARK1, PARK4	163890	4q21	Neurological	127750
844	412	Dementia, Lewy body, 127750 (3)	SNCB	SNCB	602569	5q35	Neurological	127750
845	412	Dementia, Pick disease-like, 172700 (3)	MAPT	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.1	Neurological	172700
846	412	Dementia, vascular, susceptibility to (3)	TNF	TNF, TNFA	191160	6p21.3	Neurological	
847	413	Dengue fever, protection against (3)	CD209	CD209, CDSIGN	604672	19p13.3	Immunological	
848	414	Dental anomalies, isolated (3)	RUNX2	RUNX2, CBFA1, PEBP2A1, AML3	600211	6p21	Skeletal	
849	415	Dentatorubro-pallidoluysian atrophy, 125370 (3)	DRPLA	DRPLA	607462	12p13.31	Neurological	125370
850	416	Dent disease, 300009 (3)	CLCN5	CLCN5, CLCK2, NPHL2, DENTS	300008	Xp11.22	Renal	300009
851	417	Dentin dysplasia, type II, 125420 (3)	DSPP	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q21.3	Bone	125420
852	418	Dentinogenesis imperfecta, Shields type II, 125490 (3)	DSPP	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q21.3	Bone	125490
853	418	Dentinogenesis imperfecta, Shields type III, 125500 (3)	DSPP	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q21.3	Bone	125500
854	416	Dent syndrome, 300009 (3)	OCRL	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	Renal	300009
855	420	Denys-Drash syndrome, 194080 (3)	WT1	WT1	607102	11p13	Renal	194080
856	422	Dermatofibrosarcoma protuberans (3)	PDGFB	PDGFB, SIS	190040	22q12.3-q13.1	Cancer	
857	424	De Sanctis-Cacchione syndrome, 278800 (3)	ERCC6	ERCC6, CKN2, COFS, CSB	609413	10q11	multiple	278800
858	425	Desmoid disease, hereditary, 135290 (3)	APC	APC, GS, FPC	175100	5q21-q22	Cancer	135290
859	426	Desmosterolosis, 602398 (3)	DHCR24	DHCR24, KIAA0018	606418	1p33-p31.1	Metabolic	602398
860	2427	Diabetes insipidus, nephrogenic, 304800 (3)	AVPR2	AVPR2, DIR, DI1, ADHR	300538	Xq28	Endocrine	304800
861	2427	Diabetes insipidus, nephrogenic, autosomal dominant, 125800 (3)	AQP2	AQP2	107777	12q13	Endocrine	125800
862	2427	Diabetes insipidus, nephrogenic, autosomal recessive, 222000 (3)	AQP2	AQP2	107777	12q13	Endocrine	222000
863	2427	Diabetes insipidus, neurohypophyseal, 125700 (3)	AVP	AVP, AVRP, VP	192340	20p13	Endocrine	125700
864	427	Diabetes mellitus, 125853 (3)	ABCC8	ABCC8, SUR, PHHI, SUR1	600509	11p15.1	Endocrine	125853
865	427	Diabetes mellitus, insulin-dependent, 222100 (3)	TCF1	TCF1, HNF1A, MODY3	142410	12q24.2	Endocrine	222100
866	427	Diabetes mellitus, insulin-dependent, 5, 600320 (3)	SUMO4	SUMO4, IDDM5	608829	6q25	Endocrine	600320
867	427	Diabetes mellitus, insulin-dependent, susceptibility to, 222100 (3)	PTPN8	PTPN8, PEP, PTPN22, LYP	600716	1p13	Endocrine	222100
868	427	Diabetes mellitus, insulin-resistant, with acanthosis nigricans (3)	INSR	INSR	147670	19p13.2	Endocrine	
869	427	Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension, 604367 (3)	PPARG	PPARG, PPARG1, PPARG2	601487	3p25	Endocrine	604367
870	427	Diabetes mellitus, neonatal-onset, 606176 (3)	GCK	GCK	138079	7p15-p13	Endocrine	606176
871	427	Diabetes mellitus, noninsulin-dependent, 125853 (3)	GCGR	GCGR	138033	17q25	Endocrine	125853
872	427	Diabetes mellitus, noninsulin-dependent, 125853 (3)	GPD2	GPD2	138430	2q24.1	Endocrine	125853
873	427	Diabetes mellitus, noninsulin-dependent, 125853 (3)	HNF4A	HNF4A, TCF14, MODY1	600281	20q12-q13.1	Endocrine	125853
874	427	Diabetes mellitus, noninsulin-dependent, 125853 (3)	IRS2	IRS2	600797	13q34	Endocrine	125853
875	427	Diabetes mellitus, noninsulin-dependent, 125853 (3)	MAPK8IP1	MAPK8IP1, IB1	604641	11p12-p11.2	Endocrine	125853
876	427	Diabetes mellitus, noninsulin-dependent, 125853 (3)	NEUROD1	NEUROD1, NIDDM	601724	2q32	Endocrine	125853
877	427	Diabetes mellitus, noninsulin-dependent, 125853 (3)	TCF2	TCF2, HNF2	189907	17cen-q21.3	Endocrine	125853
878	427	Diabetes mellitus, noninsulin-dependent, 2, 125853 (3)	TCF1	TCF1, HNF1A, MODY3	142410	12q24.2	Endocrine	125853
879	427	Diabetes mellitus, noninsulin-dependent (3)	IRS1	IRS1	147545	2q36	Endocrine	
880	427	Diabetes mellitus, noninsulin-dependent (3)	SLC2A2	SLC2A2, GLUT2	138160	3q26.1-q26.3	Endocrine	
881	427	Diabetes mellitus, noninsulin-dependent (3)	SLC2A4	SLC2A4, GLUT4	138190	17p13	Endocrine	
882	427	Diabetes mellitus, noninsulin-dependent, 601283 (3)	CAPN10	CAPN10	605286	2q37.3	Endocrine	601283
883	427	Diabetes mellitus, non-insulin-dependent, susceptibility to, 125853 (3)	ENPP1	ENPP1, PDNP1, NPPS, M6S1, PCA1	173335	6q22-q23	Endocrine	125853
884	427	Diabetes mellitus, noninsulin-dependent, susceptibility to, 125853 (3)	RETN	RETN, RSTN, FIZZ3	605565	19p13.2	Endocrine	125853
885	427	Diabetes mellitus, permanent neonatal, with cerebellar agenesis, 609069 (3)	PTF1A	PTF1A	607194	10p12.3	Endocrine	609069
886	427	Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3)	KCNJ11	KCNJ11, BIR, PHHI	600937	11p15.1	Endocrine	606176
887	427	Diabetes mellitus, type II, 125853 (3)	AKT2	AKT2	164731	19q13.1-q13.2	Endocrine	125853
888	427	Diabetes mellitus, type II, susceptibility to, 125853 (3)	IPF1	IPF1	600733	13q12.1	Endocrine	125853
889	427	Diabetes mellitus, type I, susceptibility to, 222100 (3)	FOXP3	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23-q13.3	Endocrine	222100
890	427	Diabetes, permanent neonatal, 606176 (3)	KCNJ11	KCNJ11, BIR, PHHI	600937	11p15.1	Endocrine	606176
891	427	Diabetic nephropathy, susceptibility to, 603933 (3)	ACE	ACE, DCP1, ACE1	106180	17q23	Endocrine	603933
892	427	Diabetic retinopathy, NIDDM-related, susceptibility to, 125853 (3)	VEGF	VEGF	192240	6p12	Endocrine	125853
893	430	Diastrophic dysplasia, 222600 (3)	SLC26A2	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32-q33.1	Skeletal	222600
894	430	Diastrophic dysplasia, broad bone-platyspondylic variant (3)	SLC26A2	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32-q33.1	Skeletal	
895	432	DiGeorge syndrome, 188400 (3)	TBX1	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.2	multiple	188400
896	433	Dihydropyrimidinuria (3)	DPYS	DPYS, DHP	222748	8q22	Metabolic	
897	434	Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3)	DSP	DSP, KPPS2, PPKS2	125647	6p24	multiple	605676
898	435	Dimethylglycine dehydrogenase deficiency, 605850 (3)	DMGDH	DMGDH, DMGDHD	605849	5q12.2-q12.3	Metabolic	605850
899	438	Disordered steroidogenesis, isolated (3)	POR	POR	124015	7q11.2	Metabolic	
900	439	Dissection of cervical arteries (3)	COL1A1	COL1A1	120150	17q21.31-q22	Connective tissue	
901	2440	DNA ligase I deficiency (3)	LIG1	LIG1	126391	19q13.2-q13.3	multiple	
902	440	DNA topoisomerase I, camptothecin-resistant (3)	TOP1	TOP1	126420	20q12-q13.1	Metabolic	
903	440	DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)	TOP2A	TOP2A, TOP2	126430	17q21-q22	Metabolic	
904	441	Dopamine-beta-hydroxylase activity levels, plasma (3)	DBH	DBH	609312	9q34	Metabolic	
905	441	Dopamine beta-hydroxylase deficiency, 223360 (3)	DBH	DBH	609312	9q34	Metabolic	223360
906	443	Dosage-sensitive sex reversal, 300018 (3)	DAX1	DAX1, AHC, AHX, NROB1	300473	Xp21.3-p21.2	Endocrine	300018
907	444	Double-outlet right ventricle, 217095 (3)	CFC1	CFC1, CRYPTIC, HTX2	605194	2q21.1	Cardiovascular	217095
908	445	Down syndrome, risk of, 190685 (3)	MTR	MTR	156570	1q43	multiple	190685
909	446	Doyne honeycomb degeneration of retina, 126600 (3)	EFEMP1	EFEMP1, FBNL, DHRD	601548	2p16	Ophthamological	126600
910	447	Drug addiction, susceptibility to (3)	FAAH	FAAH	602935	1p35-p34	Psychiatric	
911	449	Duane-radial ray syndrome, 607323 (3)	SALL4	SALL4, HSAL4	607343	20q13.13-q13.2	multiple	607323
912	450	Dubin-Johnson syndrome, 237500 (3)	ABCC2	ABCC2, CMOAT	601107	10q24	Metabolic	237500
913	451	Duchenne muscular dystrophy, 310200 (3)	DMD	DMD, BMD	300377	Xp21.2	Muscular	310200
914	452	Dyggve-Melchior-Clausen disease, 223800 (3)	DYM	DYM, FLJ90130, DMC, SMC	607461	18q12-q21.1	multiple	223800
915	453	Dysalbuminemic hyperthyroxinemia (3)	ALB	ALB	103600	4q11-q13	Hematological	
916	454	Dysautonomia, familial, 223900 (3)	IKBKAP	IKBKAP, IKAP	603722	9q31	Neurological	223900
917	455	Dyschromatosis symmetrica hereditaria, 127400 (3)	ADAR	ADAR, DRADA, DSH, DSRAD	601059	1q21.3	Dermatological	127400
918	456	Dyserythropoietic anemia with thrombocytopenia, 300367 (3)	GATA1	GATA1, GF1, ERYF1, NFE1	305371	Xp11.23	Hematological	300367
920	457	Dysfibrinogenemia, alpha type, causing recurrent thrombosis (3)	FGA	FGA	134820	4q28	Hematological	
921	457	Dysfibrinogenemia, beta type (3)	FGB	FGB	134830	4q28	Hematological	
922	457	Dysfibrinogenemia, gamma type (3)	FGG	FGG	134850	4q28	Hematological	
923	458	Dyskeratosis congenita-1, 305000 (3)	DKC1	DKC1, DKC	300126	Xq28	Dermatological	305000
924	458	Dyskeratosis congenita, autosomal dominant, 127550 (3)	TERC	TERC, TRC3, TR	602322	3q21-q28	Dermatological	127550
925	459	Dyslexia, susceptibility to, 1, 127700 (3)	DYX1C1	DYX1C1, DYXC1, DYX1	608706	15q21	Psychiatric	127700
926	459	Dyslexia, susceptibility to, 2, 600202 (3)	KIAA0319	KIAA0319, DYX2, DYLX2, DLX2	609269	6p22.2	Psychiatric	600202
927	460	Dysprothrombinemia (3)	F2	F2	176930	11p11-q12	Hematological	
928	461	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	HSPG2	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.1	Neurological	224410
929	462	Dystonia-12, 128235 (3)	ATP1A3	ATP1A3, DYT12, RDP	182350	19q12-q13.2	Neurological	128235
930	462	Dystonia-1, torsion, 128100 (3)	DYT1	DYT1, TOR1A	605204	9q34	Neurological	128100
931	462	Dystonia, DOPA-responsive, 128230 (3)	GCH1	GCH1, DYT5	600225	14q22.1-q22.2	Neurological	128230
932	462	Dystonia, early-onset atypical, with myoclonic features (3)	DYT1	DYT1, TOR1A	605204	9q34	Neurological	
933	462	Dystonia, myoclonic, 159900 (3)	DRD2	DRD2	126450	11q23	Neurological	159900
934	462	Dystonia, myoclonic, 159900 (3)	SGCE	SGCE, DYT11	604149	7q21	Neurological	159900
935	462	Dystonia, primary cervical (3)	DRD5	DRD5, DRD1B, DRD1L2	126453	4p16.1-p15.3	Neurological	
936	463	Dystransthyretinemic hyperthyroxinemia(3)	TTR	TTR, PALB	176300	18q11.2-q12.1	Hematological	
937	465	EBD, Bart type, 132000 (3)	COL7A1	COL7A1	120120	3p21.3	Dermatological	132000
938	465	EBD, localisata variant (3)	COL7A1	COL7A1	120120	3p21.3	Dermatological	
939	466	Ectodermal dysplasia-1, anhidrotic, 305100 (3)	ED1	ED1, EDA, HED	300451	Xq12-q13.1	Dermatological	305100
940	466	Ectodermal dysplasia 2, hidrotic, 129500 (3)	GJB6	GJB6, CX30, DFNA3, HED, ED2	604418	13q12	Dermatological	129500
941	466	Ectodermal dysplasia, anhidrotic, 224900 (3)	EDARADD	EDARADD	606603	1q42.2-q43	Dermatological	224900
942	466	Ectodermal dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)	IKBKG	IKBKG, NEMO, FIP3, IP2	300248	Xq28	Dermatological	300301
943	466	Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency (3)	NFKBIA	NFKBIA, IKBA	164008	14q13	Dermatological	
944	466	Ectodermal dysplasia, hypohidrotic, autosomal dominant, 129490 (3)	EDAR	EDAR, DL, ED3, EDA3	604095	2q11-q13	Dermatological	129490
945	466	Ectodermal dysplasia, hypohidrotic, autosomal recessive, 224900 (3)	EDAR	EDAR, DL, ED3, EDA3	604095	2q11-q13	Dermatological	224900
946	466	Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)	IKBKG	IKBKG, NEMO, FIP3, IP2	300248	Xq28	Dermatological	300291
947	466	Ectodermal dysplasia, Margarita Island type, 225060 (3)	HVEC	HVEC, PVRL1, PVRR1, PRR1	600644	11q23-q24	Dermatological	225060
948	466	Ectodermal dysplasia/skin fragility syndrome, 604536 (3)	PKP1	PKP1	601975	1q32	Dermatological	604536
949	467	Ectopia lentis, familial, 129600 (3)	FBN1	FBN1, MFS1, WMS	134797	15q21.1	Ophthamological	129600
950	467	Ectopia pupillae, 129750 (3)	PAX6	PAX6, AN2, MGDA	607108	11p13	Ophthamological	129750
951	468	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)	TP73L	TP73L, TP63, KET, EEC3, SHFM4, LMS, RHS	603273	3q27	Skeletal	604292
952	470	Ehlers-Danlos due to tenascin X deficiency, 606408 (3)	TNXB	TNXB, TNX, TNXB1, TNXBS, TNXB2	600985	6p21.3	Connective tissue	606408
953	470	Ehlers-Danlos syndrome, hypermobility type, 130020 (3)	TNXB	TNXB, TNX, TNXB1, TNXBS, TNXB2	600985	6p21.3	Connective tissue	130020
954	470	Ehlers-Danlos syndrome, progeroid form, 130070 (3)	B4GALT7	B4GALT7, XGALT1, XGPT1	604327	5q35.2-q35.3	Connective tissue	130070
955	470	Ehlers-Danlos syndrome, type I, 130000 (3)	COL1A1	COL1A1	120150	17q21.31-q22	Connective tissue	130000
956	470	Ehlers-Danlos syndrome, type I, 130000 (3)	COL5A1	COL5A1	120215	9q34.2-q34.3	Connective tissue	130000
957	470	Ehlers-Danlos syndrome, type I, 130000 (3)	COL5A2	COL5A2	120190	2q31	Connective tissue	130000
958	470	Ehlers-Danlos syndrome, type II, 130010 (3)	COL5A1	COL5A1	120215	9q34.2-q34.3	Connective tissue	130010
959	470	Ehlers-Danlos syndrome, type III, 130020 (3)	COL3A1	COL3A1	120180	2q31	Connective tissue	130020
960	470	Ehlers-Danlos syndrome, type IV, 130050 (3)	COL3A1	COL3A1	120180	2q31	Connective tissue	130050
961	470	Ehlers-Danlos syndrome, type VI, 225400 (3)	PLOD	PLOD, PLOD1	153454	1p36.3-p36.2	Connective tissue	225400
962	470	Ehlers-Danlos syndrome, type VII, 130060 (3)	COL1A1	COL1A1	120150	17q21.31-q22	Connective tissue	130060
963	470	Ehlers-Danlos syndrome, type VIIA2, 130060 (3)	COL1A2	COL1A2	120160	7q22.1	Connective tissue	130060
964	470	Ehlers-Danlos syndrome, type VIIC, 225410 (3)	ADAMTS2	ADAMTS2, NPI	604539	5q23	Connective tissue	225410
965	471	Elite sprint athletic performance (3)	ACTN3	ACTN3	102574	11q13-q14	Muscular	
966	472	Elliptocytosis-1 (3)	EPB41	EPB41, EL1	130500	1p36.2-p34	Hematological	
967	472	Elliptocytosis-2 (3)	SPTA1	SPTA1	182860	1q21	Hematological	
968	472	Elliptocytosis-3 (3)	SPTB	SPTB	182870	14q22-q23.2	Hematological	
969	472	Elliptocytosis, Malaysian-Melanesian type (3)	SLC4A1	SLC4A1, AE1, EPB3	109270	17q21-q22	Hematological	
970	473	Ellis-van Creveld syndrome, 225500 (3)	EVC	EVC	604831	4p16	Skeletal	225500
971	473	Ellis-van Creveld syndrome, 225500 (3)	LBN	LBN, EVC2	607261	4p16	Skeletal	225500
972	474	Emery-Dreifuss muscular dystrophy, 310300 (3)	EMD	EMD, EDMD, STA	300384	Xq28	Muscular	310300
973	474	Emery-Dreifuss muscular dystrophy, AD, 181350 (3)	LMNA	LMNA, LMN1, EMD2, FPLD, CMD1A, HGPS, LGMD1B	150330	1q21.2	Muscular	181350
974	474	Emery-Dreifuss muscular dystrophy, AR, 604929 (3)	LMNA	LMNA, LMN1, EMD2, FPLD, CMD1A, HGPS, LGMD1B	150330	1q21.2	Muscular	604929
975	475	Emphysema (3)	PI	PI, AAT	107400	14q32.1	Respiratory	
976	475	Emphysema-cirrhosis (3)	PI	PI, AAT	107400	14q32.1	Respiratory	
977	476	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)	SERPINI1	SERPINI1, PI12	602445	3q26	Neurological	604218
978	476	Encephalopathy, progressive mitochondrial, with proximal renal tubulopathy due to cytochrome c oxidase deficiency (3)	COX10	COX10	602125	17p12-p11.2	Neurological	
979	477	Enchondromatosis, Ollier type, 166000 (3)	PTHR1	PTHR1, PTHR	168468	3p22-p21.1	Cancer	166000
980	479	Endometrial carcinoma (3)	CDH1	CDH1, UVO	192090	16q22.1	Cancer	
981	479	Endometrial carcinoma (3)	MSH3	MSH3	600887	5q11-q12	Cancer	
982	479	Endometrial carcinoma (3)	MSH6	MSH6, GTBP, HNPCC5	600678	2p16	Cancer	
983	479	Endometrial carcinoma (3)	PTEN	PTEN, MMAC1	601728	10q23.31	Cancer	
984	481	Endotoxin hyporesponsiveness (3)	TLR4	TLR4	603030	9q32-q33	Immunological	
985	482	Endplate acetylcholinesterase deficiency, 603034 (3)	COLQ	COLQ, EAD	603033	3p25	Neurological	603034
986	483	Enhanced S-cone syndrome, 268100 (3)	NR2E3	NR2E3, PNR, ESCS	604485	15q23	Ophthamological	268100
987	484	Enlarged vestibular aqueduct, 603545 (3)	SLC26A4	SLC26A4, PDS, DFNB4	605646	7q31	Ear,Nose,Throat	603545
988	485	Enolase-beta deficiency (3)	ENO3	ENO3	131370	17pter-p12	Metabolic	
989	487	Enterokinase deficiency, 226200 (3)	PRSS7	PRSS7, ENTK	606635	21q21	Gastrointestinal	226200
990	491	Eosinophil peroxidase deficiency, 261500 (3)	EPX	EPX	131399	17q23.1	Hematological	261500
991	492	Epidermodysplasia verruciformis, 226400 (3)	EVER1	EVER1, EV1	605828	17q25	Dermatological	226400
992	492	Epidermodysplasia verruciformis, 226400 (3)	EVER2	EVER2, EV2	605829	17q25	Dermatological	226400
993	493	Epidermolysis bullosa dystrophica, AD, 131750 (3)	COL7A1	COL7A1	120120	3p21.3	Dermatological	131750
994	493	Epidermolysis bullosa dystrophica, AR, 226600 (3)	COL7A1	COL7A1	120120	3p21.3	Dermatological	226600
995	493	Epidermolysis bullosa, generalized atrophic benign, 226650 (3)	COL17A1	COL17A1, BPAG2	113811	10q24.3	Dermatological	226650
996	493	Epidermolysis bullosa, generalized atrophic benign, 226650 (3)	ITGB4	ITGB4	147557	17q11-qter	Dermatological	226650
997	493	Epidermolysis bullosa, generalized atrophic benign, 226650 (3)	LAMA3	LAMA3, LOCS	600805	18q11.2	Dermatological	226650
998	493	Epidermolysis bullosa, generalized atrophic benign, 226650 (3)	LAMB3	LAMB3	150310	1q32	Dermatological	226650
999	493	Epidermolysis bullosa, generalized atrophic benign, 226650 (3)	LAMC2	LAMC2, LAMNB2, LAMB2T	150292	1q25-q31	Dermatological	226650
1000	493	Epidermolysis bullosa, Herlitz junctional type, 226700 (3)	LAMB3	LAMB3	150310	1q32	Dermatological	226700
1001	493	Epidermolysis bullosa, Herlitz junctional type, 226700 (3)	LAMC2	LAMC2, LAMNB2, LAMB2T	150292	1q25-q31	Dermatological	226700
1002	493	Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)	LAMA3	LAMA3, LOCS	600805	18q11.2	Dermatological	226700
1003	493	Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)	ITGB4	ITGB4	147557	17q11-qter	Dermatological	226730
1004	493	Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)	ITGA6	ITGA6	147556	Chr.2	Dermatological	226730
1005	493	Epidermolysis bullosa, lethal acantholytic, 609638 (3)	DSP	DSP, KPPS2, PPKS2	125647	6p24	Dermatological	609638
1006	493	Epidermolysis bullosa of hands and feet, 131800 (3)	ITGB4	ITGB4	147557	17q11-qter	Dermatological	131800
1007	493	Epidermolysis bullosa, pretibial, 131850 (3)	COL7A1	COL7A1	120120	3p21.3	Dermatological	131850
1008	493	Epidermolysis bullosa pruriginosa, 604129 (3)	COL7A1	COL7A1	120120	3p21.3	Dermatological	604129
1009	493	Epidermolysis bullosa simplex, Koebner, Dowling-Meara, and Weber-Cockayne types, 131900, 131760, 131800 (3)	KRT14	KRT14	148066	17q12-q21	Dermatological	131800
1010	493	Epidermolysis bullosa simplex, Koebner, Dowling-Meara, and Weber-Cockayne types, 131900, 131760, 131800 (3)	KRT5	KRT5	148040	12q13	Dermatological	131800
1011	493	Epidermolysis bullosa simplex, Ogna type, 131950 (3)	PLEC1	PLEC1, PLTN, EBS1	601282	8q24	Dermatological	131950
1012	493	Epidermolysis bullosa simplex, recessive, 601001 (3)	KRT14	KRT14	148066	17q12-q21	Dermatological	601001
1013	493	Epidermolysis bullosa simplex with mottled pigmentation, 131960 (3)	KRT5	KRT5	148040	12q13	Dermatological	131960
1014	494	Epidermolytic hyperkeratosis, 113800 (3)	KRT10	KRT10	148080	17q21-q22	Dermatological	113800
1015	494	Epidermolytic hyperkeratosis, 113800 (3)	KRT1	KRT1	139350	12q13	Dermatological	113800
1016	494	Epidermolytic palmoplantar keratoderma, 144200 (3)	KRT9	KRT9, EPPK	607606	17q12-q21	Dermatological	144200
1017	495	Epilepsy, benign, neonatal, type 1, 121200 (3)	KCNQ2	KCNQ2, EBN1	602235	20q13.3	Neurological	121200
1018	495	Epilepsy, benign neonatal, type 2, 121201 (3)	KCNQ3	KCNQ3, EBN2, BFNC2	602232	8q24	Neurological	121201
1019	495	Epilepsy, childhood absence, 607681 (3)	GABRG2	GABRG2, GEFSP3, CAE2, ECA2	137164	5q31.1-q33.1	Neurological	607681
1020	495	Epilepsy, childhood absence, 607682 (3)	CLCN2	CLCN2, EGMA, ECA3, EGI3	600570	3q26-qter	Neurological	607682
1021	495	Epilepsy, childhood absence, evolving to juvenile myoclonic epilepsy (3)	JRK	JRK, JH8	603210	8q24	Neurological	
1022	495	Epilepsy, generalized idiopathic, 600669 (3)	CACNB4	CACNB4, EJM	601949	2q22-q23	Neurological	600669
1023	495	Epilepsy, generalized, with febrile seizures plus, 604233 (3)	GABRG2	GABRG2, GEFSP3, CAE2, ECA2	137164	5q31.1-q33.1	Neurological	604233
1078	520	Factor H and factor H-like 1 (3)	HF1	HF1, CFH, HUS	134370	1q32	Hematological	1
1024	495	Epilepsy, generalized, with febrile seizures plus, type 2, 604233 (3)	SCN1A	SCN1A, GEFSP2, SMEI	182389	2q24	Neurological	604233
1025	495	Epilepsy, idopathic generalized, susceptibility to, 600669 (3)	ME2	ME2	154270	18q21	Neurological	600669
1026	495	Epilepsy, juvenile absence, 607631 (3)	CLCN2	CLCN2, EGMA, ECA3, EGI3	600570	3q26-qter	Neurological	607631
1027	495	Epilepsy, juvenile myoclonic, 606904 (3)	CACNB4	CACNB4, EJM	601949	2q22-q23	Neurological	606904
1028	495	Epilepsy, juvenile myoclonic, 606904 (3)	CLCN2	CLCN2, EGMA, ECA3, EGI3	600570	3q26-qter	Neurological	606904
1029	495	Epilepsy, juvenile myoclonic, 606904 (3)	GABRA1	GABRA1, EJM	137160	5q34-q35	Neurological	606904
1030	495	Epilepsy, myoclonic, Lafora type, 254780 (3)	EPM2A	EPM2A, MELF, EPM2	607566	6q24	Neurological	254780
1031	495	Epilepsy, myoclonic, Lafora type, 254780 (3)	NHLRC1	NHLRC1, EPM2A, EPM2B	608072	6p22.3	Neurological	254780
1032	495	Epilepsy, neonatal myoclonic, with suppression-burst pattern, 609304 (3)	SLC25A22	SLC25A22, GC1	609302	11p15.5	Neurological	609304
1033	495	Epilepsy, nocturnal frontal lobe, 1, 600513 (3)	CHRNA4	CHRNA4, ENFL1	118504	20q13.2-q13.3	Neurological	600513
1034	495	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)	CHRNB2	CHRNB2, EFNL3	118507	1q21	Neurological	605375
1035	495	Epilepsy, partial, with auditory features, 600512 (3)	LGI1	LGI1, EPT, ETL1	604619	10q24	Neurological	600512
1036	495	Epilepsy, progressive myoclonic 1, 254800 (3)	CSTB	CSTB, STFB, EPM1	601145	21q22.3	Neurological	254800
1037	495	Epilepsy, progressive myoclonic 2B, 254780 (3)	NHLRC1	NHLRC1, EPM2A, EPM2B	608072	6p22.3	Neurological	254780
1038	495	Epilepsy, severe myoclonic, of infancy, 607208 (3)	SCN1A	SCN1A, GEFSP2, SMEI	182389	2q24	Neurological	607208
1039	495	Epilepsy with grand mal seizures on awakening, 607628 (3)	CLCN2	CLCN2, EGMA, ECA3, EGI3	600570	3q26-qter	Neurological	607628
1040	495	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)	SYN1	SYN1	313440	Xp11.4-p11.2	Neurological	300491
1041	496	Epiphyseal dysplasia, multiple 1, 132400 (3)	COMP	COMP, EDM1, MED, PSACH	600310	19p13.1	Bone	132400
1042	496	Epiphyseal dysplasia, multiple, 226900 (3)	SLC26A2	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32-q33.1	Bone	226900
1043	496	Epiphyseal dysplasia, multiple, 3, 600969 (3)	COL9A3	COL9A3, EDM3, IDD	120270	20q13.3	Bone	600969
1044	496	Epiphyseal dysplasia, multiple, 5, 607078 (3)	MATN3	MATN3, EDM5, HOA	602109	2p24-p23	Bone	607078
1045	496	Epiphyseal dysplasia, multiple, COL9A1-related (3)	COL9A1	COL9A1, MED	120210	6q13	Bone	
1046	496	Epiphyseal dysplasia, multiple, type 2, 600204 (3)	COL9A2	COL9A2, EDM2	120260	1p33-p32.2	Bone	600204
1047	496	Epiphyseal dysplasia, multiple, with myopathy (3)	COL9A3	COL9A3, EDM3, IDD	120270	20q13.3	Bone	
1048	497	Episodic ataxia/myokymia syndrome, 160120 (3)	KCNA1	KCNA1, AEMK, EA1	176260	12p13	Neurological	160120
1049	497	Episodic ataxia, type 2, 108500 (3)	CACNA1A	CACNA1A, CACNL1A4, SCA6	601011	19p13	Neurological	108500
1050	498	Epithelial ovarian cancer, somatic, 604370 (3)	OPCML	OPCML	600632	11q25	Cancer	604370
1051	500	Epstein syndrome, 153650 (3)	MYH9	MYH9, MHA, FTNS, DFNA17	160775	22q11.2	Hematological	153650
1052	502	Erythermalgia, primary, 133020 (3)	SCN9A	SCN9A, NENA, PN1	603415	2q24	Neurological	133020
1053	504	Erythremias, alpha-(3)	HBA1	HBA1	141800	16pter-p13.3	Hematological	
1054	504	Erythremias, beta-(3)	HBB	HBB	141900	11p15.5	Hematological	
1055	505	Erythrocytosis (3)	HBA2	HBA2	141850	16pter-p13.3	Hematological	
1056	505	Erythrocytosis, familial, 133100 (3)	EPOR	EPOR	133171	19p13.3-p13.2	Hematological	133100
1057	507	Erythrokeratoderma, progressive symmetric, 602036 (3)	LOR	LOR	152445	1q21	Dermatological	602036
1058	507	Erythrokeratodermia variabilis, 133200 (3)	GJB3	GJB3, CX31, DFNA2	603324	1p35.1	Dermatological	133200
1059	507	Erythrokeratodermia variabilis with erythema gyratum repens, 133200 (3)	GJB4	GJB4, CX30.3	605425	1p35.1	Dermatological	133200
1060	508	Esophageal cancer, 133239 (3)	TGFBR2	TGFBR2, HNPCC6	190182	3p22	Cancer	133239
1061	508	Esophageal carcinoma, somatic, 133239 (3)	RNF6	RNF6	604242	13q12.11	Cancer	133239
1062	508	Esophageal squamous cell carcinoma, 133239 (3)	LZTS1	LZTS1, F37, FEZ1	606551	8p22	Cancer	133239
1063	508	Esophageal squamous cell carcinoma, 133239 (3)	WWOX	WWOX, FOR	605131	16q23.3-q24.1	Cancer	133239
1064	509	Estrogen resistance (3)	ESR1	ESR1, ESR	133430	6q25.1	Endocrine	
1065	510	Ethylmalonic encephalopathy, 602473 (3)	ETHE1	ETHE1, HSCO, D83198	608451	19q13.32	Metabolic	602473
1066	511	Ewing sarcoma (3)	EWSR1	EWSR1, EWS	133450	22q12	Cancer	
1067	512	Exertional myoglobinuria due to deficiency of LDH-A (3)	LDHA	LDHA, LDH1	150000	11p15.4	Metabolic	
1068	514	Exostoses, multiple, type 1, 133700 (3)	EXT1	EXT1	608177	8q24.11-q24.13	Bone	133700
1069	514	Exostoses, multiple, type 2, 133701 (3)	EXT2	EXT2	608210	11p12-p11	Bone	133701
1070	515	Exudative vitreoretinopathy, 133780 (3)	FZD4	FZD4, EVR1	604579	11q14-q21	Ophthamological	133780
1071	515	Exudative vitreoretinopathy, dominant, 133780 (3)	LRP5	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2	603506	11q13.4	Ophthamological	133780
1072	515	Exudative vitreoretinopathy, recessive, 601813 (3)	LRP5	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2	603506	11q13.4	Ophthamological	601813
1073	515	Exudative vitreoretinopathy, X-linked, 305390 (3)	NDP	NDP, ND	310600	Xp11.4	Ophthamological	305390
1074	516	Eye anomalies, multiplex (3)	PAX6	PAX6, AN2, MGDA	607108	11p13	Ophthamological	
1075	517	Ezetimibe, nonresponse to (3)	NPC1L1	NPC1L1	608010	7p13	Unclassified	
1076	518	Fabry disease (3)	GLA	GLA	301500	Xq22	Metabolic	
1077	519	Facioscapulohumeral muscular dystrophy-1A (3)	FSHMD1A	FSHMD1A, FSHD1A	158900	4q35	Muscular	
1079	520	Factor V and factor VIII, combined deficiency of, 227300 (3)	MCFD2	MCFD2	607788	2p21-p16.3	Hematological	227300
1080	520	Factor VII deficiency (3)	F7	F7	227500	13q34	Hematological	
1081	520	Factor X deficiency (3)	F10	F10	227600	13q34	Hematological	
1082	520	Factor XI deficiency, autosomal dominant (3)	F11	F11	264900	4q35	Hematological	
1083	520	Factor XI deficiency, autosomal recessive (3)	F11	F11	264900	4q35	Hematological	
1084	520	Factor XII deficiency (3)	F12	F12, HAF	234000	5q33-qter	Hematological	
1085	520	Factor XIIIA deficiency (3)	F13A1	F13A1, F13A	134570	6p25-p24	Hematological	
1086	520	Factor XIIIB deficiency (3)	F13B	F13B	134580	1q31-q32.1	Hematological	
1087	522	Familial Mediterranean fever, 249100 (3)	MEFV	MEFV, MEF, FMF	608107	16p13	Immunological	249100
1088	523	Fanconi anemia, complementation group A, 227650 (3)	FANCA	FANCA, FACA, FA1, FA, FAA	607139	16q24.3	multiple	227650
1089	523	Fanconi anemia, complementation group B, 300514 (3)	FAAP95	FAAP95, FAAP90, FLJ34064, FANCB	300515	Xp22.31	multiple	300514
1090	523	Fanconi anemia, complementation group C (3)	FANCC	FANCC, FACC	227645	9q22.3	multiple	
1091	523	Fanconi anemia, complementation group D1, 605724 (3)	BRCA2	BRCA2, FANCD1	600185	13q12.3	multiple	605724
1092	523	Fanconi anemia, complementation group D2 (3)	FANCD2	FANCD2, FANCD, FACD, FAD	227646	3p25.3	multiple	
1093	523	Fanconi anemia, complementation group E (3)	FANCE	FANCE, FACE	600901	6p22-p21	multiple	
1094	523	Fanconi anemia, complementation group F (3)	FANCF	FANCF	603467	11p15	multiple	
1095	523	Fanconi anemia, complementation group G (3)	XRCC9	XRCC9, FANCG	602956	9p13	multiple	
1096	523	Fanconi anemia, complementation group J, 609054 (3)	BRIP1	BRIP1, BACH1, FANCJ	605882	17q22	multiple	609054
1097	523	Fanconi anemia, complementation group L (3)	PHF9	PHF9, FANCL	608111	2p16.1	multiple	
1098	523	Fanconi anemia, complementation group M (3)	FANCM	FANCM, KIAA1596	609644	14q21.3	multiple	
1099	524	Fanconi-Bickel syndrome, 227810 (3)	SLC2A2	SLC2A2, GLUT2	138160	3q26.1-q26.3	Metabolic	227810
1100	526	Farber lipogranulomatosis (3)	ASAH	ASAH, AC	228000	8p22-p21.3	Metabolic	
1101	527	Fatty liver, acute, of pregnancy (3)	HADHA	HADHA, MTPA	600890	2p23	Metabolic	
1102	528	Favism (3)	G6PD	G6PD, G6PD1	305900	Xq28	Metabolic	
1103	530	Fechtner syndrome, 153640 (3)	MYH9	MYH9, MHA, FTNS, DFNA17	160775	22q11.2	multiple	153640
1104	531	Feingold syndrome, 164280 (3)	MYCN	MYCN, NMYC, ODED, MODED	164840	2p24.1	multiple	164280
1105	532	Fertile eunuch syndrome, 228300 (3)	GNRHR	GNRHR, LHRHR	138850	4q21.2	Endocrine	228300
1106	535	Fibrocalculous pancreatic diabetes, susceptibility to (3)	SPINK1	SPINK1, PSTI, PCTT, TATI	167790	5q32	Gastrointestinal	
1107	537	Fibromatosis, gingival, 135300 (3)	SOS1	SOS1, GINGF, GF1, HGF	182530	2p22-p21	Connective tissue	135300
1108	537	Fibromatosis, juvenile hyaline, 228600 (3)	ANTXR2	ANTXR2, CMG2, JHF, ISH	608041	4q21	Connective tissue	228600
1109	538	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)	KIF21A	KIF21A, KIAA1708, FEOM1, CFEOM1	608283	12q12	Ophthamological	135700
1110	538	Fibrosis of extraocular muscles, congenital, 2, 602078 (3)	PHOX2A	PHOX2A, ARIX, CFEOM2	602753	11q13.3-q13.4	Ophthamological	602078
1111	539	Fibular hypoplasia and complex brachydactyly, 228900 (3)	GDF5	GDF5, CDMP1	601146	20q11.2	Skeletal	228900
1112	540	Fish-eye disease, 136120 (3)	LCAT	LCAT	606967	16q22.1	Metabolic	136120
1113	541	Fish-odor syndrome, 602079 (3)	FMO3	FMO3	136132	1q23-q25	Metabolic	602079
1114	542	Fitzgerald factor deficiency (3)	KNG	KNG	228960	3q27	Hematological	
1115	544	Fluorouracil toxicity, sensitivity to (3)	DPYD	DPYD, DPD	274270	1p22	Metabolic	
1116	545	Focal cortical dysplasia, Taylor balloon cell type, 607341 (3)	TSC1	TSC1, LAM	605284	9q34	Developmental	607341
1117	546	Follicle-stimulating hormone deficiency, isolated, 229070 (3)	FSHB	FSHB	136530	11p13	Endocrine	229070
1118	547	Forebrain defects (3)	TDGF1	TDGF1	187395	3p23-p21	Neurological	
1119	548	Foveal hypoplasia, isolated, 136520 (3)	PAX6	PAX6, AN2, MGDA	607108	11p13	Ophthamological	136520
1120	549	Foveomacular dystrophy, adult-onset, with choroidal neovascularization, 608161 (3)	RDS	RDS, RP7, PRPH2, PRPH, AVMD, AOFMD	179605	6p21.1-cen	Ophthamological	608161
1121	550	Fragile X syndrome (3)	FMR1	FMR1, FRAXA	309550	Xq27.3	Neurological	
1122	551	Fraser syndrome, 219000 (3)	FRAS1	FRAS1	607830	4q21	multiple	219000
1123	551	Fraser syndrome, 219000 (3)	FREM2	FREM2	608945	13q13.3	multiple	219000
1124	552	Frasier syndrome, 136680 (3)	WT1	WT1	607102	11p13	multiple	136680
1125	553	Friedreich ataxia, 229300 (3)	FRDA	FRDA, FARR	606829	9q13	Neurological	229300
1126	553	Friedreich ataxia with retained reflexes, 229300 (3)	FRDA	FRDA, FARR	606829	9q13	Neurological	229300
1127	554	Frontometaphyseal dysplasia, 304120 (3)	FLNA	FLNA, FLN1, ABPX, NHBP, OPD1, OPD2, FMD, MNS	300017	Xq28	Skeletal	304120
1128	555	Fructose-bisphosphatase deficiency (3)	FBP1	FBP1	229700	9q22.2-q22.3	Metabolic	
1129	556	Fructose intolerance (3)	ALDOB	ALDOB	229600	9q22.3	Metabolic	
1130	557	Fructosuria (3)	KHK	KHK	229800	2p23.3-p23.2	Metabolic	
1131	558	Fuchs endothelial corneal dystrophy, 136800 (3)	COL8A2	COL8A2, FECD, PPCD2	120252	1p34.3-p32.3	Ophthamological	136800
1132	559	Fucosidosis (3)	FUCA1	FUCA1	230000	1p34	Metabolic	
1133	560	Fucosyltransferase-6 deficiency (3)	FUT6	FUT6	136836	19p13.3	Metabolic	
1134	561	Fumarase deficiency, 606812 (3)	FH	FH	136850	1q42.1	Metabolic	606812
1135	562	Fundus albipunctatus, 136880 (3)	RDH5	RDH5	601617	12q13-q14	Ophthamological	136880
1136	562	Fundus albipunctatus, 136880 (3)	RLBP1	RLBP1	180090	15q26	Ophthamological	136880
1137	562	Fundus flavimaculatus, 248200 (3)	ABCA4	ABCA4, ABCR, STGD1, FFM, RP19	601691	1p21-p13	Ophthamological	248200
1138	563	G6PD deficiency (3)	G6PD	G6PD, G6PD1	305900	Xq28	Metabolic	
1139	564	GABA-transaminase deficiency (3)	ABAT	ABAT, GABAT	137150	16p13.3	Metabolic	
1140	565	Galactokinase deficiency with cataracts, 230200 (3)	GALK1	GALK1	604313	17q24	Metabolic	230200
1141	566	Galactose epimerase deficiency, 230350 (3)	GALE	GALE	606953	1p36-p35	Metabolic	230350
1142	567	Galactosemia, 230400 (3)	GALT	GALT	606999	9p13	Metabolic	230400
1143	568	Galactosialidosis (3)	PPGB	PPGB, GSL, NGBE, GLB2, CTSA	256540	20q13.1	Metabolic	
1144	570	GAMT deficiency (3)	GAMT	GAMT	601240	19p13.3	Metabolic	
1145	571	Gardner syndrome (3)	APC	APC, GS, FPC	175100	5q21-q22	Cancer	
1146	572	Gastric cancer, 137215 (3)	APC	APC, GS, FPC	175100	5q21-q22	Cancer	137215
1147	572	Gastric cancer, 137215 (3)	IRF1	IRF1, MAR	147575	5q31.1	Cancer	137215
1148	572	Gastric cancer, familial diffuse, 137215 (3)	CDH1	CDH1, UVO	192090	16q22.1	Cancer	137215
1149	572	Gastric cancer risk after H. pylori infection, 137215 (3)	IL1B	IL1B	147720	2q14	Cancer	137215
1150	572	Gastric cancer risk after H. pylori infection, 137215 (3)	IL1RN	IL1RN	147679	2q14.2	Cancer	137215
1151	572	Gastric cancer, somatic, 137215 (3)	CASP10	CASP10, MCH4, ALPS2	601762	2q33-q34	Cancer	137215
1152	572	Gastric cancer, somatic, 137215 (3)	ERBB2	ERBB2, NGL, NEU, HER2	164870	17q21.1	Cancer	137215
1153	572	Gastric cancer, somatic, 137215 (3)	FGFR2	FGFR2, BEK, CFD1, JWS	176943	10q26	Cancer	137215
1154	572	Gastric cancer, somatic, 137215 (3)	KLF6	KLF6, COPEB, BCD1, ZF9	602053	10p15	Cancer	137215
1155	572	Gastric cancer, somatic, 137215 (3)	MUTYH	MUTYH	604933	1p34.3-p32.1	Cancer	137215
1156	574	Gastrointestinal stromal tumor, somatic, 606764 (3)	KIT	KIT, PBT	164920	4q12	Cancer	606764
1157	574	Gastrointestinal stromal tumor, somatic, 606764 (3)	PDGFRA	PDGFRA	173490	4q12	Cancer	606764
1158	575	Gaucher disease, 230800 (3)	GBA	GBA	606463	1q21	Metabolic	230800
1159	575	Gaucher disease, variant form (3)	PSAP	PSAP, SAP1	176801	10q22.1	Metabolic	
1160	575	Gaucher disease with cardiovascular calcification, 231005 (3)	GBA	GBA	606463	1q21	Metabolic	231005
1161	576	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)	ROBO3	ROBO3, RBIG1, RIG1, HGPPS	608630	11q23-q25	Neurological	607313
1162	578	Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)	KCNMA1	KCNMA1, SLO	600150	10q22.3	Neurological	609446
1163	578	Generalized epilepsy with febrile seizures plus, 604233 (3)	SCN1B	SCN1B, GEFSP1	600235	19q13.1	Neurological	604233
1164	580	Germ cell tumor (3)	BCL10	BCL10	603517	1p22	Cancer	
1165	580	Germ cell tumors, 273300 (3)	KIT	KIT, PBT	164920	4q12	Cancer	273300
1166	581	Gerstmann-Straussler disease, 137440 (3)	PRNP	PRNP, PRIP	176640	20pter-p12	Neurological	137440
1167	582	Giant axonal neuropathy-1, 256850 (3)	GAN	GAN, GAN1	605379	16q24.1	Neurological	256850
1168	583	Giant-cell fibroblastoma (3)	PDGFB	PDGFB, SIS	190040	22q12.3-q13.1	Cancer	
1169	2584	Giant cell hepatitis, neonatal, 231100 (3)	CYP7B1	CYP7B1	603711	8q21.3	Gastrointestinal	231100
1170	584	Giant platelet disorder, isolated (3)	GP1BB	GP1BB	138720	22q11.2	Hematological	
1171	586	Gilbert syndrome, 143500 (3)	UGT1A1	UGT1A1, UGT1, GNT1	191740	2q37	Metabolic	143500
1172	587	Gitelman syndrome, 263800 (3)	SLC12A3	SLC12A3, NCCT, TSC	600968	16q13	Renal	263800
1173	588	Glanzmann thrombasthenia, type A, 273800 (3)	ITGA2B	ITGA2B, GP2B, CD41B	607759	17q21.32	Hematological	273800
1174	588	Glanzmann thrombasthenia, type B (3)	ITGB3	ITGB3, GP3A	173470	17q21.32	Hematological	
1175	589	Glaucoma 1A, primary open angle, juvenile-onset, 137750 (3)	MYOC	MYOC, TIGR, GLC1A, JOAG, GPOA	601652	1q24.3-q25.2	Ophthamological	137750
1176	589	Glaucoma 1A, primary open angle, recessive (3)	MYOC	MYOC, TIGR, GLC1A, JOAG, GPOA	601652	1q24.3-q25.2	Ophthamological	
1177	589	Glaucoma 1E, primary open angle, adult-onset, 137760 (3)	OPTN	OPTN, GLC1E, FIP2, HYPL, NRP	602432	10p15-p14	Ophthamological	137760
1178	589	Glaucoma 3A, primary congenital, 231300 (3)	CYP1B1	CYP1B1, GLC3A	601771	2p22-p21	Ophthamological	231300
1179	589	Glaucoma, early-onset, digenic (3)	CYP1B1	CYP1B1, GLC3A	601771	2p22-p21	Ophthamological	
1180	589	Glaucoma, early-onset, digenic (3)	MYOC	MYOC, TIGR, GLC1A, JOAG, GPOA	601652	1q24.3-q25.2	Ophthamological	
1181	589	Glaucoma, normal tension, susceptibility to, 606657 (3)	OPA1	OPA1, NTG, NPG	605290	3q28-q29	Ophthamological	606657
1182	589	Glaucoma, normal tension, susceptibility to, 606657 (3)	OPTN	OPTN, GLC1E, FIP2, HYPL, NRP	602432	10p15-p14	Ophthamological	606657
1183	589	Glaucoma, primary open angle, adult-onset, 137760 (3)	CYP1B1	CYP1B1, GLC3A	601771	2p22-p21	Ophthamological	137760
1184	589	Glaucoma, primary open angle, juvenile-onset, 137750 (3)	CYP1B1	CYP1B1, GLC3A	601771	2p22-p21	Ophthamological	137750
1185	590	Glioblastoma, early-onset, 137800 (3)	MSH2	MSH2, COCA1, FCC1, HNPCC1	609309	2p22-p21	Cancer	137800
1186	590	Glioblastoma multiforme, somatic, 137800 (3)	DMBT1	DMBT1	601969	10q25.3-q26.1	Cancer	137800
1187	590	Glioblastoma, somatic, 137800 (3)	ERBB2	ERBB2, NGL, NEU, HER2	164870	17q21.1	Cancer	137800
1188	590	Glioblastoma, somatic, 137800 (3)	LGI1	LGI1, EPT, ETL1	604619	10q24	Cancer	137800
1189	590	Glioblastoma, susceptibility to, 137800 (3)	PPARG	PPARG, PPARG1, PPARG2	601487	3p25	Cancer	137800
1190	594	Glomerulocystic kidney disease, hypoplastic, 137920 (3)	TCF2	TCF2, HNF2	189907	17cen-q21.3	Renal	137920
1191	596	Glomerulosclerosis, focal segmental, 1, 603278 (3)	ACTN4	ACTN4, FSGS1, FSGS	604638	19q13	Renal	603278
1192	596	Glomerulosclerosis, focal segmental, 2, 603965 (3)	TRPC6	TRPC6, TRP6, FSGS2	603652	11q21-q22	Renal	603965
1193	596	Glomerulosclerosis, focal segmental, 3, 607832 (3)	CD2AP	CD2AP, CMS	604241	Chr.6	Renal	607832
1194	597	Glomuvenous malformations, 138000 (3)	GLML	GLML, GVM, VMGLOM	601749	1p22-p21	Cardiovascular	138000
1195	598	Glucocorticoid deficiency 2, 607398 (3)	MRAP	MRAP, FALP, C21orf61	609196	21q22.1	Endocrine	607398
1196	598	Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3)	MC2R	MC2R	607397	18p11.2	Endocrine	202200
1197	599	Glucose/galactose malabsorption, 606824 (3)	SLC5A1	SLC5A1, SGLT1	182380	22q13.1	Metabolic	606824
1198	600	Glucose transport defect, blood-brain barrier, 606777 (3)	SLC2A1	SLC2A1, GLUT1	138140	1p35-p31.3	Metabolic	606777
1199	601	Glucosidase I deficiency, 606056 (3)	GCS1	GCS1	601336	2p13-p12	Metabolic	606056
1200	602	Glutamate formiminotransferase deficiency, 229100 (3)	FTCD	FTCD	606806	21q22.3	Metabolic	229100
1201	603	Glutaricaciduria, type I, 231670 (3)	GCDH	GCDH	608801	19p13.2	Metabolic	231670
1202	603	Glutaricaciduria, type IIA, 231680 (3)	ETFA	ETFA, GA2, MADD	608053	15q23-q25	Metabolic	231680
1203	603	Glutaricaciduria, type IIB, 231680 (3)	ETFB	ETFB, MADD	130410	19q13.3	Metabolic	231680
1204	603	Glutaricaciduria, type IIC, 231680 (3)	ETFDH	ETFDH, MADD	231675	4q32-qter	Metabolic	231680
1205	604	Glutathione synthetase deficiency, 266130 (3)	GSS	GSS, GSHS	601002	20q11.2	Metabolic	266130
1206	607	Glycerol kinase deficiency, 307030 (3)	GK	GK	300474	Xp21.3-p21.2	Metabolic	307030
1207	608	Glycine encephalopathy, 605899 (3)	AMT	AMT, NKH, GCE	238310	3p21.2-p21.1	Metabolic	605899
1208	608	Glycine encephalopathy, 605899 (3)	GCSH	GCSH, NKH	238330	16q24	Metabolic	605899
1209	608	Glycine encephalopathy, 605899 (3)	GLDC	GLDC, HYGN1, GCSP, GCE, NKH	238300	9p22	Metabolic	605899
1210	608	Glycine N-methyltransferase deficiency, 606664 (3)	GNMT	GNMT	606628	6p12	Metabolic	606664
1211	609	Glycogenosis, hepatic, autosomal (3)	PHKG2	PHKG2	172471	16p12.1-p11.2	Metabolic	
1212	609	Glycogenosis, X-linked hepatic, type I (3)	PHKA2	PHKA2, PHK	306000	Xp22.2-p22.1	Metabolic	
1213	609	Glycogenosis, X-linked hepatic, type II (3)	PHKA2	PHKA2, PHK	306000	Xp22.2-p22.1	Metabolic	
1214	610	Glycogen storage disease I (3)	G6PC	G6PC, G6PT	232200	17q21	Metabolic	
1215	610	Glycogen storage disease Ib, 232220 (3)	G6PT1	G6PT1	602671	11q23	Metabolic	232220
1216	610	Glycogen storage disease Ic, 232240 (3)	G6PT1	G6PT1	602671	11q23	Metabolic	232240
1217	610	Glycogen storage disease II, 232300 (3)	GAA	GAA	606800	17q25.2-q25.3	Metabolic	232300
1218	610	Glycogen storage disease IIb, 300257 (3)	LAMP2	LAMP2, LAMPB	309060	Xq24	Metabolic	300257
1219	610	Glycogen storage disease IIIa (3)	AGL	AGL, GDE	232400	1p21	Metabolic	
1220	610	Glycogen storage disease IIIb (3)	AGL	AGL, GDE	232400	1p21	Metabolic	
1221	610	Glycogen storage disease IV, 232500 (3)	GBE1	GBE1	607839	3p12	Metabolic	232500
1222	610	Glycogen storage disease, type 0, 240600 (3)	GYS2	GYS2	138571	12p12.2	Metabolic	240600
1223	610	Glycogen storage disease VI (3)	PYGL	PYGL	232700	14q21-q22	Metabolic	
1224	610	Glycogen storage disease VII (3)	PFKM	PFKM	232800	12q13.3	Metabolic	
1225	614	GM1-gangliosidosis (3)	GLB1	GLB1	230500	3p21.33	Metabolic	
1226	614	GM2-gangliosidosis, AB variant (3)	GM2A	GM2A	272750	5q31.3-q33.1	Metabolic	
1227	614	GM2-gangliosidosis, several forms, 272800 (3)	HEXA	HEXA, TSD	606869	15q23-q24	Metabolic	272800
1228	615	Gnthodiaphyseal dysplasia, 166260 (3)	TMEM16E	TMEM16E, GDD1	608662	11p14.3	Bone	166260
1229	617	Goiter, congenital (3)	TPO	TPO, TPX	606765	2p25	Endocrine	
1230	617	Goiter, nonendemic, simple (3)	TG	TG, AITD3	188450	8q24.2-q24.3	Endocrine	
1231	618	Goldberg-Shprintzen megacolon syndrome, 609460 (3)	KIAA1279	KIAA1279	609367	10q22.1	multiple	609460
1232	619	Gonadal dysgenesis, 46XY, partial, with minifascicular neuropathy, 607080 (3)	DHH	DHH	605423	12q13.1	Endocrine	607080
1233	619	Gonadal dysgenesis, XY type (3)	SRY	SRY, TDF	480000	Yp11.3	Endocrine	
1234	622	GRACILE syndrome, 603358 (3)	BCS1L	BCS1L, FLNMS, GRACILE	603647	2q33	Metabolic	603358
1235	623	Graft-versus-host disease, protection against (3)	IL10	IL10, CSIF	124092	1q31-q32	Immunological	
1236	624	Graves disease, susceptibility to, 275000 (3)	CTLA4	CTLA4	123890	2q33	Endocrine	275000
1237	624	Graves disease, susceptibility to, 3, 275000 (3)	GC	GC, DBP	139200	4q12	Endocrine	275000
1238	625	Greenberg dysplasia, 215140 (3)	LBR	LBR, PHA	600024	1q42.1	Skeletal	215140
1239	626	Greig cephalopolysyndactyly syndrome, 175700 (3)	GLI3	GLI3, PAPA, PAPB, ACLS	165240	7p13	Skeletal	175700
1240	627	Griscelli syndrome, type 1, 214450 (3)	MYO5A	MYO5A, MYH12, GS1	160777	15q21	Dermatological	214450
1241	627	Griscelli syndrome, type 2, 607624 (3)	RAB27A	RAB27A, RAM, GS2	603868	15q21	Dermatological	607624
1242	627	Griscelli syndrome, type 3, 609227 (3)	MLPH	MLPH	606526	2q37	Dermatological	609227
1243	628	Growth hormone deficient dwarfism (3)	GHRHR	GHRHR	139191	7p15-p14	Endocrine	
1244	628	Growth hormone insensitivity with immunodeficiency, 245590 (3)	STAT5B	STAT5B	604260	17q11.2	Endocrine	245590
1245	2628	Growth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 (3)	IGF1	IGF1	147440	12q22-q24.1	Developmental	608747
1246	630	Guttmacher syndrome, 176305 (3)	HOXA13	HOXA13, HOX1J	142959	7p15-p14.2	multiple	176305
1247	632	Gyrate atrophy of choroid and retina with ornithinemia, B6 responsive or unresponsive (3)	OAT	OAT	258870	10q26	Metabolic	
1248	633	Hailey-Hailey disease, 169600 (3)	ATP2C1	ATP2C1, BCPM, HHD	604384	3q21-q24	Dermatological	169600
1249	634	Haim-Munk syndrome, 245010 (3)	CTSC	CTSC, CPPI, PALS, PLS, HMS	602365	11q14.1-q14.3	multiple	245010
1250	638	Hand-foot-uterus syndrome, 140000 (3)	HOXA13	HOXA13, HOX1J	142959	7p15-p14.2	multiple	140000
1251	639	Harderoporphyrinuria (3)	CPO	CPO	121300	3q12	Metabolic	
1252	640	HARP syndrome, 607236 (3)	PANK2	PANK2, NBIA1, PKAN, HARP	606157	20p13-p12.3	Metabolic	607236
1253	641	Hartnup disorder, 234500 (3)	SLC6A19	SLC6A19, HND	608893	5p15	Metabolic	234500
1254	643	Hay-Wells syndrome, 106260 (3)	TP73L	TP73L, TP63, KET, EEC3, SHFM4, LMS, RHS	603273	3q27	multiple	106260
1255	644	HDL deficiency, familial, 604091 (3)	ABCA1	ABCA1, ABC1, HDLDT1, TGD	600046	9q22-q31	Metabolic	604091
1256	644	HDL response to hormone replacement, augmented (3)	ESR1	ESR1, ESR	133430	6q25.1	Metabolic	
1257	646	Hearing loss, low-frequency sensorineural, 600965 (3)	WFS1	WFS1, WFRS, WFS, DFNA6	606201	4p16.1	Ear,Nose,Throat	600965
1258	647	Heart block, nonprogressive, 113900 (3)	SCN5A	SCN5A, LQT3, IVF, HB1, SSS1	600163	3p21	Cardiovascular	113900
1259	647	Heart block, progressive, type I, 113900 (3)	SCN5A	SCN5A, LQT3, IVF, HB1, SSS1	600163	3p21	Cardiovascular	113900
1260	648	Heinz body anemia (3)	HBA2	HBA2	141850	16pter-p13.3	Hematological	
1261	648	Heinz body anemias, alpha-(3)	HBA1	HBA1	141800	16pter-p13.3	Hematological	
1262	648	Heinz body anemias, beta-(3)	HBB	HBB	141900	11p15.5	Hematological	
1263	649	HELLP syndrome, maternal, of pregnancy (3)	HADHA	HADHA, MTPA	600890	2p23	Metabolic	
1264	650	Hemangioblastoma, cerebellar, somatic (3)	VHL	VHL	608537	3p26-p25	Cancer	
1265	651	Hemangioma, capillary infantile, somatic, 602089 (3)	FLT4	FLT4, VEGFR3, PCL	136352	5q35.3	Cancer	602089
1266	651	Hemangioma, capillary infantile, somatic, 602089 (3)	KDR	KDR	191306	4q12	Cancer	602089
1267	652	Hematopoiesis, cyclic, 162800 (3)	ELA2	ELA2	130130	19p13.3	Hematological	162800
1268	653	Hematuria, familial benign (3)	COL4A4	COL4A4	120131	2q36-q37	Renal	
1269	654	Heme oxygenase-1 deficiency (3)	HMOX1	HMOX1	141250	22q12	Metabolic	
1270	656	Hemiplegic migraine, familial, 141500 (3)	CACNA1A	CACNA1A, CACNL1A4, SCA6	601011	19p13	Neurological	141500
1271	657	Hemochromatosis (3)	HFE	HFE, HLA-H, HFE1	235200	6p21.3	Metabolic	
1272	657	Hemochromatosis, juvenile, 602390 (3)	HAMP	HAMP, LEAP1, HEPC, HFE2	606464	19q13	Metabolic	602390
1273	657	Hemochromatosis, juvenile, digenic, 602390 (3)	HAMP	HAMP, LEAP1, HEPC, HFE2	606464	19q13	Metabolic	602390
1274	657	Hemochromatosis, type 2A, 602390 (3)	HJV	HJV, HFE2A	608374	1q21	Metabolic	602390
1275	657	Hemochromatosis, type 3, 604250 (3)	TFR2	TFR2, HFE3	604720	7q22	Metabolic	604250
1276	657	Hemochromatosis, type 4, 606069 (3)	SLC40A1	SLC40A1, SLC11A3, FPN1, IREG1, HFE4	604653	2q32	Metabolic	606069
1277	659	Hemoglobin H disease (3)	HBA2	HBA2	141850	16pter-p13.3	Hematological	
1278	660	Hemolytic anemia due to adenylate kinase deficiency (3)	AK1	AK1	103000	9q34.1	Hematological	
1279	660	Hemolytic anemia due to band 3 defect defect (3)	SLC4A1	SLC4A1, AE1, EPB3	109270	17q21-q22	Hematological	
1280	660	Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3)	BPGM	BPGM	222800	7q31-q34	Hematological	
1281	660	Hemolytic anemia due to G6PD deficiency (3)	G6PD	G6PD, G6PD1	305900	Xq28	Hematological	
1282	660	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3)	GCLC	GCLC, GLCLC	606857	6p12	Hematological	230450
1283	660	Hemolytic anemia due to glucosephosphate isomerase deficiency (3)	GPI	GPI	172400	19q13.1	Hematological	
1284	660	Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)	GSS	GSS, GSHS	601002	20q11.2	Hematological	231900
1285	660	Hemolytic anemia due to hexokinase deficiency (3)	HK1	HK1	142600	10q22	Hematological	
1286	660	Hemolytic anemia due to PGK deficiency (3)	PGK1	PGK1, PGKA	311800	Xq13	Hematological	
1287	660	Hemolytic anemia due to triosephosphate isomerase deficiency (3)	TPI1	TPI1	190450	12p13	Hematological	
1288	661	Hemolytic-uremic syndrome, 235400 (3)	HF1	HF1, CFH, HUS	134370	1q32	Hematological	235400
1289	662	Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3)	PRF1	PRF1, HPLH2	170280	10q22	Hematological	603553
1290	662	Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	UNC13D	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3	608897	17q25.1	Hematological	608898
1291	663	Hemophilia A (3)	F8	F8, F8C, HEMA	306700	Xq28	Hematological	
1292	663	Hemophilia B (3)	F9	F9, HEMB	306900	Xq27.1-q27.2	Hematological	
1293	664	Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3)	PI	PI, AAT	107400	14q32.1	Hematological	
1294	664	Hemorrhagic diathesis due to factor V deficiency (3)	F5	F5	227400	1q23	Hematological	
1295	665	Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3)	CP	CP	117700	3q23-q24	Hematological	604290
1296	668	Hepatic adenoma, 142330 (3)	TCF1	TCF1, HNF1A, MODY3	142410	12q24.2	Cancer	142330
1297	666	Hepatic failure, early onset, and neurologic disorder (3)	SCOD1	SCOD1, SCO1	603644	17p13-p12	Gastrointestinal	
1298	4666	Hepatic lipase deficiency (3)	LIPC	LIPC	151670	15q21-q23	Metabolic	
1299	668	Hepatoblastoma (3)	CTNNB1	CTNNB1	116806	3p22-p21.3	Cancer	
1300	668	Hepatocellular cancer, 114550 (3)	PDGFRL	PDGFRL, PDGRL, PRLTS	604584	8p22-p21.3	Cancer	114550
1301	668	Hepatocellular carcinoma, 114550 (3)	AXIN1	AXIN1, AXIN	603816	16p13.3	Cancer	114550
1302	668	Hepatocellular carcinoma, 114550 (3)	CTNNB1	CTNNB1	116806	3p22-p21.3	Cancer	114550
1303	668	Hepatocellular carcinoma, 114550 (3)	TP53	TP53, P53, LFS1	191170	17p13.1	Cancer	114550
1304	668	Hepatocellular carcinoma (3)	IGF2R	IGF2R, MPRI	147280	6q26	Cancer	
1305	668	Hepatocellular carcinoma, childhood type, 114550 (3)	MET	MET	164860	7q31	Cancer	114550
1306	668	Hepatocellular carcinoma, somatic, 114550 (3)	CASP8	CASP8, MCH5	601763	2q33-q34	Cancer	114550
1307	669	Hereditary hemorrhagic telangiectasia-1, 187300 (3)	ENG	ENG, END, HHT1, ORW	131195	9q34.1	Cardiovascular	187300
1308	669	Hereditary hemorrhagic telangiectasia-2, 600376 (3)	ACVRL1	ACVRL1, ACVRLK1, ALK1, HHT2	601284	12q11-q14	Cardiovascular	600376
1309	2669	Hereditary persistence of alpha-fetoprotein (3)	AFP	AFP, HPAFP	104150	4q11-q13	Hematological	
1310	670	Hermansky-Pudlak syndrome, 203300 (3)	HPS1	HPS1	604982	10q23.1	multiple	203300
1311	670	Hermansky-Pudlak syndrome, 203300 (3)	HPS3	HPS3	606118	3q24	multiple	203300
1312	670	Hermansky-Pudlak syndrome, 203300 (3)	HPS4	HPS4	606682	22q11.2-q12.2	multiple	203300
1313	670	Hermansky-pudlak syndrome, 203300 (3)	HPS5	HPS5, RU2, KIAA1017	607521	11p15-p13	multiple	203300
1314	670	Hermansky-Pudlak syndrome, 203300 (3)	HPS6	HPS6, RU	607522	10q24.32	multiple	203300
1315	670	Hermansky-Pudlak syndrome, 608233 (3)	AP3B1	AP3B1, ADTB3A, HPS2	603401	5q14.1	multiple	608233
1316	670	Hermansky-Pudlak syndrome 7, 203300 (3)	DTNBP1	DTNBP1, HPS7	607145	6p22.3	multiple	203300
1317	675	Heterotaxy, visceral, 605376 (3)	CFC1	CFC1, CRYPTIC, HTX2	605194	2q21.1	multiple	605376
1318	675	Heterotaxy, X-linked visceral, 306955 (3)	ZIC3	ZIC3, HTX1, HTX	300265	Xq26.2	multiple	306955
1319	676	Heterotopia, periventricular, 300049 (3)	FLNA	FLNA, FLN1, ABPX, NHBP, OPD1, OPD2, FMD, MNS	300017	Xq28	Neurological	300049
1320	676	Heterotopia, periventricular, ED variant, 300537 (3)	FLNA	FLNA, FLN1, ABPX, NHBP, OPD1, OPD2, FMD, MNS	300017	Xq28	Neurological	300537
1321	676	Heterotopia, periventricular nodular, with frontometaphyseal dysplasia, 300049 (3)	FLNA	FLNA, FLN1, ABPX, NHBP, OPD1, OPD2, FMD, MNS	300017	Xq28	Neurological	300049
1322	677	Hex A pseudodeficiency, 272800 (3)	HEXA	HEXA, TSD	606869	15q23-q24	Metabolic	272800
1323	679	High-molecular-weight kininogen deficiency (3)	KNG	KNG	228960	3q27	Hematological	
1324	681	Hirschsprung disease, 142623 (3)	EDN3	EDN3	131242	20q13.2-q13.3	Gastrointestinal	142623
1325	681	Hirschsprung disease, 142623 (3)	GDNF	GDNF	600837	5p13.1-p12	Gastrointestinal	142623
1326	681	Hirschsprung disease, 142623 (3)	NRTN	NRTN, NTN	602018	19p13.3	Gastrointestinal	142623
1327	681	Hirschsprung disease, 142623 (3)	RET	RET, MEN2A	164761	10q11.2	Gastrointestinal	142623
1328	681	Hirschsprung disease-2, 600155 (3)	EDNRB	EDNRB, HSCR2, ABCDS	131244	13q22	Gastrointestinal	600155
1329	681	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3)	ECE1	ECE1	600423	1p36.1	Gastrointestinal	
1330	681	Hirschsprung disease, short-segment, 142623 (3)	PMX2B	PMX2B, NBPHOX, PHOX2B	603851	4p12	Gastrointestinal	142623
1331	682	Histidinemia, 235800 (3)	HAL	HAL, HSTD	609457	12q22-q23	Metabolic	235800
1332	683	Histiocytoma (3)	TP53	TP53, P53, LFS1	191170	17p13.1	Cancer	
1333	684	HIV-1 disease, delayed progression of (3)	CCL5	CCL5, SCYA5, D17S136E, TCP228	187011	17q11.2-q12	Immunological	
1334	684	HIV-1 disease, rapid progression of (3)	CCL5	CCL5, SCYA5, D17S136E, TCP228	187011	17q11.2-q12	Immunological	
1335	684	HIV-1, susceptibility to (3)	IL10	IL10, CSIF	124092	1q31-q32	Immunological	
1336	684	HIV infection, susceptibility/resistance to (3)	CMKBR2	CMKBR2, CCR2	601267	3p21	Immunological	
1337	684	HIV infection, susceptibility/resistance to (3)	CMKBR5	CMKBR5, CCCKR5	601373	3p21	Immunological	
1338	686	HMG-CoA lyase deficiency (3)	HMGCL	HMGCL	246450	1pter-p33	Metabolic	
1339	686	HMG-CoA synthase-2 deficiency, 605911 (3)	HMGCS2	HMGCS2	600234	1p13-p12	Metabolic	605911
1340	688	Holocarboxylase synthetase deficiency, 253270 (3)	HLCS	HLCS, HCS	609018	21q22.1	Metabolic	253270
1341	689	Holoprosencephaly-2, 157170 (3)	SIX3	SIX3, HPE2	603714	2p21	Developmental	157170
1342	689	Holoprosencephaly-3, 142945 (3)	SHH	SHH, HPE3, HLP3, SMMCI	600725	7q36	Developmental	142945
1343	689	Holoprosencephaly-4, 142946 (3)	TGIF	TGIF, HPE4	602630	18p11.3	Developmental	142946
1344	689	Holoprosencephaly-5, 609637 (3)	ZIC2	ZIC2, HPE5	603073	13q32	Developmental	609637
1345	689	Holoprosencephaly-7 (3)	PTCH	PTCH, NBCCS, BCNS, HPE7	601309	9q22.3	Developmental	
1346	696	Holt-Oram syndrome, 142900 (3)	TBX5	TBX5	601620	12q24.1	Developmental	142900
1347	697	Homocysteine, total plasma, elevated (3)	CTH	CTH	607657	1p31.1	Metabolic	
1348	698	Homocystinuria, B6-responsive and nonresponsive types (3)	CBS	CBS	236200	21q22.3	Metabolic	
1349	698	Homocystinuria due to MTHFR deficiency, 236250 (3)	MTHFR	MTHFR	607093	1p36.3	Metabolic	236250
1350	699	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3)	MTRR	MTRR	602568	5p15.3-p15.2	Metabolic	236270
1351	701	Homozygous 2p16 deletion syndrome, 606407 (3)	SLC3A1	SLC3A1, ATR1, D2H, NBAT	104614	2p16.3	multiple	606407
1352	702	Hoyeraal-Hreidarsson syndrome, 300240 (3)	DKC1	DKC1, DKC	300126	Xq28	multiple	300240
1353	703	HPFH, deletion type (3)	HBB	HBB	141900	11p15.5	Hematological	
1354	703	HPFH, nondeletion type A (3)	HBG1	HBG1	142200	11p15.5	Hematological	
1355	703	HPFH, nondeletion type G (3)	HBG2	HBG2	142250	11p15.5	Hematological	
1356	704	HPRT-related gout, 300323 (3)	HPRT1	HPRT1, HPRT	308000	Xq26-q27.2	Metabolic	300323
1357	705	H. pylori infection, susceptibility to, 600263 (3)	IFNGR1	IFNGR1	107470	6q23-q24	Immunological	600263
1358	708	Huntington disease (3)	HD	HD, IT15	143100	4p16.3	Neurological	
1359	708	Huntington disease-like 1, 603218 (3)	PRNP	PRNP, PRIP	176640	20pter-p12	Neurological	603218
1360	708	Huntington disease-like 2, 606438 (3)	JPH3	JPH3, JP3, HDL2	605268	16q24.3	Neurological	606438
1361	708	Huntington disease-like-4, 607136 (3)	TBP	TBP, SCA17	600075	6q27	Neurological	607136
1362	710	Hyalinosis, infantile systemic, 236490 (3)	ANTXR2	ANTXR2, CMG2, JHF, ISH	608041	4q21	multiple	236490
1363	712	Hydrocephalus due to aqueductal stenosis, 307000 (3)	L1CAM	L1CAM, CAML1, HSAS1	308840	Xq28	Neurological	307000
1364	712	Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)	L1CAM	L1CAM, CAML1, HSAS1	308840	Xq28	Neurological	307000
1365	712	Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3)	L1CAM	L1CAM, CAML1, HSAS1	308840	Xq28	Neurological	142623
1366	716	Hyperalphalipoproteinemia, 143470 (3)	CETP	CETP	118470	16q21	Metabolic	143470
1367	717	Hyperammonemia with hypoornithinemia, hypocitrullinemia, hypoargininemia, and hypoprolinemia (3)	PYCS	PYCS, GSAS	138250	10q24.3	Metabolic	
1368	718	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency (3)	CYP21A2	CYP21A2, CYP21, CA21H	201910	6p21.3	Endocrine	
1369	719	Hyperapobetalipoproteinemia, susceptibility to (3)	PPARA	PPARA, PPAR	170998	22q12-q13.1	Metabolic	
1370	720	Hyperbilirubinemia, familial transcient neonatal, 237900 (3)	UGT1A1	UGT1A1, UGT1, GNT1	191740	2q37	Gastrointestinal	237900
1371	721	Hypercalciuria, absorptive, susceptibility to, 143870 (3)	SAC	SAC, HCA2	605205	1q24	Renal	143870
1372	723	Hypercholanemia, familial, 607748 (3)	BAAT	BAAT	602938	9q22.3	Gastrointestinal	607748
1373	723	Hypercholanemia, familial, 607748 (3)	EPHX1	EPHX1	132810	1q42.1	Gastrointestinal	607748
1374	723	Hypercholanemia, familial, 607748 (3)	TJP2	TJP2, ZO2	607709	9q12-q13	Gastrointestinal	607748
1375	724	Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)	APOB	APOB, FLDB	107730	2p24	Metabolic	144010
1376	724	Hypercholesterolemia, familial, 143890 (3)	LDLR	LDLR, FHC, FH	606945	19p13.2	Metabolic	143890
1377	724	Hypercholesterolemia, familial, 3, 603776 (3)	PCSK9	PCSK9, NARC1, HCHOLA3, FH3	607786	1p34.1-p32	Metabolic	603776
1378	724	Hypercholesterolemia, familial, autosomal recessive, 603813 (3)	ARH	ARH, FHCB2, FHCB1	605747	1p36-p35	Metabolic	603813
1379	724	Hypercholesterolemia, familial, due to LDLR defect, modifier of, 143890 (3)	EPHX2	EPHX2	132811	8p21-p12	Metabolic	143890
1380	724	Hypercholesterolemia, familial, modification of, 143890 (3)	APOA2	APOA2	107670	1q21-q23	Metabolic	143890
1381	724	Hypercholesterolemia, susceptibility to, 143890 (3)	GSBS	GSBS	604088	7p15	Metabolic	143890
1382	724	Hypercholesterolemia, susceptibility to, 143890 (3)	ITIH4	ITIH4, PK120, ITIHL1	600564	3p21.2-p14.1	Metabolic	143890
1383	725	Hyperekplexia and spastic paraparesis (3)	GLRA1	GLRA1, STHE	138491	5q32	Neurological	
1384	725	Hyperekplexia, autosomal recessive, 149400 (3)	GLRB	GLRB	138492	4q31.3	Neurological	149400
1385	726	Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)	PDGFRA	PDGFRA	173490	4q12	Hematological	607685
1386	727	Hyperferritinemia-cataract syndrome, 600886 (3)	FTL	FTL	134790	19q13.3-q13.4	Ophthamological	600886
1387	728	Hyper-IgD syndrome, 260920 (3)	MVK	MVK, MVLK	251170	12q24	Immunological	260920
1388	731	Hyperinsulinism, familial, 602485 (3)	GCK	GCK	138079	7p15-p13	Metabolic	602485
1389	732	Hyperinsulinism-hyperammonemia syndrome, 606762 (3)	GLUD1	GLUD1	138130	10q23.3	Metabolic	606762
1390	733	Hyperkalemic periodic paralysis, 170500 (3)	SCN4A	SCN4A, HYPP, NAC1A	603967	17q23.1-q25.3	Neurological	170500
1391	734	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3)	CCM1	CCM1, CAM, KRIT1	604214	7q11.2-q21	Neurological	116860
1392	736	Hyperlipidemia, familial combined, susceptibility to, 602491 (3)	USF1	USF1, HYPLIP1	191523	1q22-q23	Metabolic	602491
1393	737	Hyperlipoproteinemia, type Ib, 207750 (3)	APOC2	APOC2	608083	19q13.2	Metabolic	207750
1394	737	Hyperlipoproteinemia, type III (3)	APOE	APOE, AD2	107741	19q13.2	Metabolic	
1395	738	Hyperlysinemia, 238700 (3)	AASS	AASS	605113	7q31.3	Metabolic	238700
1396	739	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency (3)	MAT1A	MAT1A, MATA1, SAMS1	250850	10q22	Metabolic	
1397	739	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase (3)	AHCY	AHCY, SAHH	180960	20cen-q13.1	Metabolic	
1398	740	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)	SLC25A15	SLC25A15, ORNT1, HHH	603861	13q14	Metabolic	238970
1399	741	Hyperostosis, endosteal, 144750 (3)	LRP5	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2	603506	11q13.4	Bone	144750
1400	742	Hyperoxaluria, primary, type 1, 259900 (3)	AGXT	AGXT, SPAT	604285	2q36-q37	Metabolic	259900
1401	742	Hyperoxaluria, primary, type II, 260000 (3)	GRHPR	GRHPR, GLXR	604296	9cen	Metabolic	260000
1402	743	Hyperparathyroidism, AD, 145000 (3)	MEN1	MEN1	131100	11q13	Endocrine	145000
1403	743	Hyperparathyroidism, familial primary, 145000 (3)	HRPT2	HRPT2, C1orf28	607393	1q25-q31	Endocrine	145000
1404	743	Hyperparathyroidism-jaw tumor syndrome, 145001 (3)	HRPT2	HRPT2, C1orf28	607393	1q25-q31	Endocrine	145001
1405	743	Hyperparathyroidism, neonatal, 239200 (3)	CASR	CASR, HHC1, PCAR1, FIH	601199	3q13.3-q21	Endocrine	239200
1406	746	Hyperphenylalaninemia due to pterin-4a-carbinolamine dehydratase deficiency, 264070 (3)	PCBD	PCBD, DCOH	126090	10q22	Metabolic	264070
1407	746	Hyperphenylalaninemia, mild (3)	PAH	PAH, PKU1	261600	12q24.1	Metabolic	
1408	748	Hyperproinsulinemia, familial (3)	INS	INS	176730	11p15.5	Endocrine	
1409	749	Hyperprolinemia, type I, 239500 (3)	PRODH	PRODH, PRODH2, SCZD4	606810	22q11.2	Metabolic	239500
1410	749	Hyperprolinemia, type II, 239510 (3)	ALDH4A1	ALDH4A1, ALDH4, P5CDH	606811	1p36	Metabolic	239510
1411	750	Hyperproreninemia (3)	REN	REN	179820	1q32	Cardiovascular	
1412	751	Hyperprothrombinemia (3)	F2	F2	176930	11p11-q12	Hematological	
1413	752	Hypertension, diastolic, resistance to, 608622 (3)	KCNMB1	KCNMB1	603951	5q34	Cardiovascular	608622
1414	752	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)	NR3C2	NR3C2, MLR, MCR	600983	4q31.1	Cardiovascular	605115
1415	752	Hypertension, essential, 145500 (3)	AGTR1	AGTR1, AGTR1A, AT2R1	106165	3q21-q25	Cardiovascular	145500
1416	752	Hypertension, essential, 145500 (3)	PTGIS	PTGIS, CYP8A1, PGIS, CYP8	601699	20q13.11-q13.13	Cardiovascular	145500
1417	752	Hypertension, essential, salt-sensitive, 145500 (3)	ADD1	ADD1	102680	4p16.3	Cardiovascular	145500
1418	752	Hypertension, essential, susceptibility to, 145500 (3)	AGT	AGT, SERPINA8	106150	1q42-q43	Cardiovascular	145500
1419	752	Hypertension, essential, susceptibility to, 145500 (3)	ECE1	ECE1	600423	1p36.1	Cardiovascular	145500
1420	752	Hypertension, essential, susceptibility to, 145500 (3)	GNB3	GNB3	139130	12p13	Cardiovascular	145500
1421	752	Hypertension, insulin resistance-related, susceptibility to, 125853 (3)	RETN	RETN, RSTN, FIZZ3	605565	19p13.2	Cardiovascular	125853
1422	752	Hypertension, mild low-renin (3)	HSD11B2	HSD11B2, HSD11K	218030	16q22	Cardiovascular	
1423	752	Hypertension, pregnancy-induced, 189800 (3)	NOS3	NOS3	163729	7q36	Cardiovascular	189800
1424	752	Hypertension, salt-sensitive essential, susceptibility to, 145500 (3)	CYP3A5	CYP3A5, P450PCN3	605325	7q22.1	Cardiovascular	145500
1425	752	Hypertension, susceptibility to, 145500 (3)	NOS3	NOS3	163729	7q36	Cardiovascular	145500
1426	754	Hyperthroidism, congenital (3)	TSHR	TSHR	603372	14q31	Endocrine	
1427	755	Hyperthyroidism, congenital (3)	TPO	TPO, TPX	606765	2p25	Endocrine	
1428	757	Hypertriglyceridemia, one form (3)	APOA1	APOA1	107680	11q23	Metabolic	
1429	757	Hypertriglyceridemia, susceptibility to, 145750 (3)	APOA5	APOA5	606368	11q23	Metabolic	145750
1430	757	Hypertriglyceridemia, susceptibility to, 145750 (3)	LIPI	LIPI, LPDL, PRED5	609252	21q11.2	Metabolic	145750
1431	757	Hypertriglyceridemia, susceptibility to, 145750 (3)	RP1	RP1, ORP1	603937	8q11-q13	Metabolic	145750
1432	758	Hypertrypsinemia, neonatal (3)	CFTR	CFTR, ABCC7, CF, MRP7	602421	7q31.2	Gastrointestinal	
1433	759	Hyperuricemic nephropathy, familial juvenile, 162000 (3)	UMOD	UMOD, HNFJ, FJHN, MCKD2, ADMCKD2	191845	16p12.3	Renal	162000
1434	761	Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3)	CYP11B2	CYP11B2	124080	8q21	Metabolic	203400
1435	761	Hypoaldosteronism, congenital, due to CMO II deficiency (3)	CYP11B2	CYP11B2	124080	8q21	Metabolic	
1436	762	Hypoalphalipoproteinemia (3)	APOA1	APOA1	107680	11q23	Metabolic	
1437	763	Hypobetalipoproteinemia (3)	APOB	APOB, FLDB	107730	2p24	Metabolic	
1438	764	Hypocalcemia, autosomal dominant, 146200 (3)	CASR	CASR, HHC1, PCAR1, FIH	601199	3q13.3-q21	Endocrine	146200
1439	764	Hypocalcemia, autosomal dominant, with Bartter syndrome (3)	CASR	CASR, HHC1, PCAR1, FIH	601199	3q13.3-q21	Endocrine	
1440	765	Hypocalciuric hypercalcemia, type I, 145980 (3)	CASR	CASR, HHC1, PCAR1, FIH	601199	3q13.3-q21	Endocrine	145980
1441	766	Hypoceruloplasminemia, hereditary, 604290 (3)	CP	CP	117700	3q23-q24	Metabolic	604290
1442	767	Hypochondroplasia, 146000 (3)	FGFR3	FGFR3, ACH	134934	4p16.3	Skeletal	146000
1443	768	Hypochromic microcytic anemia (3)	HBA2	HBA2	141850	16pter-p13.3	Hematological	
1444	769	Hypodontia, 106600 (3)	PAX9	PAX9	167416	14q12-q13	Skeletal	106600
1445	769	Hypodontia, autosomal dominant, 106600 (3)	MSX1	MSX1, HOX7, HYD1, OFC5	142983	4p16.1	Skeletal	106600
1446	769	Hypodontia with orofacial cleft, 106600 (3)	MSX1	MSX1, HOX7, HYD1, OFC5	142983	4p16.1	Skeletal	106600
1447	770	Hypofibrinogenemia, gamma type (3)	FGG	FGG	134850	4q28	Hematological	
1448	771	Hypoglobulinemia and absent B cells (3)	BLNK	BLNK, SLP65	604515	10q23.2	Immunological	
1449	772	Hypoglycemia of infancy, leucine-sensitive, 240800 (3)	ABCC8	ABCC8, SUR, PHHI, SUR1	600509	11p15.1	Metabolic	240800
1450	772	Hypoglycemia of infancy, persistent hyperinsulinemic, 256450 (3)	ABCC8	ABCC8, SUR, PHHI, SUR1	600509	11p15.1	Metabolic	256450
1451	773	Hypogonadism, hypergonadotropic (3)	LHB	LHB	152780	19q13.32	Endocrine	
1452	774	Hypogonadotropic hypogonadism, 146110 (3)	GPR54	GPR54	604161	19p13.3	Endocrine	146110
1453	774	Hypogonadotropic hypogonadism, 146110 (3)	NELF	NELF	608137	9q34.3	Endocrine	146110
1454	774	Hypogonadotropic hypogonadism (3)	GNRHR	GNRHR, LHRHR	138850	4q21.2	Endocrine	
1455	774	Hypogonadotropic hypogonadism (3)	LHCGR	LHCGR	152790	2p21	Endocrine	
1456	775	Hypohaptoglobinemia (3)	HP	HP	140100	16q22.1	Hematological	
1457	776	Hypokalemic periodic paralysis, 170400 (3)	CACNA1S	CACNA1S, CACNL1A3, CCHL1A3	114208	1q32	Renal	170400
1458	776	Hypokalemic periodic paralysis, 170400 (3)	KCNE3	KCNE3, HOKPP	604433	11q13-q14	Renal	170400
1459	776	Hypokalemic periodic paralysis, 170400 (3)	SCN4A	SCN4A, HYPP, NAC1A	603967	17q23.1-q25.3	Renal	170400
1460	777	Hypolactasia, adult type, 223100 (3)	LCT	LCT, LAC, LPH	603202	2q21	Metabolic	223100
1461	777	Hypolactasia, adult type, 223100 (3)	MCM6	MCM6	601806	2q21	Metabolic	223100
1462	778	Hypomagnesemia-2, renal, 154020 (3)	FXYD2	FXYD2, ATP1G1, HOMG2	601814	11q23	Renal	154020
1463	778	Hypomagnesemia, primary, 248250 (3)	CLDN16	CLDN16, PCLN1	603959	3q27	Renal	248250
1464	778	Hypomagnesemia with secondary hypocalcemia, 602014 (3)	TRPM6	TRPM6, CHAK2	607009	9q22	Renal	602014
1465	779	Hypoparathyroidism, autosomal dominant(3)	PTH	PTH	168450	11p15.3-p15.1	Endocrine	
1466	779	Hypoparathyroidism, autosomal recessive (3)	PTH	PTH	168450	11p15.3-p15.1	Endocrine	
1467	779	Hypoparathyroidism, familial isolated, 146200 (3)	GCMB	GCMB	603716	6p24.2	Endocrine	146200
1468	780	Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)	TBCE	TBCE, KCS, KCS1, HRD	604934	1q42-q43	Endocrine	241410
1469	781	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)	GATA3	GATA3, HDR	131320	10p15	Endocrine	146255
1470	782	Hypophosphatasia, childhood, 241510 (3)	ALPL	ALPL, HOPS, TNSALP	171760	1p36.1-p34	Metabolic	241510
1471	782	Hypophosphatasia, infantile, 241500 (3)	ALPL	ALPL, HOPS, TNSALP	171760	1p36.1-p34	Metabolic	241500
1472	783	Hypophosphatemia, type III (3)	CLCN5	CLCN5, CLCK2, NPHL2, DENTS	300008	Xp11.22	Metabolic	
1473	783	Hypophosphatemia, X-linked, 307800 (3)	PHEX	PHEX, HYP, HPDR1	300550	Xp22.2-p22.1	Metabolic	307800
1474	784	Hypophosphatemic rickets, autosomal dominant, 193100 (3)	FGF23	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.3	Bone	193100
1475	785	Hypoplastic enamel pitting, localized, 608563 (3)	ENAM	ENAM	606585	4q21	Connective tissue	608563
1476	2785	Hypoplastic left heart syndrome, 241550 (3)	GJA1	GJA1, CX43, ODDD, SDTY3, ODOD	121014	6q21-q23.2	Cardiovascular	241550
1477	786	Hypoprothrombinemia (3)	F2	F2	176930	11p11-q12	Hematological	
1478	787	Hypothyroidism, autoimmune, 140300 (3)	CTLA4	CTLA4	123890	2q33	Endocrine	140300
1479	787	Hypothyroidism, congenital, 274400 (3)	SLC5A5	SLC5A5, NIS	601843	19p13.2-p12	Endocrine	274400
1480	787	Hypothyroidism, congenital, due to DUOX2 deficiency, 607200 (3)	DUOX2	DUOX2, THOX2	606759	15q15.3	Endocrine	607200
1481	787	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)	PAX8	PAX8	167415	2q12-q14	Endocrine	218700
1482	787	Hypothyroidism, congenital, due to TSH resistance, 275200 (3)	TSHR	TSHR	603372	14q31	Endocrine	275200
1483	787	Hypothyroidism, hereditary congenital (3)	TG	TG, AITD3	188450	8q24.2-q24.3	Endocrine	
1484	787	Hypothyroidism, nongoitrous (3)	TSHB	TSHB	188540	1p13	Endocrine	
1485	787	Hypothyroidism, subclinical (3)	TSHR	TSHR	603372	14q31	Endocrine	
1486	788	Hypotrichosis, congential, with juvenile macular dystrophy, 601553 (3)	CDH3	CDH3, CDHP, PCAD, HJMD	114021	16q22.1	Dermatological	601553
1487	788	Hypotrichosis, localized, autosomal recessive, 607903 (3)	DSG4	DSG4, LAH	607892	18q12	Dermatological	607903
1488	788	Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)	SOX18	SOX18, HLTS	601618	20q13.33	Dermatological	607823
1489	788	Hypotrichosis simplex of scalp, 146520 (3)	CDSN	CDSN, HTSS	602593	6p21.3	Dermatological	146520
1490	791	Hypouricemia, renal, 220150 (3)	SLC22A12	SLC22A12, OAT4L, URAT1	607096	11q13	Renal	220150
1491	792	Hystrix-like ichthyosis with deafness, 602540 (3)	GJB2	GJB2, CX26, DFNB1, PPK, DFNA3, KID, HID	121011	13q11-q12	multiple	602540
1492	793	Ichthyosiform erythroderma, congenital, 242100 (3)	TGM1	TGM1, ICR2, LI1	190195	14q11.2	Dermatological	242100
1493	793	Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)	ALOX12B	ALOX12B	603741	17pter-p13.1	Dermatological	242100
1494	793	Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)	ALOXE3	ALOXE3	607206	17p13.1	Dermatological	242100
1495	794	Ichthyosis bullosa of Siemens, 146800 (3)	KRT2A	KRT2A, KRT2E	600194	12q11-q13	Dermatological	146800
1496	794	Ichthyosis, congenital, autosomal recessive (3)	ICHYN	ICHYN	609383	5q33	Dermatological	
1497	794	Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)	KRT10	KRT10	148080	17q21-q22	Dermatological	607602
1498	794	Ichthyosis, harlequin, 242500 (3)	ABCA12	ABCA12, ICR2B, LI2	607800	2q34	Dermatological	242500
1499	794	Ichthyosis histrix, Curth-Macklin type, 146590 (3)	KRT1	KRT1	139350	12q13	Dermatological	146590
1500	794	Ichthyosis, lamellar 2, 601277 (3)	ABCA12	ABCA12, ICR2B, LI2	607800	2q34	Dermatological	601277
1501	794	Ichthyosis, lamellar, autosomal recessive, 242300 (3)	TGM1	TGM1, ICR2, LI1	190195	14q11.2	Dermatological	242300
1502	794	Ichthyosis, X-linked (3)	STS	STS, ARSC1, ARSC, SSDD	308100	Xp22.32	Dermatological	
1503	795	ICOS deficiency, 607594 (3)	ICOS	ICOS, AILIM	604558	2q33	Immunological	607594
1504	797	IgE levels QTL, 147050 (3)	PHF11	PHF11, NYREN34	607796	13q14.1	Immunological	147050
1505	798	IgG2 deficiency, selective (3)	IGHG2	IGHG2	147110	14q32.33	Immunological	
1506	799	IgG receptor I, phagocytic, familial deficiency of (3)	FCGR1A	FCGR1A, IGFR1, CD64	146760	1q21.2-q21.3	Immunological	
1507	801	Immunodeficiency-centromeric instability-facial anomalies syndrome, 242860 (3)	DNMT3B	DNMT3B, ICF	602900	20q11.2	multiple	242860
1508	802	Immunodeficiency due to defect in CD3-epsilon (3)	CD3E	CD3E	186830	11q23	Immunological	
1509	802	Immunodeficiency due to defect in CD3-gamma (3)	CD3G	CD3G	186740	11q23	Immunological	
1510	802	Immunodeficiency with hyper-IgM, type 2, 605258 (3)	AICDA	AICDA, AID, HIGM2	605257	12p13	Immunological	605258
1511	802	Immunodeficiency with hyper-IgM, type 3, 606843 (3)	TNFRSF5	TNFRSF5, CD40	109535	20q12-q13.2	Immunological	606843
1512	802	Immunodeficiency with hyper IgM, type 4, 608106 (3)	UNG	UNG, DGU, HIGM4	191525	12q23-q24.1	Immunological	608106
1513	802	Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)	TNFSF5	TNFSF5, CD40LG, HIGM1, IGM	300386	Xq26	Immunological	308230
1514	803	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3)	FOXP3	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23-q13.3	multiple	304790
1515	804	Immunoglobulin A deficiency, 609529 (3)	TNFRSF14B	TNFRSF14B, TACI	604907	17p11.2	Immunological	609529
1516	805	Inclusion body myopathy-3, 605637 (3)	MYH2	MYH2	160740	17p13.1	Muscular	605637
1517	805	Inclusion body myopathy, autosomal recessive, 600737 (3)	GNE	GNE, GLCNE, IBM2, DMRV, NM	603824	9p12-p11	Muscular	600737
1518	805	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)	VCP	VCP, IBMPFD	601023	9p13-p12	Muscular	167320
1519	806	Incontinentia pigmenti, type II, 308300 (3)	IKBKG	IKBKG, NEMO, FIP3, IP2	300248	Xq28	Dermatological	308300
1520	807	Infantile spasm syndrome, 308350 (3)	ARX	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54	300382	Xp22.13	Neurological	308350
1521	809	Infundibular hypoplasia and hypopituitarism (3)	SOX3	SOX3, MRGH	313430	Xq26.3	Endocrine	
1522	810	Inosine triphosphatase deficiency (3)	ITPA	ITPA	147520	20p	Metabolic	
1523	811	Insensitivity to pain, congenital, with anhidrosis, 256800 (3)	NTRK1	NTRK1, TRKA, MTC	191315	1q21-q22	Neurological	256800
1524	812	Insomnia (3) ()	GABRB3	GABRB3	137192	15q11.2-q12	Psychiatric	-3
1525	812	Insomnia, fatal familial, 600072 (3)	PRNP	PRNP, PRIP	176640	20pter-p12	Psychiatric	600072
1526	814	Insulin resistance, severe, digenic, 604367 (3)	PPARG	PPARG, PPARG1, PPARG2	601487	3p25	Metabolic	604367
1527	814	Insulin resistance, severe, digenic, 604367 (3)	PPP1R3A	PPP1R3A, PPP1R3	600917	7q11.23-q21.11	Metabolic	604367
1528	814	Insulin resistance, susceptibility to (3)	PTPN1	PTPN1, PTP1B	176885	20q13.1-q13.2	Metabolic	
1529	816	Interleukin-2 receptor, alpha chain, deficiency of (3)	IL2RA	IL2RA, IL2R	147730	10p15-p14	Immunological	
1530	817	Intervertebral disc disease, susceptibility to, 603932 (3)	COL9A2	COL9A2, EDM2	120260	1p33-p32.2	Neurological	603932
1531	817	Intervertebral disc disease, susceptibility to, 603932 (3)	COL9A3	COL9A3, EDM3, IDD	120270	20q13.3	Neurological	603932
1532	819	Intrauterine and postnatal growth retardation (3)	IGF1R	IGF1R	147370	15q25-q26	Developmental	
1533	819	Intrauterine and postnatal growth retardation (3)	IGF2	IGF2	147470	11p15.5	Developmental	
1534	820	Intrinsic factor deficiency, 261000 (3)	GIF	GIF, IF	609342	11q13	Hematological	261000
1535	821	IRAK4 deficiency, 607676 (3)	IRAK4	IRAK4, REN64	606883	12q12	Immunological	607676
1536	822	Iridogoniodysgenesis, 601631 (3)	FOXC1	FOXC1, FKHL7, FREAC3	601090	6p25	Ophthamological	601631
1537	822	Iridogoniodysgenesis syndrome-2, 137600 (3)	PITX2	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25-q26	Ophthamological	137600
1538	823	Iris hypoplasia and glaucoma (3)	FOXC1	FOXC1, FKHL7, FREAC3	601090	6p25	Ophthamological	
1539	824	Iron deficiency anemia, susceptibility to (3)	TF	TF	190000	3q21	Hematological	
1540	824	Iron overload, autosomal dominant (3)	FTH1	FTH1, FTHL6	134770	11q12-q13	Hematological	
1541	825	Isolated growth hormone deficiency, Illig type with absent GH and Kowarski type with bioinactive GH (3)	GH1	GH1, GHN	139250	17q22-q24	Endocrine	
1542	826	Isovaleric acidemia, 243500 (3)	IVD	IVD	607036	15q14-q15	Metabolic	243500
1543	827	Jackson-Weiss syndrome, 123150 (3)	FGFR1	FGFR1, FLT2, KAL2	136350	8p11.2-p11.1	Skeletal	123150
1544	827	Jackson-Weiss syndrome, 123150 (3)	FGFR2	FGFR2, BEK, CFD1, JWS	176943	10q26	Skeletal	123150
1545	829	Jensen syndrome, 311150 (3)	TIMM8A	TIMM8A, DFN1, DDP, MTS, DDP1	300356	Xq22	Neurological	311150
1546	830	Jervell and Lange-Nielsen syndrome, 220400 (3)	KCNE1	KCNE1, JLNS, LQT5	176261	21q22.1-q22.2	multiple	220400
1547	830	Jervell and Lange-Nielsen syndrome, 220400 (3)	KCNQ1	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB1	607542	11p15.5	multiple	220400
1548	831	Joubert syndrome, 213300 (3)	NPHP1	NPHP1, NPH1, SLSN1	607100	2q13	multiple	213300
1549	831	Joubert syndrome-3, 608629 (3)	AHI1	AHI1	608894	6q23.3	multiple	608629
1550	832	Juberg-Marsidi syndrome, 309590 (3)	ATRX	ATRX, XH2, XNP, MRXS3, SHS	300032	Xq13	multiple	309590
1551	833	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)	MADH4	MADH4, DPC4, SMAD4, JIP	600993	18q21.1	Cancer	175050
1552	835	Kallikrein, decreased urinary activity of (3)	KLK1	KLK1, KLKR	147910	19q13.2-q13.4	Renal	
1553	836	Kallmann syndrome 2, 147950 (3)	FGFR1	FGFR1, FLT2, KAL2	136350	8p11.2-p11.1	multiple	147950
1554	836	Kallmann syndrome (3)	KAL1	KAL1, KMS, ADMLX	308700	Xp22.3	multiple	
1555	837	Kanzaki disease, 609242 (3)	NAGA	NAGA	104170	22q11	Metabolic	609242
1556	838	Kaposi sarcoma, susceptibility to, 148000 (3)	IL6	IL6, IFNB2, BSF2	147620	7p21	Immunological	148000
1557	839	Kappa light chain deficiency (3)	IGKC	IGKC	147200	2p12	Immunological	
1558	840	Kartagener syndrome, 244400 (3)	DNAH11	DNAH11, DNAHC11	603339	Chr.7	multiple	244400
1559	840	Kartagener syndrome, 244400 (3)	DNAH5	DNAH5, HL1, PCD, CILD3	603335	5p15-p14	multiple	244400
1560	840	Kartagener syndrome, 244400 (3)	DNAI1	DNAI1, CILD1, ICS, PCD	604366	9p21-p13	multiple	244400
1561	841	Kenny-Caffey syndrome-1, 244460 (3)	TBCE	TBCE, KCS, KCS1, HRD	604934	1q42-q43	multiple	244460
1562	842	Keratitis, 148190 (3)	PAX6	PAX6, AN2, MGDA	607108	11p13	Ophthamological	148190
1563	843	Keratitis-ichthyosis-deafness syndrome, 148210 (3)	GJB2	GJB2, CX26, DFNB1, PPK, DFNA3, KID, HID	121011	13q11-q12	multiple	148210
1564	844	Keratoconus, 148300 (3)	VSX1	VSX1, RINX, PPCD, PPD, KTCN	605020	20p11.2	Ophthamological	148300
1565	845	Keratoderma, palmoplantar, with deafness, 148350 (3)	GJB2	GJB2, CX26, DFNB1, PPK, DFNA3, KID, HID	121011	13q11-q12	Dermatological	148350
1566	847	Keratosis follicularis spinulosa decalvans, 308800 (3)	SAT	SAT, SSAT, KFSD	313020	Xp22.1	Dermatological	308800
1567	847	Keratosis palmoplantaria striata, 148700 (3)	KRT1	KRT1	139350	12q13	Dermatological	148700
1568	847	Keratosis palmoplantaris striata I, 148700 (3)	DSG1	DSG1	125670	18q12.1-q12.2	Dermatological	148700
1569	847	Keratosis palmoplantaris striata II (3)	DSP	DSP, KPPS2, PPKS2	125647	6p24	Dermatological	
1570	847	Keratosis palmoplantaris striata III, 607654 (3)	KRT1	KRT1	139350	12q13	Dermatological	607654
1571	848	Ketoacidosis due to SCOT deficiency (3)	SCOT	SCOT, OXCT	245050	5p13	Metabolic	
1572	849	Keutel syndrome, 245150 (3)	MGP	MGP, NTI	154870	12p13.1-p12.3	multiple	245150
1573	850	Kindler syndrome, 173650 (3)	KIND1	KIND1, URP1, C20orf42	607900	20p13	Dermatological	173650
1574	851	Kininogen deficiency (3)	KNG	KNG	228960	3q27	Hematological	
1575	853	Klippel-Trenaunay syndrome, 149000 (3)	VG5Q	VG5Q, HUS84971, FLJ10283	608464	5q13.3	multiple	149000
1576	854	Kniest dysplasia, 156550 (3)	COL2A1	COL2A1	120140	12q13.11-q13.2	Skeletal	156550
1577	855	Knobloch syndrome, 267750 (3)	COL18A1	COL18A1, KNO	120328	21q22.3	multiple	267750
1578	856	Krabbe disease, 245200 (3)	GALC	GALC	606890	14q31	Neurological	245200
1579	857	L-2-hydroxyglutaric aciduria, 236792 (3)	L2HGDH	L2HGDH, C14orf160	609584	14q22.1	Metabolic	236792
1580	858	Lactate dehydrogenase-B deficiency (3)	LDHB	LDHB	150100	12p12.2-p12.1	Metabolic	
1581	859	Lacticacidemia due to PDX1 deficiency, 245349 (3)	PDX1	PDX1	608769	11p13	Metabolic	245349
1582	862	Langer mesomelic dysplasia, 249700 (3)	SHOX	SHOX, GCFX, SS, PHOG	312865	Xpter-p22.32	Skeletal	249700
1583	862	Langer mesomelic dysplasia, 249700 (3)	SHOXY	SHOXY	400020	Ypter-p11.2	Skeletal	249700
1584	863	Laron dwarfism, 262500 (3)	GHR	GHR	600946	5p13-p12	Skeletal	262500
1585	865	Larson syndrome, 150250 (3)	FLNB	FLNB, SCT, AOI	603381	3p14.3	Skeletal	150250
1586	868	Laryngoonychocutaneous syndrome, 245660 (3)	LAMA3	LAMA3, LOCS	600805	18q11.2	multiple	245660
1587	869	Lathosterolosis, 607330 (3)	SC5DL	SC5DL, ERG3	602286	11q23.3	Metabolic	607330
1588	870	LCHAD deficiency (3)	HADHA	HADHA, MTPA	600890	2p23	Metabolic	
1589	871	Lead poisoning, susceptibility to (3)	ALAD	ALAD	125270	9q34	Metabolic	
1590	872	Leanness, inherited (3)	AGRP	AGRP, ART, AGRT	602311	16q22	Nutritional	
1591	873	Leber congenital amaurosis, 204000 (3)	CRB1	CRB1, RP12	604210	1q31-q32.1	Ophthamological	204000
1592	873	Leber congenital amaurosis, 204000 (3)	CRX	CRX, CORD2, CRD	602225	19q13.3	Ophthamological	204000
1593	873	Leber congenital amaurosis, 204000 (3)	RPGRIP1	RPGRIP1, LCA6, CORD9	605446	14q11	Ophthamological	204000
1594	873	Leber congenital amaurosis-2, 204100 (3)	RPE65	RPE65, RP20	180069	1p31	Ophthamological	204100
1595	873	Leber congenital amaurosis, 604393 (3)	AIPL1	AIPL1, LCA4	604392	17p13.1	Ophthamological	604393
1596	873	Leber congenital amaurosis, type I, 204000 (3)	GUCY2D	GUCY2D, GUC2D, LCA1, CORD6	600179	17p13.1	Ophthamological	204000
1597	873	Leber congenital amaurosis, type III, 604232 (3)	RDH12	RDH12, LCA3	608830	14q23.3	Ophthamological	604232
1598	874	Left-right axis malformations (3)	ACVR2B	ACVR2B	602730	3p22-p21.3	Developmental	
1599	874	Left-right axis malformations (3)	EBAF	EBAF, TGFB4, LEFTY2, LEFTA, LEFTYA	601877	1q42.1	Developmental	
1600	875	Left ventricular noncompaction, familial isolated, 1, 604169 (3)	DTNA	DTNA, D18S892E, DRP3, LVNC1	601239	18q12.1-q12.2	Cardiovascular	604169
1601	875	Left ventricular noncompaction with congenital heart defects, 606617 (3)	DTNA	DTNA, D18S892E, DRP3, LVNC1	601239	18q12.1-q12.2	Cardiovascular	606617
1602	876	Legionaire disease, susceptibility to, 608556 (3)	TLR5	TLR5, TIL3	603031	1q41-q42	Immunological	608556
1603	877	Leigh syndrome, 256000 (3)	BCS1L	BCS1L, FLNMS, GRACILE	603647	2q33	Neurological	256000
1604	877	Leigh syndrome, 256000 (3)	DLD	DLD, LAD, PHE3	238331	7q31-q32	Neurological	256000
1605	877	Leigh syndrome, 256000 (3)	NDUFS3	NDUFS3	603846	11p11.11	Neurological	256000
1606	877	Leigh syndrome, 256000 (3)	NDUFS4	NDUFS4, AQDQ	602694	5q11.1	Neurological	256000
1607	877	Leigh syndrome, 256000 (3)	NDUFS7	NDUFS7, PSST	601825	19p13	Neurological	256000
1608	877	Leigh syndrome, 256000 (3)	NDUFS8	NDUFS8	602141	11q13	Neurological	256000
1609	877	Leigh syndrome, 256000 (3)	NDUFV1	NDUFV1, UQOR1	161015	11q13	Neurological	256000
1610	877	Leigh syndrome, 256000 (3)	SDHA	SDHA, SDH2, SDHF	600857	5p15	Neurological	256000
1611	877	Leigh syndrome, due to COX deficiency, 256000 (3)	SURF1	SURF1	185620	9q34	Neurological	256000
1612	877	Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3)	COX15	COX15	603646	10q24	Neurological	256000
1613	877	Leigh syndrome, French-Canadian type, 220111 (3)	LRPPRC	LRPPRC, LRP130, LSFC	607544	2p21-p16	Neurological	220111
1614	877	Leigh syndrome, X-linked, 308930 (3)	PDHA1	PDHA1, PHE1A	312170	Xp22.2-p22.1	Neurological	308930
1615	878	Leiomyomatosis and renal cell cancer, 605839 (3)	FH	FH	136850	1q42.1	Cancer	605839
1616	878	Leiomyomatosis, diffuse, with Alport syndrome, 308940 (3)	COL4A6	COL4A6	303631	Xq22.3	Cancer	308940
1617	880	Leopard syndrome, 151100 (3)	PTPN11	PTPN11, PTP2C, SHP2, NS1	176876	12q24.1	multiple	151100
1618	881	Leprechaunism, 246200 (3)	INSR	INSR	147670	19p13.2	Developmental	246200
1619	882	Leprosy, susceptibility to, 607572 (3)	PRKN	PRKN, PARK2, PDJ	602544	6q25.2-q27	Immunological	607572
1620	883	Leri-Weill dyschondrosteosis, 127300 (3)	SHOX	SHOX, GCFX, SS, PHOG	312865	Xpter-p22.32	Skeletal	127300
1621	883	Leri-Weill dyschondrosteosis, 127300 (3)	SHOXY	SHOXY	400020	Ypter-p11.2	Skeletal	127300
1622	884	Lesch-Nyhan syndrome, 300322, (3)	HPRT1	HPRT1, HPRT	308000	Xq26-q27.2	Metabolic	300322
1623	886	Leukemia-1, T-cell acute lymphocytic (3)	TAL1	TAL1, TCL5, SCL	187040	1p32	Cancer	
1624	886	Leukemia-2, T-cell acute lymphoblastic (3)	TAL2	TAL2	186855	9q31	Cancer	
1625	886	Leukemia, acute lymphoblastic (3)	FLT3	FLT3	136351	13q12	Cancer	
1626	886	Leukemia, acute lymphoblastic (3)	NBS1	NBS1, NBS	602667	8q21	Cancer	
1627	886	Leukemia, acute lymphoblastic (3)	ZNFN1A1	ZNFN1A1, IK1, LYF1	603023	7p12	Cancer	
1628	886	Leukemia, acute lymphoblastic, susceptibility to (3)	HOXD4	HOXD4, HOX4B	142981	2q31-q32	Cancer	
1629	886	Leukemia, acute lymphocytic (3)	BCR	BCR, CML, PHL, ALL	151410	22q11.21	Cancer	
1630	886	Leukemia, acute myeloblastic (3)	ARNT	ARNT	126110	1q21	Cancer	
1631	886	Leukemia, acute myelogenous (3)	KRAS2	KRAS2, RASK2	190070	12p12.1	Cancer	
1632	886	Leukemia, acute myelogenous, 601626 (3)	GMPS	GMPS	600358	3q24	Cancer	601626
1633	886	Leukemia, acute myeloid, 601626 (3)	AF10	AF10	602409	10p12	Cancer	601626
1634	886	Leukemia, acute myeloid, 601626 (3)	ARHGEF12	ARHGEF12, LARG, KIAA0382	604763	11q23.3	Cancer	601626
1635	886	Leukemia, acute myeloid, 601626 (3)	CALM	CALM, CLTH	603025	11q14	Cancer	601626
1636	886	Leukemia, acute myeloid, 601626 (3)	CEBPA	CEBPA, CEBP	116897	19q13.1	Cancer	601626
1637	886	Leukemia, acute myeloid, 601626 (3)	CHIC2	CHIC2, BTL	604332	4q11-q12	Cancer	601626
1638	886	Leukemia, acute myeloid, 601626 (3)	FLT3	FLT3	136351	13q12	Cancer	601626
1639	886	Leukemia, acute myeloid, 601626 (3)	KIT	KIT, PBT	164920	4q12	Cancer	601626
1640	886	Leukemia, acute myeloid, 601626 (3)	LPP	LPP	600700	3q28	Cancer	601626
1641	886	Leukemia, acute myeloid, 601626 (3)	NPM1	NPM1	164040	5q35	Cancer	601626
1642	886	Leukemia, acute myeloid, 601626 (3)	NUP214	NUP214, D9S46E, CAN, CAIN	114350	9q34.1	Cancer	601626
1643	886	Leukemia, acute myeloid, 601626 (3)	RUNX1	RUNX1, CBFA2, AML1	151385	21q22.3	Cancer	601626
1644	886	Leukemia, acute myeloid, 601626 (3)	WHSC1L1	WHSC1L1, NSD3	607083	8p12	Cancer	601626
1645	886	Leukemia, acute myeloid, reduced survival in (3)	FLT3	FLT3	136351	13q12	Cancer	
1646	886	Leukemia, acute myelomonocytic (3)	AF1Q	AF1Q	604684	1q21	Cancer	
1647	886	Leukemia, acute promyelocytic, NPM/RARA type (3)	NPM1	NPM1	164040	5q35	Cancer	
1648	886	Leukemia, acute promyelocytic, NUMA/RARA type (3)	NUMA1	NUMA1	164009	11q13	Cancer	
1649	886	Leukemia, acute promyelocytic, PL2F/RARA type (3)	ZNF145	ZNF145, PLZF	176797	11q23.1	Cancer	
1650	886	Leukemia, acute promyelocytic, PML/RARA type (3)	PML	PML, MYL	102578	15q22	Cancer	
1651	886	Leukemia, acute promyeloyctic, STAT5B/RARA type (3)	STAT5B	STAT5B	604260	17q11.2	Cancer	
1652	886	Leukemia, acute T-cell lymphoblastic (3)	AF10	AF10	602409	10p12	Cancer	
1653	886	Leukemia, acute T-cell lymphoblastic (3)	CALM	CALM, CLTH	603025	11q14	Cancer	
1654	886	Leukemia, chronic lymphatic, susceptibility to, 151400 (3)	ARL11	ARL11, ARLTS1	609351	13q14.3	Cancer	151400
1655	886	Leukemia, chronic lymphatic, susceptibility to, 151400 (3)	P2RX7	P2RX7, P2X7	602566	12q24	Cancer	151400
1656	886	Leukemia, chronic myeloid, 608232 (3)	BCR	BCR, CML, PHL, ALL	151410	22q11.21	Cancer	608232
1657	886	Leukemia, juvenile myelomonocytic, 607785 (3)	GRAF	GRAF	605370	5q31	Cancer	607785
1658	886	Leukemia, juvenile myelomonocytic, 607785 (3)	NF1	NF1, VRNF, WSS, NFNS	162200	17q11.2	Cancer	607785
1659	886	Leukemia, juvenile myelomonocytic, 607785 (3)	PTPN11	PTPN11, PTP2C, SHP2, NS1	176876	12q24.1	Cancer	607785
1660	886	Leukemia/lymphoma, B-cell, 2 (3)	BCL2	BCL2	151430	18q21.3	Cancer	2
1661	886	Leukemia/lymphoma, chronic B-cell, 151400 (3)	CCND1	CCND1, PRAD1, BCL1	168461	11q13	Cancer	151400
1662	886	Leukemia/lymphoma, T-cell (3)	TCRA	TCRA	186880	14q11.2	Cancer	
1663	886	Leukemia, megakaryoblastic, of Down syndrome, 190685 (3)	GATA1	GATA1, GF1, ERYF1, NFE1	305371	Xp11.23	Cancer	190685
1664	886	Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3)	GATA1	GATA1, GF1, ERYF1, NFE1	305371	Xp11.23	Cancer	190685
1665	886	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)	ABL1	ABL1	189980	9q34.1	Cancer	
1666	886	Leukemia, post-chemotherapy, susceptibility to (3)	NQO1	NQO1, DIA4, NMOR1	125860	16q22.1	Cancer	
1667	886	Leukemia, T-cell acute lymphoblastic (3)	NUP214	NUP214, D9S46E, CAN, CAIN	114350	9q34.1	Cancer	
1668	889	Leukocyte adhesion deficiency, 116920 (3)	ITGB2	ITGB2, CD18, LCAMB, LAD	600065	21q22.3	Immunological	116920
1669	891	Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B1	EIF2B1, EIF2BA	606686	Chr.12	Neurological	603896
1670	891	Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B2	EIF2B2	606454	14q24	Neurological	603896
1671	891	Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B3	EIF2B3	606273	1p34.1	Neurological	603896
1672	891	Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B5	EIF2B5, LVWM, CACH, CLE	603945	3q27	Neurological	603896
1673	891	Leukoencephaly with vanishing white matter, 603896 (3)	EIF2B4	EIF2B4	606687	2p23.3	Neurological	603896
1674	894	Leydig cell adenoma, with precocious puberty (3)	LHCGR	LHCGR	152790	2p21	Cancer	
1675	895	Lhermitte-Duclos syndrome (3)	PTEN	PTEN, MMAC1	601728	10q23.31	Cancer	
1676	896	Liddle syndrome, 177200 (3)	SCNN1B	SCNN1B	600760	16p13-p12	Renal	177200
1677	896	Liddle syndrome, 177200 (3)	SCNN1G	SCNN1G, PHA1	600761	16p13-p12	Renal	177200
1678	897	Li Fraumeni syndrome, 151623 (3)	CDKN2A	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21	Cancer	151623
1679	898	Li-Fraumeni syndrome, 151623 (3)	TP53	TP53, P53, LFS1	191170	17p13.1	Cancer	151623
1680	898	Li-Fraumeni syndrome, 609265 (3)	CHEK2	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	Cancer	609265
1681	899	LIG4 syndrome, 606593 (3)	LIG4	LIG4	601837	13q22-q34	multiple	606593
1682	901	Limb-mammary syndrome, 603543 (3)	TP73L	TP73L, TP63, KET, EEC3, SHFM4, LMS, RHS	603273	3q27	multiple	603543
1683	902	Lipodystrophy, congenital generalized, type 1, 608594 (3)	AGPAT2	AGPAT2, LPAAB, BSCL, BSCL1	603100	9q34.3	Metabolic	608594
1684	902	Lipodystrophy, congenital generalized, type 2, 269700 (3)	BSCL2	BSCL2, SPG17	606158	11q13	Metabolic	269700
1685	902	Lipodystrophy, familial partial, 151660 (3)	LMNA	LMNA, LMN1, EMD2, FPLD, CMD1A, HGPS, LGMD1B	150330	1q21.2	Metabolic	151660
1686	902	Lipodystrophy, familial partial, 151660 (3)	PPARG	PPARG, PPARG1, PPARG2	601487	3p25	Metabolic	151660
1687	902	Lipodystrophy, familial partial, with decreased subcutaneous fat of face and neck (3)	PPARGC1A	PPARGC1A, PPARGC1	604517	4p15.1	Metabolic	
1688	903	Lipoid adrenal hyperplasia, 201710 (3)	STAR	STAR	600617	8p11.2	Endocrine	201710
1689	903	Lipoid congenital adrenal hyperplasia, 201710 (3)	CYP11A	CYP11A, P450SCC	118485	15q23-q24	Endocrine	201710
1690	2903	Lipoid proteinosis, 247100 (3)	ECM1	ECM1	602201	1q21	Metabolic	247100
1691	904	Lipoma (3)	HMGA2	HMGA2, HMGIC, BABL, LIPO	600698	12q14.3	Cancer	
1692	904	Lipoma (3)	LPP	LPP	600700	3q28	Cancer	
1693	904	Lipoma, sporadic (3)	MEN1	MEN1	131100	11q13	Cancer	
1694	904	Lipomatosis, mutiple, 151900 (3)	HMGA2	HMGA2, HMGIC, BABL, LIPO	600698	12q14.3	Cancer	151900
1695	906	Lipoprotein lipase deficiency (3)	LPL	LPL, LIPD	238600	8p22	Metabolic	
1696	908	Lissencephaly-1, 607432 (3)	PAFAH1B1	PAFAH1B1, LIS1	601545	17p13.3	Neurological	607432
1697	908	Lissencephaly syndrome, Norman-Roberts type, 257320 (3)	RELN	RELN, RL	600514	7q22	Neurological	257320
1698	908	Lissencephaly, X-linked, 300067 (3)	DCX	DCX, DBCN, LISX	300121	Xq22.3-q23	Neurological	300067
1699	908	Lissencephaly, X-linked with ambiguous genitalia, 300215 (3)	ARX	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54	300382	Xp22.13	Neurological	300215
1700	909	Listeria monocytogenes, susceptibility to (3)	CDH1	CDH1, UVO	192090	16q22.1	Immunological	
1701	910	Loeys-Dietz syndrome, 609192 (3)	TGFBR1	TGFBR1	190181	9q33-q34	Connective tissue	609192
1702	910	Loeys-Dietz syndrome, 609192 (3)	TGFBR2	TGFBR2, HNPCC6	190182	3p22	Connective tissue	609192
1703	911	Longevity, exceptional, 152430 (3)	CETP	CETP	118470	16q21	Developmental	152430
1704	911	Longevity, reduced, 152430 (3)	AKAP10	AKAP10	604694	17p11.1	Developmental	152430
1705	912	Long QT syndrome-1, 192500 (3)	KCNQ1	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB1	607542	11p15.5	Cardiovascular	192500
1706	912	Long QT syndrome-2 (3)	KCNH2	KCNH2, LQT2, HERG	152427	7q35-q36	Cardiovascular	
1707	912	Long QT syndrome-3, 603830 (3)	SCN5A	SCN5A, LQT3, IVF, HB1, SSS1	600163	3p21	Cardiovascular	603830
1708	912	Long QT syndrome 4, 600919 (3)	ANK2	ANK2, LQT4	106410	4q25-q27	Cardiovascular	600919
1709	912	Long QT syndrome-5 (3)	KCNE1	KCNE1, JLNS, LQT5	176261	21q22.1-q22.2	Cardiovascular	
1710	912	Long QT syndrome-6 (3)	KCNE2	KCNE2, MIRP1, LQT6	603796	21q22.1	Cardiovascular	
1711	912	Long QT syndrome-7, 170390 (3)	KCNJ2	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7	600681	17q23.1-q24.2	Cardiovascular	170390
1712	913	Lower motor neuron disease, progressive, without sensory symptoms, 607641 (3)	DCTN1	DCTN1	601143	2p13	Neurological	607641
1713	914	Lowe syndrome, 309000 (3)	OCRL	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	Metabolic	309000
1714	915	Low renin hypertension, susceptibility to (3)	CYP11B2	CYP11B2	124080	8q21	Cardiovascular	
1715	916	LPA deficiency, congenital (3)	LPA	LPA	152200	6q27	Metabolic	
1716	917	Lumbar disc disease, susceptibility to, 603932 (3)	CILP	CILP	603489	15q22	Skeletal	603932
1717	918	Lung cancer, 211980 (3)	KRAS2	KRAS2, RASK2	190070	12p12.1	Cancer	211980
1718	918	Lung cancer, 211980 (3)	PPP2R1B	PPP2R1B	603113	11q22-q24	Cancer	211980
1719	918	Lung cancer, 211980 (3)	SLC22A1L	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.5	Cancer	211980
1720	918	Lung cancer, somatic, 211980 (3)	MAP3K8	MAP3K8, COT, EST, TPL2	191195	10p11.2	Cancer	211980
1721	919	Lupus nephritis, susceptibility to (3)	FCGR2A	FCGR2A, IGFR2, CD32	146790	1q21-q23	Connective tissue	
1722	920	Lymphangioleiomyomatosis, 606690 (3)	TSC1	TSC1, LAM	605284	9q34	Respiratory	606690
1723	920	Lymphangioleiomyomatosis, somatic, 606690 (3)	TSC2	TSC2, LAM	191092	16p13.3	Respiratory	606690
1724	921	Lymphedema and ptosis, 153000 (3)	FOXC2	FOXC2, FKHL14, MFH1	602402	16q24.3	Hematological	153000
1725	921	Lymphedema-distichiasis syndrome, 153400 (3)	FOXC2	FOXC2, FKHL14, MFH1	602402	16q24.3	Hematological	153400
1726	921	Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus (3)	FOXC2	FOXC2, FKHL14, MFH1	602402	16q24.3	Hematological	
1727	921	Lymphedema, hereditary I, 153100 (3)	FLT4	FLT4, VEGFR3, PCL	136352	5q35.3	Hematological	153100
1728	921	Lymphedema, hereditary II, 153200 (3)	FOXC2	FOXC2, FKHL14, MFH1	602402	16q24.3	Hematological	153200
1729	925	Lymphocytic leukemia, acute T-cell (3)	RAP1GDS1	RAP1GDS1	179502	4q21-q25	Cancer	
1730	925	Lymphoma, B-cell non-Hodgkin, somatic (3)	ATM	ATM, ATA, AT1	607585	11q22.3	Cancer	
1731	925	Lymphoma, diffuse large cell (3)	BCL8	BCL8	601889	15q11-q13	Cancer	
1732	925	Lymphoma, follicular (3)	BCL10	BCL10	603517	1p22	Cancer	
1733	925	Lymphoma, MALT (3)	BCL10	BCL10	603517	1p22	Cancer	
1734	925	Lymphoma, mantle cell (3)	ATM	ATM, ATA, AT1	607585	11q22.3	Cancer	
1735	925	Lymphoma, non-Hodgkin (3)	RAD54B	RAD54B	604289	8q21.3-q22	Cancer	
1736	925	Lymphoma, non-Hodgkin (3)	RAD54L	RAD54L, HR54, HRAD54	603615	1p32	Cancer	
1737	925	Lymphoma, progression of (3)	FCGR2B	FCGR2B, CD32	604590	1q22	Cancer	
1738	925	Lymphoma, somatic (3)	MAD1L1	MAD1L1, TXBP181	602686	7p22	Cancer	
1739	925	Lymphoma, T-cell (3)	MSH2	MSH2, COCA1, FCC1, HNPCC1	609309	2p22-p21	Cancer	
1740	925	Lymphoproliferative syndrome, X-linked, 308240 (3)	SH2D1A	SH2D1A, LYP, IMD5, XLP, XLPD	300490	Xq25	Cancer	308240
1741	930	Lynch cancer family syndrome II, 114400 (3)	MSH2	MSH2, COCA1, FCC1, HNPCC1	609309	2p22-p21	Cancer	114400
1742	931	Lysinuric protein intolerance, 222700 (3)	SLC7A7	SLC7A7, LPI	603593	14q11.2	Metabolic	222700
1849	992	Merkel cell carcinoma, somatic (3)	SDHD	SDHD, PGL1	602690	11q23	Cancer	
1743	933	Machado-Joseph disease, 109150 (3)	ATXN3	ATXN3, MJD, SCA3	607047	14q24.3-q31	Neurological	109150
1744	935	Macrocytic anemia, refractory, of 5q-syndrome, 153550 (3)	IRF1	IRF1, MAR	147575	5q31.1	Hematological	153550
1745	936	Macrothrombocytopenia, 300367 (3)	GATA1	GATA1, GF1, ERYF1, NFE1	305371	Xp11.23	Hematological	300367
1746	2937	Macular corneal dystrophy, 217800 (3)	CHST6	CHST6, MCDC1	605294	16q22	Ophthamological	217800
1747	937	Macular degeneration, age-related, 1, 603075 (3)	HF1	HF1, CFH, HUS	134370	1q32	Ophthamological	603075
1748	937	Macular degeneration, age-related, 1, 603075 (3)	HMCN1	HMCN1, FBLN6, FIBL6	608548	1q24-q25	Ophthamological	603075
1749	937	Macular degeneration, age-related, 3, 608895 (3)	FBLN5	FBLN5, ARMD3	604580	14q32.1	Ophthamological	608895
1750	937	Macular degeneration, juvenile, 248200 (3)	CNGB3	CNGB3, ACHM3	605080	8q21-q22	Ophthamological	248200
1751	937	Macular degeneration, X-linked atrophic (3)	RPGR	RPGR, RP3, CRD, RP15, COD1	312610	Xp21.1	Ophthamological	
1752	2937	Macular dystrophy (3)	RDS	RDS, RP7, PRPH2, PRPH, AVMD, AOFMD	179605	6p21.1-cen	Ophthamological	
1753	2937	Macular dystrophy, age-related, 2, 153800 (3)	ABCA4	ABCA4, ABCR, STGD1, FFM, RP19	601691	1p21-p13	Ophthamological	153800
1754	2937	Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3)	ELOVL4	ELOVL4, ADMD, STGD2, STGD3	605512	6q14	Ophthamological	600110
1755	2937	Macular dystrophy, vitelliform, 608161 (3)	RDS	RDS, RP7, PRPH2, PRPH, AVMD, AOFMD	179605	6p21.1-cen	Ophthamological	608161
1756	2937	Macular dystrophy, vitelliform type, 153700 (3)	VMD2	VMD2	607854	11q13	Ophthamological	153700
1757	938	Maculopathy, bull's-eye, 153870 (3)	VMD2	VMD2	607854	11q13	Ophthamological	153870
1758	939	Major depressive disorder and accelerated response to antidepressant drug treatment, 608616 (3)	FKBP5	FKBP5, FKBP51	602623	6p21.3-p21.2	Psychiatric	608616
1759	940	Malaria, cerebral, reduced risk of, 248310 (3)	CD36	CD36	173510	7q11.2	Immunological	248310
1760	940	Malaria, cerebral, susceptibility to, 248310 (3)	CD36	CD36	173510	7q11.2	Immunological	248310
1761	940	Malaria, cerebral, susceptibility to (3)	ICAM1	ICAM1	147840	19p13.3-p13.2	Immunological	
1762	940	Malaria, cerebral, susceptibility to (3)	TNF	TNF, TNFA	191160	6p21.3	Immunological	
1763	940	Malaria, resistance to, 248310 (3)	GYPC	GYPC, GE, GPC	110750	2q14-q21	Immunological	248310
1764	940	Malaria, resistance to, 248310 (3)	NOS2A	NOS2A, NOS2	163730	17cen-q11.2	Immunological	248310
1765	942	Malignant hyperthermia susceptibility 1, 145600 (3)	RYR1	RYR1, MHS, CCO	180901	19q13.1	Neurological	145600
1766	942	Malignant hyperthermia susceptibility 5, 601887 (3)	CACNA1S	CACNA1S, CACNL1A3, CCHL1A3	114208	1q32	Neurological	601887
1767	943	Malonyl-CoA decarboxylase deficiency, 248360 (3)	MLYCD	MLYCD, MCD	606761	16q24	Metabolic	248360
1768	944	MALT lymphoma (3)	MALT1	MALT1, MLT	604860	18q21	Cancer	
1769	945	Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3)	ZMPSTE24	ZMPSTE24, FACE1, STE24, MADB	606480	1p34	multiple	608612
1770	947	Mannosidosis, alpha-, types I and II, 248500 (3)	MAN2B1	MAN2B1, MANB	609458	19cen-q12	Metabolic	248500
1771	947	Mannosidosis, beta, 248510 (3)	MANBA	MANBA, MANB1	609489	4q22-q25	Metabolic	248510
1772	948	Maple syrup urine disease, type Ia, 248600 (3)	BCKDHA	BCKDHA, MSUD1	608348	19q13.1-q13.2	Metabolic	248600
1773	948	Maple syrup urine disease, type Ib (3)	BCKDHB	BCKDHB, E1B	248611	6p22-p21	Metabolic	
1774	948	Maple syrup urine disease, type II (3)	DBT	DBT, BCATE2	248610	1p31	Metabolic	
1775	948	Maple syrup urine disease, type III, 248600 (3)	DLD	DLD, LAD, PHE3	238331	7q31-q32	Metabolic	248600
1776	950	Marfan syndrome, 154700 (3)	FBN1	FBN1, MFS1, WMS	134797	15q21.1	Connective tissue	154700
1777	950	Marfan syndrome, atypical (3)	COL1A2	COL1A2	120160	7q22.1	Connective tissue	
1778	952	Maroteaux-Lamy syndrome, several forms (3)	ARSB	ARSB, MPS6	253200	5q11-q13	Metabolic	
1779	953	Marshall syndrome, 154780 (3)	COL11A1	COL11A1, STL2	120280	1p21	multiple	154780
1780	955	MASA syndrome, 303350 (3)	L1CAM	L1CAM, CAML1, HSAS1	308840	Xq28	multiple	303350
1781	956	MASP2 deficiency (3)	MASP2	MASP2	605102	1p36.3-p36.2	Immunological	
1782	957	MASS syndrome, 604308 (3)	FBN1	FBN1, MFS1, WMS	134797	15q21.1	Connective tissue	604308
1783	958	Mast cell leukemia (3)	KIT	KIT, PBT	164920	4q12	Cancer	
1784	959	Mastocytosis with associated hematologic disorder (3)	KIT	KIT, PBT	164920	4q12	Immunological	
1785	960	Mast syndrome, 248900 (3)	ACP33	ACP33, MAST, SPG21	608181	15q21-q22	Neurological	248900
1786	961	May-Hegglin anomaly, 155100 (3)	MYH9	MYH9, MHA, FTNS, DFNA17	160775	22q11.2	Hematological	155100
1787	962	McArdle disease, 232600 (3)	PYGM	PYGM	608455	11q13	Metabolic	232600
1788	963	McCune-Albright syndrome, 174800 (3)	GNAS	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO	139320	20q13.2	multiple	174800
1789	964	McKusick-Kaufman syndrome, 236700 (3)	MKKS	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12	Developmental	236700
1790	965	McLeod syndrome (3)	XK	XK	314850	Xp21.2-p21.1	Hematological	
1791	965	McLeod syndrome with neuroacanthosis (3)	XK	XK	314850	Xp21.2-p21.1	Hematological	
1792	969	Medullary cystic kidney disease 2, 603860 (3)	UMOD	UMOD, HNFJ, FJHN, MCKD2, ADMCKD2	191845	16p12.3	Renal	603860
1793	2969	Medullary thyroid carcinoma, 155240 (3)	RET	RET, MEN2A	164761	10q11.2	Cancer	155240
1794	2969	Medullary thyroid carcinoma, familial, 155240 (3)	NTRK1	NTRK1, TRKA, MTC	191315	1q21-q22	Cancer	155240
1795	970	Medulloblastoma, 155255 (3)	PTCH2	PTCH2	603673	1p32	Cancer	155255
1796	970	Medulloblastoma, desmoplastic, 155255 (3)	SUFU	SUFU, SUFUXL, SUFUH	607035	10q24-q25	Cancer	155255
1797	971	Meesmann corneal dystrophy, 122100 (3)	KRT12	KRT12	601687	17q12	Ophthamological	122100
1798	971	Meesmann corneal dystrophy, 122100 (3)	KRT3	KRT3	148043	12q13	Ophthamological	122100
1799	973	Megakaryoblastic leukemia, acute (3)	MKL1	MKL1, AMKL, MAL	606078	22q13	Cancer	
1800	974	Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3)	MLC1	MLC1, LVM, VL	605908	22qter	Neurological	604004
1801	975	Megaloblastic anemia-1, Finnish type, 261100 (3)	CUBN	CUBN, IFCR, MGA1	602997	10p12.1	Hematological	261100
1802	975	Megaloblastic anemia-1, Norwegian type, 261100 (3)	AMN	AMN	605799	14q32	Hematological	261100
1803	978	Melanoma (3)	CDK4	CDK4, CMM3	123829	12q14	Cancer	
1804	978	Melanoma and neural system tumor syndrome, 155755 (3)	CDKN2A	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21	Cancer	155755
1805	978	Melanoma, cutaneous malignant, 2, 155601 (3)	CDKN2A	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21	Cancer	155601
1806	978	Melanoma, cutaneous malignant, susceptibility to (3)	XRCC3	XRCC3	600675	14q32.3	Cancer	
1807	978	Melanoma, malignant sporadic (3)	STK11	STK11, PJS, LKB1	602216	19p13.3	Cancer	
1808	978	Melanoma, melignant, somatic (3)	BRAF	BRAF	164757	7q34	Cancer	
1809	979	Meleda disease, 248300 (3)	SLURP1	SLURP1, MDM	606119	8qter	Dermatological	248300
1810	981	Melnick-Needles syndrome, 309350 (3)	FLNA	FLNA, FLN1, ABPX, NHBP, OPD1, OPD2, FMD, MNS	300017	Xq28	Skeletal	309350
1811	982	Melorheostosis with osteopoikilosis, 155950 (3)	LEMD3	LEMD3, MAN1	607844	12q14	Developmental	155950
1812	984	Memory impairment, susceptibility to (3)	BDNF	BDNF	113505	11p13	Neurological	
1813	985	Meniere disease 156000 (3) ()	COCH	COCH, DFNA9	603196	14q12-q13	Neurological	-3
1814	986	Meningioma, 607174 (3)	MN1	MN1, MGCR	156100	22q12.3-qter	Cancer	607174
1815	986	Meningioma, 607174 (3)	PTEN	PTEN, MMAC1	601728	10q23.31	Cancer	607174
1816	986	Meningioma, NF2-related, somatic, 607174 (3)	NF2	NF2	607379	22q12.2	Cancer	607174
1817	986	Meningioma, SIS-related (3)	PDGFB	PDGFB, SIS	190040	22q12.3-q13.1	Cancer	
1818	987	Meningococcal disease, susceptibility to (3)	MBL2	MBL2, MBL, MBP1	154545	10q11.2-q21	Immunological	
1819	988	Menkes disease, 309400 (3)	ATP7A	ATP7A, MNK, MK, OHS	300011	Xq12-q13	Neurological	309400
1820	990	Mental retardation, nonsyndromic, autosomal recessive, 249500 (3)	PRSS12	PRSS12, BSSP3	606709	4q25-q26	Neurological	249500
1821	990	Mental retardation, nonsyndromic, autosomal recessive, 2A, 607417 (3)	CRBN	CRBN, MRT2A	609262	3p26.2	Neurological	607417
1822	990	Mental retardation, X-linked, 300425 (3)	NLGN4	NLGN4, KIAA1260, AUTSX2	300427	Xp22.33	Neurological	300425
1823	990	Mental retardation, X-linked, 300458 (3)	MECP2	MECP2, RTT, PPMX, MRX16, MRX79	300005	Xq28	Neurological	300458
1824	990	Mental retardation, X-linked 30, 300558 (3)	PAK3	PAK3, MRX30, MRX47	300142	Xq21.3-q24	Neurological	300558
1825	990	Mental retardation, X-linked, 34, 300426 (3)	IL1RAPL	IL1RAPL, MRX34	300206	Xp22.1-p21.3	Neurological	300426
1826	990	Mental retardation, X-linked 36, 300430 (3)	ARX	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54	300382	Xp22.13	Neurological	300430
1827	990	Mental retardation, X-linked (3)	SLC6A8	SLC6A8, CRTR	300036	Xq28	Neurological	
1828	990	Mental retardation, X-linked-44, 300501 (3)	FTSJ1	FTSJ1, JM23, SPB1, MRX44, MRX9	300499	Xp11.23	Neurological	300501
1829	990	Mental retardation, X-linked 45, 300498 (3)	ZNF81	ZNF81, MRX45	314998	Xp22.1-p11	Neurological	300498
1830	990	Mental retardation, X-linked 54, 300419 (3)	ARX	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54	300382	Xp22.13	Neurological	300419
1831	990	Mental retardation, X-linked 58, 300218 (3)	TM4SF2	TM4SF2, MXS1, A15	300096	Xq11	Neurological	300218
1832	990	Mental retardation, X-linked, 60, 300486 (3)	OPHN1	OPHN1	300127	Xq12	Neurological	300486
1833	990	Mental retardation, X-linked-9, 309549 (3)	FTSJ1	FTSJ1, JM23, SPB1, MRX44, MRX9	300499	Xp11.23	Neurological	309549
1834	990	Mental retardation, X-linked, FRAXE type (3)	FMR2	FMR2, FRAXE, MRX2	309548	Xq28	Neurological	
1835	990	Mental retardation, X-linked, JARID1C-related, 300534 (3)	SMCX	SMCX, MRXJ, DXS1272E, XE169, JARID1C	314690	Xp11.22-p11.21	Neurological	300534
1836	990	Mental retardation, X-linked nonspecific, 309541 (3)	GDI1	GDI1, RABGD1A, MRX41, MRX48	300104	Xq28	Neurological	309541
1837	990	Mental retardation, X-linked nonspecific, 63, 300387 (3)	FACL4	FACL4, ACS4, MRX63	300157	Xq22.3	Neurological	300387
1838	990	Mental retardation, X-linked nonspecific, type 19 (3)	RPS6KA3	RPS6KA3, RSK2, MRX19	300075	Xp22.2-p22.1	Neurological	19
1839	990	Mental retardation, X-linked nonspecific, type 46, 300436 (3)	ARHGEF6	ARHGEF6, MRX46, COOL2	300267	Xq26	Neurological	300436
1840	990	Mental retardation, X-linked nonsyndromic (3)	AGTR2	AGTR2	300034	Xq22-q23	Neurological	
1841	990	Mental retardation, X-linked nonsyndromic (3)	FGD1	FGD1, FGDY, AAS	305400	Xp11.21	Neurological	
1842	990	Mental retardation, X-linked nonsyndromic (3)	ZNF41	ZNF41	314995	Xp22.1-cen	Neurological	
1843	990	Mental retardation, X-linked nonsyndromic, DLG3-related (3)	DLG3	DLG3, NEDLG, SAP102, MRX	300189	Xq13.1	Neurological	
1844	990	Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)	SMS	SMS, SRS, MRSR	300105	Xp22.1	Neurological	309583
1845	990	Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3)	SOX3	SOX3, MRGH	313430	Xq26.3	Neurological	300123
1846	990	Mental retardation, X-linked, with progressive spasticity, 300279 (3)	MECP2	MECP2, RTT, PPMX, MRX16, MRX79	300005	Xq28	Neurological	300279
1847	990	Mental retardation, X-linked, with seizures and carrier manifestations, 300397 (3)	SLC6A8	SLC6A8, CRTR	300036	Xq28	Neurological	300397
1848	991	Mephenytoin poor metabolizer (3)	CYP2C	CYP2C, CYP2C19	124020	10q24.1-q24.3	Metabolic	
1850	993	Mesangial sclerosis, isolated diffuse, 256370 (3)	WT1	WT1	607102	11p13	Renal	256370
1851	995	Mesothelioma (3)	BCL10	BCL10	603517	1p22	Cancer	
1852	996	Metachromatic leukodystrophy, 250100 (3)	ARSA	ARSA	607574	22q13.31-qter	Neurological	250100
1853	996	Metachromatic leukodystrophy due to deficiency of SAP-1 (3)	PSAP	PSAP, SAP1	176801	10q22.1	Neurological	
1854	997	Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)	PTHR1	PTHR1, PTHR	168468	3p22-p21.1	Connective tissue	156400
1855	997	Metaphyseal chondrodysplasia, Schmid type (3)	COL10A1	COL10A1	120110	6q21-q22.3	Connective tissue	
1856	997	Metaphyseal dysplasia without hypotrichosis, 250460 (3)	RMRP	RMRP, RMRPR, CHH	157660	9p21-p12	Connective tissue	250460
1857	999	Methemoglobinemia due to cytochrome b5 deficiency (3)	CYB5	CYB5	250790	18q23	Hematological	
1858	999	Methemoglobinemias, alpha-(3)	HBA1	HBA1	141800	16pter-p13.3	Hematological	
1859	999	Methemoglobinemias, beta-(3)	HBB	HBB	141900	11p15.5	Hematological	
1860	999	Methemoglobinemia, type I (3)	DIA1	DIA1	250800	22q13.31-qter	Hematological	
1861	999	Methemoglobinemia, type II (3)	DIA1	DIA1	250800	22q13.31-qter	Hematological	
1862	1001	Methionine adenosyltransferase deficiency, autosomal recessive (3)	MAT1A	MAT1A, MATA1, SAMS1	250850	10q22	Metabolic	
1863	1002	Methylcobalamin deficiency, cblG type, 250940 (3)	MTR	MTR	156570	1q43	Metabolic	250940
1864	1003	Methylmalonate semialdehyde dehydrogenase deficiency (3)	ALDH6A1	ALDH6A1, MMSDH	603178	14q24.3	Metabolic	
1865	1004	Methylmalonic aciduria, mut(0) type, 251000 (3)	MUT	MUT, MCM	609058	6p21	Metabolic	251000
1866	1004	Methylmalonic aciduria, vitamin B12-responsive, 251100 (3)	MMAA	MMAA	607481	4q31.1-q31.2	Metabolic	251100
1867	1004	Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3)	MMAB	MMAB	607568	12q24	Metabolic	251110
1868	1005	Mevalonicaciduria (3)	MVK	MVK, MVLK	251170	12q24	Metabolic	
1869	1006	MHC class II deficiency, complementation group B, 209920 (3)	RFXANK	RFXANK	603200	19p12	Immunological	209920
1870	1007	Microcephaly, Amish type, 607196 (3)	SLC25A19	SLC25A19, DNC, MUP1, MCPHA	606521	17q25.3	Neurological	607196
1871	1007	Microcephaly, autosomal recessive 1, 251200 (3)	MCPH1	MCPH1	607117	8p23	Neurological	251200
1872	1007	Microcephaly, primary autosomal recessive, 3, 604804 (3)	CDK5RAP2	CDK5RAP2, KIAA1633, MCPH3	608201	9q33.3	Neurological	604804
1873	1007	Microcephaly, primary autosomal recessive, 5, 608716 (3)	ASPM	ASPM, MCPH5	605481	1q31	Neurological	608716
1874	1007	Microcephaly, primary autosomal recessive, 6, 608393 (3)	CEMPJ	CEMPJ, CPAP, MCPH6	609279	13q12.2	Neurological	608393
1875	1009	Microcoria-congenital nephrosis syndrome, 609049 (3)	LAMB2	LAMB2, LAMS	150325	3p21	Ophthamological	609049
1876	1011	Micropenis (3)	LHCGR	LHCGR	152790	2p21	Renal	
1877	1012	Microphthalmia, cataracts, and iris abnormalities (3)	CHX10	CHX10, HOX10	142993	14q24.3	Ophthamological	
1878	1012	Microphthalmia, SIX6-related (3)	SIX6	SIX6	606326	14q23	Ophthamological	
1879	1012	Microphthalmia with associated anomalies 2, 300412 (3)	BCOR	BCOR, KIAA1575, MAA2, ANOP2	300485	Xp11.4	Ophthamological	300412
1880	1013	Migraine, familial hemiplegic, 2, 602481 (3)	ATP1A2	ATP1A2, FHM2, MHP2	182340	1q21-q23	Neurological	602481
1881	1013	Migraine, resistance to, 157300 (3)	EDNRA	EDNRA	131243	4q31.2	Neurological	157300
1882	1013	Migraine, susceptibility to, 157300 (3)	ESR1	ESR1, ESR	133430	6q25.1	Neurological	157300
1883	1013	Migraine without aura, susceptibility to, 157300 (3)	TNF	TNF, TNFA	191160	6p21.3	Neurological	157300
1884	1014	Miller-Dieker lissencephaly, 247200 (3)	YWHAE	YWHAE, MDCR, MDS	605066	17p13.3	multiple	247200
1885	1016	Mitochondrial complex I deficiency, 252010 (3)	NDUFS1	NDUFS1	157655	2q33-q34	multiple	252010
1886	1016	Mitochondrial complex I deficiency, 252010 (3)	NDUFS2	NDUFS2	602985	1q23	multiple	252010
1887	1016	Mitochondrial complex I deficiency, 252010 (3)	NDUFS4	NDUFS4, AQDQ	602694	5q11.1	multiple	252010
1888	1016	Mitochondrial complex I deficiency, 252010 (3)	NDUFV1	NDUFV1, UQOR1	161015	11q13	multiple	252010
1889	1016	Mitochondrial complex III deficiency, 124000 (3)	BCS1L	BCS1L, FLNMS, GRACILE	603647	2q33	multiple	124000
1890	1016	Mitochondrial complex III deficiency, 124000 (3)	UQCRB	UQCRB, UQBP, QPC	191330	8q22	multiple	124000
1891	3016	Mitochondrial DNA depletion myopathy, 251880 (3)	TK2	TK2	188250	16q22	Muscular	251880
1892	5016	Mitochondrial DNA depletion syndrome, 251880 (3)	SUCLA2	SUCLA2	603921	13q12.2-q13	multiple	251880
1893	5016	Mitochondrial DNA-depletion syndrome, hepatocerebral form, 251880 (3)	DGUOK	DGUOK, DGK	601465	2p13	multiple	251880
1894	7016	Mitochondrial myopathy and sideroblastic anemia, 600462 (3)	PUS1	PUS1, MLASA	608109	12q24.33	multiple	600462
1895	1016	Mitochondrial respiratory chain complex II deficiency, 252011 (3)	SDHA	SDHA, SDH2, SDHF	600857	5p15	multiple	252011
1896	1018	Miyoshi myopathy, 254130 (3)	DYSF	DYSF, LGMD2B	603009	2p13.3-p13.1	Muscular	254130
1897	1020	MODY5 with nephron agenesis (3)	TCF2	TCF2, HNF2	189907	17cen-q21.3	Endocrine	
1898	1020	MODY5 with non-diabetic renal disease and Mullerian aplasia (3)	TCF2	TCF2, HNF2	189907	17cen-q21.3	Endocrine	
1899	1020	MODY, one form, 125850 (3)	INS	INS	176730	11p15.5	Endocrine	125850
1900	1020	MODY, type I, 125850 (3)	HNF4A	HNF4A, TCF14, MODY1	600281	20q12-q13.1	Endocrine	125850
1901	1020	MODY, type II, 125851 (3)	GCK	GCK	138079	7p15-p13	Endocrine	125851
1902	1020	MODY, type III, 600496 (3)	TCF1	TCF1, HNF1A, MODY3	142410	12q24.2	Endocrine	600496
1903	1020	MODY, type IV (3)	IPF1	IPF1	600733	13q12.1	Endocrine	
1904	1020	MODY, type V, 604284 (3)	TCF2	TCF2, HNF2	189907	17cen-q21.3	Endocrine	604284
1905	1022	Mohr-Tranebjaerg syndrome, 304700 (3)	TIMM8A	TIMM8A, DFN1, DDP, MTS, DDP1	300356	Xq22	Neurological	304700
1906	1023	Molybdenum cofactor deficiency, type A, 252150 (3)	MOCS1	MOCS1, MOCOD	603707	6p21.3	Metabolic	252150
1907	1023	Molybdenum cofactor deficiency, type B, 252150 (3)	MOCS2	MOCS2, MPTS	603708	5q11	Metabolic	252150
1908	1023	Molybdenum cofactor deficiency, type C, 252150 (3)	GPH	GPH, KIAA1385, GEPH	603930	14q24	Metabolic	252150
1909	1024	Monilethrix, 158000 (3)	KRTHB1	KRTHB1, HB1	602153	12q13	Dermatological	158000
1910	1024	Monilethrix, 158000 (3)	KRTHB6	KRTHB6, HB6	601928	12q13	Dermatological	158000
1911	1026	Morning glory disc anomaly (3)	PAX6	PAX6, AN2, MGDA	607108	11p13	Skeletal	
1912	1028	Mowat-Wilson syndrome, 235730 (3)	ZFHX1B	ZFHX1B, SMADIP1, SIP1	605802	2q22	Developmental	235730
1913	1029	Moyamoya disease 3 (3)	MYMY3	MYMY3	608796	8q24	Neurological	3
1914	1030	Muckle-Wells syndrome, 191900 (3)	CIAS1	CIAS1, C1orf7, FCU, FCAS	606416	1q44	multiple	191900
1915	1031	Mucoepidermoid salivary gland carcinoma (3)	MAML2	MAML2, MAM3	607537	11q21	Cancer	
1916	1031	Mucoepidermoid salivary gland carcinoma (3)	MECT1	MECT1, KIAA0616	607536	19p13	Cancer	
1917	1032	Mucolipidosis IIIA, 252600 (3)	GNPTAB	GNPTAB, GNPTA	607840	4q21-q23	Metabolic	252600
1918	1032	Mucolipidosis IIIC, 252605 (3)	GNPTAG	GNPTAG	607838	16p	Metabolic	252605
1919	1032	Mucolipidosis IV, 252650 (3)	MCOLN1	MCOLN1, ML4	605248	19p13.3-p13.2	Metabolic	252650
1920	1033	Mucopolysaccharidosis Ih, 607014 (3)	IDUA	IDUA, IDA	252800	4p16.3	Metabolic	607014
1921	1033	Mucopolysaccharidosis Ih/s, 607015 (3)	IDUA	IDUA, IDA	252800	4p16.3	Metabolic	607015
1922	1033	Mucopolysaccharidosis II (3)	IDS	IDS, MPS2, SIDS	309900	Xq28	Metabolic	
1923	1033	Mucopolysaccharidosis Is, 607016 (3)	IDUA	IDUA, IDA	252800	4p16.3	Metabolic	607016
1924	1033	Mucopolysaccharidosis IVA (3)	GALNS	GALNS, MPS4A	253000	16q24.3	Metabolic	
1925	1033	Mucopolysaccharidosis IVB (3)	GLB1	GLB1	230500	3p21.33	Metabolic	
1926	1033	Mucopolysaccharidosis type IIID, 252940 (3)	GNS	GNS, G6S	607664	12q14	Metabolic	252940
1927	1033	Mucopolysaccharidosis type IX, 601492 (3)	HYAL1	HYAL1	607071	3p21.3-p21.2	Metabolic	601492
1928	1033	Mucopolysaccharidosis VII (3)	GUSB	GUSB, MPS7	253220	7q21.11	Metabolic	
1929	1034	Muenke syndrome, 602849 (3)	FGFR3	FGFR3, ACH	134934	4p16.3	Skeletal	602849
1930	1035	Muir-Torre syndrome, 158320 (3)	MLH1	MLH1, COCA2, HNPCC2	120436	3p21.3	Cancer	158320
1931	1035	Muir-Torre syndrome, 158320 (3)	MSH2	MSH2, COCA1, FCC1, HNPCC1	609309	2p22-p21	Cancer	158320
1932	1036	Mulibrey nanism, 253250 (3)	TRIM37	TRIM37, MUL, KIAA0898	605073	17q22-q23	multiple	253250
1933	3037	Multiple cutaneous and uterine leiomyomata, 150800 (3)	FH	FH	136850	1q42.1	Cancer	150800
1934	1037	Multiple endocrine neoplasia I (3)	MEN1	MEN1	131100	11q13	Cancer	
1935	1037	Multiple endocrine neoplasia IIA, 171400 (3)	RET	RET, MEN2A	164761	10q11.2	Cancer	171400
1936	1037	Multiple endocrine neoplasia IIB, 162300 (3)	RET	RET, MEN2A	164761	10q11.2	Cancer	162300
1937	5037	Multiple malignancy syndrome (3)	TP53	TP53, P53, LFS1	191170	17p13.1	Cancer	
1938	9037	Multiple myeloma (3)	IRF4	IRF4, LSIRF	601900	6p25-p23	Cancer	
1939	9037	Multiple myeloma, resistance to, 254500 (3)	LIG4	LIG4	601837	13q22-q34	Cancer	254500
1940	9038	Multiple sclerosis, susceptibility to, 126200 (3)	MHC2TA	MHC2TA, C2TA	600005	16p13	Neurological	126200
1941	9038	Multiple sclerosis, susceptibility to, 126200 (3)	PTPRC	PTPRC, CD45, LCA	151460	1q31-q32	Neurological	126200
1942	9039	Multiple sulfatase deficiency, 272200 (3)	SUMF1	SUMF1, FGE	607939	3p26	Metabolic	272200
1943	1038	Muscle-eye-brain disease, 253280 (3)	POMGNT1	POMGNT1, MEB	606822	1p34-p33	multiple	253280
1944	1039	Muscle glycogenosis (3)	PHKA1	PHKA1	311870	Xq13	Muscular	
1945	1039	Muscle hypertrophy (3)	GDF8	GDF8, MSTN	601788	2q32.2	Muscular	
1946	1040	Muscular dystrophy, congenital, 1C (3)	FKRP	FKRP, MDC1C, LGMD2I	606596	19q13.3	Muscular	
1947	1040	Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)	LAMA2	LAMA2, LAMM	156225	6q22-q23	Muscular	607855
1948	1040	Muscular dystrophy, congenital merosin-deficient, 607855 (3)	LAMA2	LAMA2, LAMM	156225	6q22-q23	Muscular	607855
1949	1040	Muscular dystrophy, congenital, type 1D, 608840 (3)	LARGE	LARGE, KIAA0609, MDC1D	603590	22q12.3-q13.1	Muscular	608840
1950	1040	Muscular dystrophy, Fukuyama congenital, 253800 (3)	FCMD	FCMD	607440	9q31	Muscular	253800
1951	1040	Muscular dystrophy, limb-girdle, type 1A, 159000 (3)	TTID	TTID, MYOT	604103	5q31	Muscular	159000
1952	1040	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)	CAPN3	CAPN3, CANP3	114240	15q15.1-q21.1	Muscular	253600
1953	1040	Muscular dystrophy, limb-girdle, type 2B, 253601 (3)	DYSF	DYSF, LGMD2B	603009	2p13.3-p13.1	Muscular	253601
1954	1040	Muscular dystrophy, limb-girdle, type 2C, 253700 (3)	SGCG	SGCG, LGMD2C, DMDA1, SCG3	608896	13q12	Muscular	253700
1955	1040	Muscular dystrophy, limb-girdle, type 2D, 608099 (3)	SGCA	SGCA, ADL, DAG2, LGMD2D, DMDA2	600119	17q12-q21.33	Muscular	608099
1956	1040	Muscular dystrophy, limb-girdle, type 2E, 604286 (3)	SGCB	SGCB, LGMD2E	600900	4q12	Muscular	604286
1957	1040	Muscular dystrophy, limb-girdle, type 2F, 601287 (3)	SGCD	SGCD, SGD, LGMD2F, CMD1L	601411	5q33	Muscular	601287
1958	1040	Muscular dystrophy, limb-girdle, type 2G, 601954 (3)	TCAP	TCAP, LGMD2G, CMD1N	604488	17q12	Muscular	601954
1959	1040	Muscular dystrophy, limb-girdle, type 2H, 254110 (3)	TRIM32	TRIM32, HT2A, LGMD2H	602290	9q31-q34.1	Muscular	254110
1960	1040	Muscular dystrophy, limb-girdle, type 2I, 607155 (3)	FKRP	FKRP, MDC1C, LGMD2I	606596	19q13.3	Muscular	607155
1961	1040	Muscular dystrophy, limb-girdle, type 2J, 608807 (3)	TTN	TTN, CMD1G, TMD, LGMD2J	188840	2q24.3	Muscular	608807
1962	1040	Muscular dystrophy, limb-girdle, type 2K, 609308 (3)	POMT1	POMT1	607423	9q34.1	Muscular	609308
1963	1040	Muscular dystrophy, limb-girdle, type IC, 607801 (3)	CAV3	CAV3, LGMD1C	601253	3p25	Muscular	607801
1964	1040	Muscular dystrophy, rigid spine, 1, 602771 (3)	SEPN1	SEPN1, SELN, RSMD1	606210	1p36-p35	Muscular	602771
1965	1040	Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)	PLEC1	PLEC1, PLTN, EBS1	601282	8q24	Muscular	226670
1966	1041	Myasthenia, familial infantile, 1, 605809 (3)	CMS1A1	CMS1A1, FIM1	605809	17p13	Muscular	605809
1967	1042	Myasthenic syndrome (3)	SCN4A	SCN4A, HYPP, NAC1A	603967	17q23.1-q25.3	Muscular	
1968	1042	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)	CHRNB1	CHRNB1, ACHRB, SCCMS, CMS2A, CMS1D	100710	17p12-p11	Muscular	608931
1969	1042	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)	CHRNE	CHRNE, SCCMS, CMS2A, FCCMS, CMS1E, CMS1D	100725	17p13-p12	Muscular	608931
1970	1042	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)	RAPSN	RAPSN, CMS1D, CMS1E	601592	11p11.2-p11.1	Muscular	608931
1971	1042	Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)	CHAT	CHAT, CMS1A2	118490	10q11.2	Muscular	254210
1972	1042	Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency, 608931 (3)	RAPSN	RAPSN, CMS1D, CMS1E	601592	11p11.2-p11.1	Muscular	608931
1973	1042	Myasthenic syndrome, fast-channel congenital, 608930 (3)	CHRNA1	CHRNA1, ACHRD, CMS2A, SCCMS, FCCMS	100690	2q24-q32	Muscular	608930
1974	1042	Myasthenic syndrome, fast-channel congenital, 608930 (3)	CHRND	CHRND, ACHRD, SCCMS, CMS2A, FCCMS	100720	2q33-q34	Muscular	608930
1975	1042	Myasthenic syndrome, fast-channel congenital, 608930 (3)	CHRNE	CHRNE, SCCMS, CMS2A, FCCMS, CMS1E, CMS1D	100725	17p13-p12	Muscular	608930
1976	1042	Myasthenic syndrome, slow-channel congenital, 601462 (3)	CHRNA1	CHRNA1, ACHRD, CMS2A, SCCMS, FCCMS	100690	2q24-q32	Muscular	601462
1977	1042	Myasthenic syndrome, slow-channel congenital, 601462 (3)	CHRNB1	CHRNB1, ACHRB, SCCMS, CMS2A, CMS1D	100710	17p12-p11	Muscular	601462
1978	1042	Myasthenic syndrome, slow-channel congenital, 601462 (3)	CHRND	CHRND, ACHRD, SCCMS, CMS2A, FCCMS	100720	2q33-q34	Muscular	601462
1979	1042	Myasthenic syndrome, slow-channel congenital, 601462 (3)	CHRNE	CHRNE, SCCMS, CMS2A, FCCMS, CMS1E, CMS1D	100725	17p13-p12	Muscular	601462
1980	1043	Mycobacterial and salmonella infections, susceptibility to, 209950 (3)	IL12RB1	IL12RB1	601604	19p13.1	Immunological	209950
1981	1043	Mycobacterial infection, atypical, familial disseminated, 209950 (3)	IFNGR1	IFNGR1	107470	6q23-q24	Immunological	209950
1982	1043	Mycobacterial infection, atypical, familial disseminated, 209950 (3)	IFNGR2	IFNGR2, IFNGT1, IFGR2	147569	21q22.1-q22.2	Immunological	209950
1983	1043	Mycobacterial infection, atypical, familial disseminated, 209950 (3)	STAT1	STAT1	600555	2q32.2-q32.3	Immunological	209950
1984	1043	Mycobacterium tuberculosis, suceptibility to infection by, 607948 (3)	NRAMP1	NRAMP1, NRAMP	600266	2q35	Immunological	607948
1985	1045	Myelodysplasia syndrome-1 (3)	MDS1	MDS1	600049	3q26	Muscular	
1986	1045	Myelodysplastic syndrome (3)	FACL6	FACL6, ACS2	604443	5q31	Muscular	
1987	1045	Myelodysplastic syndrome, preleukemic (3)	IRF1	IRF1, MAR	147575	5q31.1	Muscular	
1988	1046	Myelofibrosis, idiopathic, 254450 (3)	JAK2	JAK2	147796	9p24	Hematological	254450
1989	1047	Myelogenous leukemia, acute (3)	FACL6	FACL6, ACS2	604443	5q31	Cancer	
1990	1047	Myelogenous leukemia, acute (3)	IRF1	IRF1, MAR	147575	5q31.1	Cancer	
1991	1047	Myeloid leukemia, acute, M4Eo subtype (3)	CBFB	CBFB	121360	16q22	Cancer	
1992	1047	Myeloid malignancy, predisposition to (3)	CSF1R	CSF1R, FMS	164770	5q33.2-q33.3	Cancer	
1993	1049	Myelokathexis, isolated (3)	CXCR4	CXCR4, D2S201E, NPY3R, WHIM	162643	2q21	Immunological	
1994	1050	Myelomonocytic leukemia, chronic (3)	PDGFRB	PDGFRB, PDGFR	173410	5q31-q32	Cancer	
1995	1051	Myeloperoxidase deficiency, 254600 (3)	MPO	MPO	606989	17q23.1	Immunological	254600
1996	1052	Myeloproliferative disorder with eosinophilia, 131440 (3)	PDGFRB	PDGFRB, PDGFR	173410	5q31-q32	Cancer	131440
1997	1053	Myoadenylate deaminase deficiency (3)	AMPD1	AMPD1	102770	1p21-p13	Muscular	
1998	1054	Myocardial infarction, decreased susceptibility to (3)	F7	F7	227500	13q34	Cardiovascular	
1999	1054	Myocardial infarction susceptibility (3)	APOE	APOE, AD2	107741	19q13.2	Cardiovascular	
2000	1054	Myocardial infarction, susceptibility to (3)	ACE	ACE, DCP1, ACE1	106180	17q23	Cardiovascular	
2001	1054	Myocardial infarction, susceptibility to (3)	ALOX5AP	ALOX5AP, FLAP	603700	13q12	Cardiovascular	
2002	1054	Myocardial infarction, susceptibility to (3)	LGALS2	LGALS2	150571	22q13.1	Cardiovascular	
2003	1054	Myocardial infarction, susceptibility to (3)	LTA	LTA, TNFB	153440	6p21.3	Cardiovascular	
2004	1054	Myocardial infarction, susceptibility to (3)	OLR1	OLR1, LOX1	602601	12p13-p12	Cardiovascular	
2005	1054	Myocardial infarction, susceptibility to (3)	THBD	THBD, THRM	188040	20p11.2	Cardiovascular	
2006	1054	Myocardial infarction, susceptibility to, 608446 (3)	GCLM	GCLM, GLCLR	601176	1p22.1	Cardiovascular	608446
2007	1054	Myocardial infarction, susceptibility to, 608446 (3)	TNFSF4	TNFSF4, GP34, OX4OL	603594	1q25	Cardiovascular	608446
2008	1055	Myoclonic epilepsy, juvenile, 1, 254770 (3)	EFHC1	EFHC1, FLJ10466, EJM1	608815	6p12-p11	Neurological	254770
2009	1055	Myoclonic epilepsy, severe, of infancy, 607208 (3)	GABRG2	GABRG2, GEFSP3, CAE2, ECA2	137164	5q31.1-q33.1	Neurological	607208
2065	1091	Neuroblastoma, 256700 (3)	PMX2B	PMX2B, NBPHOX, PHOX2B	603851	4p12	Cancer	256700
2010	1055	Myoclonic epilepsy with mental retardation and spasticity, 300432 (3)	ARX	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54	300382	Xp22.13	Neurological	300432
2011	1056	Myoglobinuria/hemolysis due to PGK deficiency (3)	PGK1	PGK1, PGKA	311800	Xq13	Metabolic	
2012	1057	Myokymia with neonatal epilepsy, 606437 (3)	KCNQ2	KCNQ2, EBN1	602235	20q13.3	Neurological	606437
2013	1058	Myoneurogastrointestinal encephalomyopathy syndrome, 603041 (3)	ECGF1	ECGF1	131222	22q13.32-qter	multiple	603041
2014	1059	Myopathy, actin, congenital, with cores (3)	ACTA1	ACTA1, ASMA, NEM3, NEM1	102610	1q42.1	Muscular	
2015	1059	Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3)	ACTA1	ACTA1, ASMA, NEM3, NEM1	102610	1q42.1	Muscular	161800
2016	1059	Myopathy, cardioskeletal, desmin-related, with cataract, 608810 (3)	CRYAB	CRYAB, CRYA2, CTPP2	123590	11q22.3-q23.1	Muscular	608810
2017	1059	Myopathy, centronuclear, 160150 (3)	MYF6	MYF6	159991	12q21	Muscular	160150
2018	1059	Myopathy, congenital (3)	ITGA7	ITGA7	600536	12q13	Muscular	
2019	1059	Myopathy, desmin-related, cardioskeletal, 601419 (3)	DES	DES, CMD1I	125660	2q35	Muscular	601419
2020	1059	Myopathy, distal, with anterior tibial onset, 606768 (3)	DYSF	DYSF, LGMD2B	603009	2p13.3-p13.1	Muscular	606768
2021	1059	Myopathy, distal, with decreased caveolin 3 (3)	CAV3	CAV3, LGMD1C	601253	3p25	Muscular	3
2022	1059	Myopathy due to CPT II deficiency, 255110 (3)	CPT2	CPT2	600650	1p32	Muscular	255110
2023	1059	Myopathy due to phosphoglycerate mutase deficiency (3)	PGAM2	PGAM2, PGAMM	261670	7p13-p12.3	Muscular	
2024	1059	Myopathy, Laing distal, 160500 (3)	MYH7	MYH7, CMH1, MPD1	160760	14q12	Muscular	160500
2025	1059	Myopathy, myosin storage, 608358 (3)	MYH7	MYH7, CMH1, MPD1	160760	14q12	Muscular	608358
2026	1059	Myopathy, nemaline, 3, 161800 (3)	ACTA1	ACTA1, ASMA, NEM3, NEM1	102610	1q42.1	Muscular	161800
2027	1061	Myotilinopathy, 609200 (3)	TTID	TTID, MYOT	604103	5q31	Muscular	609200
2028	1062	Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3)	SCN4A	SCN4A, HYPP, NAC1A	603967	17q23.1-q25.3	Muscular	608390
2029	1062	Myotonia congenita, dominant, 160800 (3)	CLCN1	CLCN1	118425	7q35	Muscular	160800
2030	1062	Myotonia congenita, recessive, 255700 (3)	CLCN1	CLCN1	118425	7q35	Muscular	255700
2031	1062	Myotonia levior, recessive (3)	CLCN1	CLCN1	118425	7q35	Muscular	
2032	1063	Myotonic dystrophy, 160900 (3)	DMPK	DMPK, DM, DMK	605377	19q13.2-q13.3	Muscular	160900
2033	1063	Myotonic dystrophy, type 2, 602668 (3)	ZNF9	ZNF9, CNBP1, DM2, PROMM	116955	3q13.3-q24	Muscular	602668
2034	1064	Myotubular myopathy, X-linked, 310400 (3)	MTM1	MTM1, MTMX	300415	Xq28	Muscular	310400
2035	1065	Myxoid liposarcoma (3)	DDIT3	DDIT3, GADD153, CHOP10	126337	12q13.1-q13.2	Cancer	
2036	1066	Myxoma, intracardiac, 255960 (3)	PRKAR1A	PRKAR1A, TSE1, CNC1, CAR	188830	17q23-q24	Cardiovascular	255960
2037	1067	N-acetylglutamate synthase deficiency, 237310 (3)	NAGS	NAGS	608300	17q21.31	Metabolic	237310
2038	1070	Nail-patella syndrome, 161200 (3)	LMX1B	LMX1B, NPS1	602575	9q34.1	multiple	161200
2039	1070	Nail-patella syndrome with open-angle glaucoma, 137750 (3)	LMX1B	LMX1B, NPS1	602575	9q34.1	multiple	137750
2040	1071	Nance-Horan syndrome, 302350 (3)	NHS	NHS	300457	Xp22.13	Ophthamological	302350
2041	1073	Narcolepsy, 161400 (3)	HCRT	HCRT, OX	602358	17q21	Psychiatric	161400
2042	1074	Nasopharyngeal carcinoma, 161550 (3)	TP53	TP53, P53, LFS1	191170	17p13.1	Cancer	161550
2043	1075	Nasu-Hakola disease, 221770 (3)	TREM2	TREM2	605086	6p21.2	Bone	221770
2044	1075	Nasu-Hakola disease, 221770 (3)	TYROBP	TYROBP, PLOSL, DAP12	604142	19q13.1	Bone	221770
2045	1077	Naxos disease, 601214 (3)	JUP	JUP, DP3, PDGB	173325	17q21	multiple	601214
2046	1078	Nemaline myopathy, 161800 (3)	TPM2	TPM2, TMSB, AMCD1, DA1	190990	9p13.2-p13.1	Muscular	161800
2047	1078	Nemaline myopathy 1, autosomal dominant, 161800 (3)	TPM3	TPM3, NEM1	191030	1q22-q23	Muscular	161800
2048	1078	Nemaline myopathy 2, autosomal recessive, 256030 (3)	NEB	NEB, NEM2	161650	2q22	Muscular	256030
2049	1078	Nemaline myopathy, Amish type, 605355 (3)	TNNT1	TNNT1, ANM	191041	19q13.4	Muscular	605355
2050	3079	Neonatal ichthyosis-sclerosing cholangitis syndrome, 607626 (3)	CLDN1	CLDN1, SEMP1	603718	3q28-q29	multiple	607626
2051	1080	Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)	AVPR2	AVPR2, DIR, DI1, ADHR	300538	Xq28	Renal	300539
2052	1081	Nephrolithiasis, type I, 310468 (3)	CLCN5	CLCN5, CLCK2, NPHL2, DENTS	300008	Xp11.22	Renal	310468
2053	1081	Nephrolithiasis, uric acid, susceptibility to, 605990 (3)	ZNF365	ZNF365, UAN	607818	10q21.2	Renal	605990
2054	1082	Nephronophthisis 2, infantile, 602088 (3)	INVS	INVS, INV, NPHP2, NPH2	243305	9q31	Renal	602088
2055	1082	Nephronophthisis 4, 606966 (3)	NPHP4	NPHP4, SLSN4	607215	1p36	Renal	606966
2056	1082	Nephronophthisis, adolescent, 604387 (3)	NPHP3	NPHP3, NPH3	608002	3q22	Renal	604387
2057	1082	Nephronophthisis, juvenile, 256100 (3)	NPHP1	NPHP1, NPH1, SLSN1	607100	2q13	Renal	256100
2058	1084	Nephropathy, chronic hypocomplementemic (3)	HF1	HF1, CFH, HUS	134370	1q32	Renal	
2059	1085	Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3)	CD151	CD151, PETA3, SFA1	602243	11p15.5	Renal	609057
2060	1087	Nephrosis-1, congenital, Finnish type, 256300 (3)	NPHS1	NPHS1, NPHN	602716	19q13.1	Renal	256300
2061	1087	Nephrotic syndrome, steroid-resistant, 600995 (3)	PDCN	PDCN, NPHS2, SRN1	604766	1q25-q31	Renal	600995
2062	1088	Netherton syndrome, 256500 (3)	SPINK5	SPINK5, LEKTI	605010	5q32	Dermatological	256500
2063	1090	Neural tube defects, maternal risk of, 601634 (3)	MTHFD	MTHFD, MTHFC	172460	14q24	Developmental	601634
2064	1091	Neuroblastoma, 256700 (3)	NME1	NME1, NM23	156490	17q21.3	Cancer	256700
2066	1092	Neurodegeneration, pantothenate kinase-associated, 234200 (3)	PANK2	PANK2, NBIA1, PKAN, HARP	606157	20p13-p12.3	Neurological	234200
2067	1093	Neuroectodermal tumors, supratentorial primitive, with cafe-au-lait spots, 608623 (3)	PMS2	PMS2, PMSL2, HNPCC4	600259	7p22	multiple	608623
2068	1095	Neurofibromatosis, familial spinal, 162210 (3)	NF1	NF1, VRNF, WSS, NFNS	162200	17q11.2	Cancer	162210
2069	1096	Neurofibromatosis-Noonan syndrome, 601321 (3)	NF1	NF1, VRNF, WSS, NFNS	162200	17q11.2	Cancer	601321
2070	1097	Neurofibromatosis, type 1 (3)	NF1	NF1, VRNF, WSS, NFNS	162200	17q11.2	Cancer	1
2071	1097	Neurofibromatosis, type 2, 101000 (3)	NF2	NF2	607379	22q12.2	Cancer	101000
2072	1097	Neurofibromatosis, type I, with leukemia, 162200 (3)	MSH2	MSH2, COCA1, FCC1, HNPCC1	609309	2p22-p21	Cancer	162200
2073	1098	Neurofibrosarcoma (3)	MXI1	MXI1	600020	10q25	Cancer	
2074	1099	Neuropathy, congenital hypomyelinating, 1, 605253 (3)	EGR2	EGR2, KROX20	129010	10q21.1-q22.1	Neurological	605253
2075	1099	Neuropathy, congenital hypomyelinating, 605253 (3)	MPZ	MPZ, CMT1B, CMTDI3, CHM, DSS	159440	1q22	Neurological	605253
2076	1099	Neuropathy, distal hereditary motor, 608634 (3)	HSPB1	HSPB1, HSP27, CMT2F	602195	7q11.23	Neurological	608634
2077	1099	Neuropathy, distal hereditary motor, type II, 158590 (3)	HSPB8	HSPB8, H11, E2IG1, DHMN2	608014	12q24-qter	Neurological	158590
2078	1099	Neuropathy, hereditary sensory and autonomic, type 1, 162400 (3)	SPTLC1	SPTLC1, LBC1, SPT1, HSN1, HSAN	605712	9q22.1-q22.3	Neurological	162400
2079	1099	Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)	NGFB	NGFB, HSAN5	162030	1p13.1	Neurological	608654
2080	1099	Neuropathy, hereditary sensory, type II, 201300 (3)	HSN2	HSN2	608620	12p13.33	Neurological	201300
2081	1099	Neuropathy, recurrent, with pressure palsies, 162500 (3)	PMP22	PMP22, CMT1A, CMT1E, DSS	601097	17p11.2	Neurological	162500
2082	1101	Neutropenia, alloimmune neonatal (3)	FCGR3A	FCGR3A, CD16, IGFR3	146740	1q23	Hematological	
2083	1101	Neutropenia, congenital, 202700 (3)	ELA2	ELA2	130130	19p13.3	Hematological	202700
2084	1101	Neutropenia, severe congenital, 202700 (3)	GFI1	GFI1, ZNF163	600871	1p22	Hematological	202700
2085	1101	Neutropenia, severe congenital, X-linked, 300299 (3)	WAS	WAS, IMD2, THC	300392	Xp11.23-p11.22	Hematological	300299
2086	1102	Neutrophil immunodeficiency syndrome, 608203 (3)	RAC2	RAC2	602049	22q12.3-q13.2	Immunological	608203
2087	1103	Nevo syndrome, 601451 (3)	PLOD	PLOD, PLOD1	153454	1p36.3-p36.2	Connective tissue	601451
2088	1104	Nevus, epidermal, epidermolytic hyperkeratotic type, 600648 (3)	KRT10	KRT10	148080	17q21-q22	Dermatological	600648
2089	1105	Newfoundland rod-cone dystrophy, 607476 (3)	RLBP1	RLBP1	180090	15q26	Ophthamological	607476
2090	1106	Nicotine addiction, protection from (3)	CYP2A6	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	Psychiatric	
2091	1106	Nicotine addiction, susceptibility to, 188890 (3)	CHRNA4	CHRNA4, ENFL1	118504	20q13.2-q13.3	Psychiatric	188890
2092	1106	Nicotine dependence, susceptibility to, 188890 (3)	GPR51	GPR51, GABBR2	607340	9q22.1	Psychiatric	188890
2093	1107	Niemann-Pick disease, type A, 257200 (3)	SMPD1	SMPD1, NPD	607608	11p15.4-p15.1	Metabolic	257200
2094	1107	Niemann-Pick disease, type B, 607616 (3)	SMPD1	SMPD1, NPD	607608	11p15.4-p15.1	Metabolic	607616
2095	1107	Niemann-Pick disease, type C1, 257220 (3)	NPC1	NPC1, NPC	607623	18q11-q12	Metabolic	257220
2096	1107	Niemann-pick disease, type C2, 607625 (3)	NPC2	NPC2, HE1	601015	14q24.3	Metabolic	607625
2097	1107	Niemann-Pick disease, type D, 257220 (3)	NPC1	NPC1, NPC	607623	18q11-q12	Metabolic	257220
2098	1110	Night blindness, congenital stationary (3)	GNAT1	GNAT1	139330	3p21	Ophthamological	
2099	1110	Night blindness, congenital stationary, type 1, 310500 (3)	CSNB1	CSNB1, NYX	300278	Xp11.4	Ophthamological	310500
2100	1110	Night blindness, congenital stationary, type 3, 163500 (3)	PDE6B	PDE6B, PDEB, CSNB3	180072	4p16.3	Ophthamological	163500
2101	1110	Night blindness, congenital stationary, X-linked, type 2, 300071 (3)	CACNA1F	CACNA1F, CSNB2	300110	Xp11.23	Ophthamological	300071
2102	1110	Night blindness, congenital stationery, rhodopsin-related (3)	RHO	RHO, RP4, OPN2	180380	3q21-q24	Ophthamological	
2103	1111	Nijmegen breakage syndrome, 251260 (3)	NBS1	NBS1, NBS	602667	8q21	multiple	251260
2104	1112	Nonaka myopathy, 605820 (3)	GNE	GNE, GLCNE, IBM2, DMRV, NM	603824	9p12-p11	Muscular	605820
2105	1113	Noncompaction of left ventricular myocardium, isolated, 300183 (3)	TAZ	TAZ, EFE2, BTHS, CMD3A, LVNCX	300394	Xq28	Cardiovascular	300183
2106	1114	Non-Hodgkin lymphoma, somatic, 605027 (3)	CASP10	CASP10, MCH4, ALPS2	601762	2q33-q34	Cancer	605027
2107	1115	Nonsmall cell lung cancer (3)	IRF1	IRF1, MAR	147575	5q31.1	Cancer	
2108	1115	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)	EGFR	EGFR	131550	7p12.3-p12.1	Cancer	211980
2109	1115	Nonsmall cell lung cancer, somatic (3)	BRAF	BRAF	164757	7q34	Cancer	
2110	1116	Noonan syndrome 1, 163950 (3)	PTPN11	PTPN11, PTP2C, SHP2, NS1	176876	12q24.1	Developmental	163950
2111	1117	Norrie disease (3)	NDP	NDP, ND	310600	Xp11.4	Neurological	
2112	1118	Norum disease, 245900 (3)	LCAT	LCAT	606967	16q22.1	Metabolic	245900
2113	1119	Norwalk virus infection, resistance to (3)	FUT2	FUT2, SE	182100	19q13.3	Immunological	
2114	1122	Nucleoside phosphorylase deficiency, immunodeficiency due to (3)	NP	NP	164050	14q13.1	Immunological	
2115	1126	Obesity, adrenal insufficiency, and red hair (3)	POMC	POMC	176830	2p23.3	Nutritional	
2116	1126	Obesity, autosomal dominant, 601665 (3)	MC4R	MC4R	155541	18q22	Nutritional	601665
2117	1126	Obesity, hyperphagia, and developmental delay (3)	AKR1C2	AKR1C2, DDH2, DD2, HAKRD	600450	10p15-p14	Nutritional	
2118	1126	Obesity, hyperphagia, and developmental delay (3)	NTRK2	NTRK2, TRKB	600456	9q22.1	Nutritional	
2119	1126	Obesity, late-onset, 601665 (3)	AGRP	AGRP, ART, AGRT	602311	16q22	Nutritional	601665
2120	1126	Obesity, mild, early-onset, 601665 (3)	NR0B2	NR0B2, SHP	604630	1p36.1	Nutritional	601665
2121	1126	Obesity, morbid, with hypogonadism (3)	LEP	LEP, OB	164160	7q31.3	Nutritional	
2122	1126	Obesity, morbid, with hypogonadism (3)	LEPR	LEPR, OBR	601007	1p31	Nutritional	
2123	1126	Obesity, resistance to (3)	PPARG	PPARG, PPARG1, PPARG2	601487	3p25	Nutritional	
2124	1126	Obesity, severe, 601665 (3)	PPARG	PPARG, PPARG1, PPARG2	601487	3p25	Nutritional	601665
2125	1126	Obesity, severe, 601665 (3)	SIM1	SIM1	603128	6q16.3-q21	Nutritional	601665
2126	1126	Obesity, severe, and type II diabetes, 601665 (3)	UCP3	UCP3	602044	11q13	Nutritional	601665
2127	1126	Obesity, severe, due to leptin deficiency (3)	LEP	LEP, OB	164160	7q31.3	Nutritional	
2128	1126	Obesity, severe, susceptibility to, 601665 (3)	MC3R	MC3R	155540	20q13.2	Nutritional	601665
2129	1126	Obesity, susceptibility to, 300306 (3)	SLC6A14	SLC6A14, OBX	300444	Xq23-q24	Nutritional	300306
2130	1126	Obesity, susceptibility to, 601665 (3)	ADRB2	ADRB2	109690	5q32-q34	Nutritional	601665
2131	1126	Obesity, susceptibility to, 601665 (3)	ADRB3	ADRB3	109691	8p12-p11.2	Nutritional	601665
2132	1126	Obesity, susceptibility to, 601665 (3)	CART	CART	602606	5q13.2	Nutritional	601665
2133	1126	Obesity, susceptibility to, 601665 (3)	ENPP1	ENPP1, PDNP1, NPPS, M6S1, PCA1	173335	6q22-q23	Nutritional	601665
2134	1126	Obesity, susceptibility to, 601665 (3)	GHRL	GHRL	605353	3p26-p25	Nutritional	601665
2135	1126	Obesity, susceptibility to, 601665 (3)	UCP1	UCP1	113730	4q31	Nutritional	601665
2136	1126	Obesity, susceptibility to, 601665 (3)	UCP2	UCP2	601693	11q13	Nutritional	601665
2137	1126	Obestiy with impaired prohormone processing, 600955 (3)	PCSK1	PCSK1, NEC1, PC1, PC3	162150	5q15-q21	Nutritional	600955
2138	1128	Obsessive-compulsive disorder 1, 164230 (3)	SLC6A4	SLC6A4, HTT, OCD1	182138	17q11.1-q12	Psychiatric	164230
2139	1128	Obsessive-compulsive disorder, protection against, 164230 (3)	BDNF	BDNF	113505	11p13	Psychiatric	164230
2140	1128	Obsessive-compulsive disorder, susceptibility to, 164230 (3)	HTR2A	HTR2A	182135	13q14-q21	Psychiatric	164230
2141	1129	Occipital horn syndrome, 304150 (3)	ATP7A	ATP7A, MNK, MK, OHS	300011	Xq12-q13	multiple	304150
2142	1130	Ocular albinism, Nettleship-Falls type (3)	OA1	OA1	300500	Xp22.3	Ophthamological	
2143	1130	Oculocutaneous albinism, type II, modifier of (3)	MC1R	MC1R	155555	16q24.3	Ophthamological	
2144	1130	Oculocutaneous albinism, type IV, 606574 (3)	MATP	MATP, AIM1	606202	5p13.3	Ophthamological	606574
2145	1132	Oculodentodigital dysplasia, 164200 (3)	GJA1	GJA1, CX43, ODDD, SDTY3, ODOD	121014	6q21-q23.2	Skeletal	164200
2146	1133	Oculofaciocardiodental syndrome, 300166 (3)	BCOR	BCOR, KIAA1575, MAA2, ANOP2	300485	Xp11.4	multiple	300166
2147	1135	Oculopharyngeal muscular dystorphy, 164300 (3)	PABPN1	PABPN1, PABP2, PAB2	602279	14q11.2-q13	Muscular	164300
2148	1135	Oculopharyngeal muscular dystrophy, autosomal recessive, 257950 (3)	PABPN1	PABPN1, PABP2, PAB2	602279	14q11.2-q13	Muscular	257950
2149	1136	Odontohypophosphatasia, 146300 (3)	ALPL	ALPL, HOPS, TNSALP	171760	1p36.1-p34	Bone	146300
2150	1137	Oguchi disease-1, 258100 (3)	SAG	SAG	181031	2q37.1	Ophthamological	258100
2151	1137	Oguchi disease-2, 258100 (3)	RHOK	RHOK, RK, GRK1	180381	13q34	Ophthamological	258100
2152	1138	Oligodendroglioma, 137800 (3)	PTEN	PTEN, MMAC1	601728	10q23.31	Cancer	137800
2153	1139	Oligodontia, 604625 (3)	PAX9	PAX9	167416	14q12-q13	Skeletal	604625
2154	1140	Oligodontia-colorectal cancer syndrome, 608615 (3)	AXIN2	AXIN2	604025	17q24	Cancer	608615
2155	1141	Omenn syndrome, 603554 (3)	DCLRE1C	DCLRE1C, ARTEMIS, SCIDA	605988	10p	Immunological	603554
2156	1141	Omenn syndrome, 603554 (3)	RAG1	RAG1	179615	11p13	Immunological	603554
2157	1141	Omenn syndrome, 603554 (3)	RAG2	RAG2	179616	11p13	Immunological	603554
2158	1142	Opitz G syndrome, type I, 300000 (3)	MID1	MID1, OGS1, BBBG1, FXY, OSX	300552	Xp22	multiple	300000
2159	1143	Opremazole poor metabolizer (3)	CYP2C	CYP2C, CYP2C19	124020	10q24.1-q24.3	Metabolic	
2160	1144	Optic atrophy 1, 165500 (3)	OPA1	OPA1, NTG, NPG	605290	3q28-q29	Ophthamological	165500
2161	1144	Optic atrophy and cataract, 165300 (3)	OPA3	OPA3, MGA3	606580	19q13.2-q13.3	Ophthamological	165300
2162	3144	Optic nerve coloboma with renal disease, 120330 (3)	PAX2	PAX2	167409	10q24.3-q25.1	multiple	120330
2163	5144	Optic nerve hypoplasia/aplasia, 165550 (3)	PAX6	PAX6, AN2, MGDA	607108	11p13	Ophthamological	165550
2164	1145	Oral-facial-digital syndrome 1, 311200 (3)	OFD1	OFD1, CXorf5	300170	Xp22.3-p22.2	Skeletal	311200
2165	1146	Ornithine transcarbamylase deficiency, 311250 (3)	OTC	OTC	300461	Xp21.1	Metabolic	311250
2166	1147	Orofacial cleft 6, 608864 (3)	IRF6	IRF6, VWS, LPS, PIT, PPS, OFC6	607199	1q32-q41	Skeletal	608864
2167	1148	Orolaryngeal cancer, multiple, (3)	CDKN2A	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21	Cancer	
2168	1149	Oroticaciduria (3)	UMPS	UMPS, OPRT	258900	3q13	Metabolic	
2169	1150	Orthostatic intolerance, 604715 (3)	SLC6A2	SLC6A2, NAT1, NET1	163970	16q12.2	Cardiovascular	604715
2170	1151	OSMED syndrome, 215150 (3)	COL11A2	COL11A2, STL3, DFNA13	120290	6p21.3	Bone	215150
2171	1152	Osseous heteroplasia, progressive, 166350 (3)	GNAS	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO	139320	20q13.2	Bone	166350
2172	1153	Ossification of posterior longitudinal ligament of spine, 602475 (3)	ENPP1	ENPP1, PDNP1, NPPS, M6S1, PCA1	173335	6q22-q23	Connective tissue	602475
2173	1154	Osteoarthritis, hand, susceptibility to, 607850 (3)	MATN3	MATN3, EDM5, HOA	602109	2p24-p23	Connective tissue	607850
2230	1178	Pancreatic cancer, 260350 (3)	BRCA2	BRCA2, FANCD1	600185	13q12.3	Cancer	260350
2174	1154	Osteoarthritis of hip, female-specific, susceptibility to, 165720 (3)	FRZB	FRZB, FRZB1, SRFP3	605083	2q31-q33	Connective tissue	165720
2175	1154	Osteoarthritis, susceptibility to, 165720 (3)	ASPN	ASPN, PLAP1	608135	9q21.3-q22	Connective tissue	165720
2176	1154	Osteoarthrosis, 165720 (3)	COL2A1	COL2A1	120140	12q13.11-q13.2	Connective tissue	165720
2177	1156	Osteogenesis imperfecta, 3 clinical forms, 166200, 166210, 259420 (3)	COL1A2	COL1A2	120160	7q22.1	Bone	259420
2178	1156	Osteogenesis imperfecta, type I, 166200 (3)	COL1A1	COL1A1	120150	17q21.31-q22	Bone	166200
2179	1156	Osteogenesis imperfecta, type II, 166210 (3)	COL1A1	COL1A1	120150	17q21.31-q22	Bone	166210
2180	1156	Osteogenesis imperfecta, type III, 259420 (3)	COL1A1	COL1A1	120150	17q21.31-q22	Bone	259420
2181	1156	Osteogenesis imperfecta, type IV, 166220 (3)	COL1A1	COL1A1	120150	17q21.31-q22	Bone	166220
2182	1157	Osteolysis, familial expansile, 174810 (3)	TNFRSF11A	TNFRSF11A, RANK, ODFR, OFE	603499	18q22.1	Bone	174810
2183	1157	Osteolysis, idiopathic, Saudi type, 605156 (3)	MMP2	MMP2, CLG4A, MONA	120360	16q13	Bone	605156
2184	1161	Osteopetrosis, autosomal dominant, type I, 607634 (3)	LRP5	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2	603506	11q13.4	Bone	607634
2185	1161	Osteopetrosis, autosomal dominant, type II, 166600 (3)	CLCN7	CLCN7, CLC7, OPTA2	602727	16p13	Bone	166600
2186	1161	Osteopetrosis, autosomal recessive, 259700 (3)	OSTM1	OSTM1, GL	607649	6q21	Bone	259700
2187	1161	Osteopetrosis, recessive, 259700 (3)	CLCN7	CLCN7, CLC7, OPTA2	602727	16p13	Bone	259700
2188	1161	Osteopetrosis, recessive, 259700 (3)	TCIRG1	TCIRG1, TIRC7, OC116, OPTB1	604592	11q13.4-q13.5	Bone	259700
2189	1162	Osteopoikilosis, 166700 (3)	LEMD3	LEMD3, MAN1	607844	12q14	Bone	166700
2190	1163	Osteoporosis, 166710 (3)	COL1A1	COL1A1	120150	17q21.31-q22	Bone	166710
2191	1163	Osteoporosis, 166710 (3)	LRP5	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2	603506	11q13.4	Bone	166710
2192	1163	Osteoporosis (3)	CALCA	CALCA, CALC1	114130	11p15.2-p15.1	Bone	
2193	1163	Osteoporosis, hypophosphatemic, (3)	SLC17A2	SLC17A2, NPT2	182309	5q35	Bone	
2194	1163	Osteoporosis, idiopathic, 166710 (3)	COL1A2	COL1A2	120160	7q22.1	Bone	166710
2195	1163	Osteoporosis, postmenopausal, susceptibility, 166710 (3)	CALCR	CALCR, CRT	114131	7q21.3	Bone	166710
2196	1164	Osteoporosis-pseudoglioma syndrome, 259770 (3)	LRP5	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2	603506	11q13.4	Bone	259770
2197	1165	Osteoporosis, susceptibility to, 166710 (3)	RIL	RIL	603422	5q31.1	Bone	166710
2198	1166	Osteosarcoma (3)	TP53	TP53, P53, LFS1	191170	17p13.1	Cancer	
2199	1166	Osteosarcoma, somatic, 259500 (3)	CHEK2	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	Cancer	259500
2200	1168	Otopalatodigital syndrome, type I, 311300 (3)	FLNA	FLNA, FLN1, ABPX, NHBP, OPD1, OPD2, FMD, MNS	300017	Xq28	multiple	311300
2201	1168	Otopalatodigital syndrome, type II, 304120 (3)	FLNA	FLNA, FLN1, ABPX, NHBP, OPD1, OPD2, FMD, MNS	300017	Xq28	multiple	304120
2202	1170	Ovarian cancer (3)	BRCA1	BRCA1, PSCP	113705	17q21	Cancer	
2203	1170	Ovarian cancer (3)	MSH2	MSH2, COCA1, FCC1, HNPCC1	609309	2p22-p21	Cancer	
2204	1170	Ovarian cancer, 604370 (3)	PIK3CA	PIK3CA	171834	3q26.3	Cancer	604370
2205	1170	Ovarian cancer, endometrial type (3)	MSH6	MSH6, GTBP, HNPCC5	600678	2p16	Cancer	
2206	1170	Ovarian cancer, somatic, (3)	ERBB2	ERBB2, NGL, NEU, HER2	164870	17q21.1	Cancer	
2207	1170	Ovarian carcinoma (3)	CDH1	CDH1, UVO	192090	16q22.1	Cancer	
2208	1170	Ovarian carcinoma (3)	RRAS2	RRAS2, TC21	600098	11pter-p15.5	Cancer	
2209	1170	Ovarian carcinoma, endometrioid type (3)	CTNNB1	CTNNB1	116806	3p22-p21.3	Cancer	
2210	3171	Ovarian dysgenesis 1, 233300 (3)	FSHR	FSHR, ODG1	136435	2p21-p16	Endocrine	233300
2211	3171	Ovarian dysgenesis 2, 300510 (3)	BMP15	BMP15, GDF9B, ODG2	300247	Xp11.2	Endocrine	300510
2212	5170	Ovarian hyperstimulation syndrome, gestational, 608115 (3)	FSHR	FSHR, ODG1	136435	2p21-p16	Endocrine	608115
2213	7170	Ovarian sex cord tumors (3)	FSHR	FSHR, ODG1	136435	2p21-p16	Cancer	
2214	1171	Ovarioleukodystrophy, 603896 (3)	EIF2B2	EIF2B2	606454	14q24	Neurological	603896
2215	1171	Ovarioleukodystrophy, 603896 (3)	EIF2B4	EIF2B4	606687	2p23.3	Neurological	603896
2216	1171	Ovarioleukodystrophy, 603896 (3)	EIF2B5	EIF2B5, LVWM, CACH, CLE	603945	3q27	Neurological	603896
2217	1172	Pachyonychia congenita, Jackson-Lawler type, 167210 (3)	KRT17	KRT17, PC2, PCHC1	148069	17q12-q21	Dermatological	167210
2218	1172	Pachyonychia congenita, Jackson-Lawler type, 167210 (3)	KRT6B	KRT6B, PC2	148042	12q13	Dermatological	167210
2219	1172	Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3)	KRT16	KRT16	148067	17q12-q21	Dermatological	167200
2220	1172	Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3)	KRT6A	KRT6A	148041	12q13	Dermatological	167200
2221	1173	Paget disease, juvenile, 239000 (3)	TNFRSF11B	TNFRSF11B, OPG, OCIF	602643	8q24	Bone	239000
2222	1173	Paget disease of bone, 602080 (3)	SQSTM1	SQSTM1, P62, PDB3	601530	5q35	Bone	602080
2223	1173	Paget disease of bone, 602080 (3)	TNFRSF11A	TNFRSF11A, RANK, ODFR, OFE	603499	18q22.1	Bone	602080
2224	1174	Pallidopontonigral degeneration, 168610 (3)	MAPT	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.1	Neurological	168610
2225	1175	Pallister-Hall syndrome, 146510 (3)	GLI3	GLI3, PAPA, PAPB, ACLS	165240	7p13	multiple	146510
2226	1176	Palmoplantar keratoderma, nonepidermolytic, 600962 (3)	KRT16	KRT16	148067	17q12-q21	Dermatological	600962
2227	1176	Palmoplantar verrucous nevus, unilateral, 144200 (3)	KRT16	KRT16	148067	17q12-q21	Dermatological	144200
2228	3178	Pancreatic agenesis, 260370 (3)	IPF1	IPF1	600733	13q12.1	Gastrointestinal	260370
2229	1178	Pancreatic cancer, 260350 (3)	ARMET	ARMET, ARP	601916	3p21.1	Cancer	260350
2231	1178	Pancreatic cancer, 260350 (3)	TP53	TP53, P53, LFS1	191170	17p13.1	Cancer	260350
2232	1178	Pancreatic cancer (3)	MADH4	MADH4, DPC4, SMAD4, JIP	600993	18q21.1	Cancer	
2233	1178	Pancreatic cancer/melanoma syndrome, 606719 (3)	CDKN2A	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21	Cancer	606719
2234	1178	Pancreatic cancer, somatic (3)	ACVR1B	ACVR1B, ACVRLK4, ALK4	601300	12q13	Cancer	
2235	1178	Pancreatic cancer, sporadic (3)	STK11	STK11, PJS, LKB1	602216	19p13.3	Cancer	
2236	1178	Pancreatic carcinoma, somatic, 260350 (3)	KRAS2	KRAS2, RASK2	190070	12p12.1	Cancer	260350
2237	1178	Pancreatic carcinoma, somatic (3)	RBBP8	RBBP8, RIM	604124	18q11.2	Cancer	
2238	1179	Pancreatitis, hereditary, 167800 (3)	PRSS1	PRSS1, TRY1	276000	7q35	Gastrointestinal	167800
2239	1179	Pancreatitis, hereditary, 167800 (3)	SPINK1	SPINK1, PSTI, PCTT, TATI	167790	5q32	Gastrointestinal	167800
2240	1179	Pancreatitis, idiopathic (3)	CFTR	CFTR, ABCC7, CF, MRP7	602421	7q31.2	Gastrointestinal	
2241	1183	Papillary serous carcinoma of the peritoneum (3)	BRCA1	BRCA1, PSCP	113705	17q21	Cancer	
2242	1184	Papillon-Lefevre syndrome, 245000 (3)	CTSC	CTSC, CPPI, PALS, PLS, HMS	602365	11q14.1-q14.3	multiple	245000
2243	1186	Paraganglioma, familial malignant, 168000 (3)	SDHB	SDHB, SDH1, SDHIP	185470	1p36.1-p35	Cancer	168000
2244	1186	Paragangliomas, familial central nervous system, 168000 (3)	SDHD	SDHD, PGL1	602690	11q23	Cancer	168000
2245	1186	Paragangliomas, familial nonchromaffin, 1, with and without deafness, 168000 (3)	SDHD	SDHD, PGL1	602690	11q23	Cancer	168000
2246	1186	Paragangliomas, familial nonchromaffin, 3, 605373 (3)	SDHC	SDHC, PGL3	602413	1q21	Cancer	605373
2247	1186	Paraganglioma, sporadic corotid body, 168000 (3)	SDHD	SDHD, PGL1	602690	11q23	Cancer	168000
2248	1188	Paramyotonia congenita, 168300 (3)	SCN4A	SCN4A, HYPP, NAC1A	603967	17q23.1-q25.3	Muscular	168300
2249	1189	Parathyroid adenoma, sporadic (3)	MEN1	MEN1	131100	11q13	Cancer	
2250	1189	Parathyroid adenoma with cystic changes, 145001 (3)	HRPT2	HRPT2, C1orf28	607393	1q25-q31	Cancer	145001
2251	1189	Parathyroid carcinoma, 608266 (3)	HRPT2	HRPT2, C1orf28	607393	1q25-q31	Cancer	608266
2252	1190	Parietal foramina 1, 168500 (3)	MSX2	MSX2, CRS2, HOX8	123101	5q34-q35	Skeletal	168500
2253	1190	Parietal foramina 2, 168500 (3)	ALX4	ALX4, PFM2, FPP	605420	11p11.2	Skeletal	168500
2254	1190	Parietal foramina with cleidocranial dysplasia, 168550 (3)	MSX2	MSX2, CRS2, HOX8	123101	5q34-q35	Skeletal	168550
2255	1191	Parkes Weber syndrome, 608355 (3)	RASA1	RASA1, GAP, CMAVM, PKWS	139150	5q13.3	multiple	608355
2256	1192	Parkinson disease, 168600 (3)	NR4A2	NR4A2, NURR1, NOT, TINUR	601828	2q22-q23	Neurological	168600
2257	1192	Parkinson disease, 168600 (3)	SNCAIP	SNCAIP	603779	5q23.1-q23.3	Neurological	168600
2258	1192	Parkinson disease, 168600 (3)	TBP	TBP, SCA17	600075	6q27	Neurological	168600
2259	1192	Parkinson disease 4, autosomal dominant Lewy body, 605543 (3)	SNCA	SNCA, NACP, PARK1, PARK4	163890	4q21	Neurological	605543
2260	1192	Parkinson disease 7, autosomal recessive early-onset, 606324 (3)	DJ1	DJ1, PARK7	602533	1p36	Neurological	606324
2261	1192	Parkinson disease-8, 607060 (3)	LRRK2	LRRK2, PARK8	609007	12q12	Neurological	607060
2262	1192	Parkinson disease, early onset, 605909 (3)	PINK1	PINK1, PARK6	608309	1p36	Neurological	605909
2263	1192	Parkinson disease, familial, 168600 (3)	UCHL1	UCHL1, PARK5	191342	4p14	Neurological	168600
2264	1192	Parkinson disease, familial, 168601 (3)	SNCA	SNCA, NACP, PARK1, PARK4	163890	4q21	Neurological	168601
2265	1192	Parkinson disease, juvenile, type 2, 600116 (3)	PRKN	PRKN, PARK2, PDJ	602544	6q25.2-q27	Neurological	600116
2266	1192	Parkinson disease, resistance to, 168600 (3)	DBH	DBH	609312	9q34	Neurological	168600
2267	1192	Parkinson disease, susceptibility to, 168600 (3)	NDUFV2	NDUFV2	600532	18p11.31-p11.2	Neurological	168600
2268	3195	Paroxysmal nocturnal hemoglobinuria (3)	PIGA	PIGA	311770	Xp22.1	Hematological	
2269	1195	Paroxysmal nonkinesigenic dyskinesia, 118800 (3)	MR1	MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8	609023	2q35	Neurological	118800
2270	1196	Partington syndrome, 309510 (3)	ARX	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54	300382	Xp22.13	Neurological	309510
2271	1198	PCWH, 609136 (3)	SOX10	SOX10, WS4	602229	22q13	Neurological	609136
2272	1199	Pelger-Huet anomaly, 169400 (3)	LBR	LBR, PHA	600024	1q42.1	Hematological	169400
2273	1200	Pelizaeus-Merzbacher disease, 312080 (3)	PLP1	PLP1, PMD	300401	Xq22	Neurological	312080
2274	1201	Pelizaeus-Merzbacher-like disease, autosomal recessive, 608804 (3)	GJA12	GJA12, CX47, PMLDAR	608803	1q41-q42	Neurological	608804
2275	1204	Pendred syndrome, 274600 (3)	SLC26A4	SLC26A4, PDS, DFNB4	605646	7q31	Ear,Nose,Throat	274600
2276	1205	Perineal hypospadias (3)	AR	AR, DHTR, TFM, SBMA, KD, SMAX1	313700	Xq11-q12	Endocrine	
2277	1206	Periodic fever, familial, 142680 (3)	TNFRSF1A	TNFRSF1A, TNFR1, TNFAR, FPF	191190	12p13.2	Immunological	142680
2278	1207	Periodontitis, juvenile, 170650 (3)	CTSC	CTSC, CPPI, PALS, PLS, HMS	602365	11q14.1-q14.3	Ear,Nose,Throat	170650
2279	1209	Periventricular heterotopia with microcephaly, 608097 (3)	ARFGEF2	ARFGEF2, BIG2	605371	20q13.13	Neurological	608097
2280	1210	Peroxisomal biogenesis disorder, complementation group 4 (3)	PEX6	PEX6, PXAAA1, PAF2	601498	6p21.1	multiple	4
2281	1210	Peroxisomal biogenesis disorder, complementation group 6 (3)	PEX6	PEX6, PXAAA1, PAF2	601498	6p21.1	multiple	6
2282	1210	Peroxisome biogenesis factor 12 (3)	PEX12	PEX12	601758	Chr.17	multiple	12
2283	3212	Persistent hyperinsulinemic hypoglycemia of infancy, 256450 (3)	KCNJ11	KCNJ11, BIR, PHHI	600937	11p15.1	Metabolic	256450
2284	1212	Persistent Mullerian duct syndrome, type I, 261550 (3)	AMH	AMH, MIF	600957	19p13.3-p13.2	Developmental	261550
2285	1212	Persistent Mullerian duct syndrome, type II, 261550 (3)	AMHR2	AMHR2, AMHR	600956	12q13	Developmental	261550
2286	1213	Peters anomaly, 603807 (3)	PAX6	PAX6, AN2, MGDA	607108	11p13	Developmental	603807
2287	1213	Peters anomaly, 604229 (3)	CYP1B1	CYP1B1, GLC3A	601771	2p22-p21	Developmental	604229
2288	1214	Peutz-Jeghers syndrome, 175200 (3)	STK11	STK11, PJS, LKB1	602216	19p13.3	Cancer	175200
2289	1215	Pfeiffer syndrome, 101600 (3)	FGFR1	FGFR1, FLT2, KAL2	136350	8p11.2-p11.1	Skeletal	101600
2290	1215	Pfeiffer syndrome, 101600 (3)	FGFR2	FGFR2, BEK, CFD1, JWS	176943	10q26	Skeletal	101600
2291	1216	Phenylketonuria (3)	PAH	PAH, PKU1	261600	12q24.1	Metabolic	
2292	1216	Phenylketonuria due to dihydropteridine reductase deficiency (3)	QDPR	QDPR, DHPR	261630	4p15.31	Metabolic	
2293	1216	Phenylketonuria due to PTS deficiency (3)	PTS	PTS	261640	11q22.3-q23.3	Metabolic	
2294	1217	Phenylthiocarbamide tasting, 171200 (3)	TAS2R38	TAS2R38, T2R61, PTC	607751	7q35-q36	Ear,Nose,Throat	171200
2295	1218	Pheochromocytoma, 171300 (3)	SDHD	SDHD, PGL1	602690	11q23	Cancer	171300
2296	1218	Pheochromocytoma, 171300 (3)	VHL	VHL	608537	3p26-p25	Cancer	171300
2297	1218	Pheochromocytoma, extraadrenal, and cervical paraganglioma, 115310 (3)	SDHB	SDHB, SDH1, SDHIP	185470	1p36.1-p35	Cancer	115310
2298	1220	Phosphoglycerate dehydrogenase deficiency, 601815 (3)	PHGDH	PHGDH	606879	1q12	Metabolic	601815
2299	1221	Phosphoribosyl pyrophosphate synthetase-related gout (3)	PRPS1	PRPS1	311850	Xq22-q24	Metabolic	
2300	1222	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)	PHKB	PHKB	172490	16q12-q13	Metabolic	261750
2301	1223	Phosphoserine phosphatase deficiency (3)	PSP	PSP	172480	7p15.2-p15.1	Metabolic	
2302	1225	Pick disease, 172700 (3)	PSEN1	PSEN1, AD3	104311	14q24.3	Neurological	172700
2303	1226	Piebaldism (3)	KIT	KIT, PBT	164920	4q12	Dermatological	
2304	1227	Pigmentation of hair, skin, and eyes, variation in (3)	MATP	MATP, AIM1	606202	5p13.3	Dermatological	
2305	3229	Pigmented adrenocortical disease, primary isolated, 160980 (3)	PRKAR1A	PRKAR1A, TSE1, CNC1, CAR	188830	17q23-q24	Cancer	160980
2306	1229	Pigmented paravenous chorioretinal atrophy, 172870 (3)	CRB1	CRB1, RP12	604210	1q31-q32.1	Ophthamological	172870
2307	1230	Pilomatricoma, 132600 (3)	CTNNB1	CTNNB1	116806	3p22-p21.3	Cancer	132600
2308	1232	Pituitary ACTH-secreting adenoma (3)	GNAI2	GNAI2, GNAI2B, GIP	139360	3p21	Cancer	
2309	1232	Pituitary ACTH secreting adenoma (3)	GNAS	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO	139320	20q13.2	Cancer	
2310	1232	Pituitary adenoma, nonfunctioning (3)	THRA	THRA, ERBA1, THRA1	190120	17q11.2	Cancer	
2311	3232	Pituitary anomalies with holoprosencephaly-like features (3)	GLI2	GLI2	165230	2q14	multiple	
2312	5232	Pituitary hormone deficiency, combined (3)	POU1F1	POU1F1, PIT1	173110	3p11	Endocrine	
2313	5232	Pituitary hormone deficiency, combined (3)	PROP1	PROP1	601538	5q	Endocrine	
2314	5232	Pituitary hormone deficiency, combined, HESX1-related, 182230 (3)	HESX1	HESX1, RPX	601802	3p21.2-p21.1	Endocrine	182230
2315	5232	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)	LHX3	LHX3	600577	9q34.3	Endocrine	262600
2316	7232	Pituitary tumor, invasive (3)	PRKCA	PRKCA, PKCA	176960	17q22-q23.2	Cancer	
2317	1233	Placental abruption (3)	NOS3	NOS3	163729	7q36	Unclassified	
2318	5233	Placental steroid sulfatase deficiency (3)	STS	STS, ARSC1, ARSC, SSDD	308100	Xp22.32	Metabolic	
2319	1234	Plasmin inhibitor deficiency (3)	PLI	PLI, SERPINF2	262850	17pter-p12	Hematological	
2320	1235	Plasminogen Tochigi disease (3)	PLG	PLG	173350	6q26	Hematological	
2321	1237	Platelet-activating factor acetylhydrolase deficiency (3)	PLA2G7	PLA2G7, PAFAH	601690	6p21.2-p12	Hematological	
2322	1237	Platelet ADP receptor defect (3)	P2RY12	P2RY12, P2Y12	600515	3q24-q25	Hematological	
2323	1237	Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)	RUNX1	RUNX1, CBFA2, AML1	151385	21q22.3	Hematological	601399
2324	1237	Platelet glycoprotein IV deficiency, 608404 (3)	CD36	CD36	173510	7q11.2	Hematological	608404
2325	1238	Pneumonitis, desquamative interstitial, 263000 (3)	SFTPC	SFTPC, SFTP2	178620	8p21	Respiratory	263000
2326	1239	Pneumothorax, primary spontaneous, 173600 (3)	FLCN	FLCN, BHD	607273	17p11.2	Respiratory	173600
2327	1241	Polycystic kidney and hepatic disease, 263200 (3)	FCYT	FCYT, PKHD1, ARPKD	606702	6p21.1-p12	Renal	263200
2328	1241	Polycystic kidney disease, adult type I, 173900 (3)	PKD1	PKD1	601313	16p13.3-p13.12	Renal	173900
2329	1241	Polycystic kidney disease, adult, type II (3)	PKD2	PKD2, PKD4	173910	4q21-q23	Renal	
2330	1241	Polycystic kidney disease, infantile severe, with tuberous sclerosis (3)	PKDTS	PKDTS	600273	16p13.3	Renal	
2331	3241	Polycystic liver disease, 174050 (3)	PRKCSH	PRKCSH, G19P1, PCLD	177060	19p13.2-p13.1	Gastrointestinal	174050
2332	3241	Polycystic liver disease, 174050 (3)	SEC63	SEC63	608648	6q21	Gastrointestinal	174050
2333	1242	Polycythemia, benign familial, 263400 (3)	VHL	VHL	608537	3p26-p25	Hematological	263400
2334	1242	Polycythemia vera, 263300 (3)	JAK2	JAK2	147796	9p24	Hematological	263300
2335	1243	Polydactyly, postaxial, types A1 and B, 174200 (3)	GLI3	GLI3, PAPA, PAPB, ACLS	165240	7p13	Skeletal	174200
2336	1243	Polydactyly, preaxial, type IV, 174700 (3)	GLI3	GLI3, PAPA, PAPB, ACLS	165240	7p13	Skeletal	174700
2337	1244	Polymicrogyria, bilateral frontoparietal, 606854 (3)	GPR56	GPR56, TM7XN1, BFPP	604110	16q13	Neurological	606854
2338	1245	Polyposis, juvenile intestinal, 174900 (3)	BMPR1A	BMPR1A, ACVRLK3, ALK3	601299	10q22.3	Cancer	174900
2339	1245	Polyposis, juvenile intestinal, 174900 (3)	MADH4	MADH4, DPC4, SMAD4, JIP	600993	18q21.1	Cancer	174900
2340	1246	Popliteal pterygium syndrome, 119500 (3)	IRF6	IRF6, VWS, LPS, PIT, PPS, OFC6	607199	1q32-q41	multiple	119500
2341	1247	Porencephaly, 175780 (3)	COL4A1	COL4A1	120130	13q34	Neurological	175780
2342	1249	Porphyria, acute hepatic (3)	ALAD	ALAD	125270	9q34	Metabolic	
2343	1249	Porphyria, acute intermittent (3)	HMBS	HMBS, PBGD, UPS	176000	11q23.3	Metabolic	
2344	1249	Porphyria, acute intermittent, nonerythroid variant (3)	HMBS	HMBS, PBGD, UPS	176000	11q23.3	Metabolic	
2345	1249	Porphyria, congenital erythropoietic, 263700 (3)	UROS	UROS	606938	10q25.2-q26.3	Metabolic	263700
2346	1249	Porphyria cutanea tarda (3)	UROD	UROD	176100	1p34	Metabolic	
2347	1249	Porphyria, hepatoerythropoietic (3)	UROD	UROD	176100	1p34	Metabolic	
2348	1249	Porphyria variegata, 176200 (3)	HFE	HFE, HLA-H, HFE1	235200	6p21.3	Metabolic	176200
2349	1249	Porphyria variegata, 176200 (3)	PPOX	PPOX	600923	1q22	Metabolic	176200
2350	1253	PPM-X syndrome, 300055 (3)	MECP2	MECP2, RTT, PPMX, MRX16, MRX79	300005	Xq28	Neurological	300055
2351	1254	Prader-Willi syndrome, 176270 (3)	NDN	NDN	602117	15q11-q13	multiple	176270
2352	1254	Prader-Willi syndrome, 176270 (3)	SNRPN	SNRPN	182279	15q12	multiple	176270
2353	1256	Precocious puberty, male, 176410 (3)	LHCGR	LHCGR	152790	2p21	Developmental	176410
2354	1257	Preeclampsia/eclampsia 4 (3)	STOX1	STOX1, PEE4	609397	10q22.1	Cardiovascular	4
2355	1257	Preeclampsia, susceptibility to, 189800 (3)	EPHX1	EPHX1	132810	1q42.1	Cardiovascular	189800
2356	1257	Preeclampsia, susceptibility to (3)	AGT	AGT, SERPINA8	106150	1q42-q43	Cardiovascular	
2357	1259	Prekallikrein deficiency (3)	KLKB1	KLKB1, KLK3	229000	4q35	Hematological	
2358	3260	Premature chromosome condensation with microcephaly and mental retardation, 606858 (3)	MCPH1	MCPH1	607117	8p23	Neurological	606858
2359	1260	Premature ovarian failure, 300511 (3)	DIAPH2	DIAPH2, DIA, POF2	300108	Xq22	Renal	300511
2360	1260	Premature ovarian failure 3, 608996 (3)	FOXL2	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q23	Renal	608996
2361	1261	Primary lateral sclerosis, juvenile, 606353 (3)	ALS2	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33	Neurological	606353
2362	1263	Prion disease with protracted course, 606688 (3)	PRNP	PRNP, PRIP	176640	20pter-p12	Neurological	606688
2363	1265	Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)	C10orf2	C10orf2, TWINKLE, PEO1, PEO	606075	10q24	Ophthamological	157640
2364	1265	Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)	POLG	POLG, POLG1, POLGA, PEO	174763	15q25	Ophthamological	157640
2365	1265	Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)	SLC25A4	SLC25A4, ANT1, T1, PEO3	103220	4q35	Ophthamological	157640
2366	1266	Proguanil poor metabolizer (3)	CYP2C	CYP2C, CYP2C19	124020	10q24.1-q24.3	Metabolic	
2367	1267	Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)	MEN1	MEN1	131100	11q13	Endocrine	
2368	1268	Prolidase deficiency (3)	PEPD	PEPD	170100	19cen-q13.11	Connective tissue	
2369	1270	Properdin deficiency, X-linked, 312060 (3)	PFC	PFC, PFD	300383	Xp11.4-p11.23	Immunological	312060
2370	1271	Propionicacidemia, 606054 (3)	PCCA	PCCA	232000	13q32	Metabolic	606054
2371	1271	Propionicacidemia, 606054 (3)	PCCB	PCCB	232050	3q21-q22	Metabolic	606054
2372	1272	Prostate cancer 1, 176807, 601518 (3)	RNASEL	RNASEL, RNS4, PRCA1, HPC1	180435	1q25	Cancer	601518
2373	1272	Prostate cancer, 176807 (3)	BRCA2	BRCA2, FANCD1	600185	13q12.3	Cancer	176807
2374	1272	Prostate cancer, 176807 (3)	PTEN	PTEN, MMAC1	601728	10q23.31	Cancer	176807
2375	1272	Prostate cancer (3)	AR	AR, DHTR, TFM, SBMA, KD, SMAX1	313700	Xq11-q12	Cancer	
2376	1272	Prostate cancer, familial, 176807 (3)	CHEK2	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	Cancer	176807
2377	1272	Prostate cancer, hereditary, 176807 (3)	MSR1	MSR1	153622	8p22	Cancer	176807
2378	1272	Prostate cancer, progression and metastasis of, 176807 (3)	EPHB2	EPHB2, EPHT3, DRT, ERK	600997	1p36.1-p35	Cancer	176807
2379	1272	Prostate cancer, somatic, 176807 (3)	KLF6	KLF6, COPEB, BCD1, ZF9	602053	10p15	Cancer	176807
2380	1272	Prostate cancer, somatic, 176807 (3)	MAD1L1	MAD1L1, TXBP181	602686	7p22	Cancer	176807
2381	1272	Prostate cancer, susceptibility to, 176807 (3)	AR	AR, DHTR, TFM, SBMA, KD, SMAX1	313700	Xq11-q12	Cancer	176807
2382	1272	Prostate cancer, susceptibility to, 176807 (3)	ATBF1	ATBF1	104155	16q22.3-q23.1	Cancer	176807
2383	1272	Prostate cancer, susceptibility to, 176807 (3)	ELAC2	ELAC2, HPC2	605367	17p11	Cancer	176807
2384	1272	Prostate cancer, susceptibility to, 176807 (3)	MXI1	MXI1	600020	10q25	Cancer	176807
2385	1273	Protein S deficiency (3)	PROS1	PROS1	176880	3p11.1-q11.2	Hematological	
2386	1274	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis (3)	CLCN5	CLCN5, CLCK2, NPHL2, DENTS	300008	Xp11.22	Renal	
2387	1276	Protoporphyria, erythropoietic (3)	FECH	FECH, FCE	177000	18q21.3	Metabolic	
2388	1276	Protoporphyria, erythropoietic, recessive, with liver failure (3)	FECH	FECH, FCE	177000	18q21.3	Metabolic	
2389	1277	Proud syndrome, 300004 (3)	ARX	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54	300382	Xp22.13	multiple	300004
2390	1278	Pseudoachondroplasia, 177170 (3)	COMP	COMP, EDM1, MED, PSACH	600310	19p13.1	Skeletal	177170
2391	1279	Pseudohermaphroditism, male, with gynecomastia, 264300 (3)	HSD17B3	HSD17B3, EDH17B3	605573	9q22	Developmental	264300
2392	1279	Pseudohermaphroditism, male, with Leydig cell hypoplasia (3)	LHCGR	LHCGR	152790	2p21	Developmental	
2393	1281	Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1A	SCNN1A	600228	12p13	Endocrine	264350
2394	1281	Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1B	SCNN1B	600760	16p13-p12	Endocrine	264350
2395	1281	Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1G	SCNN1G, PHA1	600761	16p13-p12	Endocrine	264350
2396	1281	Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3)	NR3C2	NR3C2, MLR, MCR	600983	4q31.1	Endocrine	177735
2397	1281	Pseudohypoaldosteronism type II (3)	WNK4	WNK4, PRKWNK4, PHA2B	601844	17q21-q22	Endocrine	
2398	1281	Pseudohypoaldosteronism, type IIC, 145260 (3)	WNK1	WNK1, PRKWNK1, KDP, PHA2C	605232	12p13	Endocrine	145260
2399	1282	Pseudohypoparathyroidism, type Ia, 103580 (3)	GNAS	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO	139320	20q13.2	Endocrine	103580
2400	1282	Pseudohypoparathyroidism, type Ib, 603233 (3)	GNAS	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO	139320	20q13.2	Endocrine	603233
2401	1283	Pseudovaginal perineoscrotal hypospadias, 264600 (3)	SRD5A2	SRD5A2	607306	2p23	Unclassified	264600
2402	1284	Pseudovitamin D deficiency rickets 1 (3)	CYP27B1	CYP27B1, PDDR, VDD1	264700	12q14	Bone	1
2403	1285	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3)	ABCC6	ABCC6, ARA, ABC34, MLP1, PXE	603234	16p13.1	Connective tissue	177850
2404	1285	Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)	ABCC6	ABCC6, ARA, ABC34, MLP1, PXE	603234	16p13.1	Connective tissue	264800
2405	1288	Psoriasis, susceptibility to, 177900 (3)	PSORS6	PSORS6	605364	19p13	Dermatological	177900
2406	1288	Psoriatic arthritis, susceptibility to, 607507 (3)	CARD15	CARD15, NOD2, IBD1, CD, ACUG, PSORAS1	605956	16q12	Dermatological	607507
2407	1291	Pulmonary alveolar proteinosis, 265120 (3)	CSF2RB	CSF2RB	138981	22q12.2-q13.1	Respiratory	265120
2408	1291	Pulmonary alveolar proteinosis, 265120 (3)	SFTPC	SFTPC, SFTP2	178620	8p21	Respiratory	265120
2409	1291	Pulmonary alveolar proteinosis, congenital, 265120 (3)	SFTPB	SFTPB, SFTB3	178640	2p12-p11.2	Respiratory	265120
2410	1291	Pulmonary fibrosis, idiopathic, familial, 178500 (3)	SFTPC	SFTPC, SFTP2	178620	8p21	Respiratory	178500
2411	1291	Pulmonary fibrosis, idiopathic, susceptibility to, 178500 (3)	SFTPA1	SFTPA1, SFTP1	178630	10q22.2-q23.1	Respiratory	178500
2412	5291	Pulmonary hypertension, familial primary, 178600 (3)	BMPR2	BMPR2, PPH1	600799	2q33	Cardiovascular	178600
2413	1293	Pycnodysostosis, 265800 (3)	CTSK	CTSK	601105	1q21	Skeletal	265800
2414	1294	Pyloric stenosis, infantile hypertrophic, susceptibility to, 179010 (3)	NOS1	NOS1	163731	12q24.2-q24.31	Developmental	179010
2415	1295	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)	PSTPIP1	PSTPIP1, PSTPIP, CD2BP1, PAPAS	606347	15q24-q25.1	Dermatological	604416
2416	1296	Pyropoikilocytosis (3)	SPTA1	SPTA1	182860	1q21	Hematological	
2417	1297	Pyruvate carboxylase deficiency, 266150 (3)	PC	PC	608786	11q13.4-q13.5	Metabolic	266150
2418	1297	Pyruvate dehydrogenase deficiency (3)	PDHA1	PDHA1, PHE1A	312170	Xp22.2-p22.1	Metabolic	
2419	1297	Pyruvate dehydrogenase E1-beta deficiency (3)	PDHB	PDHB	179060	3p13-q23	Metabolic	
2420	1298	Rabson-Mendenhall syndrome, 262190 (3)	INSR	INSR	147670	19p13.2	multiple	262190
2421	1301	Radioulnar synostosis with amegakaryocytic thrombocytopenia, 605432 (3)	HOXA11	HOXA11, HOX1I	142958	7p15-p14.2	multiple	605432
2422	1303	RAPADILINO syndrome, 266280 (3)	RECQL4	RECQL4, RTS, RECQ4	603780	8q24.3	multiple	266280
2423	1304	Rapid progression to AIDS from HIV1 infection (3)	CX3CR1	CX3CR1, GPR13, V28	601470	3pter-p21	Immunological	
2424	1305	Rapp-Hodgkin syndrome, 129400 (3)	TP73L	TP73L, TP63, KET, EEC3, SHFM4, LMS, RHS	603273	3q27	multiple	129400
2425	1306	Red hair/fair skin (3)	MC1R	MC1R	155555	16q24.3	Dermatological	
2426	1307	Refsum disease, 266500 (3)	PEX7	PEX7, RCDP1	601757	6q22-q24	Neurological	266500
2427	1307	Refsum disease, 266500 (3)	PHYH	PHYH, PAHX	602026	10pter-p11.2	Neurological	266500
2428	1307	Refsum disease, infantile, 266510 (3)	PEX1	PEX1, ZWS1	602136	7q21-q22	Neurological	266510
2429	1307	Refsum disease, infantile form, 266510 (3)	PEX26	PEX26	608666	22q11.21	Neurological	266510
2430	1307	Refsum disease, infantile form, 266510 (3)	PXMP3	PXMP3, PAF1, PMP35, PEX2	170993	8q21.1	Neurological	266510
2431	1308	Renal carcinoma, chromophobe, somatic, 144700 (3)	FLCN	FLCN, BHD	607273	17p11.2	Cancer	144700
2432	1308	Renal cell carcinoma, 144700 (3)	TRC8	TRC8, RCA1, HRCA1	603046	8q24.1	Cancer	144700
2433	1308	Renal cell carcinoma, clear cell, somatic, 144700 (3)	OGG1	OGG1	601982	3p26.2	Cancer	144700
2434	1308	Renal cell carcinoma, papillary, 1, 605074 (3)	PRCC	PRCC, RCCP1	179755	1q21	Cancer	605074
2435	1308	Renal cell carcinoma, papillary, 1, 605074 (3)	TFE3	TFE3	314310	Xp11.22	Cancer	605074
2436	1308	Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)	MET	MET	164860	7q31	Cancer	605074
2437	1308	Renal cell carcinoma, somatic (3)	VHL	VHL	608537	3p26-p25	Cancer	
2438	3308	Renal glucosuria, 233100 (3)	SLC5A2	SLC5A2, SGLT2	182381	16p11.2	Renal	233100
2439	5308	Renal hypoplasia, isolated (3)	PAX2	PAX2	167409	10q24.3-q25.1	Renal	
2440	7308	Renal tubular acidosis, distal, 179800, 602722 (3)	SLC4A1	SLC4A1, AE1, EPB3	109270	17q21-q22	Renal	602722
2441	7308	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)	ATP6V0A4	ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR	605239	7q33-q34	Renal	602722
2442	7308	Renal tubular acidosis-osteopetrosis syndrome (3)	CA2	CA2	259730	8q22	Renal	
2443	7308	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)	SLC4A4	SLC4A4, NBC1, KNBC, SLC4A5	603345	4q21	Renal	604278
2444	7308	Renal tubular acidosis with deafness, 267300 (3)	ATP6B1	ATP6B1, VPP3	192132	2cen-q13	Renal	267300
2445	9308	Renal tubular dysgenesis, 267430 (3)	ACE	ACE, DCP1, ACE1	106180	17q23	Renal	267430
2446	9308	Renal tubular dysgenesis, 267430 (3)	AGTR1	AGTR1, AGTR1A, AT2R1	106165	3q21-q25	Renal	267430
2447	9308	Renal tubular dysgenesis, 267430 (3)	AGT	AGT, SERPINA8	106150	1q42-q43	Renal	267430
2448	9308	Renal tubular dysgenesis, 267430 (3)	REN	REN	179820	1q32	Renal	267430
2449	1309	Renpenning syndrome, 309500 (3)	PQBP1	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	300463	Xp11.23	Neurological	309500
2450	1311	Response to morphine-6-glucuronide (3)	OPRM1	OPRM1	600018	6q24-q25	Neurological	
2451	1312	Resting heart rate, 607276 (3)	ADRB1	ADRB1, ADRB1R, RHR	109630	10q24-q26	Cardiovascular	607276
2452	1314	Restrictive dermopathy, lethal, 275210 (3)	ZMPSTE24	ZMPSTE24, FACE1, STE24, MADB	606480	1p34	Dermatological	275210
2453	1315	Retinal degeneration, autosomal recessive, clumped pigment type (3)	NRL	NRL, D14S46E, RP27	162080	14q11.1-q11.2	Ophthamological	
2454	1315	Retinal degeneration, autosomal recessive, prominin-related (3)	PROM1	PROM1, PROML1, AC133	604365	4p16.2-p12	Ophthamological	
2455	1315	Retinal degeneration, late-onset, autosomal dominant, 605670 (3)	C1QTNF5	C1QTNF5, CTRP5, LORD	608752	11q23.3	Ophthamological	605670
2456	1315	Retinal dystrophy, early-onset severe (3)	LRAT	LRAT	604863	4q31	Ophthamological	
2457	1316	Retinitis pigmentosa-10, 180105 (3)	IMPDH1	IMPDH1	146690	7q31.3-q32	Ophthamological	180105
2458	1316	Retinitis pigmentosa-11, 600138 (3)	PRPF31	PRPF31, PRP31	606419	19q13.4	Ophthamological	600138
2459	1316	Retinitis pigmentosa-1, 180100 (3)	RP1	RP1, ORP1	603937	8q11-q13	Ophthamological	180100
2460	1316	Retinitis pigmentosa-12, autosomal recessive, 600105 (3)	CRB1	CRB1, RP12	604210	1q31-q32.1	Ophthamological	600105
2461	1316	Retinitis pigmentosa-13, 600059 (3)	PRPF8	PRPF8, PRPC8, RP13	607300	17p13.3	Ophthamological	600059
2462	1316	Retinitis pigmentosa-14, 600132 (3)	TULP1	TULP1, RP14	602280	6p21.3	Ophthamological	600132
2463	1316	Retinitis pigmentosa-17, 600852 (3)	CA4	CA4, RP17	114760	17q23	Ophthamological	600852
2464	1316	Retinitis pigmentosa-18, 601414 (3)	HPRP3	HPRP3, RP18	607301	1q21.2	Ophthamological	601414
2465	1316	Retinitis pigmentosa-19, 601718 (3)	ABCA4	ABCA4, ABCR, STGD1, FFM, RP19	601691	1p21-p13	Ophthamological	601718
2466	1316	Retinitis pigmentosa-20 (3)	RPE65	RPE65, RP20	180069	1p31	Ophthamological	
2467	1316	Retinitis pigmentosa-2 (3)	RP2	RP2	312600	Xp11.3	Ophthamological	
2468	1316	Retinitis pigmentosa-26, 608380 (3)	CERKL	CERKL	608381	2q31.2-q32.3	Ophthamological	608380
2469	1316	Retinitis pigmentosa-27 (3)	NRL	NRL, D14S46E, RP27	162080	14q11.1-q11.2	Ophthamological	
2470	1316	Retinitis pigmentosa-30, 607921 (3)	FSCN2	FSCN2, RFSN	607643	17q25	Ophthamological	607921
2471	1316	Retinitis pigmentosa-3, 300389 (3)	RPGR	RPGR, RP3, CRD, RP15, COD1	312610	Xp21.1	Ophthamological	300389
2472	1316	Retinitis pigmentosa-4, autosomal dominant (3)	RHO	RHO, RP4, OPN2	180380	3q21-q24	Ophthamological	
2473	1316	Retinitis pigmentosa-7, 608133 (3)	RDS	RDS, RP7, PRPH2, PRPH, AVMD, AOFMD	179605	6p21.1-cen	Ophthamological	608133
2474	1316	Retinitis pigmentosa-9, 180104 (3)	RP9	RP9	607331	7p14.2	Ophthamological	180104
2475	1316	Retinitis pigmentosa, AR, 268000 (3)	RLBP1	RLBP1	180090	15q26	Ophthamological	268000
2476	1316	Retinitis pigmentosa, AR, without hearing loss, 268000 (3)	USH2A	USH2A	608400	1q41	Ophthamological	268000
2477	1316	Retinitis pigmentosa, autosomal dominant (3)	RGR	RGR	600342	10q23	Ophthamological	
2478	1316	Retinitis pigmentosa, autosomal recessive, 268000 (3)	CNGB1	CNGB1, CNCG3L, CNCG2	600724	16q13	Ophthamological	268000
2479	1316	Retinitis pigmentosa, autosomal recessive (3)	CNGA1	CNGA1, CNCG1	123825	4p12-cen	Ophthamological	
2480	1316	Retinitis pigmentosa, autosomal recessive (3)	PDE6A	PDE6A, PDEA	180071	5q31.2-q34	Ophthamological	
2481	1316	Retinitis pigmentosa, autosomal recessive (3)	PDE6B	PDE6B, PDEB, CSNB3	180072	4p16.3	Ophthamological	
2482	1316	Retinitis pigmentosa, autosomal recessive (3)	RGR	RGR	600342	10q23	Ophthamological	
2483	1316	Retinitis pigmentosa, autosomal recessive (3)	RHO	RHO, RP4, OPN2	180380	3q21-q24	Ophthamological	
2484	1316	Retinitis pigmentosa, digenic (3)	ROM1	ROM1, ROSP1	180721	11q13	Ophthamological	
2485	1316	Retinitis pigmentosa, digenic, 608133 (3)	RDS	RDS, RP7, PRPH2, PRPH, AVMD, AOFMD	179605	6p21.1-cen	Ophthamological	608133
2486	1316	Retinitis pigmentosa, juvenile (3)	AIPL1	AIPL1, LCA4	604392	17p13.1	Ophthamological	
2487	1316	Retinitis pigmentosa, late onset, 268000 (3)	NR2E3	NR2E3, PNR, ESCS	604485	15q23	Ophthamological	268000
2488	1316	Retinitis pigmentosa, late-onset dominant, 268000 (3)	CRX	CRX, CORD2, CRD	602225	19q13.3	Ophthamological	268000
2489	1316	Retinitis pigmentosa, MERTK-related, 268000 (3)	MERTK	MERTK	604705	2q14.1	Ophthamological	268000
2490	1316	Retinitis pigmentosa, X-linked with deafness and sinorespiratory infections, 300455 (3)	RPGR	RPGR, RP3, CRD, RP15, COD1	312610	Xp21.1	Ophthamological	300455
2491	1316	Retinitis pigmentosa, X-linked, with recurrent respiratory infections, 300455 (3)	RPGR	RPGR, RP3, CRD, RP15, COD1	312610	Xp21.1	Ophthamological	300455
2492	1316	Retinitis punctata albescens, 136880 (3)	RDS	RDS, RP7, PRPH2, PRPH, AVMD, AOFMD	179605	6p21.1-cen	Ophthamological	136880
2493	1316	Retinitis punctata albescens, 136880 (3)	RLBP1	RLBP1	180090	15q26	Ophthamological	136880
2494	1317	Retinoblastoma (3)	RB1	RB1	180200	13q14.1-q14.2	Cancer	
2495	1318	Retinol binding protein, deficiency of (3)	RBP4	RBP4	180250	10q24	Ophthamological	
2496	1320	Retinoschisis (3)	RS1	RS1, XLRS1	312700	Xp22.2-p22.1	Ophthamological	
2497	1321	Rett syndrome, 312750 (3)	MECP2	MECP2, RTT, PPMX, MRX16, MRX79	300005	Xq28	Neurological	312750
2498	1321	Rett syndrome, atypical, 312750 (3)	CDKL5	CDKL5, STK9	300203	Xp22	Neurological	312750
2499	1321	Rett syndrome, preserved speech variant, 312750 (3)	MECP2	MECP2, RTT, PPMX, MRX16, MRX79	300005	Xq28	Neurological	312750
2500	1322	Rhabdoid predisposition syndrome, familial (3)	SMARCB1	SMARCB1, SNF5, INI1, RDT	601607	22q11	Cancer	
2501	1322	Rhabdoid tumors (3)	SMARCB1	SMARCB1, SNF5, INI1, RDT	601607	22q11	Cancer	
2502	1323	Rhabdomyosarcoma, 268210 (3)	SLC22A1L	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.5	Cancer	268210
2503	1323	Rhabdomyosarcoma, alveolar, 268220 (3)	FOXO1A	FOXO1A, FKHR	136533	13q14.1	Cancer	268220
2504	1323	Rhabdomyosarcoma, alveolar, 268220 (3)	PAX3	PAX3, WS1, HUP2, CDHS	606597	2q35	Cancer	268220
2505	1323	Rhabdomyosarcoma, alveolar, 268220 (3)	PAX7	PAX7	167410	1p36.2-p36.12	Cancer	268220
2506	1324	Rheumatoid arthritis, progression of, 180300 (3)	IL10	IL10, CSIF	124092	1q31-q32	Connective tissue	180300
2507	1324	Rheumatoid arthritis, susceptibility to, 180300 (3)	MHC2TA	MHC2TA, C2TA	600005	16p13	Connective tissue	180300
2508	1324	Rheumatoid arthritis, susceptibility to, 180300 (3)	NFKBIL1	NFKBIL1	601022	6p21.3	Connective tissue	180300
2509	1324	Rheumatoid arthritis, susceptibility to, 180300 (3)	PADI4	PADI4, PADI5, PAD	605347	1p36	Connective tissue	180300
2510	1324	Rheumatoid arthritis, susceptibility to, 180300 (3)	PTPN8	PTPN8, PEP, PTPN22, LYP	600716	1p13	Connective tissue	180300
2511	1324	Rheumatoid arthritis, susceptibility to, 180300 (3)	RUNX1	RUNX1, CBFA2, AML1	151385	21q22.3	Connective tissue	180300
2512	1324	Rheumatoid arthritis, susceptibility to, 180300 (3)	SLC22A4	SLC22A4, OCTN1	604190	5q31	Connective tissue	180300
2513	1324	Rheumatoid arthritis, systemic juvenile, susceptibility to, 604302 (3)	MIF	MIF	153620	22q11.2	Connective tissue	604302
2514	1325	Rhizomelic chondrodysplasia punctata, type 1, 215100 (3)	PEX7	PEX7, RCDP1	601757	6q22-q24	multiple	215100
2515	1325	Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)	AGPS	AGPS, ADHAPS	603051	2q31	multiple	600121
2516	1326	Rh-mod syndrome (3)	RHAG	RHAG, RH50A	180297	6p21.1-p11	Hematological	
2517	1327	Rh-negative blood type (3)	RHD	RHD	111680	1p36.2-p34	Hematological	
2518	1327	Rh-null disease, amorph type (3)	RHCE	RHCE	111700	1p36.2-p34	Hematological	
2519	1329	Ribose 5-phosphate isomerase deficiency, 608611 (3)	RPIA	RPIA, RPI	180430	2p11.2	Metabolic	608611
2520	1330	Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)	CYP2R1	CYP2R1	608713	11p15.2	Bone	600081
2521	1330	Rickets, vitamin D-resistant, type IIA, 277440 (3)	VDR	VDR	601769	12q12-q14	Bone	277440
2522	1330	Rickets, vitamin D-resistant, type IIB, 277420 (3)	VDR	VDR	601769	12q12-q14	Bone	277420
2523	1331	Rieger anomaly (3)	FOXC1	FOXC1, FKHL7, FREAC3	601090	6p25	multiple	
2524	1331	Rieger syndrome, 180500 (3)	PITX2	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25-q26	multiple	180500
2525	1332	Ring dermoid of cornea, 180550 (3)	PITX2	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25-q26	Ophthamological	180550
2526	1333	Rippling muscle disease, 606072 (3)	CAV3	CAV3, LGMD1C	601253	3p25	Muscular	606072
2527	1334	Roberts syndrome, 268300 (3)	ESCO2	ESCO2	609353	8p21.1	Developmental	268300
2528	1335	Robinow syndrome, autosomal recessive, 268310 (3)	ROR2	ROR2, BDB1, BDB, NTRKR2	602337	9q22	multiple	268310
2529	1337	Rokitansky-Kuster-Hauser syndrome, 277000 (3)	WNT4	WNT4	603490	1p35	Developmental	277000
2530	1338	Rothmund-Thomson syndrome, 268400 (3)	RECQL4	RECQL4, RTS, RECQ4	603780	8q24.3	multiple	268400
2531	1339	Roussy-Levy syndrome, 180800 (3)	MPZ	MPZ, CMT1B, CMTDI3, CHM, DSS	159440	1q22	multiple	180800
2532	1339	Roussy-Levy syndrome, 180800 (3)	PMP22	PMP22, CMT1A, CMT1E, DSS	601097	17p11.2	multiple	180800
2533	1341	Rubenstein-Taybi syndrome, 180849 (3)	CREBBP	CREBBP, CBP, RSTS	600140	16p13.3	multiple	180849
2534	1341	Rubinstein-Taybi syndrome, 180849 (3)	EP300	EP300	602700	22q13	multiple	180849
2535	1344	Saethre-Chotzen syndrome, 101400 (3)	FGFR2	FGFR2, BEK, CFD1, JWS	176943	10q26	Developmental	101400
2536	1344	Saethre-Chotzen syndrome, 101400 (3)	TWIST	TWIST, ACS3, SCS	601622	7p21	Developmental	101400
2537	1344	Saethre-Chotzen syndrome with eyelid anomalies, 101400 (3)	TWIST	TWIST, ACS3, SCS	601622	7p21	Developmental	101400
2538	1345	Salivary adenoma (3)	HMGA2	HMGA2, HMGIC, BABL, LIPO	600698	12q14.3	Cancer	
2539	1346	Salla disease, 604369 (3)	SLC17A5	SLC17A5, SIASD, SLD	604322	6q14-q15	Metabolic	604369
2540	1347	Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)	HEXB	HEXB	606873	5q13	Metabolic	268800
2541	1348	Sanfilippo syndrome, type A, 252900 (3)	SGSH	SGSH, MPS3A, SFMD	605270	17q25.3	Metabolic	252900
2542	1348	Sanfilippo syndrome, type B (3)	NAGLU	NAGLU	252920	17q21	Metabolic	
2543	1349	Sarcoidosis, early-onset, 181000 (3)	CARD15	CARD15, NOD2, IBD1, CD, ACUG, PSORAS1	605956	16q12	Immunological	181000
2544	1349	Sarcoidosis, susceptibility to, 181000 (3)	BTNL2	BTNL2	606000	6p21.3	Immunological	181000
2545	1349	Sarcoidosis, susceptibility to, 181000 (3)	HLA-DR1B	HLA-DR1B	142857	6p21.3	Immunological	181000
2546	1350	Sarcoma, synovial (3)	SSX1	SSX1, SSRC	312820	Xp11.2	Cancer	
2547	1350	Sarcoma, synovial (3)	SSX2	SSX2	300192	Xp11.2	Cancer	
2548	1352	SARS, progression of (3)	ACE	ACE, DCP1, ACE1	106180	17q23	Immunological	
2549	1354	Schimke immunoosseous dysplasia, 242900 (3)	SMARCAL1	SMARCAL1, HARP, SIOD	606622	2q34-q36	Connective tissue	242900
2550	1355	Schindler disease, type I, 609241 (3)	NAGA	NAGA	104170	22q11	Metabolic	609241
2551	1355	Schindler disease, type III, 609241 (3)	NAGA	NAGA	104170	22q11	Metabolic	609241
2552	1357	Schizencephaly, 269160 (3)	EMX2	EMX2	600035	10q26.1	Neurological	269160
2553	1359	Schizoaffective disorder, susceptibility to, 181500 (3)	DISC1	DISC1	605210	1q42.1	Psychiatric	181500
2554	1359	Schizophrenia 5, 603175 (3)	TRAR4	TRAR4	608923	6q23.2	Psychiatric	603175
2555	1359	Schizophrenia, chronic (3)	APP	APP, AAA, CVAP, AD1	104760	21q21	Psychiatric	
2556	1359	Schizophrenia, susceptibility to, 181500 (3)	COMT	COMT	116790	22q11.2	Psychiatric	181500
2557	1359	Schizophrenia, susceptibility to, 181500 (3)	DISC1	DISC1	605210	1q42.1	Psychiatric	181500
2558	1359	Schizophrenia, susceptibility to, 181500 (3)	HTR2A	HTR2A	182135	13q14-q21	Psychiatric	181500
2559	1359	Schizophrenia, susceptibility to, 181500 (3)	RTN4R	RTN4R, NOGOR	605566	22q11	Psychiatric	181500
2560	1359	Schizophrenia, susceptibility to, 181500 (3)	SYN2	SYN2	600755	3p25	Psychiatric	181500
2561	1359	Schizophrenia, susceptibility to, 181510 (3)	EPN4	EPN4, EPNR, KIAA0171, SCZD1	607265	5q33.3	Psychiatric	181510
2562	1359	Schizophrenia, susceptibility to, 4 600850 (3)	PRODH	PRODH, PRODH2, SCZD4	606810	22q11.2	Psychiatric	600850
2563	1360	Schwannomatosis, 162091 (3)	NF2	NF2	607379	22q12.2	Cancer	162091
2564	1361	Schwartz-Jampel syndrome, type 1, 255800 (3)	HSPG2	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.1	multiple	255800
2565	1362	SCID, autosomal recessive, T-negative/B-positive type (3)	JAK3	JAK3, JAKL	600173	19p13.1	Immunological	
2566	1363	Sclerosteosis, 269500 (3)	SOST	SOST	605740	17q12-q21	Skeletal	269500
2567	1365	Scurvy (3)	GULOP	GULOP, GULO	240400	8p21.1	Nutritional	
2568	1366	Sea-blue histiocyte disease, 269600 (3)	APOE	APOE, AD2	107741	19q13.2	Hematological	269600
2569	1367	Seasonal affective disorder, susceptibility to, 608516 (3)	HTR2A	HTR2A	182135	13q14-q21	Psychiatric	608516
2570	1368	Sebastian syndrome, 605249 (3)	MYH9	MYH9, MHA, FTNS, DFNA17	160775	22q11.2	Hematological	605249
2571	1369	Seckel syndrome 1, 210600 (3)	ATR	ATR, FRP1, SCKL	601215	3q22-q24	Developmental	210600
2572	1370	Segawa syndrome, recessive (3)	TH	TH, TYH	191290	11p15.5	Neurological	
2573	1371	Seizures, afebrile, 604233 (3)	SCN2A1	SCN2A1, SCN2A	182390	2q23-q24.3	Neurological	604233
2574	1371	Seizures, benign familial neonatal-infantile, 607745 (3)	SCN2A1	SCN2A1, SCN2A	182390	2q23-q24.3	Neurological	607745
2575	1372	Selective T-cell defect (3)	ZAP70	ZAP70, SRK, STD	176947	2q12	Immunological	
2576	1373	Self-healing collodion baby, 242300 (3)	TGM1	TGM1, ICR2, LI1	190195	14q11.2	Dermatological	242300
2577	1374	SEMD, Pakistani type (3)	PAPSS2	PAPSS2, ATPSK2	603005	10q22-q24	Connective tissue	
2578	1375	Senior-Loken syndrome-1, 266900 (3)	NPHP1	NPHP1, NPH1, SLSN1	607100	2q13	Renal	266900
2579	1375	Senior-Loken syndrome 4, 606996 (3)	NPHP4	NPHP4, SLSN4	607215	1p36	Renal	606996
2580	1375	Senior-Loken syndrome 5, 609254 (3)	IQCB1	IQCB1, NPHP5, KIAA0036	609237	3q21.1	Renal	609254
2581	1376	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis, 157640 (3)	POLG	POLG, POLG1, POLGA, PEO	174763	15q25	Ophthamological	157640
2582	1377	Sepiapterin reductase deficiency (3)	SPR	SPR	182125	2p14-p12	Metabolic	
2583	1378	Sepsis, susceptibility to (3)	CASP12	CASP12, CASP12P1	608633	11q22.3	Immunological	
2584	1378	Septic shock, susceptibility to (3)	TNF	TNF, TNFA	191160	6p21.3	Immunological	
2585	1380	Septooptic dysplasia, 182230 (3)	HESX1	HESX1, RPX	601802	3p21.2-p21.1	multiple	182230
2586	1381	Sertoli cell-only syndrome, susceptibility to, 305700 (3)	USP26	USP26	300309	Xq26.2	Renal	305700
2587	1383	Severe combined immunodeficiency, Athabascan type, 602450 (3)	DCLRE1C	DCLRE1C, ARTEMIS, SCIDA	605988	10p	Immunological	602450
2588	1383	Severe combined immunodeficiency, B cell-negative, 601457 (3)	RAG1	RAG1	179615	11p13	Immunological	601457
2589	1383	Severe combined immunodeficiency, B cell-negative, 601457 (3)	RAG2	RAG2	179616	11p13	Immunological	601457
2590	1383	Severe combined immunodeficiency due to ADA deficiency, 102700 (3)	ADA	ADA	608958	20q13.11	Immunological	102700
2591	1383	Severe combined immunodeficiency due to PTPRC deficiency (3)	PTPRC	PTPRC, CD45, LCA	151460	1q31-q32	Immunological	
2592	1383	Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 600802 (3)	IL7R	IL7R	146661	5p13	Immunological	600802
2593	1383	Severe combined immunodeficiency, T-negative/B-positive type, 600802 (3)	CD3D	CD3D, T3D	186790	11q23	Immunological	600802
2594	1383	Severe combined immunodeficiency, X-linked, 300400 (3)	IL2RG	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13	Immunological	300400
2595	1384	Sex reversal, XY, with adrenal failure (3)	FTZF1	FTZF1, FTZ1, SF1	184757	9q33	Unclassified	
2596	1385	Sezary syndrome (3)	BCL10	BCL10	603517	1p22	Cancer	
2597	1386	Shah-Waardenburg syndrome, 277580 (3)	EDN3	EDN3	131242	20q13.2-q13.3	multiple	277580
2598	1387	Short stature, autosomal dominant, with normal serum growth hormone binding protein (3)	GHR	GHR	600946	5p13-p12	Skeletal	
2599	1387	Short stature, idiopathic (3)	GHR	GHR	600946	5p13-p12	Skeletal	
2600	1387	Short stature, idiopathic familial, 604271 (3)	SHOX	SHOX, GCFX, SS, PHOG	312865	Xpter-p22.32	Skeletal	604271
2601	1387	Short stature, idiopathic familial, 604271 (3)	SHOXY	SHOXY	400020	Ypter-p11.2	Skeletal	604271
2602	1387	Short stature, pituitary and cerebellar defects, and small sella turcica, 606606 (3)	LHX4	LHX4	602146	1q25	Skeletal	606606
2603	1388	Shprintzen-Goldberg syndrome, 182212 (3)	FBN1	FBN1, MFS1, WMS	134797	15q21.1	multiple	182212
2604	1389	Shwachman-Diamond syndrome, 260400 (3)	SBDS	SBDS, SDS	607444	7q11	multiple	260400
2605	1391	Sialic acid storage disorder, infantile, 269920 (3)	SLC17A5	SLC17A5, SIASD, SLD	604322	6q14-q15	Metabolic	269920
2606	1391	Sialidosis, type I, 256550 (3)	NEU1	NEU1, NEU, SIAL1	608272	6p21.3	Metabolic	256550
2607	1391	Sialidosis, type II, 256550 (3)	NEU1	NEU1, NEU, SIAL1	608272	6p21.3	Metabolic	256550
2608	1392	Sialuria, 269921 (3)	GNE	GNE, GLCNE, IBM2, DMRV, NM	603824	9p12-p11	Metabolic	269921
2609	1393	Sickle cell anemia (3)	HBB	HBB	141900	11p15.5	Hematological	
2610	1394	Sick sinus syndrome, 608567 (3)	SCN5A	SCN5A, LQT3, IVF, HB1, SSS1	600163	3p21	Cardiovascular	608567
2611	1396	Silver spastic paraplegia syndrome, 270685 (3)	BSCL2	BSCL2, SPG17	606158	11q13	Neurological	270685
2612	1397	Simpson-Golabi-Behmel syndrome, type 1, 312870 (3)	GPC3	GPC3, SDYS, SGBS1	300037	Xq26	multiple	312870
2613	1398	Sitosterolemia, 210250 (3)	ABCG5	ABCG5	605459	2p21	Metabolic	210250
2614	1398	Sitosterolemia, 210250 (3)	ABCG8	ABCG8	605460	2p21	Metabolic	210250
2615	1399	Situs ambiguus (3)	NODAL	NODAL	601265	Chr.10	Developmental	
2616	1399	Situs inversus viscerum, 270100 (3)	DNAH11	DNAH11, DNAHC11	603339	Chr.7	Developmental	270100
2617	1400	Sjogren-Larsson syndrome, 270200 (3)	ALDH3A2	ALDH3A2, ALDH10, SLS, FALDH	609523	17p11.2	Metabolic	270200
2618	1401	Skin fragility-woolly hair syndrome, 607655 (3)	DSP	DSP, KPPS2, PPKS2	125647	6p24	Dermatological	607655
2619	1403	Slow acetylation (3)	NAT2	NAT2, AAC2	243400	8p23.1-p21.3	Metabolic	
2620	1404	Slowed nerve conduction velocity, AD, 608236 (3)	ARHGEF10	ARHGEF10, KIAA0294	608136	8p23	Neurological	608236
2621	1406	Small patella syndrome, 147891 (3)	TBX4	TBX4	601719	17q21-q22	Skeletal	147891
2622	1408	SMED Strudwick type, 184250 (3)	COL2A1	COL2A1	120140	12q13.11-q13.2	Skeletal	184250
2623	1409	Smith-Fineman-Myers syndrome, 309580 (3)	ATRX	ATRX, XH2, XNP, MRXS3, SHS	300032	Xq13	multiple	309580
2624	1410	Smith-Lemli-Opitz syndrome, 270400 (3)	DHCR7	DHCR7, SLOS	602858	11q12-q13	multiple	270400
2625	1411	Smith-Magenis syndrome, 182290 (3)	RAI1	RAI1, SMCR, SMS	607642	17p11.2	multiple	182290
2626	1412	Smith-McCort dysplasia, 607326 (3)	DYM	DYM, FLJ90130, DMC, SMC	607461	18q12-q21.1	Skeletal	607326
2627	1414	Solitary median maxillary central incisor, 147250 (3)	SHH	SHH, HPE3, HLP3, SMMCI	600725	7q36	Skeletal	147250
2628	1415	Somatotrophinoma (3)	GNAS	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO	139320	20q13.2	Endocrine	
2629	1416	Sorsby fundus dystrophy, 136900 (3)	TIMP3	TIMP3, SFD	188826	22q12.1-q13.2	Ophthamological	136900
2630	1417	Sotos syndrome, 117550 (3)	NSD1	NSD1, ARA267, STO	606681	5q35	Developmental	117550
2631	1418	Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	SACS	SACS, ARSACS	604490	13q12	Neurological	270550
2632	1418	Spastic paralysis, infantile onset ascending, 607225 (3)	ALS2	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33	Neurological	607225
2633	1418	Spastic paraplegia 10, 604187 (3)	KIF5A	KIF5A, NKHC, SPG10	602821	12q13	Neurological	604187
2634	1418	Spastic paraplegia-13, 605280 (3)	HSPD1	HSPD1, SPG13, HSP60	118190	2q33.1	Neurological	605280
2635	1418	Spastic paraplegia-2, 312920 (3)	PLP1	PLP1, PMD	300401	Xq22	Neurological	312920
2636	1418	Spastic paraplegia-3A, 182600 (3)	SPG3A	SPG3A	606439	14q11-q21	Neurological	182600
2637	1418	Spastic paraplegia-4, 182601 (3)	SPG4	SPG4, SPAST	604277	2p22-p21	Neurological	182601
2638	1418	Spastic paraplegia-6, 600363 (3)	NIPA1	NIPA1, SPG6	608145	15q11.1	Neurological	600363
2639	1418	Spastic paraplegia-7, 607259 (3)	PGN	PGN, SPG7, CMAR, CAR	602783	16q24.3	Neurological	607259
2640	3419	Specific granule deficiency, 245480 (3)	CEBPE	CEBPE, CRP1	600749	14q11.2	Immunological	245480
2641	1419	Speech-language disorder-1, 602081 (3)	FOXP2	FOXP2, SPCH1, TNRC10, CAGH44	605317	7q31	Neurological	602081
2642	1422	Spermatogenic failure, susceptibility to (3)	DAZL	DAZL, DAZH, SPGYLA	601486	3p24	Renal	
2643	1423	Spherocytosis-1 (3)	SPTB	SPTB	182870	14q22-q23.2	Hematological	
2644	1423	Spherocytosis-2 (3)	ANK1	ANK1, SPH2	182900	8p11.2	Hematological	
2645	1423	Spherocytosis, hereditary (3)	SLC4A1	SLC4A1, AE1, EPB3	109270	17q21-q22	Hematological	
2646	1423	Spherocytosis, hereditary, Japanese type (3)	EPB42	EPB42	177070	15q15	Hematological	
2647	1423	Spherocytosis, recessive (3)	SPTA1	SPTA1	182860	1q21	Hematological	
2648	1425	Spina bifida, 601634 (3)	MTHFD	MTHFD, MTHFC	172460	14q24	Developmental	601634
2649	1425	Spina bifida, risk of, 601634, 182940 (3)	MTR	MTR	156570	1q43	Developmental	182940
2650	1425	Spina bifida, risk of, 601634, 182940 (3)	MTRR	MTRR	602568	5p15.3-p15.2	Developmental	182940
2651	1426	Spinal and bulbar muscular atrophy of Kennedy, 313200 (3)	AR	AR, DHTR, TFM, SBMA, KD, SMAX1	313700	Xq11-q12	Muscular	313200
2652	1426	Spinal muscrular atrophy, late-onset, Finkel type, 182980 (3)	VAPB	VAPB, VAPC, ALS8	605704	20q13.3	Muscular	182980
2653	1426	Spinal muscular atrophy-1, 253300 (3)	SMN1	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q12.2-q13.3	Muscular	253300
2654	1426	Spinal muscular atrophy-2, 253550 (3)	SMN1	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q12.2-q13.3	Muscular	253550
2655	1426	Spinal muscular atrophy-3, 253400 (3)	SMN1	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q12.2-q13.3	Muscular	253400
2656	1426	Spinal muscular atrophy-4, 271150 (3)	SMN1	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q12.2-q13.3	Muscular	271150
2657	1426	Spinal muscular atrophy, distal, type V, 600794 (3)	BSCL2	BSCL2, SPG17	606158	11q13	Muscular	600794
2658	1426	Spinal muscular atrophy, distal, type V, 600794 (3)	GARS	GARS, SMAD1, CMT2D	600287	7p15	Muscular	600794
2659	1426	Spinal muscular atrophy, juvenile (3)	HEXB	HEXB	606873	5q13	Muscular	
2660	1426	Spinal muscular atrophy with respiratory distress, 604320 (3)	IGHMBP2	IGHMBP2, SMUBP2, CATF1, SMARD1	600502	11q13.2-q13.4	Muscular	604320
2661	1428	Spinocerebellar ataxia-10 (3)	ATXN10	ATXN10, SCA10	603516	22q13	Neurological	
2662	1428	Spinocerebellar ataxia-1, 164400 (3)	ATXN1	ATXN1, ATX1, SCA1	601556	6p23	Neurological	164400
2663	1428	Spinocerebellar ataxia 12, 604326 (3)	PPP2R2B	PPP2R2B	604325	5q31-q33	Neurological	604326
2664	1428	Spinocerebellar ataxia 14, 605361 (3)	PRKCG	PRKCG, PKCC, PKCG, SCA14	176980	19q13.4	Neurological	605361
2665	1428	Spinocerebellar ataxia 17, 607136 (3)	TBP	TBP, SCA17	600075	6q27	Neurological	607136
2666	1428	Spinocerebellar ataxia-2, 183090 (3)	ATXN2	ATXN2, ATX2, SCA2	601517	12q24	Neurological	183090
2667	1428	Spinocerebellar ataxia 25 (3)	SCA25	SCA25	608703	2p21-p13	Neurological	25
2668	1428	Spinocerebellar ataxia-27, 609307 (3)	FGF14	FGF14, FHF4, SCA27	601515	13q34	Neurological	609307
2669	1428	Spinocerebellar ataxia 4, pure Japanese type, 117210 (3)	PLEKHG4	PLEKHG4	609526	16q22.1	Neurological	117210
2670	1428	Spinocerebellar ataxia-6, 183086 (3)	CACNA1A	CACNA1A, CACNL1A4, SCA6	601011	19p13	Neurological	183086
2671	1428	Spinocerebellar ataxia-7, 164500 (3)	ATXN7	ATXN7, SCA7, OPCA3	607640	3p21.1-p12	Neurological	164500
2672	1428	Spinocerebellar ataxia 8, 608768 (3)	SCA8	SCA8	603680	13q21	Neurological	608768
2673	1428	Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3)	TDP1	TDP1	607198	14q31-q32	Neurological	607250
2674	1430	Split hand/foot malformation, type 3, 600095 (3)	SHFM3	SHFM3, DAC	608071	10q24	Skeletal	600095
2675	1430	Split-hand/foot malformation, type 4, 605289 (3)	TP73L	TP73L, TP63, KET, EEC3, SHFM4, LMS, RHS	603273	3q27	Skeletal	605289
2676	1432	Spondylocarpotarsal synostosis syndrome, 272460 (3)	FLNB	FLNB, SCT, AOI	603381	3p14.3	Skeletal	272460
2677	1433	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)	DLL3	DLL3, SCDO1	602768	19q13	Skeletal	277300
2678	1433	Spondylocostal dysostosis, autosomal recessive 2, 608681 (3)	MESP2	MESP2	605195	15q26.1	Skeletal	608681
2679	1435	Spondyloepimetaphyseal dysplasia, 608728 (3)	MATN3	MATN3, EDM5, HOA	602109	2p24-p23	Skeletal	608728
2680	1435	Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3)	AGC1	AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	Skeletal	608361
2681	1435	Spondyloepiphyseal dysplasia, Omani type, 608637 (3)	CHST3	CHST3, C6ST, C6ST1	603799	10q22.1	Skeletal	608637
2682	1435	Spondyloepiphyseal dysplasia tarda, 313400 (3)	SEDL	SEDL, SEDT	300202	Xp22.2-p22.1	Skeletal	313400
2683	1435	Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)	WISP3	WISP3, PPAC, PPD	603400	6q22-q23	Skeletal	208230
2684	1436	Spondylometaphyseal dysplasia, Japanese type (3)	COL10A1	COL10A1	120110	6q21-q22.3	Skeletal	
2685	1437	Squamous cell carcinoma, burn scar-related, somatic (3)	TNFRSF6	TNFRSF6, APT1, FAS, CD95, ALPS1A	134637	10q24.1	Cancer	
2686	1437	Squamous cell carcinoma, head and neck, 601400 (3)	ING1	ING1	601566	13q34	Cancer	601400
2687	1437	Squamous cell carcinoma, head and neck, 601400 (3)	TNFRSF10B	TNFRSF10B, DR5, TRAILR2	603612	8p22-p21	Cancer	601400
2688	1438	Stapes ankylosis syndrome without symphalangism, 184460 (3)	NOG	NOG, SYM1, SYNS1	602991	17q22	multiple	184460
2689	1439	Stargardt disease-1, 248200 (3)	ABCA4	ABCA4, ABCR, STGD1, FFM, RP19	601691	1p21-p13	Ophthamological	248200
2690	1439	Stargardt disease 3, 600110 (3)	ELOVL4	ELOVL4, ADMD, STGD2, STGD3	605512	6q14	Ophthamological	600110
2691	1440	Startle disease, autosomal recessive (3)	GLRA1	GLRA1, STHE	138491	5q32	Neurological	
2692	1440	Startle disease/hyperekplexia, autosomal dominant, 149400 (3)	GLRA1	GLRA1, STHE	138491	5q32	Neurological	149400
2693	1441	STAT1 deficiency, complete (3)	STAT1	STAT1	600555	2q32.2-q32.3	Unclassified	
2694	1442	Statins, attenuated cholesterol lowering by (3)	HMGCR	HMGCR	142910	5q13.3-q14	Metabolic	
2695	1444	Steatocystoma multiplex, 184500 (3)	KRT17	KRT17, PC2, PCHC1	148069	17q12-q21	Dermatological	184500
2696	1445	Stem-cell leukemia/lymphoma syndrome (3)	ZNF198	ZNF198, SCLL, RAMP, FIM	602221	13q11-q12	Cancer	
2697	1446	Stevens-Johnson syndrome, carbamazepine-induced, susceptibility to, 608579 (3)	HLA-B	HLA-B	142830	6p21.3	Dermatological	608579
2698	1447	Stickler syndrome, type I, 108300 (3)	COL2A1	COL2A1	120140	12q13.11-q13.2	multiple	108300
2699	1447	Stickler syndrome, type II, 604841 (3)	COL11A1	COL11A1, STL2	120280	1p21	multiple	604841
2700	1447	Stickler syndrome, type III, 184840 (3)	COL11A2	COL11A2, STL3, DFNA13	120290	6p21.3	multiple	184840
2701	1449	Stomach cancer, 137215 (3)	KRAS2	KRAS2, RASK2	190070	12p12.1	Cancer	137215
2702	1454	Stroke, susceptibility to, 1, 606799 (3)	PDE4D	PDE4D, DPDE3, STRK1	600129	5q12	Cardiovascular	606799
2703	1454	Stroke, susceptibility to, 601367 (3)	ALOX5AP	ALOX5AP, FLAP	603700	13q12	Cardiovascular	601367
2704	1455	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)	LIFR	LIFR, STWS, SWS, SJS2	151443	5p13.1	multiple	601559
2705	1456	Subcortical laminal heteropia, X-linked, 300067 (3)	DCX	DCX, DBCN, LISX	300121	Xq22.3-q23	Neurological	300067
2706	1456	Subcortical laminar heterotopia (3)	PAFAH1B1	PAFAH1B1, LIS1	601545	17p13.3	Neurological	
2707	1457	Succinic semialdehyde dehydrogenase deficiency (3)	SSADH	SSADH	271980	6p22	Metabolic	
2708	1458	Sucrose intolerance (3)	SI	SI	222900	3q25-q26	Metabolic	
2709	1459	Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)	TSPYL1	TSPYL1, TSPYL, SIDDT	604714	6q22-q23	Unclassified	608800
2710	1460	Sulfite oxidase deficiency, 272300 (3)	SUOX	SUOX	606887	Chr.12	Metabolic	272300
2711	1461	Superoxide dismutase, elevated extracellular (3)	SOD3	SOD3	185490	4p15.3-p15.1	Unclassified	
2712	1462	Supranuclear palsy, progressive, 601104 (3)	MAPT	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.1	Neurological	601104
2713	1462	Supranuclear palsy, progressive atypical, 260540 (3)	MAPT	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.1	Neurological	260540
2714	1463	Supravalvar aortic stenosis, 185500 (3)	ELN	ELN	130160	7q11.2	Cardiovascular	185500
2715	1464	Surfactant deficiency, neonatal, 267450 (3)	ABCA3	ABCA3, ABC3	601615	16p13.3	Respiratory	267450
2716	1464	Surfactant protein C deficiency (3)	SFTPC	SFTPC, SFTP2	178620	8p21	Respiratory	
2717	1465	Sutherland-Haan syndrome-like, 300465 (3)	ATRX	ATRX, XH2, XNP, MRXS3, SHS	300032	Xq13	multiple	300465
2718	1466	Sweat chloride elevation without CF (3)	CFTR	CFTR, ABCC7, CF, MRP7	602421	7q31.2	Unclassified	
2719	1467	Symphalangism, proximal, 185800 (3)	NOG	NOG, SYM1, SYNS1	602991	17q22	Skeletal	185800
2720	1468	Syndactyly, type III, 186100 (3)	GJA1	GJA1, CX43, ODDD, SDTY3, ODOD	121014	6q21-q23.2	Skeletal	186100
2721	1469	Synostoses syndrome, multiple, 1, 186500 (3)	NOG	NOG, SYM1, SYNS1	602991	17q22	multiple	186500
2722	1470	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (3)	FBLN1	FBLN1	135820	22q13.3	Skeletal	608180
2723	1470	Synpolydactyly, type II, 186000 (3)	HOXD13	HOXD13, HOX4I, SPD	142989	2q31-q32	Skeletal	186000
2724	1470	Synpolydactyly with foot anomalies, 186000 (3)	HOXD13	HOXD13, HOX4I, SPD	142989	2q31-q32	Skeletal	186000
2725	1471	Systemic lupus erythematosus, susceptibility, 152700 (3)	TNFSF6	TNFSF6, APT1LG1, FASL	134638	1q23	Immunological	152700
2726	1471	Systemic lupus erythematosus, susceptibility to, 152700 (3)	DNASE1	DNASE1, DNL1	125505	16p13.3	Immunological	152700
2727	1471	Systemic lupus erythematosus, susceptibility to, 152700 (3)	PTPN8	PTPN8, PEP, PTPN22, LYP	600716	1p13	Immunological	152700
2728	1471	Systemic lupus erythematosus, susceptibility to, 2, 605218, 152700 (3)	PDCD1	PDCD1, SLEB2	600244	2q37.3	Immunological	152700
2729	1472	Tall stature, susceptibility to (3)	MCM6	MCM6	601806	2q21	Skeletal	
2730	1473	Tangier disease, 205400 (3)	ABCA1	ABCA1, ABC1, HDLDT1, TGD	600046	9q22-q31	Metabolic	205400
2731	1475	Tarsal-carpal coalition syndrome, 186570 (3)	NOG	NOG, SYM1, SYNS1	602991	17q22	Skeletal	186570
2732	1476	Tauopathy and respiratory failure (3)	MAPT	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.1	Neurological	
2733	1477	Tay-Sachs disease, 272800 (3)	HEXA	HEXA, TSD	606869	15q23-q24	Metabolic	272800
2734	1478	T-cell acute lymphoblastic leukemia (3)	BAX	BAX	600040	19q13.3-q13.4	Cancer	
2735	3478	T-cell immunodeficiency, congenital alopecia, and nail dystrophy (3)	WHN	WHN	600838	17q11-q12	Immunological	
2736	1478	T-cell prolymphocytic leukemia, sporadic (3)	ATM	ATM, ATA, AT1	607585	11q22.3	Cancer	
2737	1480	Temperature-sensitive apoptosis, cellular (3)	DAD1	DAD1	600243	14q11-q12	Unclassified	
2738	1482	Tetra-amelia, autosomal recessive, 273395 (3)	WNT3	WNT3, INT4	165330	17q21	multiple	273395
2739	1483	Tetralogy of Fallot, 187500 (3)	JAG1	JAG1, AGS, AHD	601920	20p12	Cardiovascular	187500
2740	1483	Tetralogy of Fallot, 187500 (3)	ZFPM2	ZFPM2, FOG2	603693	8q23	Cardiovascular	187500
2741	1483	Tetrology of Fallot, 187500 (3)	NKX2E	NKX2E, CSX	600584	5q34	Cardiovascular	187500
2742	1486	Thalassemia, alpha-(3)	HBA2	HBA2	141850	16pter-p13.3	Hematological	
2743	1486	Thalassemia-beta, dominant inclusion-body, 603902 (3)	HBB	HBB	141900	11p15.5	Hematological	603902
2744	1486	Thalassemia, delta-(3)	HBD	HBD	142000	11p15.5	Hematological	
2745	1486	Thalassemia due to Hb Lepore (3)	HBD	HBD	142000	11p15.5	Hematological	
2746	1486	Thalassemia, Hispanic gamma-delta-beta (3)	LCRB	LCRB	152424	11p15.5	Hematological	
2747	1486	Thalassemias, alpha-(3)	HBA1	HBA1	141800	16pter-p13.3	Hematological	
2748	1486	Thalassemias, beta-(3)	HBB	HBB	141900	11p15.5	Hematological	
2749	1490	Thanatophoric dysplasia, types I and II, 187600 (3)	FGFR3	FGFR3, ACH	134934	4p16.3	Skeletal	187600
2750	1491	Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)	SLC19A2	SLC19A2, THTR1	603941	1q23.3	Hematological	249270
2751	1493	Thrombocythemia, essential, 187950 (3)	JAK2	JAK2	147796	9p24	Hematological	187950
2752	1493	Thrombocythemia, essential, 187950 (3)	THPO	THPO, MGDF, MPLLG, TPO	600044	3q26.3-q27	Hematological	187950
2753	1494	Thrombocytopenia-2, 188000 (3)	FLJ14813	FLJ14813, THC2	608221	10p12.1	Hematological	188000
2754	1494	Thrombocytopenia, congenital amegakaryocytic, 604498 (3)	MPL	MPL, TPOR, MPLV	159530	1p34	Hematological	604498
2755	1494	Thrombocytopenia, X-linked, 313900 (3)	WAS	WAS, IMD2, THC	300392	Xp11.23-p11.22	Hematological	313900
2756	1494	Thrombocytopenia, X-linked, intermittent, 313900 (3)	WAS	WAS, IMD2, THC	300392	Xp11.23-p11.22	Hematological	313900
2757	1494	Thromboembolism susceptibility due to factor V Leiden (3)	F5	F5	227400	1q23	Hematological	
2758	1497	Thrombophilia due to factor V Liverpool (3)	F5	F5	227400	1q23	Hematological	
2759	1497	Thrombophilia due to heparin cofactor II deficiency (3)	HCF2	HCF2, HC2, SERPIND1	142360	22q11	Hematological	
2760	1497	Thrombophilia due to HRG deficiency (3)	HRG	HRG	142640	3q27	Hematological	
2761	1497	Thrombophilia due to protein C deficiency (3)	PROC	PROC	176860	2q13-q14	Hematological	
2762	1497	Thrombophilia due to thrombomodulin defect (3)	THBD	THBD, THRM	188040	20p11.2	Hematological	
2763	1497	Thrombophilia, dysfibrinogenemic (3)	FGB	FGB	134830	4q28	Hematological	
2764	1497	Thrombophilia, dysfibrinogenemic (3)	FGG	FGG	134850	4q28	Hematological	
2765	1497	Thrombosis, hyperhomocysteinemic (3)	CBS	CBS	236200	21q22.3	Hematological	
2766	1497	Thrombotic thrombocytopenic purpura, familial, 274150 (3)	ADAMTS13	ADAMTS13, VWFCP, TTP	604134	9q34	Hematological	274150
2767	1494	Thrombycytosis, susceptibility to, 187950 (3)	MPL	MPL, TPOR, MPLV	159530	1p34	Hematological	187950
2768	1502	Thymine-uraciluria (3)	DPYD	DPYD, DPD	274270	1p22	Metabolic	
2769	1503	Thyroid adenoma, hyperfunctioning (3)	TSHR	TSHR	603372	14q31	Cancer	
2770	1503	Thyroid carcinoma (3)	TP53	TP53, P53, LFS1	191170	17p13.1	Cancer	
2771	1503	Thyroid carcinoma, follicular, 188470 (3)	MINPP1	MINPP1, HIPER1	605391	10q23	Cancer	188470
2772	1503	Thyroid carcinoma, follicular, 188470 (3)	PTEN	PTEN, MMAC1	601728	10q23.31	Cancer	188470
2773	1503	Thyroid carcinoma, follicular, somatic, 188470 (3)	HRAS	HRAS	190020	11p15.5	Cancer	188470
2774	1503	Thyroid carcinoma, papillary, 188550 (3)	GOLGA5	GOLGA5, RFG5, PTC5	606918	14q	Cancer	188550
2775	1503	Thyroid carcinoma, papillary, 188550 (3)	NCOA4	NCOA4, ELE1, PTC3	601984	10q11.2	Cancer	188550
2776	1503	Thyroid carcinoma, papillary, 188550 (3)	PCM1	PCM1, PTC4	600299	8p22-p21.3	Cancer	188550
2777	1503	Thyroid carcinoma, papillary, 188550 (3)	PRKAR1A	PRKAR1A, TSE1, CNC1, CAR	188830	17q23-q24	Cancer	188550
2778	1503	Thyroid carcinoma, papillary, 188550 (3)	TIF1G	TIF1G, RFG7, PTC7	605769	1p13	Cancer	188550
2779	1503	Thyroid carcinoma, papillary, 188550 (3)	TRIM24	TRIM24, TIF1, TIF1A, PTC6	603406	7q32-q34	Cancer	188550
2780	3503	Thyroid hormone organification defect IIA, 274500 (3)	TPO	TPO, TPX	606765	2p25	Endocrine	274500
2781	3503	Thyroid hormone resistance, 188570 (3)	THRB	THRB, ERBA2, THR1	190160	3p24.3	Endocrine	188570
2782	3503	Thyroid hormone resistance, autosomal recessive, 274300 (3)	THRB	THRB, ERBA2, THR1	190160	3p24.3	Endocrine	274300
2783	1504	Thyrotoxic periodic paralysis, susceptibility to, 188580 (3)	CACNA1S	CACNA1S, CACNL1A3, CCHL1A3	114208	1q32	Endocrine	188580
2784	1505	Thyrotropin-releasing hormone resistance, generalized (3)	TRHR	TRHR	188545	8q23	Endocrine	
2785	1506	Thyroxine-binding globulin deficiency (3)	TBG	TBG	314200	Xq22.2	Hematological	
2786	1508	Tietz syndrome, 103500 (3)	MITF	MITF, WS2A	156845	3p14.1-p12.3	multiple	103500
2787	1509	Timothy syndrome, 601005 (3)	CACNA1C	CACNA1C, CACNL1A1, CCHL1A1, TS	114205	12p13.3	multiple	601005
2788	1510	Toenail dystrophy, isolated, 607523 (3)	COL7A1	COL7A1	120120	3p21.3	Dermatological	607523
2789	1511	Tolbutamide poor metabolizer (3)	CYP2C9	CYP2C9	601130	10q24	Unclassified	
2790	3512	Total iodide organification defect, 274500 (3)	TPO	TPO, TPX	606765	2p25	Endocrine	274500
2791	1514	Townes-Brocks branchiootorenal-like syndrome, 107480 (3)	SALL1	SALL1, HSAL1, TBS	602218	16q12.1	multiple	107480
2792	1514	Townes-Brocks syndrome, 107480 (3)	SALL1	SALL1, HSAL1, TBS	602218	16q12.1	multiple	107480
2793	1515	Transaldolase deficiency, 606003 (3)	TALDO1	TALDO1	602063	11p15.5-p15.4	Metabolic	606003
2794	1516	Transcobalamin II deficiency (3)	TCN2	TCN2, TC2	275350	22q11.2-qter	Hematological	
2795	1518	Transient bullous of the newborn, 131705 (3)	COL7A1	COL7A1	120120	3p21.3	Dermatological	131705
2796	1519	Transposition of great arteries, dextro-looped, 217095 (3)	CFC1	CFC1, CRYPTIC, HTX2	605194	2q21.1	Developmental	217095
2797	1519	Transposition of the great arteries, dextro-looped, 608808 (3)	THRAP2	THRAP2, PROSIT240, TRAP240L, KIAA1025	608771	12q24	Developmental	608808
2798	1520	Treacher Collins mandibulofacial dysostosis, 154500 (3)	TCOF1	TCOF1, MFD1	606847	5q32-q33.1	Developmental	154500
2799	1521	Tremor, familial essential, 2, 602134 (3)	HS1BP3	HS1BP3, FLJ14249, ETM2	609359	2p24.1	Neurological	602134
2800	1522	Trichodontoosseous syndrome, 190320 (3)	DLX3	DLX3, TDO	600525	17q21.3-q22	multiple	190320
2801	1524	Trichorhinophalangeal syndrome, type I, 190350 (3)	TRPS1	TRPS1	604386	8q24.12	Developmental	190350
2802	1524	Trichorhinophalangeal syndrome, type III, 190351 (3)	TRPS1	TRPS1	604386	8q24.12	Developmental	190351
2803	1525	Trichothiodystrophy (3)	ERCC3	ERCC3, XPB	133510	2q21	Dermatological	
2804	1525	Trichothiodystrophy, 601675 (3)	ERCC2	ERCC2, EM9	126340	19q13.2-q13.3	Dermatological	601675
2805	1525	Trichothiodystrophy, complementation group A, 601675 (3)	TGF2H5	TGF2H5, TTDA, TFB5, C6orf175	608780	6p25.3	Dermatological	601675
2806	1525	Trichothiodystrophy, nonphotosensitive 1, 234050 (3)	TTDN1	TTDN1, C7orf11, ABHS	609188	7p14	Dermatological	234050
2807	1526	Trifunctional protein deficiency, type 1 (3)	HADHA	HADHA, MTPA	600890	2p23	Metabolic	1
2808	1526	Trifunctional protein deficiency, type II (3)	HADHB	HADHB	143450	2p23	Metabolic	
2809	1528	Trismus-pseudocomptodactyly syndrome, 158300 (3)	MYH8	MYH8	160741	17p13.1	multiple	158300
2810	1529	Tropical calcific pancreatitis, 608189 (3)	SPINK1	SPINK1, PSTI, PCTT, TATI	167790	5q32	Gastrointestinal	608189
2811	1530	Troyer syndrome, 275900 (3)	SPG20	SPG20	607111	13q12.3	Neurological	275900
2812	1534	TSC2 angiomyolipomas, renal, modifier of, 191100 (3)	IFNG	IFNG	147570	12q14	multiple	191100
2813	1533	Tuberculosis, susceptibility to (3)	IFNGR1	IFNGR1	107470	6q23-q24	Respiratory	
2814	1533	Tuberculosis, susceptibility to, 607948 (3)	IFNG	IFNG	147570	12q14	Respiratory	607948
2815	1534	Tuberous sclerosis-1, 191100 (3)	TSC1	TSC1, LAM	605284	9q34	multiple	191100
2816	1534	Tuberous sclerosis-2, 191100 (3)	TSC2	TSC2, LAM	191092	16p13.3	multiple	191100
2817	1536	Turcot syndrome, 276300 (3)	APC	APC, GS, FPC	175100	5q21-q22	Cancer	276300
2818	1536	Turcot syndrome with glioblastoma, 276300 (3)	MLH1	MLH1, COCA2, HNPCC2	120436	3p21.3	Cancer	276300
2819	1536	Turcot syndrome with glioblastoma, 276300 (3)	PMS2	PMS2, PMSL2, HNPCC4	600259	7p22	Cancer	276300
2820	1538	Twinning, dizygotic, 276400 (3)	FSHR	FSHR, ODG1	136435	2p21-p16	Unclassified	276400
2821	1540	Tyrosinemia, type I (3)	FAH	FAH	276700	15q23-q25	Metabolic	
2822	1540	Tyrosinemia, type II (3)	TAT	TAT	276600	16q22.1-q22.3	Metabolic	
2823	1540	Tyrosinemia, type III (3)	HPD	HPD	276710	12q24-qter	Metabolic	
2824	1542	Ullrich congenital muscular dystrophy, 254090 (3)	COL6A1	COL6A1, OPLL	120220	21q22.3	Muscular	254090
2825	1542	Ullrich congenital muscular dystrophy, 254090 (3)	COL6A3	COL6A3	120250	2q37	Muscular	254090
2826	1542	Ullrich scleroatonic muscular dystrophy, 254090 (3)	COL6A2	COL6A2	120240	21q22.3	Muscular	254090
2827	1543	Ulnar-mammary syndrome, 181450 (3)	TBX3	TBX3	601621	12q24.1	multiple	181450
2828	1544	Unipolar depression, susceptibility to, 608516 (3)	TPH2	TPH2, NTPH	607478	12q21.1	Psychiatric	608516
2829	1545	Unna-Thost disease, nonepidermolytic, 600962 (3)	KRT1	KRT1	139350	12q13	Dermatological	600962
2830	1550	Urolithiasis, 2,8-dihydroxyadenine (3)	APRT	APRT	102600	16q24.3	Metabolic	
2831	1550	Urolithiasis, hypophosphatemic (3)	SLC17A2	SLC17A2, NPT2	182309	5q35	Metabolic	
2832	1551	Usher syndrome, type 1B (3)	MYO7A	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	multiple	
2833	1551	Usher syndrome, type 1C, 276904 (3)	USH1C	USH1C, DFNB18	605242	11p15.1	multiple	276904
2834	1551	Usher syndrome, type 1D, 601067 (3)	CDH23	CDH23, USH1D	605516	10q21-q22	multiple	601067
2835	1551	Usher syndrome, type 1F, 602083 (3)	PCDH15	PCDH15, DFNB23	605514	10q21-q22	multiple	602083
2836	1551	Usher syndrome, type 1G, 606943 (3)	SANS	SANS, USH1G	607696	17q24-q25	multiple	606943
2837	1551	Usher syndrome, type 2A, 276901 (3)	USH2A	USH2A	608400	1q41	multiple	276901
2838	1551	Usher syndrome, type 3, 276902 (3)	USH3A	USH3A, USH3	606397	3q21-q25	multiple	276902
2839	1551	Usher syndrome, type IIC, 605472 (3)	MASS1	MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14	multiple	605472
2840	1552	Uterine leiomyoma (3)	HMGA2	HMGA2, HMGIC, BABL, LIPO	600698	12q14.3	Cancer	
2841	1553	UV-induced skin damage, vulnerability to (3)	MC1R	MC1R	155555	16q24.3	Dermatological	
2842	1554	van Buchem disease, type 2, 607636 (3)	LRP5	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2	603506	11q13.4	Unclassified	607636
2843	3554	van der Woude syndrome, 119300 (3)	IRF6	IRF6, VWS, LPS, PIT, PPS, OFC6	607199	1q32-q41	Developmental	119300
2844	1555	VATER association with hydrocephalus, 276950 (3)	PTEN	PTEN, MMAC1	601728	10q23.31	multiple	276950
2845	1556	Velocardiofacial syndrome, 192430 (3)	TBX1	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.2	multiple	192430
2846	1557	Venous malformations, multiple cutaneous and mucosal, 600195 (3)	TEK	TEK, TIE2, VMCM	600221	9p21	Cardiovascular	600195
2847	1557	Venous thrombosis, susceptibility to (3)	SERPINA10	SERPINA10, ZPI	605271	14q32.1	Cardiovascular	
2848	3558	Ventricular fibrillation, idiopathic, 603829 (3)	SCN5A	SCN5A, LQT3, IVF, HB1, SSS1	600163	3p21	Cardiovascular	603829
2849	1558	Ventricular tachycardia, idiopathic, 192605 (3)	GNAI2	GNAI2, GNAI2B, GIP	139360	3p21	Cardiovascular	192605
2850	1558	Ventricular tachycardia, stress-induced polymorphic, 604772 (3)	CASQ2	CASQ2	114251	1p13.3-p11	Cardiovascular	604772
2851	1558	Ventricular tachycardia, stress-induced polymorphic, 604772 (3)	RYR2	RYR2, VTSIP	180902	1q42.1-q43	Cardiovascular	604772
2852	1559	Vertical talus, congenital, 192950 (3)	HOXD10	HOXD10, HOX4D	142984	2q31-q32	Skeletal	192950
2853	1562	Viral infections, recurrent (3)	FCGR3A	FCGR3A, CD16, IGFR3	146740	1q23	Immunological	
2854	1562	Viral infection, susceptibility to (3)	OAS1	OAS1, OIAS	164350	12q24.2	Immunological	
2855	1563	Virilization, maternal and fetal, from placental aromatase deficiency (3)	CYP19A1	CYP19A1, CYP19, ARO	107910	15q21.1	Developmental	
2856	1565	Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3)	VKORC1	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	Hematological	607473
2857	1565	Vitamin K-dependent coagulation defect, 277450 (3)	GGCX	GGCX	137167	2p12	Hematological	277450
2858	1566	Vitelliform macular dystrophy, adult-onset, 608161 (3)	VMD2	VMD2	607854	11q13	Ophthamological	608161
2859	1570	VLCAD deficiency, 201475 (3)	ACADVL	ACADVL, VLCAD	609575	17p13	Metabolic	201475
2860	1571	Vohwinkel syndrome, 124500 (3)	GJB2	GJB2, CX26, DFNB1, PPK, DFNA3, KID, HID	121011	13q11-q12	multiple	124500
2861	1571	Vohwinkel syndrome with ichthyosis, 604117 (3)	LOR	LOR	152445	1q21	multiple	604117
2862	1572	von Hippel-Lindau disease, modification of, 193300 (3)	CCND1	CCND1, PRAD1, BCL1	168461	11q13	Cancer	193300
2863	1572	von Hippel-Lindau syndrome, 193300 (3)	VHL	VHL	608537	3p26-p25	Cancer	193300
2864	3572	von Willebrand disease (3)	VWF	VWF, F8VWF	193400	12p13.3	Hematological	
2865	1573	Waardenburg-Shah syndrome, 277580 (3)	EDNRB	EDNRB, HSCR2, ABCDS	131244	13q22	multiple	277580
2866	1573	Waardenburg-Shah syndrome, 277580 (3)	SOX10	SOX10, WS4	602229	22q13	multiple	277580
2867	1574	Waardenburg syndrome/albinism, digenic, 103470 (3)	TYR	TYR	606933	11q14-q21	multiple	103470
2868	1574	Waardenburg syndrome/ocular albinism, digenic, 103470 (3)	MITF	MITF, WS2A	156845	3p14.1-p12.3	multiple	103470
2869	1574	Waardenburg syndrome, type I, 193500 (3)	PAX3	PAX3, WS1, HUP2, CDHS	606597	2q35	multiple	193500
2870	1574	Waardenburg syndrome, type IIA, 193510 (3)	MITF	MITF, WS2A	156845	3p14.1-p12.3	multiple	193510
2871	1574	Waardenburg syndrome, type III, 148820 (3)	PAX3	PAX3, WS1, HUP2, CDHS	606597	2q35	multiple	148820
2872	1574	Waardenburg syndrome, typ IID, 608890 (3)	SNAI2	SNAI2, SLUG, WS2D	602150	8q11	multiple	608890
2873	1575	Wagner syndrome, 143200 (3)	COL2A1	COL2A1	120140	12q13.11-q13.2	Ophthamological	143200
2874	1576	WAGR syndrome, 194072 (3)	WT1	WT1	607102	11p13	multiple	194072
2875	1578	Walker-Warburg syndrome, 236670 (3)	FCMD	FCMD	607440	9q31	multiple	236670
2876	1578	Walker-Warburg syndrome, 236670 (3)	POMT1	POMT1	607423	9q34.1	multiple	236670
2877	1578	Warburg micro syndrome 1, 600118 (3)	RAB3GAP	RAB3GAP, WARBM1, P130	602536	2q21.3	multiple	600118
2878	1580	Warfarin resistance, 122700 (3)	VKORC1	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	Hematological	122700
2879	1580	Warfarin sensitivity, 122700 (3)	CYP2C9	CYP2C9	601130	10q24	Hematological	122700
2880	1580	Warfarin sensitivity (3)	F9	F9, HEMB	306900	Xq27.1-q27.2	Hematological	
2881	1581	Watson syndrome, 193520 (3)	NF1	NF1, VRNF, WSS, NFNS	162200	17q11.2	Cancer	193520
2882	1582	Weaver syndrome, 277590 (3)	NSD1	NSD1, ARA267, STO	606681	5q35	Developmental	277590
2883	1583	Wegener-like granulomatosis (3)	TAP2	TAP2, ABCB3, PSF2, RING11	170261	6p21.3	Immunological	
2884	1585	Weill-Marchesani syndrome, dominant, 608328 (3)	FBN1	FBN1, MFS1, WMS	134797	15q21.1	Connective tissue	608328
2885	1585	Weill-Marchesani syndrome, recessive, 277600 (3)	ADAMTS10	ADAMTS10, WMS	608990	19p13.3-p13.2	Connective tissue	277600
2886	1586	Weissenbacher-Zweymuller syndrome, 277610 (3)	COL11A2	COL11A2, STL3, DFNA13	120290	6p21.3	Connective tissue	277610
2887	1588	Werner syndrome, 277700 (3)	RECQL2	RECQL2, RECQ3, WRN	604611	8p12-p11.2	multiple	277700
2888	1589	Wernicke-Korsakoff syndrome, susceptibility to, 277730 (3)	TKT	TKT	606781	3p14.3	Metabolic	277730
2889	1590	Weyers acrodental dysostosis, 193530 (3)	EVC	EVC	604831	4p16	Skeletal	193530
2890	1591	WHIM syndrome, 193670 (3)	CXCR4	CXCR4, D2S201E, NPY3R, WHIM	162643	2q21	Immunological	193670
2891	1592	White sponge nevus, 193900 (3)	KRT13	KRT13	148065	17q21-q22	Connective tissue	193900
2892	1592	White sponge nevus, 193900 (3)	KRT4	KRT4, CYK4	123940	12q13	Connective tissue	193900
2893	1594	Williams-Beuren syndrome, 194050 (3)	ELN	ELN	130160	7q11.2	multiple	194050
2894	1595	Wilms tumor, 194070 (3)	BRCA2	BRCA2, FANCD1	600185	13q12.3	Cancer	194070
2895	1595	Wilms tumor, somatic, 194070 (3)	GPC3	GPC3, SDYS, SGBS1	300037	Xq26	Cancer	194070
2896	1595	Wilms tumor susceptibility-5, 601583 (3)	POU6F2	POU6F2, WTSL, WT5	609062	7p14-p13	Cancer	601583
2897	1595	Wilms tumor, type 1, 194070 (3)	WT1	WT1	607102	11p13	Cancer	194070
2898	1596	Wilson disease, 277900 (3)	ATP7B	ATP7B, WND	606882	13q14.3-q21.1	Metabolic	277900
2899	1598	Wiskott-Aldrich syndrome, 301000 (3)	WAS	WAS, IMD2, THC	300392	Xp11.23-p11.22	Immunological	301000
2900	1599	Witkop syndrome, 189500 (3)	MSX1	MSX1, HOX7, HYD1, OFC5	142983	4p16.1	Developmental	189500
2901	1600	Wolcott-Rallison syndrome, 226980 (3)	EIF2AK3	EIF2AK3, PEK, PERK, WRS	604032	2p12	Bone	226980
2902	1601	Wolff-Parkinson-White syndrome, 194200 (3)	PRKAG2	PRKAG2, WPWS	602743	7q36	Cardiovascular	194200
2903	1603	Wolfram syndrome, 222300 (3)	WFS1	WFS1, WFRS, WFS, DFNA6	606201	4p16.1	Metabolic	222300
2904	1604	Wolman disease (3)	LIPA	LIPA	278000	10q24-q25	Metabolic	
2905	1607	Xanthinuria, type I, 278300 (3)	XDH	XDH	607633	2p23-p22	Metabolic	278300
2906	1608	Xeroderma pigmentosum, group A (3)	XPA	XPA	278700	9q22.3	Dermatological	
2907	1608	Xeroderma pigmentosum, group B (3)	ERCC3	ERCC3, XPB	133510	2q21	Dermatological	
2908	1608	Xeroderma pigmentosum, group C (3)	XPC	XPC, XPCC	278720	3p25	Dermatological	
2909	1608	Xeroderma pigmentosum, group D, 278730 (3)	ERCC2	ERCC2, EM9	126340	19q13.2-q13.3	Dermatological	278730
2910	1608	Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)	DDB2	DDB2	600811	11p12-p11	Dermatological	278740
2911	1608	Xeroderma pigmentosum, group F, 278760 (3)	ERCC4	ERCC4, XPF	133520	16p13.3-p13.13	Dermatological	278760
2912	1608	Xeroderma pigmentosum, group G, 278780 (3)	ERCC5	ERCC5, XPG	133530	13q33	Dermatological	278780
2913	1608	Xeroderma pigmentosum, variant type, 278750 (3)	POLH	POLH, XPV	603968	6p21.1-p12	Dermatological	278750
2914	1610	X-inactivation, familial skewed, 300087 (3)	XIC	XIC, XCE, XIST, SXI1	314670	Xq13.2	Unclassified	300087
2915	1611	XLA and isolated growth hormone deficiency, 307200 (3)	BTK	BTK, AGMX1, IMD1, XLA, AT	300300	Xq21.3-q22	Immunological	307200
2916	1613	Yellow nail syndrome, 153300 (3)	FOXC2	FOXC2, FKHL14, MFH1	602402	16q24.3	Immunological	153300
2917	1614	Yemenite deaf-blind hypopigmentation syndrome, 601706 (3)	SOX10	SOX10, WS4	602229	22q13	multiple	601706
2918	1615	Zellweger syndrome-1, 214100 (3)	PEX1	PEX1, ZWS1	602136	7q21-q22	multiple	214100
2919	1615	Zellweger syndrome, 214100 (3)	PEX10	PEX10, NALD	602859	Chr.1	multiple	214100
2920	1615	Zellweger syndrome, 214100 (3)	PEX13	PEX13, ZWS, NALD	601789	2p15	multiple	214100
2921	1615	Zellweger syndrome, 214100 (3)	PEX14	PEX14	601791	1p36.2	multiple	214100
2922	1615	Zellweger syndrome, 214100 (3)	PEX26	PEX26	608666	22q11.21	multiple	214100
2923	1615	Zellweger syndrome, 214100 (3)	PXF	PXF, HK33, D1S2223E, PEX19	600279	1q22	multiple	214100
2924	1615	Zellweger syndrome, 214100 (3)	PXR1	PXR1, PEX5, PTS1R	600414	12p13.3	multiple	214100
2925	1615	Zellweger syndrome-2 (3)	ABCD3	ABCD3, PXMP1, PMP70	170995	1p22-p21	multiple	
2926	1615	Zellweger syndrome-3 (3)	PXMP3	PXMP3, PAF1, PMP35, PEX2	170993	8q21.1	multiple	
2927	1615	Zellweger syndrome, complementation group 9 (3)	PEX16	PEX16	603360	11p12-p11.2	multiple	9
2928	1615	Zellweger syndrome, complementation group G, 214100 (3)	PEX3	PEX3	603164	6q23-q24	multiple	214100
2929	1617	Zlotogora-Ogur syndrome, 225000 (3)	HVEC	HVEC, PVRL1, PVRR1, PRR1	600644	11q23-q24	multiple	225000
